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1. Introduction 
1.1  History of Organocatalysis 
Organocatalysis is a subtopic of organic chemistry dealing with chemical transformations 
enabled by small organic molecules, the so called organocatalysts. In this regard, 
organocatalysis should be clearly distinguished from biocatalysis, as the latter one makes use 
of significantly more complex organic biomacromolecules such as e.g. enzymes. Despite its 
very rich history going back to the 19th century, organocatalysis has remained a neglected field 
of organic chemistry for a very long time. Perhaps, it was overseen due to the blossom of 
transition metal catalysis. Started in the second half of the last century, catalysis with transition 
metals has become a major domain of chemical research: It has provided solid ground for 
innumerable types of transformations which also include methods for enantioselective 
synthesis. Asymmetric organocatalysis, on the other hand, has enjoyed an explosive interest in 
the scientific community only in the 21st century. Today this discipline has become of 
comparable significance to transition metal catalysis and biocatalysis.  
From a historical perspective, catalysis with small organic molecules was discovered during the 
early age of organic chemistry. The first important contribution in this field is attributed to the 
German chemists Justus von Liebig and Friedrich Wöhler who isolated benzoin (2) during their 
studies on bitter almond oil in 1832 (Scheme 1a). Benzaldehyde (1a), the main component of 
bitter almond oil, was converted to 2 upon treatment with potassium hydroxide solution.[1] 
Several years later, Russian chemist Nikolay Zinin showed that the actual reaction catalyst was 
not the anticipated potassium hydroxide, but potassium cyanide: It was formed from hydrogen 
cyanide, another component of the bitter almond oil and major impurity present in 1a, upon 
basification of the reaction mixture.[2] Moreover, Zinin developed the first practical version of 
the benzoin reaction by simply adding catalytic amounts of potassium cyanide to benzaldehyde 
(1a).[2] 
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Scheme 1: The first known organocatalytic reactions: (a) Benzoin reaction; (b) oxamide (4) synthesis by 
hydrolysis of dicyan (3). 
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The hydrolysis of dicyan (3) to oxamide (4) in the presence of acetaldehyde is another early 
example of organocatalysis (Scheme 1b).[3] This reaction was discovered in 1860 by Liebig and 
was later used as a basis for industrial oxamide production by Degussa.[4] 
As the 20th century began, a milestone of asymmetric organocatalysis was reached for the first 
time. Pioneering work in this direction was made by Georg Bredig: He used either nicotine or 
quinidine for the kinetic resolution of racemic camphorcarboxylic acid by thermal 
decarboxylation.[5] Very soon, Bredig also carried out the first organocatalytic enantioselective 
C-C bond forming reaction.[6] He used (–)-quinine or (+)-quinidine to promote the cyanohydrin 
reaction between benzaldehyde (1a) and hydrogen cyanide leading to the formation of 
enantioenriched mandelonitrile (5) (Scheme 2). 
 
Scheme 2: The first asymmetric cyanodydrin reaction reported by Bredig.[6] 
Although the work of Bredig is regarded as a key event in asymmetric catalysis, it had little 
practical significance due to the poor enantioselectivities achieved. In fact, the ee values of 
synthesized mandelonitrile did not exceed 10% in that early study. In this respect, the proline 
(7a) mediated Robinson annulation is considered as another turning point in organocatalysis. It 
was discovered in the laboratories of Hoffmann-La Roche[7] and Schering AG[8] in the early 
1970’s and named after its principal investigators (Scheme 3). The so called Hajos-Parrish-
Eder-Sauer-Wiechert-reaction enabled asymmetric synthesis of diketoalcohol 8 and the 
Wieland-Mieschner ketone (9) from prochiral triketone 6 in excellent yields and 
enantioselectivities. Despite the tremendous importance of 9 as an intermediate for the synthesis 
of steroid derivatives with potential applications in medicine,[9] the idea of using proline as a 
catalyst did not receive much credit until the end of the century. 
 
 
Scheme 3: Hajos-Parrish-Eder-Sauer-Wiechert-reaction and subsequent elimination leading to the asymmetric 
synthesis of the Wieland-Mieschner ketone (9). 
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Things changed dramatically at the turn of the 21st century when List et al. published the first 
example of an intermolecular proline catalyzed asymmetric aldol reaction (Scheme 4).[10] It was 
predominantly inspired by the works of Sauer, Eder, Wiechert, Hajos and Parrish, whereas its 
mechanistic rationale was based on the enamine-model introduced by Agami in 1986.[11] The 
new method enabled simple access to aldol adducts between acetone (10) and various aldehydes 
1 in high yields and enantioselectivities. It still remains a mystery, why the concept of enamine 
organocatalysis escaped the imagination of several generations of synthetic chemists even 
though some prominently similar works on enamine chemistry were published by Gilbert Stork 
in the 1950’s and 1960’s.[12] 
 
Scheme 4: The first intermolecular proline catalyzed aldol reaction reported by List et al..[10] 
Catalysis with chiral secondary amines received another powerful impulse as the group of 
David McMillan reported the first organocatalytic Diels-Alder reaction (Scheme 5).[13] The 
catalyst 14, a cyclic derivative of phenylalanine, formed an iminium intermediate with a variety 
of dienophile substrates 12. Thus, LUMO-activation is achieved, leading to enhanced reactivity 
towards cyclopentadiene (13). 
 
Scheme 5: Enantioselective organocatalytic Diels-Alder reaction reported by McMillan et al..[13] 
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The introduction of enamine and iminium activation modes in the year 2000 is regarded as the 
starting point of modern asymmetric organocatalysis. These two reports received a great 
resonance in the scientific community and provided a fruitful soil for innumerous 
investigations.[14] One of the more recent landmarks demonstrating the immense synthetic 
potential associated with asymmetric amine organocatalysis is the discovery of an 
organocatalytic triple cascade by the group of Dieter Enders (Scheme 6).[15] Careful choice of 
substrates led to sequential coupling of three reactants in the presence of the Jørgensen-Hayashi 
catalyst (7b) enabling the synthesis of complex carbocyclic products 22. A one-pot sequence 
of enamine / iminium / enamine activation modes enabled the formation of three C-C bonds 
and generation of three stereogenic centers. As a result, the final products were obtained in 
excellent enantio- and diastereoselectivities. 
 
Scheme 6: Organocatalytic triple cascade reported by Enders et al..[15] 
 
1.2  Types of Organocatalysts 
Organocatalysts can be classified depending on their chemical properties leading to different 
modes of interaction with substrates. In a very general sense, it can be distinguished between 
basic and acidic organocatalysts (Scheme 7). Basic organocatalysts can be further subdivided 
into Lewis and Brønsted bases. Lewis bases are the only type of catalysts which activate the 
substrate by forming covalent bonds. For instance, the above mentioned proline derived 
    
 
 
 
5 
 
secondary amines provide activation of carbonyl compounds through the formation of enamine 
or iminium intermediates.[16] Other Lewis bases such as phosphines have found broad 
application for various types of Morita-Baylis-Hillman and umpolung reactions.[17]  
All other types of organocatalysts activate substrates by non-covalent interactions such as 
hydrogen bonding or ion pair interactions. Brønsted bases (e.g. guanidines[18] and 
phosphazenes[19]) are usually used to activate prochiral acidic substrates by proton abstraction, 
leading to the formation of reactive ion pairs. This chemistry represents a rich field of study in 
regard to different sorts of addition reactions (e.g. Aldol, Mannich and Michael reactions). 
Lewis acid organocatalysis represents a very unusual research area, since this mode of 
activation has become a classical domain of catalysis with transition metals. Studies in this area 
have led to the development of carbocation-[20a] or silyl cation-based[20b] catalysts. These metal-
free Lewis acids have found applications in catalyzing various types of Diels-Alder, Mukayama 
aldol and Michael reactions.  
Organic Brønsted acids represent the last subdivision of catalysts. Phosphoric acids,[21] for 
instance, are used for the activation of basic substrates by protonation. The use of chiral 
phosphoric acids also enables stereochemical induction by formation of ion pairs between chiral 
phosphate anions and positively charged prochiral protonated substrates. Thioureas[22] and 
squaramides,[23] owing to their comparatively low Brønsted acidity, activate substrates by 
enhancing their electrophilicity through hydrogen bond interactions. 
 
Scheme 7: Various types of organocatalysts.
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1.3  Guanidine Organocatalysis 
1.3.1  Guanidines as Brønsted Base Organocatalysts 
Today, the application of guanidines in organocatalysis is mainly limited to their use as 
Brønsted bases. The reactions which they catalyze can be generalized according to the 
mechanism presented in Scheme 8. At first, guanidine base 23 deprotonates a pronucleophilic 
substrate AH to generate a salt 23-AH consisting of guanidinium cation and a nucleophilic 
anion A−. The guanidinium cation, being a good hydrogen-bond donor, enables precoordination 
of electrophile B and subsequent nucleophilic addition of A−. Protonation of anionic 
intermediate A-B− gives the final product A-BH and liberates the active guanidine catalyst 23.  
 
Scheme 8: A general mechanistic rationale representing the Brønsted base guanidine organocatalytic cycle. 
An important step towards the development of asymmetric guanidine organocatalysis was the 
isolation and crystallographic characterization of complex 26 between α-nitrotoluene (25) and 
1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD, 24) by Davis and Wynberg (Scheme 9).[24] Based on 
their studies about the structure of 26, they suggested that the nitronate anion could add to 
various electrophiles in an asymmetric fashion, if chiral derivatives of TBD (24) were used. 
Further efforts by Wynberg et al. to develop a catalytic nitro-Michael reaction led to some 
disappointing results, as no chiral induction could be achieved. This failure was attributed to  
the overly high Brønsted basicity of the employed chiral TBD derivatives, which led to 
racemization of the formed nitro-Michael products.[25] 
 
Scheme 9: Formation of complex 26 from 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD, 24)  
and α-nitrotoluene (25). 
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One of the first asymmetric guanidine-catalyzed transformations was reported by Najera and 
coworkers (Scheme 10).[26] They realized an enantioselective Henry-reaction by using acyclic 
chiral guanidine 28. After subsequent reduction of the products 29, α-aminoalcohols 30 were 
obtained in moderate enantioselectivities. 
 
Scheme 10: Asymmetric Henry-reactions catalyzed by guanidine 28. 
Although some more efforts were dedicated to the development of enantioselective addition 
reactions employing chiral guanidines, there was not much progress in the following several 
years.[27] The real breakthrough was achieved by Corey et al. in 1999, who developed a catalyst 
31b, which is a C2-symmetric chiral derivative of 1,4,6-triazabicyclo[3.3.0]oct-4-ene (TBO, 
31a) (Scheme 11).[28] 
 
Scheme 11: Structures of TBO (31a)-based chiral bicyclic guanidines 31b and 31c. 
The new guanidine was employed for asymmetric Strecker-reaction of N-benzhydryl imines 32 
and gave the final products 33 in excellent yields and enantioselectivities of up to 99% (Scheme 
12). The asymmetric induction of this reaction arose from the hydrogen bond mediated 
coordination of both the cyanide anion and the imine to the protonated chiral catalyst 31b. 
Despite the very promising results obtained in the group of Corey, this was the only example 
of a successful application of the new catalyst.[29]  
Guanidine organocatalysis has profited from another TBO-based guanidine which was 
synthesized in the group of Tan in 2006.[30] Catalyst 31c was reported to be prepared by a novel 
 
Scheme 12: Asymmetric Strecker reactions catalyzed by guanidine 31b. 
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route in only five synthetic steps from commercially available chiral precursors. This can be 
considered as a great advancement, since the synthesis of 31b by Corey et al. consisted of a 
nine-step reaction sequence which employed elaborate manipulations of functional groups. 
Since then, 31c has become one of the most successful guanidine organocatalysts and has been 
employed in a great variety of asymmetric reactions enabling access to chiral products in 
excellent enantioselectivities. Although the majority of reported transformations can be 
rationalized according to the general mechanism shown in Scheme 8 and represent various 
types of addition reactions, 31c is also an excellent catalyst for asymmetric isomerizations[31] 
and protonations.[32] 
For instance, catalyst 31c was successfully employed in enantioselective isomerization 
reactions of alkynoate esters 34 to allenoates 35 (Scheme 13).[31] Owing to the fact that alkyne 
substrates could be easily prepared by a known procedure,[33] the new method allowed for a 
very simple access to chiral allenoates in excellent enantioselectivities. Efficient transfer of 
axial chirality was achieved when the obtained products were further utilized in several follow-
up transformations such as Diels-Alder reaction as well as NIS (N-iodosuccinimide) or 
transition metal mediated cyclizations. It is noteworthy to mention that Tan’s group also 
demonstrated a great potential for the development of novel asymmetric domino reactions: In 
a more recent work the concept of enantioselective isomerization of alkynes was complemented 
by intramolecular aza- and oxa-Michael additions enabling syntheses of various 
heterocycles.[34]  
 
Scheme 13: Asymmetric isomerization reaction of alkynoate ester 34 to allenoate 35 followed by  
Diels-Alder reaction. 
Furthermore, an elegant approach for the stereoselective synthesis of α- and β-amino acid 
derivatives was developed in the same research group (Scheme 14).[35] Guanidine 31c catalyzed 
enantioselective Mannich and amination reactions starting from malonic acid half thioesters 37. 
Mechanistic studies and DFT-calculations showed that 37 initially added to an electrophile 
(aromatic tosylimine or diethyl azodicarboxylate). The final products 38 and 39 were obtained 
after a subsequent decarboxylation step. 
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Scheme 14: Asymmetric decarboxylative Mannich and amination reactions catalyzed by bicyclic guanidine 31c. 
Among other recent applications of catalyst 31c, a γ-amination of β,γ-unsaturated thioesters 40 
with azodicarboxylate 41 should be mentioned (Scheme 15).[36] The γ-amino acid derivatives 
42 were formed via dienolate intermediates resulting from α-deprotonation of 40. Although 
formation of products of both α- and γ-amination was expected, only the latter regioisomer was 
obtained. Moreover, both enantiomers of 42 could be obtained in high ee’s and yields by merely 
choosing E- or Z- configured thioesters 40 as substrates. 
 
Scheme 15: Asymmetric γ-amination reaction catalyzed by bicyclic guanidine 31c. 
It is quite possible that the stereoselectivity of Tan’s catalyst 31c in so many reactions stems 
from the high rigidity of the TBO-scaffold which enables the formation of stereodefined 
transition states.[18a] In fact, this also explains the rather modest enantioselectivities of the 
transformations catalyzed by acyclic chiral guanidines. Although the latter are synthetically 
easily accessible, such catalysts cannot provide sufficient stereoinduction due to conformational 
flexibility. In some cases, however, enantioselective reactions were successfully developed 
without using chiral bicyclic guanidines. For instance, catalyst 44, which was reported by 
Terada et al., is an acyclic guanidine attached to a chiral binaphthyl moiety (Scheme 16).[37] 
High conformational rigidity of the catalyst is achieved by placing the guanidine functionality 
between very bulky aryl groups. In α-aminations of cyclic ketoesters 43, it did not only provide 
prominent selectivity, but also showed an exceptionally high activity, as the product 45 was 
obtained in quantitative yield with only 0.05 mol% catalyst in 4 h at –40 °C. 
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Scheme 16: Asymmetric α-amination reaction catalyzed by guanidine 44. 
A similar concept was also successfully applied for the design of the binaphthyl-based 
guanidine 47 (Scheme 17).[38] This catalyst possesses a monocyclic structure with the guanidine 
moiety embedded into a 9-membered ring. The steric bulk of two phenyl groups and the 
benzhydryl rest R on the terminal nitrogen atom provide for sufficient fixation of the 
conformation. Guanidine 47 was used as a catalyst for an enantioselective conjugate addition 
reaction of 1,3-dicarbonyl compounds to nitroalkenes leading to products 48. 
 
Scheme 17: Asymmetric nitro-Michael reaction catalyzed by guanidine 47. 
Guanidines 51a and 51b were developed in the group of Ishikawa and represent a good example 
of bifunctional organocatalysts (Scheme 18). They are constituted of a monocyclic guanidine 
scaffold and incorporate a hydroxyl-group attached to the core structure by a branched alkyl 
chain. Catalyst 51a was employed for Michael additions of glycinate 49 to various  
α,β-unsaturated carbonyl compounds and gave access to glutamic acid derivatives 52 with 
enantioselectivities higher than 90% in most cases.[39] The reaction was carried out under 
solvent free conditions and went to completion after 3 d. Related guanidine 51b catalyzed an 
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intramolecular oxa-Michael reaction of phenol 53. The use of the Z-configured substrate was 
prerequisite to achieve reasonable enantioselectivities and it was converted to chromane 54 in 
ee’s up to 76%.[40] It should be noted that the hydroxy-group is vital for the catalyst activity, as 
it stabilizes the transition states by forming an additional hydrogen-bond. Consequently, other 
Brønsted bases and related guanidines lacking the hydroxy-group were less effective or failed 
to catalyze these reactions. Furthermore, relative configurations of all three chiral centers 
present in 51a and 51b are important, since the enantioselectivities decreased dramatically 
when other diastereoisomeric catalysts were used. 
 
Scheme 18: Asymmetric conjugate additions catalyzed by bifunctional guanidine organocatalysts 51a and 51b. 
In fact, the concept of multifunctional guanidine organocatalysis has become more widespread 
in recent years. For instance, the most successful catalysts originate from unifying guanidines 
with thioureas[41] and amides.[42] Furthermore, there are examples of merging guanidines with 
chiral amines[43] and tertiary alcohols.[44] These trends clearly show that novel chiral guanidines 
do not always have to be contrived de novo, but can also adopt structural features known in 
other areas of organocatalysis. 
1.3.2  Guanidinium Salts as Hydrogen Bond Donor Organocatalysts 
Guanidinium cations are formed by protonation of neutral guanidines and can act as bidentate 
hydrogen bond donors. In nature, arginine side chains are known to act as receptors for the 
selective recognition of carboxylate and phosphate groups.[45] This property of guanidinium 
salts has been extensively studied and implemented in the area of molecular recognition leading 
to the development of artificial binding groups for various anions.[46] Despite the widespread 
use of ureas, thioureas and squaramides as hydrogen-bond donor catalysts, there are, however, 
only few examples of organocatalysis with guanidinium salts. 
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The most important contribution in this area comes from Jacobsen et al., who used chiral 
guanidinium salt 56 for the enantioselective Claisen rearrangement of allyl vinyl ethers 55 
(Scheme 19).[47] Whereas conventional hydrogen bond donors such as ureas and thioureas did 
not show high activity, using 56 as a catalyst led to a significant acceleration of reaction rate. 
Hexane was the optimal solvent enabling product formation in high ee’s and yields, despite the 
fact that 56 was insoluble in this medium. Moreover, the nature of the anion played a crucial 
role for the catalyst activity and the best results were obtained with non-coordinating tetraaryl 
borate counterions. 
 
Scheme 19: Asymmetric Claisen rearrangement of allyl vinyl ethers 55 catalyzed by guanidinium salt 56.  
This concept was also applied for Claisen-rearrangements of O-allyl β-ketoesters 58 to  
α-allylated β-ketoesters 59 with a high degree of enantio- and diastereoselectivity (Scheme 
20).[48] The reaction showed a very broad scope with respect to ketoesters and, more 
importantly, substituents on the allylic rests, which enabled simple access to products bearing 
two contiguous quaternary stereogenic centers. The synthetic utility of this method was 
demonstrated by the concise synthesis of the core structure of the antidepressant phytochemical 
hyperforin. 
 
Scheme 20: Asymmetric Claisen rearrangement of O-allyl β-ketoesters 58 catalyzed by guanidinium salt 56. 
Another useful application of guanidinium salts was found in the research group of del Amo.[49] 
Tetrafluoroborate salt 61 in combination with L-proline (7a) enabled aldol reactions between 
chloroacetone (60) and aromatic aldehydes 1 (Scheme 21). Chiral chlorohydrins 62, which are 
not easily accessible by known methods, were obtained in good yields and exceptionally high 
enantioselectivities. Upon treatment with NEt3, the reaction products 62 could be further 
converted to chiral epoxides.  
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Scheme 21: Asymmetric aldol reaction leading to chiral chlorohydrins 62. The use of guanidinium 
tetrafluoroborate salt 61 is prerequisite for achieving high regio- and stereoselectivities in this reaction. 
1.3.3  Guanidines as Lewis Base Organocatalysts 
Applications of guanidines in organic chemistry are mainly limited to their use as organic 
Brønsted superbases. These molecules possess very high pKa values {guanidine (63) pKa[H2O] 
= 13.6;[50] TBD (24) pKa[MeCN] = 28.0[51]} and were considered as the strongest organic bases 
until “proton sponges” were synthesized.[52] The Lewis basicity of guanidines, on the other 
hand, remains a rather neglected topic and to date there are only few reports dealing with this 
matter.[53] 
 
Scheme 22: Structure of guanidine. 
The first synthesis of guanidine (63, Scheme 22) was carried out by Adolph Strecker, who 
obtained it by oxidative degradation of guanine.[54] Interestingly enough, this seminal scientific 
work about guanidines also contains an observation of their Lewis basicity: It was noted that 
guanidine (63) readily formed a carbonate salt upon air exposure. The same statement can also 
be encountered in the publication on the first synthesis of TBD (24) by Arthur Ferguson 
McKay.[55] Since then, the ability of diverse nitrogen Lewis bases to react with carbon dioxide 
has been employed for CO2 fixation.[56] In this regard, guanidines and amidines are especially 
active nucleophilic bases.[57] They react with carbon dioxide and form carbamate complexes 64 
which can act as transacylating reagents and transfer CO2 to other reaction partners (Scheme 
23).[58] Although this concept has been applied for many years, the first X-ray structure of a 
CO2-guanidine complex 64 was obtained only several years ago.[59] 
 
Scheme 23: Reversible addition of TBD (24) to carbon dioxide. Resulting carbamate intermediate 64 can further 
react with various nucleophiles. 
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Carbon dioxide is a very attractive C-1 building block which is present in the atmosphere. New 
ways for its fixation would lead not only to economical benefits, but also allow to use it as a 
substitute for toxic phosgene in many industrial processes. McGee et al. showed that CO2 
reacted with amines 65 and benzyl chloride (66) to give carbamates 68 in the presence of 
stoichiometric amounts of various bases (Scheme 24).[60] Among tested structures,  
N-cyclohexyl-1,1,3,3-tetramethylguanidine (67) gave the best results in terms of selectivities 
and yields. 
 
Scheme 24: Synthesis of carbamates 68 by guanidine mediated CO2 fixation. 
TBD (24) was used by Waymouth et al. for ring opening polymerization reactions of cyclic 
esters 69 (Scheme 25).[61] The very high activity of guanidine 24 was assigned to its ability to 
catalyze acyl transfer reactions as well as being a powerful hydrogen-bond donor. Taking into 
account the high Brønsted basicity of TBD, an alternative mechanism by deprotonation and 
activation of the alcohol for nucleophilic ring-opening of lactones was also considered. 
However, the latter mechanism was ruled out, as 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene 
(MTBD, 71), despite its similar Brønsted basicity, showed vastly inferior activity. 
 
Scheme 25: TBD (24) catalyzed ring-opening polymerization of δ-valerolactone (69). 
The same group used TBD (24) as a highly active acyl transfer catalyst for the synthesis of 
amides 74 from esters 72 and primary amines 73 (Scheme 26).[62] Related guanidine TBO (31a),  
 
Scheme 26: Synthesis of amides 74 by acyl transfer reaction catalyzed by TBD (24). 
    
 
 
 
15 
 
however, showed significantly lower activity which was ascribed to its lower nucleophilicity 
and Brønsted basicity compared to TBD. 
The nucleophilicity of a series of guanidines was recently quantified in the group of Herbert  
Mayr (Scheme 27).[63] Among the investigated structures, TBD (24) was by far the most 
powerful nucleophile. Interestingly, TBD was shown to be even more nucleophilic than such 
well known Lewis bases as 4-dimethylaminopyridine (DMAP, 76) and triphenylphosphine 
(78). This study also correlates the structure of guanidines with their nucleophilicity: Bicyclic 
guanidines containing at least one 6-membered ring were significantly more nucleophilic than 
their acyclic and monocyclic counterparts.  
 
Scheme 27: Mayr’s scale showing the relative nucleophilicities of guanidines.[63] 
Here, it should be pointed out that successful Lewis base organocatalysis relies not only on 
nucleophilicity, but also Lewis basicity of a catalyst. Although these two terms are often used 
as synonyms, nucleophilicity describes relative rate constants for reactions of different 
nucleophilic species with a common electrophilic substrate and represents a merely kinetic 
term.[64] Lewis basicity, on the other hand, is a thermodynamic term and compares equilibrium 
constants for the addition of different Lewis bases to a reference Lewis acid.[64] Successful 
organocatalysts arise from the synergy of Lewis basicity and nucleophilicity: Overly high Lewis 
basicity results in poisoning of the catalyst which forms stable adducts with the substrates, 
whereas low Lewis basicity leads to insufficient stability of the active intermediates which 
preferentially dissociate to starting molecules and catalyst. Relative Lewis basicities have not 
been determined for guanidine bases yet. It can, however, be anticipated that guanidines should 
be strong Lewis bases (Scheme 28).[18a][65] By reacting with electriphiles E+, guanidines form 
complexes 24-E` which are stabilized by efficient delocalization of the positive charge. Thus, 
the high stability of the guanidinium cation does not only explain the high Brønsted basicity of 
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guanidines (for the case when E+ = H+), but can also justify their high Lewis basicity. 
Furthermore, intermediate 24-E` can form a neutral tautomer 24-E`` which would further 
contribute to a high thermodynamic stability of the formed complex by eliminating charge 
separation. 
 
Scheme 28: High Lewis basicity of guanidines is anticipated based on their ability to form stabilized adducts 
with electrophiles. 
Despite convincing precedents of high nucleophilicity and Lewis basicity of guanidines, these 
attributes remain overshadowed by their high Brønsted basicity. Nevertheless, possibilities 
associated with guanidine organocatalysis are intriguing: Elaborate implementation of their 
versatile chemical properties can enable orthogonal activation modes of various substrates in a 
one-pot fashion and lead to design of novel cascade reactions.  
1.4  Overview of the Doctoral Thesis 
This doctoral work consists of two major topics:  
a) Methodology (Chapter 2). Bicyclic guanidines were evaluated as Lewis base 
organocatalysts for the activation of allenoate esters. Different reaction pathways were 
studied depending on the types of electrophiles and substitution pattern of allenoates. 
b) Synthesis (Chapter 3). Synthetic studies towards chiral bicyclic guanidinium salts were 
carried out. Owing to great synthetic challenges associated with the synthesis of chiral 
bicyclic guanidines, the goal was to investigate a novel approach towards known 
structures. The new method had to provide a practical and scalable entry to chiral 
catalysts and be experimentally more robust compared to the known methods used 
today. 
1.4.1  Methodology: Guanidines as Multifunctional Organocatalysts 
Bicyclic guanidine MTBD (71) was applied for γ-selective Morita-Baylis-Hillman (MBH)-type 
reaction of α,γ-disubstituted allenoate esters 79 (Scheme 29). Of particular interest was not only 
the substrate scope of the reaction, but also the applicability of the obtained products 80 for the 
syntheses of highly substituted heterocycles. 
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Scheme 29: Synthesis of allenic alcohols 80 by γ-selective MBH-reaction between  
allenoate esters 79 and aldehydes 1. 
TBD (24) was evaluated for its catalytic activity in a [2+2] cycloaddition reaction leading to 
the formation of oxetanes 83 (Scheme 30). Guanidine Lewis base 24 showed a vastly superior 
activity compared to organocatalysts which were previously used for this transformation. 
Furthermore, using PPh3 (78) as a catalyst enabled the synthesis of 83 with inverted 
diastereoselectivity. 
                               
Scheme 30: Synthesis of densely substituted oxetanes from allenoate esters 81 and  
trifluoromethyl-aryl ketones 82. 
4H-1,3-dioxin-6-yl-propanoates 84 were obtained in a TBD-catalyzed reaction sequence 
between allenoate esters 81 and aldehydes 1 (Scheme 31). Preliminary mechanistic 
investigations showed that 84 were formed as products of a four-step reaction cascade. This 
reaction sequence represents the first example of using TBD as a multifunctional organocatalyst 
which acts both as Brønsted and Lewis base. 
                                 
Scheme 31: Reaction between allenoate esters 81 and aldehydes 1 leading to 4H-1,3-dioxin-6-yl-propanoates 84. 
1.4.2  Synthesis of Chiral Bicyclic Guanidinium Salts 
Bicyclic guanidine 31c had previously been reported by Tan et al. (Scheme 32).[30] Within the 
framework of this research work, a new synthetic route to 35c•HCl was investigated with the 
aim to find a simple and practical access to this valuable chiral guanidine. 
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Scheme 32: Attempted synthesis of [3.3.0]-bicyclic guanidinium salt 35c•HCl from corresponding  
α-amino acid 85. 
Furthermore, guanidine 87, which had previously been reported by Davis et al.,[27b] was 
successfully prepared by a new synthetic route (Scheme 33).  
 
Scheme 33: A new synthesis of the bicyclic guanidinium salt 87•HCl was developed. 
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2. Guanidine Catalyzed Nucleophilic Activations of Allenoate Esters 
2.1  γ-Selective Morita–Baylis–Hillman Reactions on α,γ-Dialkyl-Allenoates 
2.1.1  Introduction 
Classical Morita-Baylis-Hillman Reaction 
The Morita-Baylis-Hillman (MBH) reaction is an addition reaction of a carbonyl electrophile 
to the α-position of an alkene bearing an electron-withdrawing group which is catalyzed by a 
Lewis base.[66] It was first described in 1968, as Morita reported coupling of acetaldehyde (89) 
with acrylonitrile (88) in the presence of tricyclohexylphosphine (Scheme 34a).[67] After a 
publication of Baylis and Hillman, in which a related DABCO-catalyzed transformation of 
ethyl acrylate (91) was described (Scheme 34b),[68] this reaction was forgotten for almost 10 
years.  
 
Scheme 34: Pioneering works of Morita (a), and Baylis and Hillman (b) describing the coupling of acetaldehyde 
(89) with activated alkenes. 
For the first time, the synthetic utility of the MBH-reaction was demonstrated by Emslie, who 
applied it for the total synthesis of integerrinecic acid (95) (Scheme 35).[69] Consequently, the 
ever-growing scientific interest to this transformation has resulted in a huge number of 
publications dealing with a variety of aspects such as mechanistic details or synthetic 
applications of the MBH-reaction.[70] This chemical transformation has a great importance to 
synthetic organic chemistry due to several reasons: It is a catalytic and very atom-economic 
process which only requires inexpensive starting materials; it enables the synthesis of densely 
functionalized products which are useful intermediates for the synthesis of natural products and 
heterocycles; in course of the MBH-reaction, a new stereogenic center is formed. 
 
Scheme 35: Total synthesis of integerrinecic acid 95 from intermediate 92 obtained by MBH-reaction. 
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There have been many debates on possible mechanism of the MBH-reaction.[71] Very generally, 
it can be regarded as a three-component reaction.[72] After conjugate addition of the nucleophilic 
catalyst 96 to the activated alkene 97, a zwitterionic enolate intermediate 98 is formed. 
Subsequently, it reacts with an electrophile (e.g. aldehyde 1) to form a zwitterionic aldol 
product 99. After the proton transfer and elimination steps, the final product 101 is formed and 
the catalyst 96 is liberated (Scheme 36).  
 
Scheme 36: General mechanism of the MBH-reaction. 
MBH-Type Reactions of Allenoate Esters 
In contrast to the conventional MBH-reaction between activated alkenes and aldehydes or 
imines, related nitrogen Lewis base catalyzed transformations of allenoate esters have rather 
scarce precedence in the scientific literature. The first coupling of aldehydes to the α-position 
of ethyl butadienoate 102 was realized in the laboratory of Tsuboi (Scheme 37).[73] However, 
there have been no further reports dealing with important aspects of the reaction such as 
substrate scope or stereoselectivity.[74] 
                       
Scheme 37: MBH-reaction of ethyl butadienoate (102). 
Shi et al. discovered that α-substituted allenyl ketones 104 and aromatic aldehydes participated 
in an unprecedented γ-selective MBH-reaction (Scheme 38).[75] This transformation has, 
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however, a very limited substrate scope, as only electron-poor aromatic aldehydes were suitable 
electrophiles and tolerance of substituents on the γ-position of allenyl ketones was not reported. 
Furthermore, the synthetic potential of γ-MBH products was not disclosed, although these 
densely functionalized compounds might undoubtedly be useful substrates for further 
transformations.[76] 
                             
Scheme 38: γ-Selective MBH-reaction on α-substituted allenyl ketones 104. 
The reactivity of allenoate esters with imines has also remained a rather underdeveloped area 
in the field of nucleophilic organocatalysis. The first two systematic investigations were 
independently carried out by Shi and Miller (Scheme 39).[77] The latter reported a detailed study 
dealing with an enantioselective version of this reaction, which was catalyzed by a tetrapeptide 
107 bearing a catalytically active pyridyl-rest. After careful screening of various catalysts, the 
final products 108 were obtained in yields up to 88% and selectivities up to 95:5 e.r.. 
 
Scheme 39: Enantioselective aza-MBH-reaction of allenoate esters 102. 
Unusual MBH-Type Reactions of Allenoates: Phosphine vs. Amine Catalysis 
Regarding activation of allenoate esters by Lewis bases, it plays a crucial role whether nitrogen 
or phosphine nucleophiles are employed as catalysts. In fact, while precedence of amine 
promoted MBH-type reactions of allenoates is very scarce, phosphine-catalyzed activations of 
allenoate esters represent a very active research area in organocatalysis.[78] There is, however, 
a striking difference in reactivity depending on the choice of catalyst. If phosphines are used as 
catalysts, the allenoate esters do not show typical MBH-type reactivity, but participate in 
various cycloaddition reactions leading to carba- or heterocyclic products. 
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Scheme 40: Divergent reactivity of allenoate esters 102 depending on the type of Lewis base catalyst. 
A good example of the divergent reactivity of allenoate esters is the reaction between 
butadienoate 102 and tosylated aldimines 109. Employing DABCO as a catalyst results in the 
direct coupling of the allenoate esters with the imines, i.e. normal aza-MBH-adducts of 
allenoate esters are formed as reaction products 110 (Scheme 40, right).[77a] On the other hand, 
if triphenylphosphine is used as a catalyst, the same starting materials undergo a [3+2] 
cycloaddition to give dihydropyrroles 111 as products (Scheme 40, left).[79] 
This intriguing behavior of phosphine Lewis bases in the activation of allenoates deserves a 
more detailed explanation (Scheme 41).  After the conjugate addition of the phosphine catalyst  
 
Scheme 41: Mechanistic explanation of the divergent reactivity of allenoate esters 102 depending 
 on the type of Lewis base catalyst. 
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to the allenoate ester, a zwitterionic dienolate 114 is formed. Addition of 114 to imine 109 leads 
to intermediate 115. Subsequent intramolecular nucleophilic attack of the amide anion to the  
γ-carbon atom results in the formation of stable ylide 116. Finally, after a 1,2-proton-transfer 
and elimination of phosphine 78, the final product 111 is formed. This reactivity pattern has 
only been encountered with phosphine Lewis bases and can be explained by the high stability 
of phosphorus ylides. On the other hand, due to the inability of nitrogen Lewis bases to form 
stable ylides, amine catalysts such as DABCO enable access to normal aza-MBH-type products 
110.  
Another example of the divergent reactivity of phosphine and nitrogen-Lewis bases was 
demonstrated in the group of Shi (Scheme 42).[75] The reaction between allenyl ketone 104 and 
imine 109 in the presence of catalytic amounts of DMAP (76) resulted in the γ-selective aza-
MBH reaction leading to product 118. Alternatively, an access to tetrahydropyridines 120 was 
achieved when the same starting materials were reacted in the presence of PBu3 (119) as a 
catalyst. In the latter case, the final product was obtained as a result of the addition of two 
equivalents of aldimine 109 to ketone 104. Again, the formation of stabilized ylide 
intermediates played a crucial role in this process.  
 
Scheme 42: Divergent reactivity of allenyl ketones 104 depending on the type of Lewis base catalyst. 
Due to the fact that the majority of phosphine-catalyzed cycloaddition reactions employ  
γ-unsubstituted allenoate esters, the fate of their homologues bearing γ-alkyl groups should be 
commented. A prime example is the [3+2] cycloaddition between ethyl pentadienote (81a) and 
aromatic aldehydes leading to furans 121 (Scheme 43).[80]  
 
Scheme 43: Phosphine catalyzed [3+2] cycloaddition  
between ethyl penta-2,3-dienoate (81a) and aromatic aldehydes 1. 
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After initial conjugate addition of the phosphine catalyst to the allenoate 81a, the resulting 
zwitterionic dienolate 123 undergoes a rapid 1,4-proton transfer leading to phosphinium ylide 
124 (Scheme 44). This species is nucleophilic at the β- and δ-carbon atoms and reacts on its δ-
position with the aldehyde to give intermediate 125. Final ring closing oxa-Michael reaction 
and elimination result in the formation of furan product 121. 
                        
Scheme 44: Mechanism of the phosphine catalyzed [3+2] cycloaddition  
between ethyl pentadienote (81a) and aromatic aldehydes 1. 
In analogy to the above mentioned example, α-alkyl allenoates also tend to undergo multiple 
intramolecular proton transfers leading to stabilizied phosphorus-ylide intermediates. As 
reported by Kwon et al., dihydropyridines 128 were formed as a result of the [4+2] 
cycloaddition between 2-methyl-2,3-butadienoate 127 and tosyl imines 109 in the presence of 
tributyl phosphine (119) (Scheme 45).[81]  
 
Scheme 45: Phosphine catalyzed [4+2] cycloaddition  
between 2-methyl-2,3-butadienoate (127) and tosyl imines 109. 
According to the proposed reaction meachanism, phosphine 119 acts as a nucleophilic trigger 
and forms a zwitterionic adduct 129 upon addition to allenoate 127 (Scheme 46). This carbanion 
adds to the tosyl imine 109 to give an intermediate 130. After subsequent proton transfer steps,  
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Scheme 46: Mechanism of the phosphine catalyzed [4+2] cycloaddition  
between 2-methyl-2,3-butadienoate (127) and tosyl imines 109. 
an endo-cyclization occurs which regenerates the phosphine catalyst and produces the final 
product 128. 
These examples illustrate that the combination of α- and γ-alkylated allenoate esters with 
phosphine catalysis results in umpolung-reactivity which fully overrides the initial α- or γ-
nucleophilicity of the dienolate intermediates. In fact, this concept enables access to a variety 
of useful heterocycles and has found numerous applications in target-oriented syntheses[82] and 
drug discovery.[83] On the other hand, a major limitation of phosphine organocatalysis remains 
the fact that allenic substrates cannot be used in conventional MBH-type reactions.  
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2.1.2  Discovery of the γ-Selective MBH-Reaction of Allenoate Esters 
In order to probe the nucleophilic activity of bicyclic guanidines, the studies commenced with 
the aim to activate ethyl 2-methylpenta-2,3-dienoate (79a), a very densely substituted allenoate 
ester, for the reaction with the aromatic aldehyde 1b. We were pleased to find out that substrates 
smoothly reacted in MeCN in the presence of catalytic amounts of TBD (24) to give allenyl 
alcohol 80ab, which can be regarded as the product of a γ-selective MBH-reaction (Table 1, 
entry 1).  
Table 1: γ-Selective MBH-reaction between ethyl 2-methylpenta-2,3-dienoate (79a) and  
4-chlorobenzaldehyde (1b): Discovery and optimization of reaction conditions.[a] 
 
Entry Catalyst Solvent 79a 
[equiv.] 
t 
[hh:mm] 
Yield of 
80ab[b][c] [%] 
1 TBD MeCN 1.0 00:30 52 
2 TBD DMF 1.0 00:20 60 
3 TBD DMF 1.5 00:45 65 
4 TBD DMF 2.0 00:30 76 
5 TBD DMF 3.0 01:30 75 
6 TBD THF 2.0 06:00 n.r.[d] 
7 TBD CH2Cl2 2.0 05:15 38 
8 DMAP DMF 2.0 01:30 n.r.[d] 
9 DABCO DMF 2.0 01:30 traces 
10 DBU DMF 1.0 01:30 62 
11 DBU DMF 1.5 01:30 78 
12 DBU DMF 2.0 01:30 80 
13 MTBD DMF 2.0 01:30 88 
    14[e] MTBD DMF 2.0 15:00 81 
   15[f] MTBD DMF 2.0 01:30 84 
[a] All reactions were run on a 0.3–0.4 mmol scale. [b] Yields of isolated product. [c] The product was isolated 
in d.r. ≈ 1:1. [d] No reaction. [e] Reaction was run at –20 °C. [f] Reaction was run with 15 mol% catalyst. 
Although reaction monitoring by TLC showed complete conversion of allenoate ester 79a, 
equimolar amounts of starting materials gave the final product in only 52%. Presumably, 
polymerization of 79a took place as a concurring process leading to modest yields of the final 
product. When the reaction was carried out in DMF, the yields could be slightly improved 
(Table 1, entry 2). When the relative amount of allenoate ester was increased up to 2 
equivalents, allenic alcohol 80ab was obtained in 76% yield (Table 1, entries 3-4). The yield 
could not be further improved even when a higher excess of allenoate ester was used (Table 1, 
entry 5).  
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A short screening of solvents showed that DMF was the medium of choice, while the reaction 
completely failed in THF. When CH2Cl2 was used as a solvent, 80ab was obtained in 
diminished yields even after prolonged reaction time (Table 1, entries 6-7). Furthermore, when 
we tested well established Lewis base organocatalysts such as DABCO (75) and DMAP (76), 
no reaction took place (Table 1, entries 8-9) (Scheme 47).  
 
Scheme 47: Lewis base organocatalysts tested for the γ-selective MBH-reaction between ethyl 2-methylpenta-
2,3-dienoate (79a) and 4-chlorobenzaldehyde (1b). 
Our subsequent search for the optimal catalysts revealed that DBU (77), a known amidine 
Lewis-base,[84]  gave  the  product in  slightly  improved  yields of 80%  (Table 1, entries 10-
12). Finally, MTBD (71), another [4.4.0]-bicyclic guanidine Lewis base, was found to be the 
catalyst of choice, as it gave the final product 80ab in excellent yields of > 80% even at –20 °C 
and a catalyst loading of only 15 mol% (Table 1, entries 13-15). 
As we were interested in the structure elucidation of those unusual allenic alcohols, we prepared 
a tosylcarbamate derivative 133 (Scheme 48). This compound was crystallized in 
diastereomerically pure form and gave crystals suitable for X-ray analysis (Fig. 1).[85] 
Plausible reaction mechanism might be similar to that of the typical MBH-reaction (Scheme 
49). Addition of MTBD to the allenoate delivers dienolate 134, which is nucleophilic at α- and 
γ-carbon atoms. After subsequent addition of an aldehyde to the γ-position, proton transfer and 
elimination, the product 80 is formed and MTBD (71) is regenerated for the next catalytic cycle. 
 
 
Scheme 48: Conversion of allenic alcohol 80ab to the tosyl carbamate 133.[85] 
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Fig. 1: X-ray crystal structure of the tosylcarbamate derivative 133 of product 80ab. 
 
 
 
                                            
Scheme 49: Proposed mechanism of the MTBD catalyzed γ-selective MBH-reaction between  
ethyl 2-methylpenta-2,3-dienoate (79a) and an aromatic aldehyde. 
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2.1.3  Scope of Aldehydes 
Under the optimized reaction conditions, we investigated the generality of this reaction with 
regard to aldehydes. Electron poor and electron neutral aromatic aldehydes performed well and 
both ortho- and para- substituents were well tolerated (Table 2, entries 2-4). To our delight, 
even electron-rich aldehydes 1e and 1f gave the desired products in 85% and 68% yields 
respectively (Table 2, entries 5-6). Pivaloyl aldehyde (1g), a very sterically hindered substrate, 
reacted as well, although the expected allenic alcohol was obtained in only 15% yield (Table 2, 
entry 7). 
Table 2: Aldehyde scope of the MTBD-catalyzed γ-selective Morita–Baylis–Hillman reaction.[a] 
 
Entry R1 1 80 Yield of 80[b][c] [%] 
1  4-ClC6H4 1b 80ba 88 
2 Ph 1a 80aa 95  
3  4-NO2C6H4 1c 80ac 74  
4 2-NO2C6H4 1d 80ad 81  
5 4-OMeC6H4 1e 80ae 68  
6 3,5-(OMe)2C6H4 1f 80af 85 
7 t-Bu 1g 80ag 15 
 [a] All reactions were run on a 0.3–0.4 mmol scale. [b] Yields of isolated products. [c] The products were 
isolated in d.r. ≈ 1:1. 
 
2.1.4  Scope of Allenoate Esters 
The new protocol showed a great generality in regard to the scope of allenoate esters as well. 
Substrates with n-propyl and benzyl groups on α-position smoothly reacted with electron rich 
and electron poor aromatic aldehydes and gave the desired products in good to excellent yields 
of 61-96% (Table 3, entries 1-6). Despite the fact that allenoate 79d bearing an iso-propyl rest 
on its γ-position was significantly less reactive due to the steric bulk of the branched substituent, 
it still gave the final product in yields of up to 83% upon prolonged reaction times (Table 3, 
entries 7-10). 
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Table 3: Aldehyde scope of the MTBD-catalyzed γ-selective Morita–Baylis–Hillman reaction.[a] 
 
Entry R1 R2 79 R3 1 Cat. [mol%] t [h] 80 
Yield of 
80[b][c] [%] 
1  n-Pr Me 79b Ph 1a 20 1.5 80ba 90 
2  n-Pr Me 79b 4-ClC6H4 1b 20 1.5 80bb 96 
3  n-Pr Me 79b 3,5-(OMe)2C6H4 1f 20 1.5 80bf 90 
4  Bn Me 79c Ph 1a 20 1.5 80ca 61 
5  Bn Me 79c 4-ClC6H4 1b 20 1.5 80cb 87 
6  Bn Me 79c 3,5-(OMe)2C6H4 1f 20 1.5 80cf 73 
7 Me i-Pr 79d Ph 1a 15 5 80da 83 
8 Me i-Pr 79d 4-ClC6H4 1b 30 5 80db 54 
9 Me i-Pr 79d 4-NO2C6H4 1c 30 5 80dc 67 
10 Me i-Pr 79d 3,5-(OMe)2C6H4 1f 30 5 80df 76[d] 
 [a] All reactions were run on a 0.3–0.4 mmol scale. [b] Yields of isolated products. [c] The products were 
isolated in d.r. ≈ 1:1. [d] The product was isolated in d.r. ≈ 2:1 
2.1.5  Follow up Chemistry: Cyclization by Phosphine Organocatalysis 
Owing to the fact that the allenic moiety represents a privileged substrate motif in phosphine 
organocatalysis,[78b] we anticipated that the obtained products could be of great value as starting 
materials for the synthesis of a variety of heterocyclic compounds. As we combined the allenic 
alcohol 80ab with one equivalent of PBu3 (119), a new compound was formed in 67% yield, 
which was identified as a 3,5-dimethyl-6-aryl-2H-pyran-2-one 137ab (Table 4, entry 1). 
Substrates 80ac and 80ae gave the corresponding products in 83 and 56% yields respectively 
(Table 4, entries 2-3). It is noteworthy to mention, that a related intermolecular addition-
cyclization sequence leading to pyranones was published by Kwon et al..[86] In that work, 
however, only allenoate esters without any substituents on α- and γ-positions were employed, 
so that the previously published work did not enable preparation of highly substituted products.  
Mechanistically, the cyclization of allenic alcohols 80 to pyrones 137 can take place according 
to the proposed mechanism shown on Scheme 50. Intermediate 138 is produced after 
nucleophilic addition of tributylphosphine to 80. After intramolecular proton transfer and 
lactonization, lactone 140 and an ethanolate anion are produced. Subsequent deprotonation at 
the benzylic position by the alcoholate anion leads to stabilized phosphorus ylide 142. 
Subsequent intramolecular proton transfer and elimination afford the product 137 and 
regenerate the phosphine catalyst 119.  
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Table 4: Phosphine-catalyzed cyclization of allenic alcohols 80 to 3,5-dimethyl-6-aryl-2H-pyran-2-ones 137.[a] 
 
Entry Ar 80 137 Yield of  137[b] [%]  
1 4-ClC6H4 80ab 137ab 67 
2 4-NO2C6H4 80ac 137ac 83 
3 4-OMeC6H4 80ae 137ae 56 
[a] All reactions were run on a 0.3–0.4 mmol scale. [b] Yields of isolated products.  
 
 
Scheme 50: Proposed mechanism of the phosphine-catalyzed cyclization of allenic alcohols 80 to pyrones 137. 
 
2.1.6  Follow up Chemistry: Cyclization by Gold(I)-Catalysis 
As we further investigated the applicability of γ-MBH products 80 for the synthesis of 
heterocycles, we became interested in transition-metal catalyzed cycloisomerizations of allenic 
alcohols.[87] Although silver(I) salts AgOBz and AgO2CCF3 did not catalyze the anticipated 
transformation, a gold(I) complex formed in situ from (Ph3P)AuCl and AgOTf led to a smooth 
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conversion of 80ab to the dihydrofuran 144ab in 86% yield (Table 5, entry 1). Allenic alcohols 
80ad and 80af cyclized to the corresponding products in 61 and 88% yields respectively (Table 
5, entries 2-3). 
Table 5: Au(I)-catalyzed cyclization of allenic alcohols 80 to 2,5-dihydrofurans 144.[a] 
 
Entry Ar 80 144 Yield of 144[b][c] [%]  
1  4-ClC6H4 80ab 144ab 86 
2 2-NO2C6H4 80ad 144ad 88 
3 3,5-(OMe)2C6H4 80af 144af 61 
[a] All reactions were run on a 0.3–0.4 mmol scale. [b] Yields of isolated products. [c] The products were 
isolated in d.r. ≈ 1:1. 
 
2.1.7  Summary  
In summary, the first protocol for γ-selective MBH-reactions of α,γ-disubstituted allenoate 
esters has been developed. The catalyst of choice is the bicyclic guanidine MTBD (71), 
although guanidine TBD (24) and amidine DBU (77) are also active catalysts. Most 
importantly, conventional N-Lewis bases DABCO and DMAP showed no catalytic activity at 
all. A wide range of aromatic aldehydes can be used in the new reaction, as both electron rich 
and electron poor ones are suitable substrates. With regard to the scope of allenoate esters, 
various linear and branched alkyl chains in the α- and γ-position are also well tolerated giving 
the products in up to 96% yields.  
Allenic alcohols 80 have been shown to be versatile substrates for the synthesis of various 
heterocyclic compounds with very dense substituent pattern. On the one hand, 3,5-dimethyl-6-
aryl-2H-pyran-2-ones 137, which possess a core structure encountered in a number of 
biologically active natural products,[88] were synthesized by applying phosphine 
organocatalysis. On the other hand, Au(I)-mediated cycloisomerization gave access to 
dihydrofurans 144. 
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2.2  Synthesis of Highly Substituted Oxetanes 
2.2.1  Introduction 
2.2.1.1  Oxetanes in Nature and Chemical Industry 
Oxetanes are four-membered saturated heterocycles containing one oxygen atom. This structure 
is encountered in a number of biologically active natural products, among which paclitaxel 
(145) is undoubtedly the most prominent example (Scheme 51).[89] Along with structurally 
related docetaxel, 145 is currently used in cancer chemotherapy. The presence of the oxetane 
ring has important contributions to the biological activity of paclitaxel: It rigidifies the 
tetracyclic core of the molecule and serves as hydrogen-bond acceptor.[90] 
 
 
Scheme 51: Bioactive natural products possessing an oxetane substructure. 
Montanin D (146) is another example of a polycyclic molecular scaffold bearing an oxetane 
motif. This natural product received substantial attention recently due to its antifeedant 
activity.[91] Oxetanocin A (147) is produced by bacillus megaterium and was shown to have 
various useful biological properties such as antitumor, antibacterial and antiviral  
activities.[92][93] Its antiviral activity has been of much interest, as it has been studied for the 
development of novel anti-HIV agents.[94]  
In the recent years, oxetanes have received increased interest as building blocks in the 
pharmaceutical and crop protection industries mainly due to major contributions from the 
groups of Carreira and Roger-Evans.[95] These strained rings were shown to possess analogies 
to various widespread pharmacophores and inspired new investigations aimed towards 
syntheses of novel oxetane-containing building blocks with improved pharmacological 
properties. For instance, the introduction of oxetane-moieties to molecular scaffolds was 
beneficial for solubility and metabolic stabilities of the prepared molecules.[95] 
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In this context, crenolanib (148) should be mentioned as one of the recent examples of synthetic 
drugs candidates containing an oxetane ring (Scheme 52).[96] This molecule is being 
investigated for treatment of cancer and has shown to be a potent inhibitor of several types of 
kinases and platelet derived growth factor receptors. The tetramic acid derivative 149 
containing a 4-hydroxy oxetane motif was recently prepared in the laboratories of Syngenta. 
This structure is of potential interest for the agrochemical industry due to its insecticidal and 
phytotoxic activities.[97] 
 
Scheme 52: Synthetic bioactive molecules containing oxetane subunits. 
2.2.1.2  Synthesis of Oxetanes 
There are numerous strategies for the preparation of oxetanes. In this section, a succinct 
overview of intra- and intermolecular methods for the construction of the oxetane moiety will 
be presented. 
 
Cyclization by Williamson Ether Synthesis 
Williamson ether synthesis has been a method of choice for C-O bond formation.[98] The 
intramolecular version of this reaction was used for the very first oxetane synthesis by Reboul 
in 1878, as he cyclized 3-chloropropanol (150) upon treatment with aqueous base (Scheme 
53).[99] Moreover, related reactions were also studied in context of the synthesis of  
4,4-disubstituted oxetane-analogues by cyclization of 3-bromo-1-propanols with various 
substituents on C-2 position.[100] 
 
 
Scheme 53: The first synthesis of oxetane (151) by Reboul.[99] 
 
CuI-Catalyzed Cyclization of Vinylbromides 
Synthesis of 2-methyleneoxetanes (154) was achieved by copper(I)-catalyzed intramolecular 
coupling of vinyl bromides with alcohols (Scheme 54).[101] In particular, this method is of value 
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due to the lack of routes enabling a direct synthesis of oxetanes with a methylene functionality 
on the C-2 position.  
                                    
Scheme 54: Oxetane synthesis by CuI-catalyzed cyclization. 
Intramolecular Epoxide Ring Opening 
Highly substituted oxetanes with anti-(2,3) selectivity were synthesized by isomerization of 
epoxides (Scheme 55).[102] The reaction was facilitated by use of stoichiometric amounts 
LIDAKOR (n-BuLi-di-iso-propylamine-KOt-Bu) superbase. The advantage of this approach is 
the fact that it makes use of epoxides which can be easily accessed by a great variety of well 
established methods.[103] 
 
Scheme 55: Oxetane synthesis by intramolecular epoxide ring opening reaction. 
Epoxide Ring Expansion 
In analogy to the well-known Corey-Chaykovsky epoxidation reaction, oxetanes can be 
accessed by treatment of epoxides with sulfur ylides (Scheme 56).[104] In this reaction, the ylide 
reagent acts both as a nucleophile and a leaving group enabling the preparation of 2- or  
2,2-disubstituted oxetanes.  
 
Scheme 56: Oxetane synthesis by epoxide ring expansion. 
 
Synthesis by Ring Contraction Reaction 
A ring contraction approach was used in order to prepare oxetane-2-carboxylic acid 160 
(Scheme 57). It was obtained by treatment of mesylated lactone 159 with aqueous sodium 
hydroxide in methanol and used as an intermediate for the formal total synthesis of natural  
D-oxetanocin.[105] A similar strategy was also used for the synthesis of hitherto unknown  
L-oxetanocin.[106] 
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Scheme 57: Synthesis of oxetane-2-carboxylic acid 160 by ring contraction. 
Paternò-Büchi Reaction 
After its initial discovery in 1909,[107] the Paternò-Büchi reaction has become one of the most 
powerful methods for the preparation of densely substituted oxetanes.[108] Due to the fact that 
this approach enables the generation of up to three new stereogenic centers in one step, great 
difficulties are associated with the control of diastereoselectivity. This challenge was addressed 
in one of the recent works by Bach et al., as significant facial diastereoselectivities for the 
reactions between benzaldehyde (1a) and silyl enol ethers were reported (Scheme 58).[109] 
 
Scheme 58: Highly diastereoselective intermolecular oxetane synthesis by Paternò-Büchi reaction. 
Lewis Acid Promoted Addition of Allylsilanes to α-Keto Esters 
Akiyama et al. prepared oxetane 165 by a titanium tetrachloride mediated [2+2] cycloaddition 
of allylsilanes to α-keto esters (Scheme 59).[110] Toluene appeared to be the solvent of choice, 
as the yields were significantly lower if the reaction was performed in dichloromethane. 
Ethylpyruvate (163) and ethyl 2-oxo-2-phenylacetate were both suitable substrates and gave 
the final product as a single diastereomer in excellent yields.  
 
Scheme 59: Oxetane synthesis by titanium tetrachloride mediated [2+2] cycloaddition of allylsilanes 164 to 
ethylpyruvate (163). 
Organocatalytic Cycloaddition of Trifluoromethyl Ketones to Allenoate Esters 
Very recently, Miller et al. and Ye et al. independently reported the first organocatalytic 
oxetane synthesis by [2+2] cycloaddition between trifluoromethyl ketones and allenoate 
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esters.[111] The reaction made use of commercially available starting materials and DABCO (75) 
as a catalyst. One year later, the group of Shi realized the first enantioselective version of this 
transformation (Scheme 60).[112] When β-isocupreidine (β-ICD, 166) was used as a chiral 
catalyst, the final products were obtained in high enantiopurity. 
 
Scheme 60: Organocatalytic enantioselective oxetane synthesis reported by Shi et al..[112] 
2.2.1.3  Motivation 
The above mentioned organocatalytic syntheses of oxetanes reported by Miller, Ye and Shi, 
give access to valuable building blocks with potential applications in biomedical research. For 
instance, an oxetane motif containing a trifluoromethyl group on the C-2 position was 
incorporated into molecules of interest for the treatment of neurological diseases[113] and 
inhibitors of leukemia cell differentiation.[114] Furthermore, the double bond at the 2-position 
of the oxetane can be harnessed as a valuable structural component for the introduction of 
further functional groups. Although the new method made use of commercially available 
starting materials and was operationally simple, there still remained plenty of room for 
improvement due to long reaction times (1-6 d), high catalyst loadings and the necessity to use 
one of the reactants in excess. Also, the use of γ- and α,γ-substituted allenoates remained a 
challenge.  
2.2.2  Optimization of Reaction Conditions and Scope of Allenoate Esters 
Inspired by our first success with the use of bicyclic guanidine organocatalysts for the 
nucleophilic activation of allenoate esters, we anticipated that TBD might be a suitable catalyst 
for the synthesis of oxetanes as well. When allenoate 81a was reacted with an excess of 
trifluoromethyl-phenyl ketone (82a) in the presence of catalytic amounts of TBD, a highly 
substituted oxetanylidene 83aa was isolated as a mixture of diastereomers (d.r. = 82:18) in 39% 
yield (Scheme 61). The main isomer was determined as (E)-trans as was unambiguously 
confirmed by X-ray crystallography and NMR-spectroscopy (Fig. 2).[115] 
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Scheme 61: Initial discovery of the TBD-catalyzed [2+2] cycloaddition of trifluoromethyl-phenyl ketone (82a) 
to allenoate ester 81a. 
To our delight, when the same reaction was conducted at room temperature with stoichiometric 
amounts of starting materials, it went to completion within only 10 minutes giving the final 
product in good yield and diastereoselectivity (Table 6, entry 1). The product was obtained as 
a separable mixture of (E)- and (Z)-isomers with predominant formation of the trans-
diastereoisomer. 
 
Fig. 2: X-ray crystal structure of the oxetane product (E)-trans-83aa.[115] 
In our attempts to improve the diastereoselectivity, we lowered the reaction temperature to –20 
°C, but the diastereomeric ratio did not change significantly (Table 6, entry 2). Furthermore, 
excellent results were obtained with only 8 mol% of the catalyst (Table 6, entry 3). The reaction 
completely failed in THF and gave lower selectivities and yields when CH2Cl2 was used as a 
solvent (Table 6, entries 4-5). DMF and MeCN gave equally good results (Table 6, entry 6). 
We observed that allenoate 81b with R1 = Bn gave the same results as ethyl ester 81a (R1 = Et), 
whereas Me (81c), i-Pr (81d) and t-Bu (81e) esters reacted slower and with significantly lower 
stereoselectivities (Table 6, entry 7-10). When we used more challenging substrates 81f and 
81g with bulky γ-iso-propyl group, oxetanes 83fa and 83ga were formed mainly as (Z)-isomers. 
The minor (E)-isomers,  however, were formed in  almost diastereomerically pure form.  Even 
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Table 6: Optimization of reaction conditions and scope of allenoate esters. 
 
Entry R1 R2 R3 81 Cat. [mol%] 
t 
[hh:mm] 83 
Yield [%] 
of (E)-83[a] 
(cis:trans)[b] 
Yield [%]  
of (Z)-83[a] 
(cis:trans)[b] 
1  Et Me H 81a 25 00:10 83aa 77 (17:83) 9 (33:67) 
2[c]  Et Me H 81a 25 17:00 83aa 71 (13:87) 8 (31:69) 
3  Et Me H 81a 8 00:15 83aa 78 (18:82) 9 (48:52) 
4[d]  Et Me H 81a 10 02:00 83aa n. r.[e] n. r.[e] 
5[f]  Et Me H 81a 10 00:45 83aa 67 (43:57) 8 (63:37) 
6[g]  Et Me H 81a 10 00:10 83aa 76 (18:82) 8 (34:66) 
7 Bn Me H 81b 10 00:10 83ba 70 (19:81) 9 (43:57) 
8 Me Me H 81c 15 20:00 83ca 51 (27:73) 7 (57:43)[h] 
9 i-Pr Me H 81d 10 00:50 83da 57 (30:70) 7 (62:38)[h] 
10 t-Bu Me H 81e 15 00:50 83ea 50 (57:43) 6 (79:21)[h] 
11 Et i-Pr H 81f 15 01:20 83fa 27 (3:97) 46 (58:42) 
12 Bn i-Pr H 81g 15 01:00 83ga 23 (3:97) 48 (68:32) 
13 Et Me Me 79a 30 17:00 83ha 72 (15:85) n. d.[i] 
[a] Yields of isolated products. [b] Diastereomeric ratios determined from 1H NMR of isolated (E)- or (Z)-products. 
[c] The reaction was carried out at –20 °C. [d] The reaction was carried out in THF. [e] No reaction. [f] The 
reaction was carried out in CH2Cl2. [g] The reaction was carried out in DMF. [h] Yields and d.r. of the (Z)-isomer 
determined from 1H NMR of the crude product mixture (see experimental part). [i] Not determined. 
when we used a very hindered substrate 79a bearing two methyl groups on α- and γ-positions, 
the expected very densely substituted oxetane 83ha product was obtained in good yield and 
diastereoselectivity. 
According to previous reports on Brønsted base catalyzed isomerizations of β-alkynoate esters 
to the corresponding allenoate esters,[116][31][34] we envisioned that ethyl oct-3-ynoate (81i) 
would be a suitable substrate for this reaction as well. When it was reacted with ketone 82a 
under optimized reaction conditions, the oxetane product was smoothly formed in good yield 
within only 10 minutes (Scheme 62). This result showcases the use of TBD as a multifunctional 
catalyst, which can act both as Brønsted and Lewis base. 
 
Scheme 62: Synthesis of oxetanes 83ia from alkynoate ester 81i. 
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A plausible reaction mechanism was proposed, which is similar to that suggested by Miller and 
Ye.[111] The formation of oxetanes can be explained by TBD-induced γ-selective Morita-Baylis-
Hillman and subsequent oxa-Michael reactions (Scheme 63). Addition of TBD to the allenoate 
ester 81a leads to the formation of dienolate 168 which reacts with trifluoromethyl ketone 82a 
to intermediate 169. Subsequent intramolecular oxa-Michael reaction and elimination produce 
the oxetane product 83aa and regenerate the TBD-catalyst. 
 
Scheme 63: Proposed mechanism of the TBD-catalyzed synthesis of oxetane 83aa. 
2.2.3  Scope of Trifluoromethyl-Aryl Ketones. 
As a next step, we investigated the scope of trifluoromethyl-aryl ketones 82. In general, the 
reaction tolerated electron rich and electron poor aryl groups giving the oxetane products in 
moderate to good yields. The best results were obtained with ketones bearing alcoxyl and alkyl 
substituted phenyl groups as well as the 2-thienyl group (Table 7, entries 1-4). Oxetanes 83 
were formed in lower yields, when trifluoromethyl ketones with electron withdrawing 
substituents on the aryl moiety were used. In fact, in the latter case, incomplete conversion of 
the starting materials was observed (Table 7, entries 5-7). This effect was attributed to the very 
high reactivities of substrates 82f-82h which reacted with TBD and led to catalyst poisoning 
(see section 2.2.5 for more details). This also explained why no oxetane product was observed 
when reactions between allenoate 81a and perfluoroacetophenone (82i), the most reactive 
ketone tested, were attempted. Furthermore, the diastereoselectivity appeared to be strongly 
    
 
 
 
41 
 
sensitive to o-substituents on the aromatic ring of the trifluoromethyl-aryl ketone: When  
2-methoxy substituted ketone 82c was used as a substrate, the oxetane cis-83ac was formed as 
a major diastereomer (Table 7, entry 2).  
Table 7: Scope of trifluoromethyl-aryl ketones. 
 
Entry 82 Ar Cat. [mol%] 
t 
[hh:mm] 83 
Yield [%] 
 of (E)-83[a] 
(cis:trans)[b] 
Yield [%]  
of (Z)-83[c] 
(cis:trans) 
1  82b 4-OMeC6H4 10 00:10 83ab 76 (17:83) 9 (34:66) 
2  82c 2-OMeC6H4 15 01:00 83ac 40 (81:19) 10 (89:11) 
3  82d 2-Thienyl 10 01:00 83ad 71 (11:89) 7 (35:65) 
4 82e 4-i-PrC6H4 10 00:10 83ae 74 (21:79) 14 (45:55) 
5  82f 4-ClC6H4 10 00:25 83af 54 (25:75) 6 (48:52) 
6  82g 4-CF3C6H4 20 01:40 83ag 36 (22:78) 4 (48:52) 
7 82h 4-BrC6H4 10 00:20 83ah 60 (19:81) 7 (43:57) 
8 82i 4-CF3C6F4 10 16:00 83ai n. r. n. r. 
[a] Yields of isolated products. [b] Diastereomeric ratios determined from 1H NMR of isolated (E)-products.  
[c] Yields and d.r. determined from 1H NMR of the crude product mixture (see experimental part). 
2.2.4  Catalyst Poisoning by Reactions with Trifluoromethyl-Aryl Ketones 
During the reactions between allenoate 81a and trifluoromethyl ketones containing electron 
withdrawing groups, incomplete consumption of 81a was detected even after prolonged 
reaction times (up to 1 h 40 min for 82g). To study the possibility of concurring reactions, TBD 
was mixed with 82g in a 1:1 molar ratio in CD3CN and the reaction mixture was monitored by 
13C NMR spectroscopy (Schemes 64 and 65). A disappearance of the characteristic signal of 
the carbonyl group [δ 180.9 ppm (qCF, 2JCF = 35.6 Hz, COCF3)] indicated that the starting 
material was completely consumed. This implies, indeed, that under the conditions of the 
organocatalytic process, a reaction between TBD and 82g led to poisoning of the catalyst and 
resulted in incomplete consumption of the starting materials. As a result, the oxetane products 
83af, 83ag and 83ah were obtained in relatively low yields. 
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Scheme 64: Example 13C NMR spectrum: Trifluoromethyl ketone 82g in CD3CN. 
 
 
Scheme 65: Trifluoromethyl ketone 82g completely consumed after addition of 1 equiv. TBD (24) in CD3CN. 
COCF3 
CD3CN 
CD3CN 
CD3CN CD3CN 
TBD 
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2.2.5  TBD vs. PPh3 Catalysis 
We then turned our attention to investigations of the reactivity of allenoate esters and 
trifluoromethyl-aryl ketones depending on the nature of the Lewis base catalyst. Allenoate 79a 
and ketone 81a gave tetrahydrofuran 171 as a product, when triphenylphosphine was used as a 
catalyst (Scheme 66).  
 
Scheme 66: Divergent reactivity of allenoate 79a under TBD and PPh3 catalysis. 
This type of reactivity is very similar to that reported for γ-alkyl substituted allenoates and 
aromatic aldehydes (see section 2.1.1).[80] This result can be explained by an umpolung reaction 
of the dienolate 172 formed after conjugate addition of PPh3 to 79a (Scheme 67). The ylide 173 
is nucleophilic on its δ-carbon atom and readily attacks ketone 82. After ring closing oxa-
Michael reaction and elimination of the catalyst, tetrahydrofuran product 171 is formed. 
 
Scheme 67: Proposed mechanism of the phosphine catalyzed synthesis of tetrahydrofuran 171. 
However, this type of reactivity was not observed when the α-unsubstituted γ-methyl allenoate 
81a was used. In that case, PPh3 did not catalyze the formation of the expected tetrahydrofuran, 
but the oxetane product 83aa with inverse diastereoselectivity was formed instead (Scheme 68). 
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To the best of our knowledge, this is the first precedence of a phosphine-mediated [2+2] 
cycloaddition between an allenoate ester and a carbonyl compound. This result shows that the 
intrinsic tendency of phosphines to form ylides can be influenced, presumably by solvent effects 
or conformational effects of the reaction intermediates. 
 
Scheme 68: Diastereodivergent reactivity of allenoate 81a under TBD and PPh3 catalysis. 
2.2.6  Summary 
In summary, we have shown that TBD catalyzes the formation of very densely substituted 
oxetanes from allenoate esters and trifluoromethyl-aryl ketones and possesses activity vastly 
superior to that of the reported Lewis bases DABCO and β-ICD. The reaction has a broad scope 
of allenoate esters as γ- and α,γ-disubstituted substrates perform well. β-Alkynoate esters are 
also suitable substrates. They are readily isomerized to the corresponding allenoate esters and 
participate in subsequent cycloaddition reactions since TBD acts both as a Brønsted and a Lewis 
base. Electron rich trifluoromethyl-aryl ketones give the products in higher yields. Electron 
poor trifluoromethyl-aryl ketones give the final products in lower yields because they readily 
react with TBD which leads to catalyst poisoning and incomplete conversion of starting 
materials. 3-Alkyl-oxetane-2-ylidenes are formed in good yields and diastereoselectivities 
within short reaction times by using stoichiometric amounts of starting materials. Moreover, 
we discovered that PPh3 enables access to the same products, but with inverse 
diastereoselectivity. 
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2.3  Triple Functionalization of γ-Substituted Allenoates by a Four-Step Reaction Cascade 
2.3.1  Introduction 
In order to provide a better understanding of further chemistry studied within this doctoral work, 
some unusual types of the MBH-reaction will be summarized. In the early 1990’s, group of 
Emslie synthesized cyclic acetals 179 from acrylic ester 177 and aliphatic aldehydes (Scheme 
69).[117] These unusual products were formed as a result of an MBH-reaction followed by 
acetalization and transesterification reactions. A critical factor for the cyclization reaction was 
the type of acrylate ester. While reactions with ethyl or methyl acrylates afforded the well-
known MBH-products, esters of γ-carbonyl alcohols such as lactate, mandelate or pantolactone 
(178) reacted to cyclic acetals 179.  
 
Scheme 69: MBH-reaction and subsequent acetalization leading to the cyclic product 179. 
Obviously, this can be explained by the fact that α-carbonyl alcohols are much better leaving 
groups and thus readily participate in an intramolecular transesterification reaction after 
preceding acetalization. In fact, several other works showed that the same products can be 
obtained from aryl or 1,1,1,3,3,3-hexafluoro iso-propyl acrylates as well.[118][119]  
In addition to the fact that cyclic acetals are of great synthetic utility, above mentioned reports 
are also of fundamental importance, because they shed some light on the possible detailed 
mechanism of the MBH-reaction. McQuade et al. showed that the rate determining step of the 
reaction was second order in aldehyde and first order in acrylate (Scheme 70).[120] Based on 
kinetic studies and precedents of formation of cyclic acetal 184 as reaction byproduct, he 
postulated the formation of hemiacetal 182 as a key reaction intermediate. This zwitterionic 
species 182 undergoes a rate-limiting proton transfer to give 183 which then breaks down to 
the MBH-product 92a and aldehyde or undergoes an intramolecular esterification leading to 
cyclic acetal 184. 
Regarding the chemistry of allenoate esters, there are only two examples in the literature 
describing MBH-type  products of allenoates  participating in  subsequent acetalization and cy- 
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Scheme 70: MBH-reaction mechanism proposed by McQuade explaining the formation of cyclic acetals 184.[119] 
clization reactions. Kwon et al. showed that aromatic aldehydes react with iso-propyl buta-2,3-
dienoate (102b) to (2,6-diaryl-[1,3]dioxan-4-ylidene)-acetates 185 in presence of trimethyl 
phosphine as a catalyst (Scheme 71).[121] The reaction proceeded with complete 
diastereoselectivity and good E/Z selectivity. The products were obtained in moderate to good 
yields and best results were obtained with electron poor aromatic aldehydes. Furthermore, 
cyclic acetals were easily converted to synthetically useful δ-hydroxy-β-ketoesters 186 upon 
treatment with aqueous HCl.  
 
Scheme 71: Phosphine catalyzed formation of cyclic acetals 185 and their further  
conversion to β-ketoesters 186. 
According to the proposed reaction mechanism, product 185 is formed as a result of the 
γ-addition of the phosphonium enolate 187 to an aldehyde to form intermediate 188 (Scheme 
72). After acetalization, ring-closing oxa-Michael addition and elimination of the catalyst, 
product 185 is obtained. This reaction sequence can thus be rationalized as γ-selective MBH 
reaction / acetalization / oxa-Michael reaction cascade. 
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Scheme 72: Proposed mechanism of the phosphine catalyzed cascade enabling the synthesis  
of cyclic acetals 185. 
Very recently, a similar reaction was reported by Ye et al. (Scheme 73).[122] N-heterocyclic 
carbene catalyst 191 promoted the reaction between various trifluoromethyl-aryl ketones and 
ethyl butadienoate (102a) to afford products 192. Cyclic acetals were obtained in moderate 
yields as mixtures of diastereoisomers and best results were obtained with the ketones bearing 
electron withdrawing groups on aromatic rings. 
                                
Scheme 73: NHC catalyzed formation of cyclic acetals 192. 
2.3.2  Preceding Work and Goals of the Project 
The work on the following topic was carried out together with Dr. Philipp Selig who also 
discovered the reaction cascade and found the optimal reaction conditions. In order to provide 
a better understanding of the project goals at the time it was included into the doctoral work, 
preliminary work of Dr. Selig will now be reported.[123] 
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As can be seen from the results described in sections 2.1 and 2.2, [4.4.0]-bicyclic guanidines 
are strong Lewis bases which enable γ-selective MBH-type reactions of allenoate esters. 
Mechanistically, those reactions can be explained by formation of reactive dienolate 
intermediates from the allenoate ester and guanidine base, which then rapidly react with 
corresponding carbonyl electrophiles. Depending on the type of electrophile chosen, either a 
product of a mere addition reaction can be obtained (γ-MBH product), or a cycloaddition 
reaction can occur. Based on precedents of acetal formation in MBH-reactions presented in this 
chapter, analogous reactivity was expected for the reaction between allenoates and aromatic 
aldehydes under guanidine catalysis (Scheme 74). In contrast to phosphine-catalyzed reactions, 
however, the use of a guanidine organocatalysts would not lead to the umpolung of reactive 
intermediates, so that even γ-alkyl substituted allenoate esters 81 could be used for the title 
reaction and the synthesis of cyclic acetals 185’ would be possible. 
 
Scheme 74: Anticipated synthesis of cyclic acetals under guanidine organocatalysis. 
Indeed, it was discovered, that ethyl 2,3-pentadienoate (81a) reacted with an excess of  
4-nitrobenzaldehyde (1c) in THF in presence of catalytic amounts of TBD (24) (Table 8, entry 
1). However, the main reaction product was not the expected 1,3-dioxane-ylidene 185’, but a 
4H-1,3-dioxin-6-ylpropanoate 84ac. Also, some aldol condensation side product 193 was 
formed during the reaction. The cyclic acetal was isolated in diastereomerically pure form, 
albeit in a rather modest yield of 24%. 
When the reaction was carried out in MeCN, the formation of aldol side product 193 was 
completely inhibited (Table 8, entry 2). On the other hand, another byproduct 194 was now 
isolated which can be reagarded as a retro-aldol product of acetal 84ac. Higher temperatures 
and longer reaction times had some beneficial effect on the yield of the desired product, but 194 
was formed  in  higher amount as well  (Table 8, entry 3).  At –20 °C the formation  of the retro 
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Table 8: TBD catalyzed synthesis of cyclic acetal 84ac: Discovery  
and optimization of reaction conditions.[a] 
 
Entry Solvent Cat. Cat. [mol%] 
Temp.  
[°C] 
t 
[hh:mm] 
Yield of  
84ac[b] [%] Side products 
1  THF TBD 10 0 01:00 24 193 (16%) 
2  MeCN TBD 15 0 00:30 24 194 (4%) 
3  MeCN TBD 20 +25 24:00 35 194 (19%) 
4 MeCN TBD 20 –20 01:00 51 194 (traces)[c] 
5  MeCN TBD 10 –20 01:00 34 194 (traces)[c] 
6  MeCN TBD 15 –20 01:00 59 194 (traces)[c] 
7 MeCN DBU 15 –20 01:00 26 - 
8 MeCN DMAP 15 –20 03:00 15 - 
9 MeCN DABCO 15 –20 18:00 <5 - 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1c; c(81a) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1). [c] Not isolated. 
aldol product 194 was almost completely suppressed (Table 8, entry 4). The optimal catalyst 
loading was found to be 15 mol% giving the final product in 59% yield and the allenoate ester 
81a was fully consumed at 1 h reaction time (Table 8, entries 5-6). Furthermore, other 
frequently used nitrogen-containing Lewis bases such as DBU, DMAP and DABCO were 
significantly less active than TBD.[124] 
Based on the observations made during the optimization of reaction conditions, a mechanistic 
rationale was proposed for the formation of 1,3-dioxane-ylidene 84ac (Scheme 75). After 
conjugate addition of TBD to allenoate 81a, a highly reactive dienolate intermediate is formed 
which reacts on its γ-position with 4-nitrobenzaldehyde (1c). Subsequent acetal formation and 
oxa-Michael cyclization would give the retro-aldol adduct 194, which was supposed to be a 
possible reaction intermediate. Final aldol reaction between 194 and another equivalent of 
aldehyde gives the product 84aa. Furthermore, the 4H-1,3- dioxin-6-ylpropanoate (84ac) appe- 
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Scheme 75: Initially proposed mechanism of the TBD catalyzed synthesis of cyclic acetal 84ac. 
ared to be rather unstable under highly basic reaction conditions, as it readily decomposed to 
the retro-aldol product 194 at elevated temperatures. 
In brief, this novel four-step reaction cascade resulted in an unprecedented triple 
functionalization of allenoate esters on the α-, β- and γ-position with generation of four 
stereogenic centers. Moreover, a great degree of stereoselectivity was achieved, since the 
product was isolated as a single diastereoisomer. It is noteworthy to mention that alkynoate 
ester 81i was also a viable substrate for the discovered reaction cascade as TBD can act both as 
a Lewis and a Brønsted base (Scheme 76). That means that even five-step reaction cascade 
could be achieved under optimized reaction conditions by choice of suitable substrates. 
 
Scheme 76: Synthesis of cyclic acetal 84ic from alkynoate ester 81i. 
Based on preliminary work done by Dr. Selig, the following aspects of the new reaction cascade 
had to be investigated within this doctoral work: 
- Scope of aldehydes in reactions with alkynoate ester 
- Tolerance of bulky γ-iso-propyl rest on allenoate ester 
- Reactivity of methyl, iso-propyl and tert-butyl 2,3-pentadienoate esters 
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2.3.3  Revision of the Reaction Mechanism 
During the initial investigations of the substrate scope, the reaction between β-alkynoate ester 
81i and 4-chlorobenzaldehyde 1b was attempted. However, under optimized reaction 
conditions, no product was formed. The reaction only took place with significantly higher 
catalyst loading (30 mol%) and went to completion after 1.5 h to give the expected 4H-1,3-
dioxin-6-ylpropanoate 84ib in 37% yield (Scheme 77).  
 
Scheme 77: Discovery of the bis-MBH intermediate 197. 
Furthermore, it was discovered that during the same reaction an unusual highly substituted 
allenic diol 197 was formed as a side product in 28% yield.  This intriguing structure can be 
described as a product of a two-fold MBH reaction on both the α- and the γ-position of ethyl 
octa-2,3-dienoate with aldehyde 1b. This unexpected result provided an idea that this bis-MBH 
adduct could be the actual reaction intermediate, whereas the previously isolated retro-aldol 
product 194 was formed as a result of 4H-1,3-dioxin-6-ylpropanoate decomposition. 
In order to probe those mechanistic considerations, the isolated bis-MBH product was subjected 
to the reaction with excess 4-chloro benzaldehyde 1b (Scheme 78a). As a result, after prolonged  
 
Scheme 78: Preliminary studies to probe possible mechanism of the formation of the product 84. 
(a) Conversion of the bis-MBH adduct 197 to 84ib with complete transfer of diastereoselectivity. (b) Conversion 
of the retro-aldol product 194 to 84ac with complete loss of diastereoselectivity.[125] 
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reaction time, 4H-1,3-dioxin-6-ylpropanoate 84ib was formed. This observation strongly 
supported the intermediacy of 197. Furthermore, during this reaction a complete transfer of 
stereoinformation was observed, as the final product was formed as a mixture of 
diastereoisomers in 2:1 ratio which was exactly the same as of the isolated bis-MBH-
intermediate 197. 
On the other hand, when retro-aldol product 194 was reacted with aldehyde 1c, the final product 
was obtained as a complex mixture of diastereoisomers (Scheme 78b).[125] Although this result 
shows that either mechanism might lead to the formation of the 4H-1,3-dioxin-6-ylpropanoate 
84, the latter one does not explain the high diastereoselectivity of the reaction. It was therefore 
assumed, that the final product is most likely formed via two consecutive MBH reactions on α- 
and γ-position of the allenoate ester with subsequent acetalization and oxa-Michael cyclization 
reactions (Scheme 79). The high stereoselectivity of the reaction might be ensured by 
preferential formation of only one diastereoismer of bis-MBH adduct 197, which then reacts to 
4H-1,3-dioxin-6-ylpropanoate 84. Formation of 194 can be explained as a retro-aldol 
decomposition of the final product, which readily takes place at higher temperatures under 
strongly basic reaction conditions. 
 
Scheme 79: Revisited mechanism of the formation of the 4H-1,3-dioxin-6-ylpropanoate product 84. 
2.3.4  Further Optimization of Reaction Conditions 
Optimization of Catalyst Loading for Reactions of β-Alkynoates and γ-iso-propyl Allenoates 
After gaining first insights into the mechanism of the newly discovered four-step reaction 
cascade, various allenoate esters were reacted under optimized reaction conditions. It turned 
out that Me, i-Pr and t-Bu 2,3-pentadienoates reacted with the aldehyde 1c only in presence of 
30 mol% TBD, whereas with 15 mol% TBD the reaction did not take place at all (Table 9, 
entries 1-5). Thus, ethyl allenoates were shown to be the substrates of choice (Table 9, entry 6), 
since all other investigated esters gave the products in lower yield and needed significantly 
higher loadings of the catalyst.  
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Table 9: Performance of various 2,3-pentadienoate esters 81 in the four step reaction cascade leading to  
cyclic acetals 84.[a] 
 
Entry R 81 Cat [mol%] 
t 
[hh:mm] 84 
Yield of 
84[b] [%] 
1  Me 81c 30 00:15 84cc 48 
2 i-Pr 81d 15 02:00 84dc - 
3  i-Pr 81d 30 00:30 84dc 50 
4 t-Bu  81e 15 02:00 84ec - 
5 t-Bu 81e 30 01:00 84ec 25 
6 Et 81a 15 01:00 84ac 59 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1c; c(81) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1). 
The appropriate amount of TBD was crucial for reactions of allenoate ester 81f as well. This 
sterically hindered substrate bearing a branched iso-propyl rest on the γ-position did not react 
with aldehyde 1b in the presence of 15 mol% catalyst (Table 10, entry 1). Increasing the catalyst 
loading had a beneficial effect, as the final product could be obtained in 44% yield with 30 
mol% catalyst (Table 10, entries 2-3). Similarly, the same relative amount of TBD was found 
to be optimal for achieving maximal yields in the reactions with alkynoate ester 81i (Table 10, 
entries 4-5). 
Table 10: Optimization of catalyst loading for the reactions of allenoate 81f and  
alkynoate 81i.[a] 
 
Entry R 81 Cat.  [mol%] 
t 
[hh:mm] 84 
Yield of 
84[b] [%] 
1 i-Pr 81f 15 01:00 84fb - 
2  i-Pr 81f 25 02:30 84fb 20 
3  i-Pr 81f 30 06:00 84fb 44 
4 n-Bu 81i 15 00:35 84ib - 
5 n-Bu 81i 30 01:00 84ib 51 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1b; c(81) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1). 
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DMF vs. MeCN 
Further investigations were aimed towards the screening of electron neutral aromatic aldehydes 
(i.e. aldehydes lacking any electron withdrawing groups) (Scheme 80). When the reaction was 
carried out in MeCN, benzaldehyde (1a) gave the final product 84aa in only 16% yield. This 
result dramatically improved when DMF was chosen as a reaction solvent and 84aa was 
isolated in 47% yield. A similar trend was observed for 2-naphthaldehyde (1h).  
 
Scheme 80: Optimization of conditions for the reactions with benzaldehyde (1a) and 2-naphthaldehyde (1h). 
This promising result with electron neutral aldehydes motivated us to test DMF as solvent in 
reactions between electron poor aldehydes with allenoate 81f and alkynoate 81i, in order to 
further improve the yields of 4H-1,3-dioxin-6-ylpropanoates 84. As can be seen from Table 11, 
DMF did not have any benefits on the reaction outcome when aromatic aldehydes with electron 
withdrawing groups were used. On the contrary, reactions with methyl 4-formylbenzoate (1i) 
and isophthalaldehyde (1j) gave higher yields when MeCN was used as a solvent. 
Table 11: Comparison between DMF and MeCN as solvents for the reactions with  
electron poor aromatic aldehydes.[a] 
 
Entry Solvent R 81 Ar 84 Yield of 84[b] [%] 
1 DMF n-Bu 81f 4-CO2Me-C6H4 (1i) 84fi 44 
2 MeCN n-Bu 81f 4-CO2Me-C6H4 (1i) 84fi 52 
3 DMF n-Bu 81f 3-CHO-C6H4 (1j) 84fj 34 
4 MeCN n-Bu 81f 3-CHO-C6H4 (1j) 84fj 43 
5 DMF i-Pr 81i 4-CO2Me-C6H4 (1i) 84fi 41 
6 MeCN i-Pr 81i 4-CO2Me-C6H4 (1i) 84fi 51 
7 DMF i-Pr 81i 3-CHO-C6H4 (1j) 84fj 40 
8 MeCN i-Pr 81i 3-CHO-C6H4 (1j) 84fj 40 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1; c(81) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1). 
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Finally, a screening of electron-poor aromatic aldehydes was carried out.  In general, various 
electron withdrawing groups on aromatic aldehydes at the ortho- and meta-position were well 
tolerated. Cyclic acetals 84 with n-butyl or iso-propyl alkyl chains were isolated in yields of up 
to 52% under optimized reaction conditions in MeCN, as summarized in Table 12. 
Table 12: Scope of electron poor aromatic aldehydes in reactions with allenoate ester 81f 
and alkynoate ester 81i.[a] 
 
Entry Ar 1 Product (R = i-Pr) 
Yield of 84[b] 
(R = i-Pr) [%] 
Product 
(R = n-Bu) 
Yield of 84[b] 
(R = n-Bu) [%] 
1 4-Cl-C6H4 1b 84fb 44 84ib 51 
2 4-CO2Me-C6H4 1i 84fi 51 84ii 52 
3 3-CHO-C6H4 1j 84fj 40 84ij 43 
4 4-CF3-C6H4 1k 84fk 33 84ik 51 
5 3-F-C6H4 1l 84fl 40 84il 51 
6 3-Br-C6H4 1m 84fm 44 84im 45 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1; c(81) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1).  
2.3.5  Further Work by Dr. Selig 
With regard to the above presented work, further results obtained by Dr. Selig deserve some 
description.[123] Besides discovering and optimizing reaction conditions, his major contribution 
was also determining the scope of aldehyde substrates. After establishing optimal conditions 
for the reaction between ethyl 2,3-pentadienoate (81a) and 4-nitrobenzaldehyde (81c), a series 
of aromatic aldehydes were tested. Not only halogenated, and nitro-benzaldehydes performed 
well (Table 13, entries 1-4 and 7-11), but also carbonyl (Table 13, entries 4-5), alkyl and alkyl 
ether functionalities (Table 13, entries 12-13 and 15-16) were well tolerated. Benzaldehydes 
with substitutents at ortho-, meta- and para- position were suitable substrates. The highest 
yields were obtained with electron poor aldehydes, whereas electron rich ones gave products in 
significantly lower yields. The best results for aldehydes bearing electron donating groups were 
obtained in DMF. Due to the high Brønsted basicity of TBD, the choice of substrates was 
restricted to aromatic aldehydes, or non-enolizable aliphatic pivaloyl aldehyde (Table 13, entry 
14). When enolizable aliphatic aldehyde 1t (Table 13, entry 18) was subjected to the reaction 
conditions, unselective polymerization and aldol-condensation reactions took place without 
giving any trace of the desired product. 
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Table 13: TBD-catalyzed four-step triple functionalization of ethyl 2,3-pentadienoate (81a) with  
various aldehydes 1.[a] 
 
Entry Solvent R 84 Yield of 84[b] [%] 
1[c] MeCN 4-ClC6H4 (1b) 84ab 60 
2 MeCN 4-NO2C6H4 (1c) 84ac 59 
3 MeCN 2-NO2C6H4 (1d) 84ad 47 
4 MeCN 4-CO2Me-C6H4 (1i) 84ai 60 
5 MeCN 3-CHO-C6H4 (1j) 84aj 45 
6 MeCN 4-CF3-C6H4 (1k) 84ak 60 
7 MeCN 3-F-C6H4 (1l) 84al 51 
8 MeCN 3-Br-C6H4 (1m) 84am 44 
9 MeCN 3-NO2C6H4 (1n) 84an 41 
10 MeCN 4-F-C6H4 (1o) 84ao 42 
11 MeCN 2-F-C6H4 (1p) 84ap 62[d] 
12 DMF 4-OMeC6H4 (1e) 84ae 21 
13 DMF 3,5-(OMe)2C6H4 (1f) 84af 33 
14 DMF t-Bu (1g) 84ag 23 
15 DMF 3-Me-C6H4 (1q) 84aq 50 
16 DMF 3,4-OCH2O-C6H3 (1r) 84ar 38 
17 DMF 2-thienyl (1s) 84as 15 
18 DMF Et (1t) 84at 0 
[a] Reactions were performed on a 0.7–1.0 mmol scale with 4.0 equiv. of 1; c(81a) = 0.05–0.1M. [b] Yields of 
isolated diastereomerically pure products (d.r. > 9:1). [c] 25 mol% TBD used. [d] d.r. = 15:85. 
Structural elucidation of the products was based on X-ray crystal structures obtained for 
products 84aa, 84ag and 84al as well as comparison of NMR data, which showed great 
similarities of significant J-couplings and chemical shifts.[126] 
2.3.6  Summary  
In summary, the synthesis of 4H-1,3-dioxin-6-ylpropanoates, novel cyclic acetals, by guanidine 
organocatalysis has been developed. Products are formed from allenoate esters and non-
enolizable aldehydes by means of a four-step reaction cascade. Preliminary studies show that a 
possible reaction mechanism includes two consecutive MBH-reactions on the α- and γ-position 
of the allenoate, acetalization and a ring closing oxa-Michael reaction. The transformation leads 
to the formation of four new bonds as well as the generation of four new stereogenic centers. 
Products are formed with very high diastereoselectivity. Furthermore, a five-step reaction 
cascade was realized when alkynoate esters were used as starting materials. This was possible 
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because TBD acts both as a Brønsted and a Lewis base and isomerizes alkynoate esters to the 
corresponding allenoate esters. The new transformation was suitable for a broad scope of 
substrates, as electron poor and electron rich aromatic aldehydes as well as allenoate esters with 
branched and linear γ-alkyl substituents performed well. This transformation showcases the 
potential of TBD as a multifunctional organocatalyst enabling complex multistep reaction 
cascades by harnessing a variety of its chemical properties. 
    
 
 
 
58 
 
2.4  Summary and Outlook for Chapter 2 
The major focus of this doctoral work lied in the investigation of bicyclic guanidines as 
multifunctional catalysts (Scheme 81) with particular interest in their application as Lewis 
bases. Within the framework of this work it has been shown that they efficiently catalyze 
Morita-Baylis-Hillman (MBH) type reactions of allenoate esters and provide novel cascade 
reactions leading to highly substituted heterocycles and useful intermediates.  
 
Scheme 81: Bicyclic guanidine bases 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD, 24) and  
N-methyl TBD (MTBD, 71). 
2.4.1  γ-Selective Morita-Baylis-Hillman Reactions of Allenoate Esters 
During investigations with sterically demanding substrates it was discovered that MTBD (71) 
acted as a catalyst for the γ-selective MBH reaction between allenoate esters 79 and aromatic 
aldehydes 1 (Scheme 82). Reaction was suitable for a very broad scope of aldehydes, as electron 
rich and electron poor aromatic aldehydes were equally suitable substrates. 
                                   
Scheme 82: Synthesis of allenic alcohols 80 by γ-selective MBH reaction between allenoate esters 79  
and aromatic aldehydes 1. 
It was anticipated that the products 80 could be useful intermediates for the synthesis of 
heterocycles. By applying gold catalysis, access to dihydrofurans 144 containing a quaternary 
stereogenic center was obtained. Furthermore, reaction with tributylphosphine delivered den- 
 
Scheme 83: Synthesis of dihydrofurans 144 and pyrones 137 from allenic alcohols 80. 
    
 
 
 
59 
 
sely substituted pyrones 137, which are encountered in a number of natural products and 
biologically active compounds (Scheme 83). 
Allenic alcohols 80 can further be used as starting materials for the synthesis of other densely 
functionalized heterocycles (Scheme 84). For example, introducing of electron withdrawing 
groups which do not react with the alcohol moiety upon activation with phosphines and thus do 
not tend to cyclize to pyrones (Section 2.1.5), could be used for the synthesis of oxiranes 199. 
Furthermore, an intramolecular oxa-Michael reaction catalyzed by e.g. Lewis acids (LA) would 
enable a synthesis of oxetanes 198. 
 
Scheme 84: Possible applications of the allenic alcohols 80 for the synthesis of oxetanes 198 and oxiranes 199. 
2.4.2  Diastereoselective Synthesis of Densely Substituted Oxetanes 
TBD (24) was discovered as a new highly active catalyst for the cycloaddition of allenoates 81 
and trifluoromethyl-aryl ketones 82 which allows for the preparation of densely substituted 
oxetanes 83 in a diastereoselective manner and only requires stoichiometric amounts of both 
reactants (Scheme 85). The reaction went to completion within short reaction times and worked 
with α- and α,γ-disubstituted allenoates. 
                                  
Scheme 85: Synthesis of densely substituted oxetanes 83 from allenoate esters 81  
and trifluoromethyl-aryl ketones 82. 
Preliminary experiments also revealed triphenylphosphine as a suitable catalyst leading to the 
same product, but with lower activity and an interesting inversion of diastereoselectivity 
(Scheme 86). 
In recent years, an increased interest in the oxetane moiety for the use in drug discovery has led 
to the commercial production and distribution of numerous building blocks and intermediates 
incorporating this heterocyclic motif.  Many of them are  synthesized from  3-hydroxy oxetane, 
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Scheme 86: Diastereodivergent reactivity of allenoate ester 81a under TBD and PPh3 catalysis. 
a bulk chemical, by transformations made on the hydroxyl functionality (Scheme 87). In a 
similar manner, highly substituted trifluoromethylated oxetanes presented in this work should 
provide a starting point for elaborate investigations enabling preparation of the functionalized 
building blocks for drug discovery research. In this regard, transformations on the double bond, 
such as various types of Michael additions, should be carefully studied.  
         
Scheme 87: Trifluoromethylated oxetanes could be useful substrates for the  
synthesis of novel oxetane building blocks. 
2.4.3  Triple Functionalization of γ-Substituted Allenoate Esters 
TBD (24) catalyzed the reaction between γ-alkyl allenoate esters 81 and aromatic aldehydes to 
give 4H-1,3-dioxin-6-yl-propanoates 84 with excellent diastereoselectivity (Scheme 88). 
                              
Scheme 88: Reaction between allenoate esters 81 and aromatic aldehydes 1 leading to 4H-1,3-dioxin-6-yl-
propanoates 84. 
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Mechanistic studies revealed that these complex heterocycles were obtained as a result of a 
four-step reaction cascade consisting of two consecutive MBH reactions at the α- and γ-
position, acetalization and an oxa-Michael reaction (Scheme 89).  
 
Scheme 89: Proposed mechanism of the formation of 4H-1,3-dioxin-6-yl-propanoates 84 via  
MBH-intermediate 197. 
The obtained products represent appealing structures for studying various follow-up 
transformations which enable the synthesis of densely functionalized building blocks (Scheme 
90). Splitting of the acetal-moiety would give access to a dihydroxylated ketone 200. For 
instance, this compound might be reduced to a highly functionalized polyol 202. The ketone 
200 could also be converted to divinyl ketone 201, which could be further subjected e.g. to a 
Nazarov cyclization or various types of conjugate additions. 
 
 Scheme 90: Cyclic acetals 84 could be useful substrates for the synthesis of various 
 densely functionalized building blocks. 
A logical continuation of all the projects presented in the first part of this thesis is the 
development of corresponding enantioselective variants of the discovered reactions. For this 
purpose, chiral derivatives of bicyclic guanidines must be prepared and studied for their 
catalytic activity. Studies on novel synthetic routes towards chiral bicyclic guanidines were 
another major goal of the doctoral work and will be described in detail in the following part of 
the thesis. 
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3. Synthesis of Chiral Bicyclic Guanidines 
3.1  Introduction 
In this section, a historic perspective on the synthesis of guanidines will be given. In view of 
the particular relevance of bicyclic guanidines for this doctoral work, only the preparation of 
those with [3.3.0]- and [4.4.0]-bicyclic cores will be presented. At first, the preparation of the 
unsubstituted guanidines TBD (24) and TBO (31a) will be presented followed by the 
introduction of syntheses of their substituted derivatives including chiral modifications. 
First Synthesis of TBO and TBD 
Arthur Ferguson McKay[127] is undoubtedly one of the key personalities in modern guanidine 
chemistry. This chemist, who spent a major part of his scientific career at Monsanto Canada, 
also pioneered the syntheses of bicyclic guanidines. 
TBO (31a), a [3.3.0]-bicyclic guanidine base, was first synthesized by McKay in the 
laboratories of Monsanto Canada in 1956 (Scheme 91).[128] His route was based on the seminal 
work of Aspinall and Bianco, who used commercially available ethylene thiourea (203) as 
starting material for the preparation of monocyclic guanidines.[129]  At first, 2-methylmercapto-
2-imidazolium iodide (204) was obtained by refluxing 203 with methyl iodide. The guanidine 
functionality was introduced in the next step by refluxing 2-methylmercapto-2-imidazolium 
iodide (204) with monoethanolamine in chloroform leading to guanidinium iodide 205•HI in 
94% yield. After passing a water solution of the iodide salt through a column of activated 
Amberlite resin and subsequent acidifying with HCl, 2-(β-hydroxyethyl)-2-imidazolinium 
chloride (205•HCl) was obtained in quantitative yield. Reaction of 205•HCl with thionyl  
chloride afforded  2-(β-chloroethyl)-2-imidazolinium chloride (206). The final cyclization step 
                     
Scheme 91: First synthesis of TBO (31a). 
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was carried out in absolute ethanol with a slight excess of KOH, to maintain alkaline pH during 
the reaction. Finally, the cyclized guanidine 31a was obtained by extraction of the crude 
reaction product with boiling acetone and subsequent evaporation. 
One year later, McKay introduced another approach towards TBO (31a).[130] This time, his 
route was mainly inspired by the work of Hurwitz (Scheme 92).[131] Here, McKay refluxed a 
mixture of diethylenetriamine (207) and carbon disulfide in benzene to obtain cyclic thiourea 
208 in 31% yield. This result was in good agreement with the report of Hurwitz who obtained 
the desired thiourea in 34%. In the next step, the target compound 31a was synthesized by 
cyclization of the cyclic thiourea under various conditions: a) Refluxing with AgNO3 solution 
(47% yield), b) Stirring with HgO at room temperature (33% yield); c) refluxing with 
chloroacetic acid (77% yield).  
 
Scheme 92: Synthesis of TBO (31a) starting from diethylenetriamine (207). 
The synthesis of TBD (24) was carried out in analogy to the first route described for the 
preparation of TBO (31a) (Scheme 93).[55] Carbon disulfide was reacted with  
1,3-diaminopropane (209) and γ-aminopropyldithiocarbamic acid zwitterion intermediate was 
subsequently cyclized to hexahydropyrimidine-2-thione (210) at elevated temperature. 
Afterwards, 2-methylmercapto-Δ2-tetrahydropyrimidinium iodide (211) was obtained by 
refluxing 210 with equimolar amounts of methyliodide. Refluxing 211 with 3-amino-1-
propanol led to the formation of 2-(γ-hydroxypropylamino)-Δ2-tetrahydropyrimidinium iodide 
(212•HI). The corresponding chloride salt was obtained by passing the water solution of 
212•HI  through  a column  of activated  Amberlite resin  and subsequent acidifying  with HCl.  
 
Scheme 93: First synthesis of TBD (24). 
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Finally, chlorination with thionyl chloride and cyclization upon treatment with aqueous KOH 
solution gave the desired bicyclic guanidine 24. 
Synthesis of Substituted Bicyclic Guanidines by a Thiocarbonyl Approach 
After the opening work on the synthesis of bicyclic guanidines by McKay, more than two 
decades passed until new significant contributions in this field were made. At first, the need for 
novel synthetic routes towards bicyclic guanidines arose in the field of molecular recognition. 
Of particular interest was the application of guanidinium cations as specific binding receptors 
for a variety of anions such as carboxylates and phosphates. As Franz Schmidtchen approached 
this topic, he was interested in the possibility to embed [4.4.0]-bicyclic guanidine substructures 
in rigid molecular skeletons. For that purpose he set out to prepare symmetric TBD-derivatives 
214 with various aliphatic groups R (Scheme 94). Especially useful were the structures with 
allyl substitutents, due to the fact that allylic double bonds could be modified without destroying 
the guanidine scaffold and would thus enable the covalent binding of guanidine to other 
molecules. As a matter of fact, the synthesis of TBD developed by McKay was not applicable 
for the alkyl substituted derivatives owing to unselective regioisomer formation. Therefore, 
Schmidtchen chose to prepare a triamine precursor 215 which would be cyclized to the bicyclic 
target molecule at the late stages of the synthesis (Scheme 94).[132] 
 
Scheme 94: Retrosynthetic analysis of the substituted TBD derivative 214 using a thiocarbonyl approach. 
At first, he converted the known diethanolamine 216 to the iodide 217. Introduction of the 
allylic substituents was achieved by alkylation of α-branched esters leading to intermediate 218 
(Scheme 95).  Subsequent  transformation  of the ester  functionalities to  carboxylic acids and  
 
Scheme 95: Synthesis of alkyl substituted guanidines by developed by Schmidtchen.[132] 
    
 
 
 
65 
 
Curtius reaction followed by deprotection of the secondary amine afforded the desired triamine 
precursor 215. Afterwards, cyclic thiourea 219 was obtained by treatment of 215 with 
thiophosgene. Conversion of 219 to methylmercapto-tetrahydropyrimidinium iodide 220 and 
final cyclization gave the target guanidine 214. 
In the following years, this work of Schmidtchen has become a major reference for the 
syntheses of various types of substituted bicyclic guanidines. What is more important, the 
thiocarbonyl approach enabled syntheses of chiral bicyclic guanidines which subsequently 
found applications in the field of molecular recognition. As the tremendous potential associated 
with enantioselective guanidine organocatalysis was recognized, there was renewed interest in 
the synthesis of chiral bicyclic guanidines by this scheme. Although late cyclization stages 
included variations of the thiocarbonyl equivalent (e.g. CS2[133] or Me2CS3[27b]), the general 
strategy remained the same, as it always included the synthesis of a triamine precursor. As a 
result, a broad variety of chiral guanidines were synthesized in the following years which 
possessed either [4.4.0]- or [3.3.0]-bicyclic cores (Scheme 96). 
 
Scheme 96: Examples of chiral bicyclic guanidines prepared by the thiocarbonyl approach. 
Synthesis of Substituted Bicyclic Guanidines by Guanylation Approach 
Interestingly, another significant contribution to the synthesis of substituted bicyclic guanidines 
was made by Schmidtchen as well. In one of his very last published works, he used an approach 
which made use of guanylation reagent 224 (Scheme 97).[136] 
 
Scheme 97: Retrosynthetic analysis of the substituted TBD derivative using guanylation approach.  
LG = leaving group. 
At an early stage of the described route, protected methioninol 225 was prepared from 
methionine. The key step was the reaction between amine 225 and guanylation reagent 224 
upon treatment of the reaction mixture with catalytic amounts of TFA (Scheme 98). 
Displacement of the imidazole leaving groups by two equivalents of 225 led to the formation 
of open-chain guanidinium salt 226. Transformation of both methyl sulfide ethers to 
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dimethylsulfonium iodide leaving groups and subsequent cyclization under basic reaction 
conditions led to a chiral [4.4.0]-bicyclic guanidininium salt 227.[137] Despite the conciseness 
of this elegant route, it has never been used for the synthesis of bicyclic guanidines since then. 
 
Scheme 98: Synthesis of guanidinium salt 227 by the guanylation approach. 
3.2  Synthesis of a Chiral [3.3.0]-Bicyclic Guanidinium Salt 
3.2.1  Goals of the Project 
In the first chapter of this thesis it has already been mentioned that chiral derivatives of TBO 
have gained great success as organocatalysts. The most prominent example is the guanidine 31c 
bearing two tert-butyl groups,[30] which was first introduced by Tan et al. in 2006 and has been 
used for numerous enantioselective transformations since then.[138] According to the published 
report, this structure can be prepared in only five synthetic steps from commercially available 
tert-leucinol (228) (Scheme 99). 
 
Scheme 99: Synthesis of the chiral bicyclic guanidine 31c. 
Tan’s synthesis commenced with the cyclization of aminoalcohol 228 to aziridine 229. 
Afterwards, diamine 230 was obtained by treatment of 229 with ammonia. This intermediate 
was used without purification to open another equivalent of aziridine 229, leading to triamine 
231. Finally, deprotection of 231 and cyclization with dimethyl trithiocarbonate afforded the 
guanidine 31c. 
Despite the supposed ease and conciseness of the synthetic scheme reported by Tan et al., the 
thiocarbonyl approach turned out to suffer from a severe lack of reproducibility.[139] In fact, 
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even in the original work, only a small scale synthesis (0.16 mmol ≈ 30 mg scale!) of the related 
[3.3.0]-bicyclic guanidine was reported which suggested that the final cyclization of triamine 
232 was not a trivial task. For this reason, it was decided to develop a novel synthesis of elusive 
guanidine 31c. The new route had to follow the guanylation strategy introduced by Schmidtchen 
et al. (Scheme 100), as it had already been used in the research group of Dr. Selig for the 
syntheses of other chiral bicyclic guanidines.[140] Moreover, this method had proven to combine 
robustness with simple scalability, which would enable rapid preparation of practical amounts 
of 31c.  
 
Scheme 100: Retrosynthetic analysis of guanidine 31c by the guanylation approach. 
3.2.2  Synthesis of Acyclic Guanidinium Salt 
At first, TBDPS-protection of the hydroxy function of tert-leucinol 228 was carried out 
(Scheme 101). This step was necessary to mask the nucleophilic alcohol functionality which 
could lead to unwanted side reactions during the guanylation step.[141] Although the amounts of 
imidazole and TBDPSCl were adopted from the reported procedure,[140] chromatographic 
purification afforded the product 234 in only 44% yield. The corresponding hydrochloride salt 
was isolated as a slightly more polar fraction and was subsequently washed with aqueous 
NaHCO3 solution to give an additional portion of compound 234 in 36% yield (80% combined 
yield).  
 
Scheme 101: Protection of the aminoalcohol 228. 
Protected aminoalcohol 234 was used in the next reaction step leading to chiral acyclic 
guanidinium salt 235 (Table 14). Initial guanylation conditions were adopted from the master’s 
thesis of Roman Honeker who carried out a related reaction at 115 °C for 2 h in presence of 1 
equivalent of TFA.[140] Due to the fact that the desired product was obtained in only 26% yield 
(Table 14, entry 1), it was decided to lower the reaction temperature to avoid eventual 
decomposition of the guanylation reagent 224.[142] As a result, running the reaction at 105 °C 
for a longer time gave the guanidinium trifluoroacetate 235 in an acceptable yield of 40% (Table 
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14, entries 2-3). Reaction yields could only be estimated due to the presence of some unknown 
impurities in the final product (ca. 5 to 20 mol%). It is noteworthy to mention that the 
guanylation reaction was carried out without solvent leading to an extremely high viscosity of 
the reaction mixture which made the use of stirring bars impractical. Using a Kugelrohr oven 
as a reactor provided a brilliant solution to this problem enabling even mixing of the reaction 
mixture without using a stirring bar.[139] 
Table 14: Optimization of guanylation reaction leading to open chain guanidinium salt 235. 
 
Entry T [°C] t [h] Yield of 235[a] [%] 
1 115 2 26 
2 105 2 20 
3 105 4 40 
[a] Yield of isolated product. 
The major obstacle of this reaction step was the fact that protected aminoalcohol 234, which 
was not completely consumed during the reaction, could not be separated from the product 235 
by column chromatography. In fact, both compounds showed exactly the same Rf -values when 
a standard eluent consisting of CH2Cl2 and MeOH was used. Luckily, it was found that 
guanidinium salt 235 could be easily separated from unreacted aminoalcohol 234 by column 
chromatography when a small amount of AcOH was added to the eluent. Presumably, this led 
to the formation of the ammonium salt of 234 which was significantly more polar than the 
guanidinium salt 235 so that the latter compound could be isolated as a less polar fraction 
without concomitant starting material. 
3.2.3  Alcohol Deprotection 
Cleavage of the silyl protecting groups was carried out to afford diol 236 at the next stage 
(Scheme 102). This new compound contained two alcohol functions in addition to a 
guanidinium motif and therefore, as had been expected, had an extremely high polarity. It was 
decided to use fluoride on polymer carrier as a reagent for the deprotection instead of well-
known TBAF, since it avoided contamination of 236 with the tetrabutyl ammonium salt.[139] 
Indeed, the desired guanidinium 236 was obtained in a very pure form by simple filtration and 
washing  of the crude  reaction product with  pentane/diethyl  ether mixture.  The yield of 236  
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Scheme 102: Deprotection of the diol 235 with fluoride on polymer. 
could only be estimated because some unknown impurities were present in 235 after the 
guanylation reaction. 
3.2.4  Chlorination and Cyclization 
Synthesis of dichloride 237, which was the substrate for the final cyclization step, was achieved 
by reacting 236 with excess thionyl chloride at 65 °C (when this reaction was attempted at r.t., 
incomplete conversion of 236 was observed). The crude reaction product was directly used in 
the next stage without purification (Scheme 103). The cyclization reaction was carried out under 
reaction conditions analogous to those reported by Schmidtchen et al.. After resuspending 237 
in MeCN and adding an excess of DBU, complete conversion of the starting material was 
observed after 28h. Subsequent work up with HCl and chromatographic purification afforded 
two guanidinium salts 239 and 240. Interestingly, no traces of the desired guanidine 31c were 
detected, as 239 was the only bicyclic product formed during the reaction. 
 
Scheme 103: Chlorination of diol 236 and final cyclization. 
A possible explanation for the formation of 239 is presented in Scheme 104. We initially 
expected that formation of the desired guanidinium salt 31c would be governed by a twofold 
intramolecular chloride displacement by the sterically less substituted nitrogen atom (Scheme 
104b). This reaction pathway was supposed to be the preferred one, since alkyl substituted 
nitrogen atoms possessed a major steric hindrance due to the neighborhood of bulky tert-butyl 
groups. As we observed the exclusive formation of 239, it became apparent that the alternative 
reaction pathway, where preferential nucleophilic attack by a secondary amine group took 
place, was governed by electronic rather than steric factors (Scheme 104a). We suggest that the 
tert-butyl group had a strong electron donating effect which resulted in enhanced nucleophili- 
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Scheme 104: Proposed mechanistic rationale explaining the formation of the undesired bicyclic guanidinium salt 
239 (Patway a). Formation of the bicyclic guanidine 31c (Pathway b) was not observed. 
city of the neighboring nitrogen atom. Thus, initial nucleophilic chloride displacement took 
place on the more substituted nitrogen atom leading to intermediate 240, which subsequently 
cyclized to the bicyclic guanidinium salt 239.
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3.3  Synthesis of a Chiral [4.4.0]-Bicyclic Guanidinium Salt 
3.3.1  Goals of the project 
Owing to the fact that several racemic reactions catalyzed by [4.4.0]-bicyclic guanidines TBD 
(24) and MTBD (71) were discovered within the framework of this doctoral work, 
investigations aimed towards enantioselective versions of those transformations were highly 
desirable. For that purpose, the synthesis of a chiral [4.4.0]-bicyclic guanidine was the next 
stage of ongoing research.  
Guanidine 223, which was reported by Davis et al.,[27b] appeared to be an appealing candidate 
for enantioselective catalysis due to the significant steric bulk of two benzhydryl groups in 
direct proximity to the catalytically active center. The reported synthesis had been achieved in 
16 linear reaction steps starting from commercially available methionine (Scheme 105). 
Preparation of 223 was anything but simple, as it required elaborate choices of protecting 
groups which had to be changed several times during the reaction sequence. Also, two 
intermediates, including the triamine precursor 243, were unstable compounds which had to be 
used immediately in subsequent reactions.  
 
Scheme 105: Synthesis of the [4.4.0]-bicyclic guanidine 223 via triamine intermediate 243  
developed by Davis et al..[27b] 
We sought to address the problems associated with the choice of appropriate protecting groups 
and unstable intermediates by applying the guanylation approach (Scheme 106). The synthesis 
of a [3.3.0]-bicyclic guanidinium salt 239 (see Scheme 104) showed that the scheme introduced 
by Schmidtchen was indeed very robust and all the intermediates were bench stable. 
Application of this synthetic route to the preparation of another bicyclic guanidine was also 
important in order to further study the regioselectivity of the final cyclization step.  
 
Scheme 106: Retrosynthetic analysis of guanidine 223 by the guanylation approach. 
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3.3.2  Synthesis of the Chiral Aminoalcohol 
Synthesis of the target compound started from the chiral intermediate 246. [143] At first, primary 
alcohol and amine functionalities had to be protected in order to enable flawless removal of the 
tertiary hydroxyl group by transfer hydrogenolysis in the following step. Aminodiol 246 was 
acylated by treatment with acetic anhydride in the presence of pyridine (Scheme 107). Protected 
aminodiol 247 was obtained after acidic workup and recrystallization from hexane/EtOAc.  
 
Scheme 107: Acetylation of the aminodiol 246. 
Protection was followed by the hydrogenolysis reaction (Scheme 108). The procedure was 
operationally simple and safe because it did not involve the use of hydrogen gas and was carried 
out under transfer conditions. Using a catalytic amount of palladium on charcoal and excess 
ammonium formate, the reaction was carried out at 110 °C. It is highly recommended to monitor 
the reaction progress by NMR spectroscopy, since complete conversion of the starting material 
could not be sufficiently detected using TLC at the late stage of the reaction. The crude reaction 
product 248 was obtained after acidic work up and used in the following step without additional 
purification. 
 
Scheme 108: Hydrogenolytic removal of the benzylic hydroxyl group. 
Deacetylation of 248 under acidic conditions led to the chiral aminoalcohol 242 (Scheme 109). 
This compound was obtained after basic workup of the reaction mixture and was used for the 
subsequent transformation without additional purification. NMR spectra and specific rotation 
of 242 were in a good agreement with the reported data and indicated that no racemization 
occurred.[143] 
 
Scheme 109: Deacetylation of the chiral aminoalcohol. 
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3.3.3  TBDPS-Protection and Guanylation 
The alcohol functionality of 242 was protected with TBDPSCl in the presence of imidazole 
(Scheme 110). The whole reaction sequence starting from 246 was easily scalable, so that 7.4 
g of silylated aminoalcohol 245 could be prepared in a single run.  
 
Scheme 110: TBDPS-protection of the aminoalcohol 242. 
The guanylation step was carried out under reaction conditions used for the synthesis of the 
acyclic guanidinium salt 235 without further optimization (Scheme 111). Purification was 
analogous to that presented in the previous chapter (column chromatography with an eluent 
containing a small amount of AcOH) and the open chain guanidinium trifluoroacetate 249 was 
obtained in 38% yield. 
 
Scheme 111: Guanylation reaction leading to open chain guanidinium salt 249. 
3.3.4  Deprotection and Chlorination 
Cleavage of the silyl protecting groups was carried out to afford diol 244 at the next stage 
(Scheme 112). Owing to the very high polarity of guanidinium salt 244, all apolar impurities 
were  easily  removed  by  filtration  and  washing  of  the  crude  reaction  product  with  pen- 
 
Scheme 112: Deprotection and chlorination of the symmetric bicyclic guanidinium salt 249. 
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tane/diethyl ether. This intermediate was obtained as a mixture of guanidinium fluoride and 
trifluoroacetate salts. Therefore, the yield of this reaction is only an estimated value. 
Subsequent reaction of 244 with thionyl chloride gave dichloride 250. The crude product of this 
reaction was used in the following cyclization step without additional purification.  
3.3.5  Cyclization  
After resuspending 250 in MeCN and adding excess DBU, complete conversion of the starting 
material was observed after 20 h (Scheme 113). Subsequent work up with HCl and 
chromatographic purification afforded the desired guanidinium salt 223•HCl in 11% yield. Its 
regioisomer 251 was formed in 49% yield as a major reaction product. 
 
Scheme 113: Final cyclization step. 
The explanation for the preferential formation of undesired regioisomer 251 is similar to that 
for the previously observed formation of the [3.3.0]-bicyclic guanidinium salt 239 (Scheme 
114). It was suggested that the benzhydryl  group  had a strong  electron donating effect  which  
 
Scheme 114: Proposed mechanistic rationale explaining the preferential formation of the undesired bicyclic 
guanidinium salt 251 (Patway a). The desired guanidinium salt 223•HCl was formed as a minor regioisomer 
(Pathway b). 
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resulted in enhanced nucleophilicity of the neighboring nitrogen atom. Thus, the initial 
nucleophilic chloride displacement preferentially took place on the more substituted nitrogen 
atom leading to monocyclic intermediate 252 (Scheme 114a), which subsequently cyclized to 
the bicyclic guanidine 251. 
3.4  Summary and Outlook for Chapter 3 
Studies towards syntheses of chiral [3.3.0]- and [4.4.0]-bicyclic guanidines were undertaken. 
The strategy applied in this work made use of guanylation reagent di(1H-imidazol-1-
yl)methanimine (224). In contrast to the frequently used methodology based on cyclization of 
triamine precursors, this approach allows for the installation of the guanidine moiety into the 
molecular scaffold prior to the final cyclization step.  
Attempts to apply this new strategy for the synthesis of the [3.3.0]-bicyclic guanidine 31c failed, 
as the only bicyclic product formed in course of the final cyclization reaction was the undesired 
regioisomer 239 (Scheme 115). Preference for the observed reaction pathway was attributed to 
the higher nucleophilicity of alkyl-substituted nitrogen atoms. Presumably, it resulted from 
electron-donating effects of neighboring tert-butyl groups. 
 
Scheme 115: Attempted synthesis of the bicyclic guanidine 31c. 
The guanylation approach was also applied to the synthesis of a [4.4.0]-bicyclic guanidinium 
salt 223•HCl, which had previously been reported by Davis et al. (Scheme 116). This 
compound was prepared in 12 synthetic steps starting from commercially available methionine 
(241).[143] The last cyclization step was a critical point in this reaction sequence as well and 
gave the desired bicyclic product in only 11% yield as a minor reaction product. Again, the 
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electron-donating effect of benzhydryl groups was supposed to have a detrimental effect on 
reaction selectivity. 
Nevertheless, this investigation has shown a great potential of the applied strategy, as it was 
suitable for construction of both [4.4.0]- and [3.3.0]-bicyclic guanidine scaffolds. In fact, this 
has been the first synthesis of a chiral [3.3.0]-bicyclic guanidine by the guanylation approach.  
 
Scheme 116: Synthesis of the bicyclic guanidine 223. 
Other important advantages of the novel route are firstly its robustness, secondly its 
experimental simplicity, and lastly reproducibility of the synthetic operations. All intermediates 
are bench-stable and no special precautions concerning their storage are necessary. Overall, the 
guanylation approach  fully deserves further  investigations aimed towards regioselective con- 
 
 Scheme 117: Proposed retrosynthetic analysis enabling regioselective syntheses of [3.3.0]-bicyclic guanidinium 
salts. By using homologous amines, this approcach could also enable the synthesis of [4.4.0]-bicyclic 
guanidinium salts. PG = protecting group. 
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struction of bicyclic guanidine structures. 
Absolute regioselectivity in the final cyclization step might be achieved by protecting of the 
alkyl substituted nitrogen atoms (Scheme 117). In this case, using precursors 256 in the 
guanylation step represents a possible retrosynthetic scenario, because di(1H-imidazol-1-
yl)methanimine (224) was reported to react more readily with secondary amines than with 
primary ones.[136] The final deprotection step would lead to the target bicyclic guanidine 
structures.
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4. Experimental part 
4.1  General  
Reagents and solvents 
Liquid aldehydes (1a, 1e, 1f, 1g, 1k, 1l, 1m) were purified before use by the following 
procedure: An aldehyde was washed with saturated aqueous NaHCO3 solution, dried over 
MgSO4 and then distilled by using Kugelrohr. These aldehydes were then used immediately 
after purification. Solid aldehydes (1c, 1d, 1h, 1i, 1j) were dissolved in Et2O, washed with 
NaHCO3 (sat. aq.) and recrystallized from Et2O. 
Allenoates 79a-d, 81a-g[145] and alkynoate 81i[33] were synthesized using literature-known 
methods.  
Solvents for column chromatography and TLC (EtOAc, MeOH, CH2Cl2, pentane, Et2O) were 
of technical grade. EtOAc, MeOH and CH2Cl2 were distilled before use. THF was of technical 
grade, purified by distillation and stored over KOH. Afterwards, it was distilled over 
SOLVONA® and stored over molecular sieves (4 Å). MeCN (HPLC-grade or extra dry) and 
DMF (HPLC-grade) were obtained commercially and used without further purification. 
Working techniques 
Reactions with moisture or air sensitive compounds were carried out using the standard 
Schlenk-technique. If the reactions were carried out below room temperature, the following 
cooling baths were employed: Dry ice/isopropanol (–20 to –30 °C), crushed ice/water (0 °C). 
Glass stoppers and teflon rings were used to seal reaction vessels. The temperature of each 
reaction indicates the temperature of the cooling or heating medium. Yields of the reactions 
were calculated from the mass of purified and dried products. For column chromatography, 
silica gel 60 (230-400 mesh) was employed. 
Analysis 
Thin layer chromatography was carried out with ready-to-use glass plates coated with silica gel 
from Macherey-Nagel (G-25254). Detection was done both by irradiation of the plate with UV-
light at 254 nm and by application of specific staining reagents. The staining reagent mostain 
was prepared by dissolving 10 g (NH4)6Mo7O24·4H2O and 0.2 g Ce(SO4)2·4H2O in 200 mL of 
10% H2SO4. The staining reagent KMnO4 was prepared by dissolving 3 g KMnO4 and 10 g 
K2CO3 in 300 mL water followed by addition of 5 mL 5% aqueous NaOH. The staining reagent 
bromocresol green was prepared by adding 0.04 g bromocresol green to 100 mL EtOH. Then a 
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0.1 M NaOH solution was slowly dripped in until the solution just turned pale blue. The staining 
reagent ninhydrin was prepared by dissolving 0.1 g ninhydrin and 0.5 mL acetic acid in 100 
mL acetone. 
NMR spectra were recorded on the following spectrometers: Varian Mercury 300 (300 MHz), 
Varian Innova 400 (400 MHz) and Varian Innova 600 (600 MHz with cryogenic NMR sample 
head). Chemical shifts δ were given in ppm. Referencing of the spectra was done using solvent 
residual peaks for the samples recorded in CDCl3, methanol d-6, DMSO d-6 and CD3CN.[144] 
Coupling constants J were given in Hz. The following abbreviations were used to describe the 
signals in the NMR spectra: s – singlet, d – doublet, t – triplet, q – quartet, qi – quintet, sext – 
sextet, sept – septet and m – complex multiplet. The abbreviation “virt x” was used to show that 
the detected signal seemed to look like x (e.g. “virt t” stands for “virtual triplet”). NMR signals 
in the mixtures of diastereomers were separated with a slash “/”. 
Mass spectra were recorded with the EI device Thermo Fisher Scientific ISQ at ionization 
energy of 70 eV.  
Mass spectra were recorded using the following devices: Finnigan SSQ7000 (EI, 70 eV), 
Thermo Finnigan LCQ Deca XP Plus (ESI) or ThermoFisher Scientific LTQ Orbitrap XL (ESI, 
HR-ESI) spectrometer. 
IR spectra were recorded using a Perkin-Elmer FT-IR Spectrum 100 device with a 
diamond/KRS5 ATR-unit. 
Melting points were measured on a Büchi B-540 melting point apparatus and are uncorrected. 
4.2  Experimental Procedures and Analytical Data for Section 2.1 
4.2.1  Standard Experimental Procedures 
Standard experimental procedure (S1) for γ-MBH reactions 
Allenoates 79a-d (2.0 equiv.) and the respective aldehyde 1 are dissolved in DMF at room 
temperature in a Schlenk-flask. Catalyst (20 - 30 mol% MTBD) is added all at once, and the 
reaction mixture is stirred at r.t. for the indicated time (typically 1.5-5 h). The reaction is 
quenched by the addition of solid NH4Cl (excess), filtered and the NH4Cl washed with EtOAc. 
The organic layer is washed with H2O (30 mL) and LiCl (5% aq, 30 mL), dried over MgSO4, 
filtered and the solvent evaporated. The residue is purified by flash column chromatography to 
give the products 80. 
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Standard experimental procedure (S2) for pyrone syntheses 
The γ-MBH products 80 are dissolved in MeCN at room temperature in a Schlenk-flask. 
Tributylphosphine (119, 1 equiv.) is added, and the reaction mixture is stirred at r.t. for 18 h. 
After evaporation of the solvent, the residue is purified by flash column chromatography to give 
the products 137. 
Standard experimental procedure (S3) for dihydrofuran syntheses 
The γ-MBH products 80 are dissolved in CH2Cl2 at room temperature in a round-bottom flask. 
(PPh3)AuCl (10 mol%) and AgOTf (10 mol%) are added to the solution, and the resulting 
suspension is stirred at r.t. for 1.5 h. After evaporation of the solvent, the residue is purified by 
flash column chromatography to give the products 144. 
4.2.2  Spectroscopic Data Related to Table 2 
rac-ethyl 5-(4-chlorophenyl)-5-hydroxy-2,4-dimethyl-2,3-pentadienoate (80ab) (Table 2, 
entry 1). 
Allenoate 79a (106 mg, 756 µmol, 2.0 equiv.) and aldehyde 1b (51 mg, 366 
µmol, 1.0 equiv.) were reacted in DMF (3.8 mL) with MTBD (13 µl, 14 mg, 91 
µmol, 25 mol%) using standard procedure S1 (1.5 h, r.t.). The product 80ab (92 
mg, 326 µmol, 89%, 47:53 d.r.) was obtained as a yellowish oil after purification 
of the crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 8/2).  
Rf = 0.38 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 8.8 Hz, 2H, CHAr, both diastereomers), 7.29 (d, J = 
8.4 Hz, 2H, CHAr, minor diastereomer), 7.28 (d, J = 8.8 Hz, 2H, CHAr, major diastereomer), 
5.23 (s, 1H, CHOH, major diastereomer), 5.11 (s, 1H, CHOH, minor diastereomer), 4.24 – 4.09 
(m, 2H, CO2CH2CH3 both diastereomers), 3.02 (s br, 1H, OH, minor diastereomer), 2.99 (s br, 
1H, OH, major diastereomer), 1.87 [s, 3H, (CH3)CCO2Et, minor diastereomer], 1.85 [s, 3H, 
(CH3)CCO2Et, major diastereomer], 1.61 [s, 3H, (CH3)CCHOH, major diastereomer], 1.58 [s, 
3H, (CH3)CCHOH, minor diastereomer], 1.28 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.3 (s, =C=), 167.9 (s, COOEt), 139.9 
(s, CArCHOH), 134.0 (s, CArCl), 128.8 (d, CArH), 128.5 (d, CArH), 106.5 (s, CCHOH), 98.5 (s, 
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CCOOEt), 74.6 (d, CHOH), 61.30 (t, CO2CH2CH3), 15.49 [q, (CH3)CCO2Et], 14.53 (q, 
CO2CH2CH3). The signal (CH3)CCHOH was not included due to overlaps resulting from low 
resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.7 (s, =C=), 168.0 (s, COOEt), 139.8 
(s, CArCHOH), 133.6 (s, CArCl), 128.6 (d, CArH), 127.9 (d, CArH), 106.0 (s, CCHOH), 97.4 (s, 
CCOOEt), 74.5 (d, CHOH), 61.26 (t, CO2CH2CH3), 15.48 [q, (CH3)CCO2Et], 14.54 (q, 
CO2CH2CH3), 13.5 [q, (CH3)CCHOH].  
IR (film) ν̃ = 3912 cm-1 (w), 3438 (s), 2982 (s), 1964 (s, =C= allene), 1700 (s, CO2Et), 1589 
(m), 1484 (s), 1374 (s), 1273 (s), 1125 (s), 1023 (s), 911 (w), 842 (s), 767 (m). 
MS (EI, 70 eV) m/z (%) 281.1 (5) [M+], 263.1 (100) [(M-OH)+], 235.1 (5) [(MOEt)+], 217 
(41). 
MS (ESI, Orbitrap) m/z 303.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C15H17ClNaO3+ (M+Na+): 303.07584; found: 303.07474. 
rac-ethyl 5-hydroxy-2,4-dimethyl-5-phenyl-2,3-pentadienoate (80aa) (Table 2, entry 2). 
Allenoate 79a (93 mg, 663 µmol, 2.0 equiv.) and aldehyde 1a (34 µL, 35 mg, 332 µmol, 1.0 
equiv.) were reacted in DMF (1.7 mL) with MTBD (10 µl, 11 mg, 70 µmol, 20 
mol%) using standard procedure S1 (1.5 h, r.t.). The product 80aa (78 mg, 315 
µmol, 95%, 46:54 d.r.) was obtained as a yellowish oil after purification of the 
crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 85/15).  
Rf = 0.28 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.45 (m, 2H, CHAr, both diastereomers), 7.39 – 7.27 (m, 
3H, CHAr, both diastereomers), 5.29 (s, 1H, CHOH, minor diastereomer), 5.17 (s, 1H, CHOH, 
major diastereomer), 4.28 – 4.10 (m, 2H, CO2CH2CH3 both diastereomers), 3.01 (s br, 1H, OH, 
minor diastereomer), 2.99 (s br, 1H, OH, major diastereomer), 1.92 [s, 3H, (CH3)CCO2Et, 
major diastereomer], 1.91 [s, 3H, (CH3)CCO2Et, minor diastereomer], 1.67 [s, 3H, 
(CH3)CCHOH, minor diastereomer], 1.65 [s, 3H, (CH3)CCHOH, major diastereomer], 1.33 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.32 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer). 
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13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.4 (s, =C=), 168.1 (s, COOEt), 141.5 
(s, CArCHOH), 128.5 (d, CArH), 128.1 (d, CArH), 127.0 (d, CArH) 106.7 (s, CCOOEt), 97.0 (s, 
CCHOH), 75.2 (d, CHOH), 61.2 (t, CO2CH2CH3), 15.43 [q, (CH3)CCO2Et], 14.43 (q, 
CO2CH2CH3). The signal (CH3)CCHOH was not included due to overlaps resulting from low 
resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.9 (s, =C=), 168.2 (s, COOEt), 141.4 
(s, CArCHOH), 128.3 (d, CArH), 127.8 (d, CArH), 126.5 (d, CArH) 106.3 (s, CCOOEt), 97.9 (s, 
CCHOH), 75.0 (d, CHOH), 61.1 (t, CO2CH2CH3), 15.45 [q, (CH3)CCO2Et], 14.45 [q, 
CO2CH2CH3], 13.6 [q, (CH3)CCHOH]. 
IR (film) ν̃ = 3439 cm-1 (s), 2981 (s), 1964 (s, =C= allene), 1700 (s, CO2Et), 1451 (s), 1381 (s), 
1269 (s), 1125 (s), 1029 (s), 866 (w), 749 (s). 
MS (EI, 70 eV) m/z (%) 245.9 (1) [M+], 229.3 (15) [(M-OH)+], 201.0 (7) [(MOEt)+], 182.4 
(26), 139.8 (100), 77.4 (18) [Ph+]. 
MS (ESI, Orbitrap) m/z 285.1 (M+K+), 269.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C15H18NaO3+ (M+Na+): 269.11482; found: 269.11490. 
rac-ethyl 5-hydroxy-2,4-dimethyl-5-(4-nitrophenyl)-2,3-pentadienoate (80ac) (Table 2, 
entry 3). 
Allenoate 79a (90 mg, 642 µmol, 2.0 equiv.) and aldehyde 1c (48 mg, 321 µmol, 1.0 equiv.) 
were reacted in DMF (1.7 mL) with MTBD (9 µl, 10 mg, 63 µmol, 20 mol%) 
using standard procedure S1 (1.5 h, r.t.). The product 80ac (69 mg, 237 µmol, 
74%, 45:55 d.r.) was obtained as a yellow oil after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 8/2).  
Rf = 0.24 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 8.8 Hz, 2H, CHAr, major diastereomer), 8.16 (d, J = 
8.8 Hz, 2H, CHAr, minor diastereomer), 7.63 (d, J = 8.4 Hz, 2H, CHAr, minor diastereomer), 
7.58 (d, J = 8.4 Hz, 2H, CHAr, major diastereomer), 5.40 (s, 1H, CHOH, minor diastereomer), 
5.29 (s, 1H, CHOH, major diastereomer), 4.25 – 4.09 (m, 2H, CO2CH2CH3 both diastereomers), 
3.56 (s br, 1H, OH, major diastereomer), 3.36 (s br, 1H, OH, minor diastereomer), 1.86 [s, 3H, 
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(CH3)CCO2Et, major diastereomer], 1.84 [s, 3H, (CH3)CCO2Et, minor diastereomer], 1.62 [s, 
3H, (CH3)CCHOH, minor diastereomer], 1.61 [s, 3H, (CH3)CCHOH, major diastereomer], 1.29 
(t, J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, 
major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 207.4 (s, =C=), 168.0 (s, COOEt), 148.7 
(s, CArNO2), 147.7 (s, CArCHOH), 127.7 (d, CArH), 123.7 (d, CArH), 105.9 (s, CCOOEt), 98.2 
(s, CCHOH), 74.3 (d, CHOH), 61.5 (t, CO2CH2CH3), 15.4 [q, (CH3)CCO2Et], 14.47 (q, 
CO2CH2CH3), 13.9 [q, (CH3)CCHOH]. 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 207.8 (s, =C=), 167.8 (s, COOEt), 148.9 
(s, CArNO2), 147.5 (s, CArCHOH), 127.2 (d, CArH), 123.6 (d, CArH), 105.3 (s, CCOOEt), 97.2 
(s, CCHOH), 61.4 (t, CO2CH2CH3), 15.4 [q, (CH3)CCO2Et], 14.53 (q, CO2CH2CH3), 13.1 [q, 
(CH3)CCHOH]. The signal CHOH was not included due to overlaps resulting from low 
resolution. 
IR (film) ν̃ = 3447 cm-1 (s), 2981 (s), 1964 (m, =C= allene), 1700 (s, CO2Et), 1602 (m), 1522 
(s), 1450 (m), 1348 (s), 1271 (s), 1123 (s), 1031 (s), 860 (s), 748 (m). 
MS (EI, 70 eV) m/z (%) 274.4 (1) [(M-OH)+], 140.1 (85) [(MArCHO)+], 112.1 (52), 94.1 
(100), 66.2 (54). 
MS (ESI, Orbitrap) m/z 314.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C15H17NNaO5+ (M+Na+): 314.09989; found: 314.10132. 
rac-ethyl 5-hydroxy-2,4-dimethyl-5-(2-nitrophenyl)-2,3-pentadienoate (80ad) (Table 2, 
entry 4). 
Allenoate 79a (108 mg, 770 µmol, 2.0 equiv.) and aldehyde 1d (58 mg, 385 µmol, 1.0 equiv.) 
were reacted in DMF (2.0 mL) with MTBD (11 µl, 12 mg, 77 µmol, 20 mol%) 
using standard procedure S1 (1.5 h, r.t.). The product 80ad (93 mg, 313 µmol, 
81%, 56:44 d.r.) was obtained as a yellowish oil after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 75/25).  
Rf = 0.37 (P/EtOAc = 75/25, [UV, KMnO4]). 
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1H NMR (600 MHz, CDCl3) δ 7.92 – 7.89 (m, 2H, CHAr, major diastereomer and 1H, CHAr, 
minor diastereomer), 7.76 (dd, J = 7.8, 1.2 Hz, 1H, CHAr, minor diastereomer), 7.60 (td, J = 
7.8, 1.2 Hz, 1H, CHAr, major diastereomer), 7.56 (td, J = 7.8, 1.2 Hz, 1H, CHAr, minor 
diastereomer), 7.41 – 7.37 (m, 1H, CHAr, both diastereomers), 5.90 (s, 1H, CHOH, major 
diastereomer), 5.84 (s, 1H, CHOH, minor diastereomer), 4.11 – 4.01 (m, 2H, CO2CH2CH3 both 
diastereomers), 3.93 (s br, 1H, OH, major diastereomer), 3.81 (s br, 1H, OH, minor 
diastereomer), 1.90 [s, 3H, (CH3)CCHOH, minor diastereomer], 1.733 [s, 3H, (CH3)CCO2Et, 
major diastereomer], 1.730 [s, 3H, (CH3)CCHOH, major diastereomer], 1.52 [s, 3H, 
(CH3)CCO2Et, minor diastereomer], 1.20 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 
1.18 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 208.2 (s, =C=), 168.0 (s, COOEt), 148.0 
(s, CArCHOH), 137.1 (s, CArNO2), 133.415 (d, CArH), 128.7 (d, CArH), 128.5 (d, CArH), 124.6 
(d, CArH), 105.6 (s, CCOOEt), 97.8 (s, CCHOH), 71.3 (d, CHOH), 61.2 (t, CO2CH2CH3), 15.13 
[q, (CH3)CCHOH], 15.09 [q, (CH3)CCO2Et], 14.28 (q, CO2CH2CH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 208.0 (s, =C=), 167.8 (s, COOEt), 147.6 
(s, CArCHOH), 137.9 (s, CArNO2), 133.407 (d, CArH), 129.0 (d, CArH), 128.6 (d, CArH), 107.2 
(s, CCOOEt), 98.1 (s, CCHOH), 70.5 (d, CHOH), 16.3 [q, (CH3)CCHOH], 14.7 [q, 
(CH3)CCO2Et], 14.34 (q, CO2CH2CH3). One signal CArH and one signal CO2CH2CH3 were not 
included due to overlaps resulting from low resolution. 
IR (film) ν̃ = 3440 cm-1 (s), 2976 (s), 1965 (s, =C= allene), 1698 (s, CO2Et), 1527 (s), 1451 (s), 
1271 (s), 1126 (s), 1026 (s), 860 (m), 737 (s). 
MS (EI, 70 eV) m/z (%) 274.2 (22) [(M-OH)+], 246.2 (6) [(M-OEt)+], 140.2 (52) [(M-
ArCHO)+], 104.1 (81), 77.2 (100), 65.2 (86). 
MS (ESI, Orbitrap) m/z 314.1 (M+Na+), 292.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H17NNaO5+ (M+Na+): 314.09989; found: 314.10098. 
rac-ethyl 5-hydroxy-5-(4-methoxyphenyl)-2,4-dimethyl-2,3-pentadienoate (80ae) (Table 2, 
entry 5). 
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Allenoate 79a (98 mg, 699 µmol, 2.0 equiv.) and aldehyde 1e (43 µL, 48 mg, 
349 µmol, 1.0 equiv.) were reacted in DMF (1.8 mL) with MTBD (10 µl, 11 mg, 
70 µmol, 20 mol%) using standard procedure S1 (1.5 h, r.t.). The product 80ae 
(65 mg, 236 µmol, 68%, 53:47 d.r.) was obtained as a yellowish oil after 
purification of the crude reaction mixture by flash column chromatography (Si, 
2.0×20 cm, pentane/EtOAc = 8/2→7/3).  
Rf = 0.23 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.36 (d, J = 8.4 Hz, 2H, CHAr, minor diastereomer), 7.33 (d, J = 
8.4 Hz, 2H, CHAr, major diastereomer), 6.85 (d, J = 8.4 Hz, 2H, CHAr, both diastereomers), 
5.18 (s, 1H, CHOH, major diastereomer), 5.05 (s, 1H, CHOH, minor diastereomer), 4.24 – 4.11 
(m, 2H, CO2CH2CH3 both diastereomers), 3.779 (s, 3H, OCH3, minor diastereomer), 3.778 (s, 
3H, OCH3, major diastereomer), 2.67 (s br, 1H, OH, major diastereomer), 2.59 (s br, 1H, OH, 
minor diastereomer), 1.88 [s, 3H, (CH3)CCO2Et, minor diastereomer], 1.87 [s, 3H, 
(CH3)CCO2Et, major diastereomer], 1.61 [s, 3H, (CH3)CCHOH, major diastereomer], 1.59 [s, 
3H, (CH3)CCHOH, minor diastereomer], 1.30 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.1 (s, =C=), 168.1 (s, COOEt), 159.3 
(s, CArOCH3), 133.5 (s, CArCHOH), 127.8 (d, CArH), 113.8 (d, CArH), 106.6 (s, CCOOEt), 97.3 
(s, CCHOH), 74.6 (d, CHOH), 61.12 (t, CO2CH2CH3), 55.4 (q, OCH3), 15.6 [q, (CH3)CCO2Et], 
14.494 (q, CO2CH2CH3), 14.488 [q, (CH3)CCHOH]. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.7 (s, =C=), 168.2 (s, COOEt), 159.6 
(s, CArOCH3), 133.6 (s, CArCHOH), 128.4 (d, CArH), 113.9 (d, CArH), 106.9 (s, CCOOEt), 98.2 
(s, CCHOH), 74.8 (d, CHOH), 61.15 (t, CO2CH2CH3), 15.5 [q, (CH3)CCO2Et], 14.8 (q, 
CO2CH2CH3), 13.8 [q, (CH3)CCHOH]. The signal OCH3 was not included due to overlaps 
resulting from low resolution. 
IR (film) ν̃ = 3465 cm-1 (m), 2980 (m), 1963 (m, =C= allene), 1701 (s, CO2Et), 1610 (m), 1511 
(s), 1456 (m), 1378 (m), 1256 (s), 1123 (s), 1031 (s), 837 (m), 768 (m).  
MS (EI, 70 eV) m/z (%) 259.3 (68) [(M-OH)+], 140.0 (39) [(M−ArCHO)+], 136.8 (88) 
[ArCHO+], 109.6 (53), 77.2 (100), 66.5 (47). 
MS (ESI, Orbitrap) m/z 315.1 (M+K+), 299.1 (M+Na+). 
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HRMS (ESI, Orbitrap) calcd. for C16H20NaO4+ (M+Na+): 299.12538; found: 299.12531. 
rac-ethyl 5-(3,5-dimethoxyphenyl)-5-hydroxy-2,4-dimethyl-2,3-pentadienoate (80af) 
(Table 2, entry 6). 
Allenoate 79a (92 mg, 656 µmol, 2.0 equiv.) and aldehyde 1f (55 mg, 331 µmol, 1.0 equiv.) 
were reacted in DMF (1.6 mL) with MTBD (9 µl, 10 mg, 63 µmol, 20 mol%) 
using standard procedure S1 (1.5 h, r.t.). The product 80af (86 mg, 280 µmol, 
85%, 51:49 d.r.) was obtained as a yellowish oil after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 8/2→7/3).  
Rf = 0.37 (P/EtOAc = 7/3, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 6.58 (d, J = 2.4 Hz, 2H, CHAr, both diastereomers), 6.36 – 6.34 
(m, 1H, CHAr, both diastereomers), 5.15 (s, 1H, CHOH, major diastereomer), 5.08 (s, 1H, 
CHOH, minor diastereomer), 4.20 – 4.14 (m, 2H, CO2CH2CH3, both diastereomers), 3.76 (s, 
6H, 2×OCH3, minor diastereomer), 3.75 (s, 6H, 2×OCH3, major diastereomer), 2.87 (s br, 1H, 
OH, minor diastereomer), 2.85 (s br, 1H, OH, major diastereomer), 1.875 [s, 3H, (CH3)CCO2Et, 
minor diastereomer], 1.868 [s, 3H, (CH3)CCO2Et, major diastereomer], 1.63 [s, 3H, 
(CH3)CCHOH, major diastereomer], 1.62 [s, 3H, (CH3)CCHOH, minor diastereomer], 1.26 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.25 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.3 (s, =C=), 168.1 (s, COOEt), 160.9 
(s, CArOCH3), 143.87 (s, CArCHOH), 106.3 (s, CCOOEt), 104.7 (d, CArH), 99.7 (d, CArH), 97.3 
(s, CCHOH), 75.0 (d, CHOH), 61.19 (t, CO2CH2CH3), 55.47 (q, OCH3), 15.53 [q, 
(CH3)CCO2Et], 14.4 (q, CO2CH2CH3). The signal (CH3)CCHOH was not included due to 
overlaps resulting from low resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.1 (s, =C=), 168.0 (s, COOEt), 161.0 
(s, CArOCH3), 143.93 (s, CArCHOH), 106.5 (s, CCOOEt), 105.0 (d, CArH), 99.8 (d, CArH), 97.8 
(s, CCHOH), 75.1 (d, CHOH), 61.23 (t, CO2CH2CH3), 55.48 (q, OCH3), 15.51 [q, 
(CH3)CCO2Et], 14.2 (q, CO2CH2CH3), 13.8 [q, (CH3)CCHOH].  
IR (film) ν̃ = 3455 cm-1 (s), 2949 (s), 1964 (m, =C= allene), 1700 (s, CO2Et), 1602 (s), 1460 
(s), 1272 (s), 1150 (s), 1042 (s), 847 (m), 765 (m). 
COOEtMe
Me
OH
80af
MeO OMe
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MS (EI, 70 eV) m/z (%) 305.9 (63) [M+], 288.8 (18) [(M-OH)+], 288.1 (100), 259.0 (35), 231.9 
(60), 213.7 (99), 138.5 (29). 
MS (ESI, Orbitrap) m/z 345.1 (M+K+), 329.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C17H22NaO5+ (M+Na+): 329.13594; found: 329.13602. 
rac-ethyl 5-hydroxy-2,4,6,6-tetramethyl-2,3-heptadienoate (80ag) (Table 2, entry 7). 
Allenoate 79a (97 mg, 692 µmol, 2.0 equiv.) and aldehyde 1g (38 µL, 30 mg, 346 µmol, 1.0 
equiv.) were reacted in DMF (1.7 mL) with MTBD (10 µl, 11 mg, 70 µmol, 20 mol%) using 
standard procedure S1 (1.5 h, r.t.). The product 80ag (12 mg, 52 µmol, 15%, 
52:48 d.r.) was obtained as a yellowish oil after purification of the crude reaction 
mixture by flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 
10/1→8/2).  
Rf = 0.35 (P/EtOAc = 10/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 4.21 – 4.08 (m, 2H, CO2CH2CH3 both diastereomers), 3.77 – 
3.74 (m, 1H, CHOH), 1.87 (d, J = 3.6 Hz, 1H, OH, minor diastereomer), 1.842 (s, 3H, CH3, 
minor diastereomer), 1.837 (s, 3H, CH3, major diastereomer), 1.822 (s, 3H, CH3, minor 
diastereomer), 1.817 (s, 3H, CH3, major diastereomer), 1.69 (d, J = 5.4 Hz, 1H, OH, major 
diastereomer), 1.24 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.23 (t, J = 7.2 Hz, 
3H, CO2CH2CH3, minor diastereomer), 0.96 [s, 9H, C(CH3), major diastereomer], 0.94 [s, 9H, 
C(CH3), minor diastereomer]. 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 208.20 (s, =C=), 168.2 (s, COOEt), 104.8 
(s, CCOOEt), 97.0 (s, CCHOH), 81.0 (d, CHOH), 61.0 (t, CO2CH2CH3), 36.6 [s, C(CH3)3], 
26.3 [q, C(CH3)3], 17.3 [q, (CH3)CCHOH], 15.5 [q, (CH3)CCO2Et], 14.51 (q, CO2CH2CH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 208.22 (s, =C=), 168.1 (s, COOEt), 105.9 
(s, CCOOEt),  96.5 (s, CCHOH),  81.3 (d, CHOH),  61.2  (t, CO2CH2CH3),  36.4 [s, C(CH3)3],  
26.2 [q, C(CH3)3], 17.8 [q, (CH3)CCHOH], 15.2 [q, (CH3)CCO2Et], 14.46 (q, CO2CH2CH3). 
IR (film) ν̃ = 3446 cm-1 (s), 2949 (s), 1957 (s, =C= allene), 1703 (s, CO2Et), 1455 (s), 1383 (s), 
1261 (s), 1120 (s), 1032 (s), 762 (w), 606 (w). 
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MS (EI, 70 eV) m/z (%) 226.9 (4) [M+], 208.9 (32) [(M-OH)+], 140.2 (9) [(M-t-BuCHO)+], 67.6 
(27), 60.0 (100). 
MS (ESI, Orbitrap) m/z 249.1 (M+Na+), 227.2 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C13H22NaO3+ (M+Na+): 249.14612; found: 249.14586. 
4.2.3  Spectroscopic Data Related to Table 3 
rac-ethyl 5-hydroxy-4-methyl-5-phenyl-2-propyl-2,3-pentadienoate (80ba) (Table 3, entry 
1). 
Allenoate 79b (117 mg, 695 µmol, 2.0 equiv.) and aldehyde 1a (35 µL, 37 mg, 348 µmol, 1.0 
equiv.) were reacted in DMF (1.7 mL) with MTBD (10 µl, 11 mg, 70 µmol, 
20 mol%) using standard procedure S1 (1.5 h, r.t.). The product 80ba (92 mg, 
335 µmol, 96%, 55:45 d.r.) was obtained as a colorless oil after purification 
of the crude reaction mixture by flash column chromatography (Si, 2.0×20 
cm, pentane/EtOAc = 85/15).  
Rf = 0.35 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.49 – 7.46 (m, 2H, CHAr, both diastereomers), 7.38 – 7.34 (m, 
2H, CHAr, both diastereomers), 7.32 – 7.28 (m, 1H, CHAr, both diastereomers), 5.31 (s, 1H, 
CHOH, major diastereomer), 5.19 (s, 1H, CHOH, minor diastereomer), 4.27 – 4.15 (m, 2H, 
CO2CH2CH3, both diastereomers), 2.95 (s br, 1H, OH, both diastereomers), 2.30 – 2.20 (m, 2H, 
CH3CH2CH2, both diastereomers), 1.69 [s, 3H, (CH3)CCHOH, major diastereomer], 1.66 [s, 
3H, (CH3)CCHOH, minor diastereomer], 1.55 – 1.43 (m, 2H, CH3CH2CH2, both 
diastereomers), 1.33 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.32 (t, J = 7.2 Hz, 
3H, CO2CH2CH3, major diastereomer), 0.96 (t, J = 7.8 Hz, 3H, CH3CH2CH2, minor 
diastereomer), 0.95 (t, J = 7.8 Hz, 3H, CH3CH2CH2, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.3 (s, =C=), 167.9 (s, COOEt), 141.4 
(s, CArCHOH), 128.3 (d, CArH), 127.8 (d, CArH), 126.5 (d, CArH), 107.3 (s, CCHOH), 101.9 (s, 
CCOOEt), 75.0 (d, CHOH), 61.0 (t, CO2CH2CH3), 30.93 (t, CH3CH2CH2), 21.6 (t, 
CH3CH2CH2), 14.45 (q, CO2CH2CH3), 13.8 [q, (CH3)CCHOH], 13.7 (q, CH3CH2CH2). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.8 (s, =C=) 168.0 (s, COOEt), 141.5 
(s, CArCHOH), 128.5 (d, CArH), 128.1 (d, CArH), 127.0 (d, CArH), 107.7 (s, CCHOH), 102.9 (s, 
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CCOOEt), 75.1 (d, CHOH), 61.1 (t, CO2CH2CH3), 30.95 (t, CH3CH2CH2), 21.2 (t, 
CH3CH2CH2), 14.6 (q, CO2CH2CH3), 14.43 [q, (CH3)CCHOH], 13.88 (q, CH3CH2CH2). 
IR (film) ν̃ = 3444 cm-1 (s), 2960 (s), 1960 (m, =C= allene), 1699 (s, CO2Et), 1453 (s), 1384 
(s), 1253 (s), 1126 (s), 1030 (s), 864 (w), 741 (m). 
MS (EI, 70 eV) m/z (%) 256.5 (100) [(M-OH)+], 211.4 (24), 168.6 (41) [(M-ArCHO)+], 139.8 
(5). 
MS (ESI, Orbitrap) m/z 313.1 (M+K+), 297.1 (M+Na+), 275.2 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H23O3+ (M+H+): 275.16417; found: 275.16409. 
rac-ethyl 5-(4-chlorophenyl)-5-hydroxy-4-methyl-2-propyl-2,3-pentadienoate (80bb) 
(Table 3, entry 2). 
Allenoate 79b (116 mg, 689 µmol, 2.0 equiv.) and aldehyde 1b (48 mg, 345 µmol, 1.0 equiv.) 
were reacted in DMF (1.7 mL) with MTBD (10 µl, 11 mg, 70 µmol, 20 mol%) 
using standard procedure S1 (1.5 h, r.t.). The product 80bb (96 mg, 310 µmol, 
90%, 51:49 d.r.) was obtained as a slightly yellow oil after purification of the 
crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 85/15).  
Rf = 0.52 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.38 – 7.35 (m, 2H, CHAr, both diastereomers), 7.30 – 7.27 (m, 
2H, CHAr, both diastereomers), 5.24 (s, 1H, CHOH, major diastereomer), 5.12 (s, 1H, CHOH, 
minor diastereomer), 4.23 – 4.09 (m, 2H, CO2CH2CH3, both diastereomers), 2.95 (s br, 1H, 
OH, both diastereomers), 2.25 – 2.14 (m, 2H, CH3CH2CH2, both diastereomers), 1.62 [s, 3H, 
(CH3)CCHOH, major diastereomer], 1.60 [s, 3H, (CH3)CCHOH, minor diastereomer] 1.47 – 
1.37 (m, 2H, CH3CH2CH2, both diastereomers), 1.28 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 0.91 (t, J = 7.8 Hz, 
3H, CH3CH2CH2, minor diastereomer), 0.90 (t, J = 7.8 Hz, 3H, CH3CH2CH2, major 
diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.3 (s, =C=), 167.8 (s, COOEt), 139.9 
(s, CArCHOH), 133.5 (s, CArCl), 128.5 (d, CArH), 127.9 (d, CArH), 107.0 (s, CCHOH), 102.1 (s, 
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CCOOEt), 74.5 (d, CHOH), 61.1 (t, CO2CH2CH3), 30.89 (t, CH3CH2CH2), 21.6 (t, 
CH3CH2CH2), 14.50 (q, CO2CH2CH3), 13.85 [q, (CH3)CCHOH], 13.6 (q, CH3CH2CH2). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.9 (s, =C=), 167.9 (s, COOEt), 140.0 
(s, CArCHOH), 133.8 (s, CArCl), 128.7 (d, CArH), 128.4 (d, CArH), 107.5 (s, CCHOH), 103.1 (s, 
CCOOEt), 61.2 (t, CO2CH2CH3), 30.92 (t, CH3CH2CH2), 21.7 (t, CH3CH2CH2), 14.47 (q, 
CO2CH2CH3), 14.43 [q, (CH3)CCHOH], 13.9 (q, CH3CH2CH2). The signal CHOH was not 
included due to overlaps resulting from low resolution. 
IR (film) ν̃ = 3443 cm-1 (s), 2962 (s), 1960 (s, =C= allene), 1700 (s, CO2Et), 1486 (m), 1394 
(m), 1254 (s), 1125 (s), 1025 (s), 841 (m), 603 (w). 
MS (EI, 70 eV) m/z (%) 308.0 (6) [M+], 290.8 (85) [(M-OH)+], 263.1 (21) [(M-OEt)+], 245.9 
(100), 217.8 (22). 
MS (ESI, Orbitrap) m/z 347.1 (M+K+), 331.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C17H21ClNaO3+ (M+Na+): 331.10714; found: 331.10867. 
rac-ethyl 5-(3,5-dimethoxyphenyl)-5-hydroxy-4-methyl-2-propyl-2,3-pentadienoate 
(80bf) (Table 3, entry 3). 
Allenoate 79b (110 mg, 654 µmol, 2.0 equiv.) and aldehyde 1f (54 mg, 327 µmol, 1.0 equiv.) 
were reacted in DMF (1.6 mL) with MTBD (9 µl, 10 mg, 63 µmol, 20 
mol%) using standard procedure S1 (1.5 h, r.t.). The product 80bf (98 mg, 
293 µmol, 90%, 51:49 d.r.) was obtained as a slightly yellow oil after 
purification of the crude reaction mixture by flash column chromatography 
(Si, 2.0×20 cm, pentane/EtOAc = 8/2).  
Rf = 0.35 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 6.59 (d, J = 2.4 Hz, 2H, CHAr, both diastereomers), 5.37 – 6.35 
(m, 1H, CHAr, both diastereomers), 5.15 (s, 1H, CHOH, major diastereomer), 5.10 (s, 1H, 
CHOH, minor diastereomer), 4.17 (m, 2H, CO2CH2CH3, both diastereomers), 3.761 (s, 6H, 
2×OCH3, minor diastereomer), 3.757 (s, 6H, 2×OCH3, major diastereomer), 2.67 (s br, 1H, OH, 
both diastereomers), 2.25 – 2.17 (m, 2H, CH3CH2CH2, both diastereomers), 1.65 [s, 3H, 
(CH3)CCHOH, minor diastereomer], 1.63 [s, 3H, (CH3)CCHOH, major diastereomer], 1.47 – 
1.41 (m, 2H, CH3CH2CH2, both diastereomers), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
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diastereomer), 1.26 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 0.915 (t, J = 7.8 Hz, 
3H, CH3CH2CH2, minor diastereomer), 0.907 (t, J = 7.8 Hz, 3H, CH3CH2CH2, major 
diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 207.1 (s, =C=), 167.8 (s, COOEt), 160.97 
(s, CArOMe), 143.9 (s, CArCHOH), 107.4 (s, CCHOH), 104.7 (d, CArH), 102.4 (s, CCOOEt), 
99.8 (d, CArH), 75.11 (d, CHOH), 61.09 (t, CO2CH2CH3), 55.48 (q, OCH3), 31.0 (t, 
CH3CH2CH2), 21.66 (t, CH3CH2CH2), 14.4 (q, CO2CH2CH3), 14.0 [q, (CH3)CCHOH], 13.86 
(q, CH3CH2CH2). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 167.9 (s, COOEt), 161.03 (s, CArOMe), 
143.8 (s, CArCHOH), 107.5 (s, CCHOH), 105.0 (d, CArH), 102.8 (s, CCOOEt), 99.9 (d, CArH), 
75.14 (d, CHOH), 61.14 (t, CO2CH2CH3), 55.47 (q, OCH3), 30.92 (t, CH3CH2CH2), 21.71 (t, 
CH3CH2CH2), 14.34 (q, CO2CH2CH3), 13.88 (q, CH3CH2CH2). The signals =C=, 
(CH3)CCHOH were not included due to overlaps resulting from low resolution. 
IR (film) ν̃ = 3455 cm-1 (s), 2948 (s), 1960 (m, =C= allene), 1699 (s, CO2Et), 1602 (s), 1458 
(s), 1245 (s), 1149 (s), 1049 (s), 845 (m), 727 (w). 
MS (EI, 70 eV) m/z (%) 334.2 (100) [M+], 316.6 (70) [(M-OH)+], 288.9 (37) [(M-OEt)+], 242.9 
(60), 230.7 (75), 203.4 (30), 138.9 (13). 
MS (ESI, Orbitrap) m/z 357.2 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C19H26NaO5+ (M+Na+): 357.16725; found: 357.16644. 
rac-ethyl 2-benzyl-5-hydroxy-4-methyl-5-phenyl-2,3-pentadienoate (80ca) (Table 3, entry 
4). 
Allenoate 79c (132 mg, 610 µmol, 2.0 equiv.) and aldehyde 1a (31 µL, 32 mg, 305 µmol, 1.0 
equiv.) were reacted in DMF (1.5 mL) with MTBD (9 µl, 10 mg, 63 µmol, 
20 mol%) using standard procedure S1 (1.5 h, r.t.). The product 80ca (88 
mg, 267 µmol, 87%, 54:46 d.r.) was obtained as a colorless oil after 
purification of the crude reaction mixture by flash column chromatography 
(Si, 2.0×20 cm, pentane/EtOAc = 85/15).  
Rf = 0.35 (P/EtOAc = 85/15, [UV, KMnO4]). 
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1H NMR (600 MHz, CDCl3) δ 7.33 – 7.21 (m, 10H, CHAr, both diastereomers), 5.13 (s, 1H, 
CHOH, major diastereomer), 5.04 (s, 1H, CHOH, minor diastereomer), 4.28 – 4.16 (m, 2H, 
CO2CH2CH3, both diastereomers), 3.61 (virt t, J = 15.6 Hz, 2H, CH2Ph, both diastereomers), 
2.53 (s br, 1H, OH, minor diastereomer), 2.21 (s br, 1H, OH, major diastereomer), 1.58 [s, 3H, 
(CH3)CCHOH, minor diastereomer], 1.53 [s, 3H, (CH3)CCHOH, major diastereomer], 1.314 
(t, J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.310 (t, J = 7.2 Hz, 3H, CO2CH2CH3, 
major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 208.2 (s, =C=), 167.3 (s, COOEt), 140.7 
(s, CArCHOH), 139.55 (s, CArCH2), 129.3 (d, CArH), 128.45 (d, CArH), 128.36 (d, CArH), 127.8 
(d, CArH), 126.53 (d, CArH), 126.52 (d, CArH), 108.1 (s, CCHOH), 102.6 (s, CCOOEt), 74.9 (d, 
CHOH), 61.19 (t, CO2CH2CH3), 35.54 (t, CH2Ph), 14.42 (q, CO2CH2CH3), 13.2 [q, 
(CH3)CCHOH]. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 207.8 (s, =C=), 167.4 (s, COOEt), 140.9 
(s, CArCHOH), 139.49 (s, CArCH2), 129.2 (d, CArH), 128.50 (d, CArH), 128.41 (d, CArH), 128.0 
(d, CArH), 126.9 (d, CArH), 126.50 (d, CArH), 108.7 (s, CCHOH), 103.2 (s, CCOOEt), 75.0 (d, 
CHOH), 61.25 (t, CO2CH2CH3), 35.49 (t, CH2Ph), 14.40 (q, CO2CH2CH3), 14.3 [q, 
(CH3)CCHOH]. 
IR (film) ν̃ = 3421 cm-1 (s), 2982 (m), 1961 (m, =C= allene), 1701 (s, CO2Et), 1450 (s), 1383 
(m), 1259 (s), 1189 (s), 1024 (s), 864 (w), 739 (s). 
MS (EI, 70 eV) m/z (%) 305.6 (100) [(M-OH)+], 259.6 (28), 215.9 (99) [(M-ArCHO)+], 141.8 
(27). 
MS (ESI, Orbitrap) m/z 361.1 (M+K+), 345.2 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C21H22NaO3+ (M+Na+): 345.14612; found: 345.14587. 
rac-ethyl 2-benzyl-5-(4-chlorophenyl)-5-hydroxy-4-methyl-2,3-pentadienoate (80cb) 
(Table 3, entry 5). 
Allenoate 80c (137 mg, 633 µmol, 2.0 equiv.) and aldehyde 1b (45 mg, 317 µmol, 1.0 equiv.) 
were reacted in DMF (1.6 mL) with MTBD (9 µl, 10 mg, 63 µmol, 20 mol%) using standard 
procedure S1 (1.5 h, r.t.). The product 80cb (69 mg, 193 µmol, 61%, 56:44 d.r.) was obtained 
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as a brownish oil after purification of the crude reaction mixture by flash 
column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 85/15).  
Rf = 0.25 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H, CHAr, both diastereomers), 
7.25 – 7.20 (m, 3H, CHAr, both diastereomers), 7.19 – 7.16 (m, 2H, CHAr, 
both diastereomers), 7.13 – 7.09 (m, 2H, CHAr, both diastereomers), 5.05 (s, 1H, CHOH, major 
diastereomer), 4.96 (s, 1H, CHOH, minor diastereomer), 4.27 – 4.11 (m, 2H, CO2CH2CH3, both 
diastereomers), 3.58 (s, 2H, CH2Ph, major diastereomer), 3.57 (s, 2H, CH2Ph, minor 
diastereomer), 2.34 (s br, 1H, OH, minor diastereomer), 1.97 (s br, 1H, OH, major 
diastereomer), 1.53 [s, 3H, (CH3)CCHOH, minor diastereomer], 1.47 [s, 3H, (CH3)CCHOH, 
major diastereomer], 1.29 (t, J = 7.2 Hz, 3H, CO2CH2CH3, both diastereomers). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 208.2 (s, =C=), 167.1 (s, COOEt), 139.37 
(s, CArCHOH), 139.160 (s, CArCH2), 133.5 (s, CArCl), 129.4 (d, CArH), 128.57 (d, CArH), 128.55 
(d, CArH), 128.0 (d, CArH), 126.62 (d, CArH), 108.0 (s, CCHOH), 103.1 (s, CCOOEt), 74.3 (d, 
CHOH), 61.3 (t, CO2CH2CH3), 35.5 (t, CH2Ph), 14.48 (q, CO2CH2CH3), 13.1 [q, 
(CH3)CCHOH]. 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 207.8 (s, =C=), 167.3 (s, COOEt), 139.45 
(s, CArCHOH), 139.154 (s, CArCH2), 133.7 (s, CArCl), 129.2 (d, CArH), 128.60 (d, CArH), 128.53 
(d, CArH), 128.3 (d, CArH), 126.65 (d, CArH), 108.5 (s, CCHOH), 103.6 (s, CCOOEt), 74.4 (d, 
CHOH), 61.4 (t, CO2CH2CH3), 35.4 (t, CH2Ph), 14.47 (q, CO2CH2CH3), 14.2 [q, 
(CH3)CCHOH]. 
IR (film) ν̃ = 3429 cm-1 (s), 2922 (m), 1961 (m, =C= allene), 1702 (s, CO2Et), 1597 (w), 1449 
(s), 1257 (s), 1189 (s), 1091 (s), 837 (m), 702 (m). 
MS (EI, 70 eV) m/z (%) 339.0 (76) [(M-OH)+], 216.0 (12) [(M-ArCHO)+], 201.5 (19), 141.7 
(100) [C7H6ClO+], 140.7 (74) [ArCHO+], 115.5 (64). 
MS (ESI, Orbitrap) m/z 395.1 (M+K+), 379.1 (M+Na+), 357.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C21H22ClO3+ (M+H+): 357.12520; found: 357.12531. 
rac-ethyl 2-benzyl-5-(3,5-dimethoxyphenyl)-5-hydroxy-4-methyl-2,3-pentadienoate (80cf) 
(Table 3, entry 6). 
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Allenoate 80c (134 mg, 619 µmol, 2.0 equiv.) and aldehyde 1f (52 mg, 310 µmol, 1.0 equiv.) 
were reacted in DMF (1.5 mL) with MTBD (9 µl, 10 mg, 62 µmol, 20 
mol%) using standard procedure S1 (1.5 h, r.t.). The product 80cf (87 mg, 
227 µmol, 73%, 53:47 d.r.) was obtained as a brownish oil after 
purification of the crude reaction mixture by flash column chromatography 
(Si, 2.0×20 cm, pentane/EtOAc = 8/2).  
Rf = 0.27 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.29 – 7.25 (m, 2H, CHAr, both diastereomers), 7.21 – 7.17 (m, 
3H, CHAr, both diastereomers), 6.53 (d, J = 2.4 Hz, 2H, CHAr, minor diastereomer), 6.51 (d, J 
= 2.4 Hz, 2H, CHAr, major diastereomer), 6.36 (virt t, J = 2.4 Hz, 1H, CHAr, minor 
diastereomer), 6.35 (virt t, J = 2.4 Hz, 1H, CHAr, major diastereomer), 5.04 (s, 1H, CHOH, 
major diastereomer), 4.94 (s, 1H, CHOH, minor diastereomer), 4.22 – 4.14 (m, 2H, 
CO2CH2CH3, both diastereomers), 3.75 (s, 6H, 2×OCH3, minor diastereomer), 3.74 (s, 6H, 
2×OCH3, major diastereomer), 3.580 (s, 2H, CH2Ph, minor diastereomer), 3.576 (s, 2H, CH2Ph, 
major diastereomer), 2.25 (s br, 1H, OH, minor diastereomer), 1.91 (s br, 1H, OH, major 
diastereomer), 1.59 [s, 3H, (CH3)CCHOH, minor diastereomer], 1.53 [s, 3H, (CH3)CCHOH, 
major diastereomer], 1.261 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.256 (t, J = 
7.2 Hz, 3H, CO2CH2CH3, minor diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 208.6 (s, =C=), 167.1 (s, COOEt), 160.9 
(s, CArOMe), 143.2 (s, CArCHOH), 139.7 (s, CArCH2), 129.2 (d, CArH), 128.44 (d, CArH), 126.54 
(d, CArH), 107.8 (s, CCHOH), 104.5 (d, CArH), 102.3 (s, CCOOEt), 99.7 (d, CArH), 74.91 (d, 
CHOH), 61.2 (t, CO2CH2CH3), 55.48 (q, OCH3), 35.64 (t, CH2Ph), 14.39 (q, CO2CH2CH3), 
13.0 [q, (CH3)CCHOH]. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 207.8 (s, =C=), 167.3 (s, COOEt), 161.0 
(s, CArOMe), 143.5 (s, CArCHOH), 139.6 (s, CArCH2), 129.0 (d, CArH), 128.48 (d, CArH), 126.53 
(d, CArH), 108.5 (s, CCHOH), 105.2 (d, CArH), 103.3 (s, CCOOEt), 99.9 (d, CArH), 75.11 (d, 
CHOH),  61.3  (t, CO2CH2CH3),  55.46  (q, OCH3),  35.62  (t, CH2Ph),  14.6 (q, CO2CH2CH3), 
14.36 [q, (CH3)CCHOH]. 
IR (film) ν̃ = 3463 cm-1 (s), 2938 (s), 1961 (m, =C= allene), 1702 (s, CO2Et), 1601 (s), 1458 
(s), 1261 (s), 1157 (s), 1062 (s), 845 (m), 701 (m). 
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MS (EI, 70 eV) m/z (%) 382.0 (35) [M+], 365.7 (10) [(M-OH)+], 336.8 (6) [(M-OEt)+], 289.9 
(100), 275.3 (38), 244.4 (18). 
MS (ESI, Orbitrap) m/z 421.1 (M+K+), 405.2 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C23H26NaO5+ (M+Na+): 405.16725; found: 405.16714. 
rac-ethyl 4-[hydroxy(phenyl)methyl]-2,5-dimethyl-2,3-hexadienoate (80da) (Table 2, entry 
7). 
Allenoate 80d (99 mg, 588 µmol, 2.0 equiv.) and aldehyde 1a (31 µL, 31 mg, 294 µmol, 1.0 
equiv.) were reacted in DMF (1.5 mL) with MTBD (13 µl, 14 mg, 90 µmol, 
30 mol%) using standard procedure S1 (5 h, r.t.). The product 80da (44 mg, 
160 µmol, 54%, 40:60 d.r.) was obtained as a yellowish oil after purification 
of the crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 85/15).  
Rf = 0.37 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.47 – 7.43 (m, 2H, CHAr, major diastereomer), 7.41 – 7.37 (m, 
2H, CHAr, minor diastereomer), 7.35 – 7.24 (m, 3H, CHAr, both diastereomers), 5.27 (s, 1H, 
CHOH, minor diastereomer), 5.18 (s, 1H, CHOH, major diastereomer), 4.23 – 4.10 (m, 2H, 
CO2CH2CH3 both diastereomers), 2.54 (s br, 1H, OH, minor diastereomer), 2.40 (s br, 1H, OH, 
major diastereomer), 2.17 (hept, J = 6.8 Hz, 1H, CHMe2, minor diastereomer), 2.04 (hept, J = 
6.8 Hz, 1H, CHMe2, major diastereomer), 1.90 (s, 3H, CH3, major diastereomer), 1.85 (s, 3H, 
CH3, minor diastereomer), 1.29 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.26 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.02 [d, J = 6.8 Hz, 3H, CHCH3(CH3), 
major diastereomer], 1.00 [d, J = 6.8 Hz, 3H, CHCH3(CH3), minor diastereomer], 0.99 [d, J = 
6.8 Hz, 3H, CHCH3(CH3), minor diastereomer], 0.94 [d, J = 6.8 Hz, 3H, CHCH3(CH3), major 
diastereomer]. 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 206.3 (s, =C=), 168.2 (s, COOEt), 142.0 
(s, CArCHOH), 128.5 (d, CArH), 128.3 (d, CArH), 127.4 (d, CArH), 118.8 (s, CCOOEt), 101.2 
(s, CCHOH), 74.0 (d, CHOH), 61.0 (t, CO2CH2CH3), 29.2 (d, CHMe2), 22.78 [q, 
CHCH3(CH3)], 22.0 [q, CHCH3(CH3)], 15.4 [q, (CH3)CCO2Et], 14.45 (q, CO2CH2CH3). 
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13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 207.0 (s, =C=), 168.1 (s, COOEt), 141.9 
(s, CArCHOH), 128.4 (d, CArH), 128.0 (d, CArH), 126.8 (d, CArH), 119.0 (s, CCOOEt), 100.6 
(s, CCHOH), 61.02 (t, CO2CH2CH3), 28.9 (d, CHMe2), 22.76 [q, CHCH3(CH3)], 22.5 [q, 
CHCH3(CH3)], 15.3 [q, (CH3)CCO2Et], 14.44 (q, CO2CH2CH3). The signal CHOH was not 
included due to overlaps resulting from low resolution. 
IR (film) ν̃ = 3442 cm-1 (s), 2965 (s), 1957 (m, =C= allene), 1701 (s, CO2Et), 1455 (m), 1377 
(m), 1268 (s), 1124 (s), 1027 (m), 908 (w), 760 (m). 
MS (EI, 70 eV) m/z (%) 274.2 (2) [M+], 257.6 (100) [(M-OH)+], 228.6 (5) [(M−OEt)+], 211.6 
(11), 76.9 (16) [Ph+]. 
MS (ESI, Orbitrap) m/z 313.1 (M+K+), 297.1 (M+Na+), 275.2 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H23O3+ (M+H+): 275.16417; found: 275.16406. 
rac-ethyl 4-[(4-chlorophenyl)(hydroxy)methyl]-2,5-dimethyl-2,3-hexadienoate (80db) 
(Table 3, entry 8). 
Allenoate 80d (90 mg, 535 µmol, 2.0 equiv.) and aldehyde 1b (36 mg, 256 µmol, 1.0 equiv.) 
were reacted in DMF (1.5 mL) with MTBD (6 µl, 6 mg, 39 µmol, 15 mol%) 
using standard procedure S1 (5 h, r.t.). The product 80db (65 mg, 212 µmol, 
83%, 44:56 d.r.) was obtained as a yellowish oil after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 85/15).  
Rf = 0.35 (P/EtOAc = 7/3, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.8 Hz, 2H, CHAr, major diastereomer), 7.31 (d, J = 
8.8 Hz, 2H, CHAr, minor diastereomer), 7.29 – 7.25 (m, 2H, CHAr, both diastereomers), 5.23 (s, 
1H, CHOH, minor diastereomer), 5.15 (s, 1H, CHOH, major diastereomer), 4.22 – 4.09 (m, 2H, 
CO2CH2CH3 both diastereomers), 2.80 (s br, 1H, OH, minor diastereomer), 2.70 (s br, 1H, OH, 
major diastereomer), 2.16 (hept, J = 6.8 Hz, 1H, CHMe2, minor diastereomer), 2.02 (hept, J = 
6.8 Hz, 1H, CHMe2, major diastereomer), 1.87 (s, 3H, CH3, major diastereomer), 1.82 (s, 3H, 
CH3, minor diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.25 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.01 – 0.92 [m, 6H, CH(CH3)2, both 
diastereomers]. 
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13C NMR (major diastereomer, 101 MHz, CDCl3) δ 206.4 (s, =C=), 168.01 (s, COOEt), 140.50 
(s, CArCHOH), 134.0 (s, CArCl), 128.8 (d, CArH), 128.6 (d, CArH), 118.6 (s, CCOOEt), 100.5 
(s, CCHOH), 73.3 (d, CHOH), 61.08 (t, CO2CH2CH3), 29.1 (d, CHMe2), 22.78 [q, 
CHCH3(CH3)], 22.0 [q, CHCH3(CH3)], 15.3 [q, (CH3)CCO2Et], 14.5 (q, CO2CH2CH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 207.2 (s, =C=), 167.97 (s, COOEt), 140.51 
(s, CArCHOH), 133.6 (s, CArCl), 128.5 (d, CArH), 128.1 (d, CArH), 118.8 (s, CCOOEt), 101.3 
(s, CCHOH), 73.4 (d, CHOH), 61.13 (t, CO2CH2CH3), 28.8 (d, CHMe2), 22.85 [q, 
CHCH3(CH3)], 22.5 [q, CHCH3(CH3)], 15.2 [q, (CH3)CCO2Et], 14.4 (q, CO2CH2CH3).  
IR (film) ν̃ = 3439 cm-1 (s), 2966 (s), 1957 (m, =C= allene), 1701 (s, CO2Et), 1592 (w), 1488 
(m), 1375 (m), 1268 (s), 1124 (s), 1018 (m), 907 (w), 835 (m), 763 (m). 
MS (EI, 70 eV) m/z (%) 291.1 (100) [(M-OH)+], 263.1 (10) [(M−OEt)+], 168.1 (100), 153.1 
(58), 125.1 (30). 
MS (ESI, Deca) m/z 640.6 (2M+Na+), 331.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C17H21ClNaO3+ (M+Na+): 331.10714; found: 331.10690. 
rac-ethyl 4-[hydroxy(4-nitrophenyl)methyl]-2,5-dimethyl-2,3-hexadienoate (80dc) (Table 
3, entry 9). 
Allenoate 80d (98 mg, 582 µmol, 2.0 equiv.) and aldehyde 1c (44 mg, 291 µmol, 1.0 equiv.) 
were reacted in DMF (1.5 mL) with MTBD (13 µl, 14 mg, 90 µmol, 30 mol%) 
using standard procedure S1 (5 h, r.t.). The product 80dc (62 mg, 195 µmol, 
67%, 42:58 d.r.) was obtained as a yellow solid after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 8/2).  
Rf = 0.33 (P/EtOAc = 8/2, [UV, KMnO4]). 
Mp 100-102 °C (EtOAc) 
1H NMR (400 MHz, CDCl3) δ 8.159 (d, J = 8.8 Hz, 2H, CHAr, major diastereomer), 8.156 (d, 
J = 8.8 Hz, 2H, CHAr, minor diastereomer), 7.61 – 7.56 (m, 2H, CHAr, both diastereomers), 5.40 
(s, 1H, CHOH, minor diastereomer), 5.33 (s, 1H, CHOH, major diastereomer), 4.21 – 4.11 (m, 
2H, CO2CH2CH3 both diastereomers), 3.03 (s br, 1H, OH, both diastereomers), 2.24 (hept, J = 
COOEtMe
OH
80dc
Me
Me
NO2
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6.8 Hz, 1H, CHMe2, minor diastereomer), 2.10 (hept, J = 6.8 Hz, 1H, CHMe2, major 
diastereomer), 1.85 (s, 3H, CH3, major diastereomer), 1.78 (s, 3H, CH3, minor diastereomer), 
1.26 (t, J = 7.2 Hz, 3H, CO2CH2CH3, both diastereomers), 1.04 [d, J = 6.8 Hz, 3H, 
CHCH3(CH3), minor diastereomer], 0.99 [d, J = 6.8 Hz, 3H, CHCH3(CH3), major 
diastereomer], 0.98 [d, J = 6.8 Hz, 3H, CHCH3(CH3), major diastereomer], 0.94 [d, J = 6.8 Hz, 
3H, CHCH3(CH3), minor diastereomer]. 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 206.9 (s, =C=), 167.7 (s, COOEt), 149.2 
(s, CArCHOH), 147.7 (s, CArNO2), 128.0 (d, CArH), 123.6 (d, CArH), 118.07 (s, CCOOEt), 101.4 
(s, CCHOH), 73.2 (d, CHOH), 61.2 (t, CO2CH2CH3), 29.0 (d, CHMe2), 22.8 [q, CHCH3(CH3)], 
22.2 [q, CHCH3(CH3)], 15.3 [q, (CH3)CCO2Et], 14.50 (q, CO2CH2CH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 207.8 (s, =C=), 167.8 (s, COOEt), 149.5 
(s, CArCHOH), 147.5 (s, CArNO2), 127.4 (d, CArH), 123.5 (d, CArH), 118.15 (s, CCOOEt), 100.6 
(s, CCHOH), 73.4 (d, CHOH), 61.3 (t, CO2CH2CH3), 28.7 (d, CHMe2), 23.0 [q, CHCH3(CH3)], 
22.5 [q, CHCH3(CH3)], 15.0 [q, (CH3)CCO2Et], 14.47 (q, CO2CH2CH3).  
IR (ATR) ν̃ = 3504 cm-1 (m), 2968 (m), 1951 (m, =C= allene), 1700 (s, CO2Et), 1599 (m), 1510 
(s), 1338 (s), 1260 (s), 1111 (s), 1051 (s), 906 (w), 755 (m). 
MS (EI, 70 eV) m/z (%) 318.9 (1) [M+], 302.4 (100) [(M-OH)+], 274.6 (14) [(M−OEt)+], 168.7 
(55) [(M-ArCHO)+]. 
MS (ESI, Orbitrap) m/z 358.1 (M+K+), 342.1 (M+Na+), 320.2 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H21KNO5+ (M+K+): 358.10513; found: 358.10598. 
rac-ethyl 4-[(3,5-dimethoxyphenyl)(hydroxy)methyl]-2,5-dimethyl-2,3-hexadienoate 
(80df) (Table 3, entry 10). 
Allenoate 80d (116 mg, 689 µmol, 2.0 equiv.) and aldehyde 1f (57 mg, 343 µmol, 1.0 equiv.) 
were reacted in DMF (1.7 mL) with MTBD (15 µl, 16 mg, 103 µmol, 30 
mol%) using standard procedure S1 (5 h, r.t.). The product 80df (87 mg, 261 
µmol, 76%, 36:64 d.r.) was obtained as a yellowish oil after purification of 
the crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 75/25).  
Rf = 0.21 (P/EtOAc = 8/2, [UV, KMnO4]). 
COOEtMe
OH
80df
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1H NMR (600 MHz, CDCl3) δ 6.60 (d, J = 2.4 Hz, 2H, CHAr, major diastereomer), 6.55 (d, J = 
1.8 Hz, 2H, CHAr, minor diastereomer), 6.36 (virt t, J = 2.4 Hz, 1H, CHAr, major diastereomer), 
6.35 (virt t, J = 2.4 Hz, 1H, CHAr, minor diastereomer), 5.16 (s, 1H, CHOH, minor 
diastereomer), 5.11 (s, 1H, CHOH, major diastereomer), 4.23 – 4.17 (m, 1H, CO2CHHCH3, 
both diastereomers), 4.14 – 4.07 (m, 1H, CO2CHHCH3, both diastereomers), 3.76 (s, 6H, 
2×OCH3, major diastereomer), 3.75 (s, 6H, 2×OCH3, minor diastereomer), 2.45 (s br, 1H, OH, 
both diastereomers), 2.16 (hept, J = 6.6 Hz, 1H, CHMe2, minor diastereomer), 2.08 (hept, J = 
7.2 Hz, 1H, CHMe2, major diastereomer), 1.88 (s, 3H, CH3, major diastereomer), 1.86 (s, 3H, 
CH3, minor diastereomer), 1.31 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.27 – 
1.23 (m, 3H, CO2CH2CH3, both diastereomers), 1.013 [d, J = 6.6 Hz, 3H, CHCH3(CH3), minor 
diastereomer], 1.006 [d, J = 7.2 Hz, 3H, CHCH3(CH3), major diastereomer], 0.98 [d, J = 6.6 
Hz, 3H, CHCH3(CH3), minor diastereomer], 0.96 [d, J = 7.2 Hz, 3H, CHCH3(CH3), major 
diastereomer]. 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 206.5 (s, =C=), 168.1 (s, COOEt), 161.0 
(s, CArOMe), 144.4 (s, CArCHOH), 118.5 (s, CCHOH), 105.5 (d, CArH), 101.1 (s, CCOOEt), 
99.9 (d, CArH), 73.98 (d, CHOH), 61.05 (t, CO2CH2CH3), 55.50 (q, OCH3), 29.02 (d, CHMe2), 
22.8 [q, CHCH3(CH3)], 22.1 [q, CHCH3(CH3)], 15.44 [q, (CH3)CCO2Et], 14.36 (q, 
CO2CH2CH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 206.9 (s, =C=), 168.0 (s, COOEt), 160.9 
(s, CArOMe), 144.3 (s, CArCHOH), 118.9 (s, CCHOH), 105.0 (d, CArH), 100.7 (s, CCOOEt), 
73.97 (d, CHOH), 61.06 (t, CO2CH2CH3), 55.48 (q, OCH3), 28.98 (d, CHMe2), 22.7 [q, 
CHCH3(CH3)], 22.5 [q, CHCH3(CH3)], 15.34 [q, (CH3)CCO2Et], 14.38 (q, CO2CH2CH3). One 
CArH was not included due to overlaps resulting from low resolution. 
IR (film) ν̃ = 3464 cm-1 (s), 2961 (s), 1957 (s, =C= allene), 1701 (s, CO2Et), 1602 (s), 1462 (s), 
1268 (s), 1150 (s), 1060 (s), 847 (s), 763 (w). 
MS (EI, 70 eV) m/z (%) 334.4 (82) [M+], 316.8 (100) [(M-OH)+], 270.7 (49), 244.0 (92), 218.1 
(27), 139.0 (8). 
MS (ESI, Orbitrap) m/z 373.2 (M+K+), 357.2 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C19H26NaO5+ (M+Na+): 357.16725; found: 357.16678. 
    
 
 
 
100 
 
4.2.4  Spectroscopic Data Related to Table 4  
6-(4-chlorophenyl)-3,5-dimethyl-2H-pyran-2-one (137ab) (Table 4, entry 1). 
The compound 80ab (90 mg, 320 µmol) and tributylphosphine (79 µL, 65 mg, 320 µmol, 1.0 
equiv.) were reacted in MeCN (1.6 mL) using experimental procedure S2 (18 h, r.t.). Flash 
column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 8/2) gave 
product 137ab (50 mg, 215 µmol, 67%) as a yellowish solid.  
Rf = 0.38 (P/EtOAc = 8/2, [UV, KMnO4]). 
m.p. 111-113 °C (EtOAc) 
1H NMR (600 MHz, CDCl3) δ 7.49 (d, J = 9.0 Hz, 2H, CHAr), 7.39 (d, J = 9.0 Hz, 2H, CHAr), 
7.07 (q, J = 1.2 Hz, 1H, CH), 2.12 (d, J = 1.2 Hz, 3H, CH3), 2.11 (s, 3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 163.5 (s, C=O), 153.9 [s, C(O)CAr], 144.8 (d, CH), 135.7 [s, 
CArC(O)], 131.2 (s, CArCl), 130.1 (d, CArH), 128.8 (d, CArH), 124.5 [s, C(CO)CH3], 111.8 [s, 
C(CH)CH3], 17.0 [q, C(CO)CH3], 16.7 [q, C(CH)CH3]. 
IR (ATR) ν̃ = 3098 cm-1 (w), 2921 (w), 2052 (w), 1705 (s, C=O), 1556 (s), 1487 (s), 1078 (s), 
908 (m), 829 (s), 657 (m). 
MS (EI, 70 eV) m/z (%) 234.0 (100) [M+], 206.1 (89), 163.0 (22), 139.0 (17), 111 (15). 
MS (ESI, Orbitrap) m/z 235.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C13H12ClO2+ (M+H+): 235.05183; found: 235.05203. 
3,5-dimethyl-6-(4-nitrophenyl)-2H-pyran-2-one (137ac) (Table 4, entry 2). 
The compound 80ac (64 mg, 220 µmol) and tributylphosphine (54 µL, 44 mg, 220 µmol, 1.0 
equiv.) were reacted in MeCN (1.0 mL) using experimental procedure S2 
(18 h, r.t.). Flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc 
= 75/25→7/3) gave product 137ac (45 mg, 183 µmol, 83%) as a yellow 
solid.  
Rf = 0.24 (P/EtOAc = 8/2, [UV, KMnO4]). 
m.p. 199-201 °C (EtOAc) 
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1H NMR (600 MHz, CDCl3) δ 8.30 (d, J = 9.0 Hz, 2H, CHAr), 7.76 (d, J = 9.0 Hz, 2H, CHAr), 
7.13 (q, J = 1.2 Hz, 1H, CH), 2.19 (s, 3H, CH3), 2.16 (d, J = 1.2 Hz, 3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 162.9 (s, C=O), 152.3 [s, C(O)CAr], 148.1 (s, CArNO2), 144.5 
[s, CArC(O)], 138.6 (d, CH), 129.6 (d, CArH), 126.1 [s, C(CO)CH3], 123.8 (d, CArH), 113.6 [s, 
C(CH)CH3], 17.1 [q, C(CO)CH3], 16.7 [q, C(CH)CH3]. 
IR (ATR) ν̃ = 3213 cm-1 (s), 2923 (w), 2328 (w), 1908 (w), 1707 (s, C=O), 1506 (s), 1308 (s), 
1073 (s), 918 (m), 722 (s), 698 (s). 
MS (EI, 70 eV) m/z (%) 245.5 (100) [M+], 217.7 (59), 186.7 (15), 141.7 (7), 127.9 (9), 115.6 
(6). 
MS (ESI, Orbitrap) m/z 268.1 (M+Na+), 246.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C13H12NO4+ (M+H+): 246.07582; found: 246.07608. 
6-(4-methoxyphenyl)-3,5-dimethyl-2H-pyran-2-one (137ae) (Table 4, entry 3). 
The compound 80ae (90 mg, 326 µmol) and tributylphosphine (80 µL, 66 mg, 326 µmol, 1.0 
equiv.) were reacted in MeCN (1.6 mL) using experimental procedure S2 (18 h, r.t.). Flash 
column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 75/25→7/3) 
gave product 137ae (42 mg, 182 µmol, 56%) as a yellowish solid.  
Rf = 0.23 (P/EtOAc = 8/2, [UV, KMnO4]). 
m.p. 102-104 °C (EtOAc) 
1H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 9.0 Hz, 2H, CHAr), 7.00 (d, J = 1.2 Hz, 1H, CH), 
6.91 (q, J = 9.0 Hz, 2H, CHAr), 3.81 (s, 3H, OCH3), 2.10 (s, 3H, CH3), 2.09 (d, J = 1.2 Hz, 3H, 
CH3). 
13C NMR (151 MHz, CDCl3) δ 163.9 (s, C=O), 160.5 (s, CArOMe), 155.1 [s, C(O)CAr], 145.2 
(d, CH), 130.2 (d, CArH), 125.3 [s, CArC(O)], 123.1 [s, C(CO)CH3], 113.9 (d, CArH), 110.7 [s, 
C(CH)CH3], 55.5 (q, OCH3), 17.1 [q, C(CO)CH3], 16.5 [q, C(CH)CH3]. 
IR (ATR) ν̃ = 3385 cm-1 (w), 2941 (m), 2300 (w), 2109 (w), 1691 (s, C=O), 1563 (s), 1498 
(s), 1334 (m), 1019 (s), 832 (s), 752 (s). 
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MS (EI, 70 eV) m/z (%) 230.02 (50) [M+], 229.2 (100), 202.8 (52), 187.5 (39), 171.7 (9), 157.8 
(10), 128.6 (5). 
MS (ESI, Orbitrap) m/z 253.1 (M+Na+), 231.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C14H15O3+ (M+H+): 231.10157; found: 231.10219. 
4.2.5  Spectroscopic Data Related to Table 5 
rac-ethyl 5-(4-chlorophenyl)-2,4-dimethyl-2,5-dihydro-2-furancarboxylate (144ab) (Table 
5, entry 1). 
The compound 80ab (71 mg, 253 µmol, 48:52 d.r.) was reacted with (Ph3P)AuCl (12.5 mg, 25 
µmol, 0.1 equiv.) and AgOTf (6.5 mg, 25 µmol, 0.1 equiv.) in CH2Cl2 
(3.0 mL) using experimental procedure S3 (90 min, r.t.). Flash column 
chromatography (Si, 2.0×20 cm, pentane/EtOAc = 10/1) gave product 
144ab (61 mg, 217 µmol, 86%, 48:52 d.r.) as a yellow oil.  
Rf = 0.73 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H, CHAr major diastereomer and 4H, CHAr 
minor diastereomer), 7.20 (d, J = 8.4 Hz, 2H, CHAr major diastereomer), 5.65 – 5.62 (m, CHAr, 
1H, minor diastereomer and C=CH, 1H, major diastereomer), 5.60 – 5.58 (m, C=CH, 1H, minor 
diastereomer), 5.56 – 5.54 (m, CHAr, 1H, major diastereomer), 4.28 – 4.13 (m, 2H, 
COOCH2CH3, both diastereomers), 1.64 [s, 3H, C(CO2Et)CH3, minor diastereomer], 1.54 [s, 
3H, C(CO2Et)CH3, major diastereomer], 1.51 (dd, J = 1.6, 1.2 Hz, 3H, C=CCH3, major 
diastereomer), 1.49 (dd, J = 1.6, 1.2 Hz, 3H, C=CCH3, minor diastereomer), 1.274 (t, J = 7.2 
Hz, 3H, COOCH2CH3, major diastereomer), 1.272 (t, J = 7.2 Hz, 3H, COOCH2CH3, minor 
diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 173.3 (s, COOEt), 139.8 (s, CHCAr), 
138.66 (s, C=CMe), 134.0 (s, CArCl), 128.9 (d, CArH), 128.7 (d, CArH), 125.3 (d, C=CH), 90.3 
(d, CHCAr), 90.1 [s, C(CH3)CO2Et], 61.42 (t, COOCH2CH3), 25.16 [q, C(CH3)CO2Et], 14.39 
(q, COOCH2CH3), 12.53 (q, C=CCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 173.8 (s, COOEt), 140.0 (s, CHCAr), 
138.74 (s, C=CMe), 134.1 (s, CArCl), 128.84 (d, CArH), 128.78 (d, CArH), 125.4 (d, C=CH), 
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90.5 (d, CHCAr), 89.7 [s, C(CH3)CO2Et], 61.38 (t, COOCH2CH3), 25.14 [q, C(CH3)CO2Et], 
14.43 (q, COOCH2CH3), 12.64 (q, C=CCH3). 
IR (film) ν̃ = 3436 cm-1 (m), 2980 (s), 2119 (w), 1964 (w), 1736 (s, COOEt), 1596 (w), 1448 
(s), 1383 (s), 1260 (s), 1022 (s), 832 (s), 757 (w). 
MS (EI, 70 eV) m/z (%) 280.1 (2) [M+], 206.3 (40), 191.7 (15), 170.8 (25), 151.8 (10), 141.6 
(13), 128.2 (100), 102.4 (17). 
MS (ESI, Orbitrap) m/z 319.0 (M+K+), 303.1 (M+Na+), 281.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H18ClO3+ (M+H+): 281.09390; found: 281.09256. 
rac-ethyl 2,4-dimethyl-5-(2-nitrophenyl)-2,5-dihydro-2-furancarboxylate (144ad) (Table 
5, entry 2). 
The compound 80ad (78 mg, 268 µmol, 56:44 d.r.) was reacted with (Ph3P)AuCl (13 mg, 27 
µmol, 0.1 equiv.) and AgOTf (7 mg, 27 µmol, 0.1 equiv.) in CH2Cl2 (3.0 
mL) using experimental procedure S3 (90 min, r.t.). Flash column 
chromatography (Si, 2.0×20 cm, pentane/EtOAc = 75/25) gave product 
144ad (69 mg, 237 µmol, 88%, 56:44 d.r.) as a yellow oil.  
Rf = 0.79 (P/EtOAc = 7/3, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.92 (dd, J = 7.8, 1.2 Hz, 1H, CHAr major diastereomer), 7.87 
(dd, J = 7.8, 1.2 Hz, 1H, CHAr minor diastereomer), 7.86 (dd, J = 8.4, 1.2 Hz, 1H, CHAr major 
diastereomer), 7.62 – 7.57 (m, 1H, CHAr major diastereomer and 2H, CHAr minor diastereomer), 
7.42 – 7.38 (m, 1H, CHAr both diastereomers), 6.39 – 6.37 (m, CHAr, 1H, minor diastereomer), 
6.35 – 6.33 (m, 1H, CHAr, major diastereomer), 5.70 – 5.68 (m, C=CH, 1H, major 
diastereomer), 5.64 – 5.62 (m, C=CH, 1H, minor diastereomer), 4.24 – 4.16 (m, 2H, 
COOCH2CH3, both diastereomers), 1.68 [s, 3H, C(CO2Et)CH3, minor diastereomer], 1.60 (virt 
t, J = 1.2 Hz, 3H, C=CCH3, major diastereomer), 1.59 (virt t, J = 1.2 Hz, 3H, C=CCH3, minor 
diastereomer), 1.55 [s, 3H, C(CO2Et)CH3, major diastereomer], 1.29 (t, J = 7.2 Hz, 3H, 
COOCH2CH3, major diastereomer), 1.26 (t, J = 7.2 Hz, 3H, COOCH2CH3, minor 
diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 173.1 (s, COOEt), 149.1 (s, CArNO2), 140.4 
(s, C=CMe), 135.7 (d, CHCAr), 133.7 (d, CArH), 130.2 (d, CArH), 128.8 (d, CArH), 126.14 (d, 
O
Me
EtO2C
Me
NO2
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C=CH), 124.0 (d, CArH), 90.1 [s, C(CH3)CO2Et], 84.2 (d, CHCAr), 61.5 (t, COOCH2CH3), 25.1 
[q, C(CH3)CO2Et], 14.4 (q, COOCH2CH3), 12.8 (q, C=CCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 173.5 (s, COOEt), 149.2 (s, CArNO2), 141.7 
(s, C=CMe), 135.6 (d, CHCAr), 133.5 (d, CArH), 129.7 (d, CArH), 128.9 (d, CArH), 126.10 (d, 
C=CH), 124.2 (d, CArH), 89.7 [s, C(CH3)CO2Et], 84.9 (d, CHCAr), 24.6 [q, C(CH3)CO2Et], 12.9 
(q, C=CCH3). The signals COOCH2CH3 and COOCH2CH3 were not included due to overlaps 
resulting from low resolution. 
IR (film) ν̃ = 3464 cm-1 (w), 2981 (s), 2377 (w), 1965 (w), 1737 (s, COOEt), 1528 (s), 1447 (s), 
1354 (s), 1261 (s), 1032 (s), 845 (s), 744 (s). 
MS (EI, 70 eV) m/z (%) 291.7 (25) [M+], 218.9 (85), 176.1 (20), 141.0 (41), 128.6 (42), 115.7 
(29), 102.3 (14), 49.2 (100). 
MS (ESI, Orbitrap) m/z 330.1 (M+K+), 314.1 (M+Na+), 292.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H18NO5+ (M+H+): 292.11795; found: 292.11707. 
rac-ethyl 5-(3,5-dimethoxyphenyl)-2,4-dimethyl-2,5-dihydro-2-furancarboxylate (144af) 
(Table 5, entry 3). 
The compound 80af (100 mg, 326 µmol, 39:61 d.r.) was reacted with (Ph3P)AuCl (16 mg, 32 
µmol, 0.1 equiv.) and AgOTf (8 mg, 32 µmol, 0.1 equiv.) in CH2Cl2 
(3.0 mL) using experimental procedure S3 (90 min, r.t.). Flash column 
chromatography (Si, 2.0×20 cm, pentane/EtOAc = 85/15) gave 
product 144af (61 mg, 199 µmol, 61%, 36:64 d.r.) as a yellow oil.  
Rf = 0.31 (P/EtOAc = 10/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 6.55 (dd, J = 2.4, 0.4 Hz, 2H, CHAr, major diastereomer), 6.43 
(d, J = 2.0 Hz, 2H, CHAr, minor diastereomer), 6.37 (virt t, J = 2.0 Hz, 1H, CHAr, minor 
diastereomer), 6.35 (virt t, J = 2.4 Hz, 1H, CHAr, major diastereomer), 5.61 – 5.58 (m, C=CH, 
1H, major diastereomer and CHAr, 1H, minor diastereomer), 5.57 – 5.55 (m, C=CH, 1H, minor 
diastereomer), 5.51 – 5.49 (m, 1H, CHAr, major diastereomer), 4.24 – 4.14 (m, 2H, 
COOCH2CH3, both diastereomers), 3.752 (s, 6H, 2×OCH3, minor diastereomer), 3.747 (s, 6H, 
2×OCH3, major diastereomer), 1.64 [s, 3H, C(CO2Et)CH3, minor diastereomer], 1.55 (dd, J = 
1.6, 1.2 Hz, 3H, C=CCH3, major diastereomer), 1.54 [s, 3H, C(CO2Et)CH3, major 
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diastereomer], 1.53 (dd, J = 1.6, 1.2 Hz, 3H, C=CCH3, minor diastereomer), 1.264 (t, J = 7.2 
Hz, 3H, COOCH2CH3, minor diastereomer), 1.260 (t, J = 7.2 Hz, 3H, COOCH2CH3, major 
diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 173.4 (s, COOEt), 160.98 (s, CArOMe), 
142.6 (s, CHCAr), 140.1 (s, C=CMe), 124.8 (d, C=CH), 105.2 (d, CArH), 100.2 (d, CArH), 91.0 
(d, CHCAr), 90.0 [s, C(CH3)CO2Et], 61.31 (t, COOCH2CH3), 55.46 (q, OCH3), 25.3 [q, 
C(CH3)CO2Et], 14.37 (q, COOCH2CH3), 12.6 (q, C=CCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 173.9 (s, COOEt), 161.01 (s, CArOMe), 
141.2 (s, C=CMe), 125.1 (d, C=CH), 105.4 (d, CArH), 100.1 (d, CArH), 91.2 (d, CHCAr), 89.7 
[s, C(CH3)CO2Et], 61.29 (t, COOCH2CH3), 55.45 (q, OCH3), 25.1 [q, C(CH3)CO2Et], 14.41 (q, 
COOCH2CH3), 12.7 (q, C=CCH3). The signal CHCAr was not included due to overlaps resulting 
from low resolution. 
IR (film) ν̃ = 3398 cm-1 (m), 2977 (s), 2088 (w), 1735 (s, COOEt), 1602 (s), 1460 (s), 1343 (s), 
1258 (s), 1038 (s), 841 (s), 109 (w). 
MS (EI, 70 eV) m/z (%) 305.9 (49) [M+], 233.2 (100), 217.2 (21), 190.6 (53), 175.6 (51), 159.7 
(25), 145.8 (18), 115.5 (26). 
MS (ESI, Orbitrap) m/z 345.1 (M+K+), 329.1 (M+Na+), 307.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H23O5+ (M+H+): 307.15400; found: 307.15250. 
4.2.6  Spectroscopic Data of Tosylcarbamate Derivative 133 
rac-ethyl 5-(4-chlorophenyl)-2,4-dimethyl-5-[([(4-methylphenyl)sulfonyl]amino-
carbonyl)oxy]-2,3-pentadienoate (133) 
Compound 80ab (88 mg, 313 µmol, 48:52 d.r.) was dissolved in CH2Cl2 (6 mL) and the solution 
was cooled in an ice bath. After addition of tosyl isocyanate (53 µL, 68 mg, 345 µmol, 1.1 
equiv.), the resulting solution was stirred and slowly warmed to r.t. overnight. After 16 h, the 
solvent was removed under reduced pressure and the crude product 
purified by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 8/2→7/3). The resulting thick oil (94 mg, 63%) 
was dissolved in ethanol (1.5 mL) and the product 133 (31 mg, 67 
µmol, 21%, d.r. > 1:9) crystallized from the solution as colorless 
crystals when 2/3 of EtOH evaporated (standing for 45 h at r.t.).  
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Rf = 0.23 (P/EtOAc = 8/2, [UV, KMnO4]). 
m.p. 120-122 °C (EtOH) 
1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.4 Hz, 2H, CHAr), 7.57 (s br, 1H, NH), 7.31 – 7.15 
(m, 6H, CHAr), 5.84 (s, 1H, CHOCONHTs), 4.17 (2×dq, J = 10.8, 7.2 Hz, 2H, CO2CH2CH3), 
2.42 (s, 3H, CArCH3), 1.65 [s, 3H, (CH3)CCO2Et], 1.57 [s, 3H, (CH3)CCHOCONHTs], 1.30 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3). 
13C NMR (151 MHz, CDCl3) δ 206.7 (s, =C=), 167.6 (s, COOEt), 149.5 (s, NHCOOR), 145.3 
[s, CH(OCONHTs)CAr], 135.6 (s, CArCH3), 135.3 (s, CArSO2), 134.7 (s, CArCl), 129.8 (d, CArH), 
128.9 (d, CArH), 128.5 (d, CArH), 102.4 [s, CCH(OCONHTs)], 99.3 (s, CCOOEt), 77.7 [d, 
CH(OCONHTs)], 61.3 (t, CO2CH2CH3), 21.9 (q, CArCH3), 15.4 [q, (CH3)CCH(OCONHTs)], 
14.7 [q, (CH3)CCOOEt], 14.5 [q, CO2CH2CH3]. One signal CArH was not included due to 
overlaps resulting from low resolution. 
IR (ATR) ν̃ = 3411 cm-1 (w), 2877 (w), 2294 (w), 1976 (w, =C= allene), 1746 (s, CO2Et), 1682 
(s), 1476 (s), 1355 (s), 1223 (s), 1154 (s), 1015 (s), 868 (s), 663 (m). 
MS (EI, 70 eV) m/z (%) 280.5 (32), 263.9 (100) [(M-OCONHTs)+], 235.1 (22), 217.6 (82). 
MS (ESI, Orbitrap) m/z 516.1 (M+K+), 500.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C23H24ClNNaO6S+ (M+Na+): 500.09051; found: 500.08871. 
4.3  Experimental Procedures and Analytical Data for the Section 2.2 
4.3.1  Standard Experimental Procedure 
Standard experimental procedure (S4) for Oxetane Synthesis 
Allenoates 81a-g or alkynoate 81h and the respective trifluoromethylketone 82 (1.0 equiv.) are 
dissolved in MeCN at r.t. in a Schlenk-flask. Catalyst (8 - 30 mol% TBD) is added all at once, 
and the reaction mixture is stirred at r.t. until TLC indicates complete conversion of the 
allenoate or alkynoate ester (typically 10-20 min). The reaction is quenched by the addition of 
solid NH4Cl (excess), filtered and the NH4Cl washed with CH2Cl2. After evaporation of the 
solvents, the residue is purified by flash column chromatography to give the product(s).  
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4.3.2  Determination of the Double Bond Configuration of 83ha 
The double bond configuration of products 83aa-ga and 83ab-ai could be unambiguously 
determined by crystallographic methods and comparison of characteristic chemical shifts of the 
α-protons. Due to the fact that the oxetane 83ha does not bear α-protons, additional NMR 
experiments were performed in order to determine its double bond configuration. For this 
purpose a 1D NOESY was measured (see Schemes 118 and 119).  
O
CH3O
O
C6H5
H3C
H
F3C
NOE
NOE
NOE
1.11 ppm
4.15 ppm
1.81 ppm
7.45 ppm
 
Scheme 118: Characteristic NOE signals of 83ha 
Upon selective excitation of the α-methyl protons (1.11 ppm, positive signal), the relaxation 
(negative signals) of three different groups was detected: γ-Methyl group (1.81 ppm), ethylene 
protons of the ethyl carboxylate group (4.15 ppm) as well as phenyl group (7.45 ppm). The 
obtained  spectra showed  significantly stronger relaxation  signals of the aromatic protons than  
 
Scheme 119: 1D NOESY spectrum of 83ha. After selective excitation of the protons at 1.11 ppm (positive 
signal), relaxation of the protons at 1.81, 4.15 and 7.45 ppm (negative signals) was detected. 
HAr COOCH2CH3 CHCH3 
=C(CH3)CO2Et 
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of the γ-methyl group. This implied that the α-methyl group is closer to the phenyl groups than 
to the γ-methyl group and therefore the isolated compound has the (E)-configuration. In the 
case of an opposite double bond configuration, a stronger relaxation of the γ-methyl than of the 
phenyl group should be expected. 
4.3.3  Determination of Diastereomeric Ratios of Products and Yields of (Z)-Oxetanes 
from 1H NMR Spectra of Crude Reaction Mixtures 
The guantification of (Z)-configured oxetanes proved to be rather complicated in many cases 
due to the presence of inseparable impurities. The relative ratios of the (E)- and (Z)-isomers 
were determined by 1H NMR integration in the crude product mixture prior to the isolation of 
the (E)-isomer. The respective yield of the (Z)-isomer was then calculated by multiplication of 
this (E)/(Z)-ratio with the yield of the isolated, pure (E)-isomer. The relative amounts of both 
configurational isomers were based on integration of the signals of corresponding α-protons 
which were well separated and enabled secure integration (see Schemes 120, 121 and 122).  
Taking into account longer relaxation times needed for these olefinic protons, their intensity 
was only 80–90% of the expected value under a standard 1H NMR pulse sequence (relaxation 
delay 1.0 sec, 45° pulse, 16 scans, 400 MHz or relaxation delay 1.0 sec, 45° pulse, 4 scans, 600 
MHz). In order to estimate the possible inaccuracy of the integration, a standard 1H NMR 
spectrum of the crude reaction mixture containing (E)-83aa and (Z)-83aa was recorded and the 
integrals were compared to those obtained after 1H NMR experiment with modified delay time 
and pulse angle (relaxation delay 25.0 sec, 90° pulse, 16 scans, 400 MHz). As can be seen 
below, both the relative integrals of the configurational isomers [(E)-83aa:(Z)-83aa = 89:11] 
and the diastereomeric ratios [17:83 for (E)-83aa and 34:66 for (Z)-83aa] remain the same 
under either conditions. Therefore, using a standard 1H NMR pulse sequence was sufficient for 
the chosen purpose.  
 
 
 
Scheme 120: All isomers of the product 83aa present in the crude mixture after the reaction  
between 81a and 82a. 
Ш Б Д Ж 
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Scheme 121:  Example 1H NMR spectrum of 83aa. Mixture of (E)- and (Z)-83aa. Standard pulse sequence 
(relaxation delay 1.0 sec, 45° pulse, 16 scans, 400 MHz). 
 
 
Scheme 122:  Example 1H NMR spectrum of 83aa. Mixture of (E)- and (Z)-83aa. Modified pulse sequence 
(relaxation delay 25.0 sec, 90° pulse, 16 scans, 400 MHz). 
 
4.3.4  Spectroscopic Data Related to Table 6 
rac-ethyl 2-[(3R,4R)-3-methyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate (83aa) 
(Table 6, Entry 3) 
Allenoate 81a (72 mg, 570 µmol) and ketone 82a (80 µL, 99 mg, 570 µmol, 1.0 equiv.) were 
reacted in MeCN (2.3 mL) with TBD (6.4 mg, 46 µmol, 8 mol%) using standard procedure S4 
(15 min, r.t.). Flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 20/1) gave 
product (E)-83aa (133.7 mg, 445 µmol, 78%, 18:82 d.r.) as a colorless oil which solidified 
upon standing at 7 °C. An additional more polar fraction was isolated and purified by column 
chromatography (Si, 1.5×10 cm, pentane/EtOAc = 20/1) to afford minor product (Z)-83aa (14.9 
mg, 50 µmol, 9%, 48:52 d.r.) as a colorless oil. 
Ш 
Ш 
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(E)-83aa: 
Rf = 0.39 (P/EtOAc = 96/4, [UV, KMnO4]). 
m.p. 59-62 °C (pentane) 
1H NMR (600 MHz, CDCl3) δ 7.46 – 7.36 (m, 5H, CHAr, both diastereomers), 
5.40 (d, J = 1.8 Hz, 1H, CHCOOEt, major diastereomer), 5.37 (d, J = 2.4 Hz, 
1H, CHCOOEt, minor diastereomer), 4.20 (qd, J = 7.2, 1.8 Hz, 1H, CHCH3, 
major diastereomer), 4.15 – 4.09 (m, 2H, CO2CH2CH3, both diastereomers and 
1H, CHCH3, minor diastereomer), 1.75 (dd, J = 7.8, 1.8 Hz, 3H, CHCH3, minor 
diastereomer), 1.25 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major diastereomer), 1.23 (t, J = 6.6 Hz, 
3H, CO2CH2CH3, minor diastereomer), 1.15 (d, J = 7.2 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 178.1 (s, COOEt), 166.6 (s, 
C=CHCOOEt), 135.1 (CAr), 129.6 (CAr), 128.75 (CAr), 126.2 (CAr) 124.5 (qCF, 1JCF = 283.4 Hz, 
CF3), 93.29 (d, CHCOOEt), 89.5 (qCF, 2JCF = 31.7 Hz, CCF3), 60.06 (t, CO2CH2CH3), 44.0 (d, 
CHCH3), 14.47 (q, CO2CH2CH3), 13.1 (q, CHCH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 177.6 (s, COOEt), 166.5 (d, CHCOOEt), 
130.7 (CAr), 128.70 (CAr), 125.5 (CAr) 123.7 (qCF, 1JCF = 283.7 Hz, CF3), 93.32 (d, CHCOOEt), 
88.7 (qCF, 2JCF = 31.3 Hz, CCF3), 60.03 (t, CO2CH2CH3), 49.2 (d, CHCH3), 14.49 (q, 
CO2CH2CH3), 11.5 (q, CHCH3). One CAr-signal was not included due to overlaps resulting 
from low resolution. 
19F NMR (282 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.9 (major diastereomer). 
IR (ATR) ν̃ = 2991 cm-1 (w), 2095 (w), 1908 (w), 1705 (s, CO2Et), 1705 (s), 1452 (m), 1374 
(m), 1246 (m), 1170 (s), 1109 (s), 915 (m), 722 (s), 664 (m). 
MS (EI, 70 eV) m/z (%) 300.1 (3) [M+], 254.4 (4) [(M−OEt)+], 230.9 (8) [(M−Ph)+], 185.9 (100) 
[C10H9F3+], 121.0 (67), 116.9 [C9H9+] (99), 77.1 (20) [Ph+], 69.1 (74) [CF3+]. 
MS (ESI, Orbitrap) m/z 339.1 (M+K+), 323.1 (M+Na+), 301.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H15F3NaO3+ (M+Na+): 323.08655; found: 323.08527 
(Z)-83aa: 
Rf = 0.18 (P/EtOAc = 96/4, [UV, KMnO4]). 
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1H NMR (600 MHz, CDCl3) δ 7.47 – 7.39 (m, 5H, CHAr, both 
diastereomers), 4.88 (d, J = 1.2 Hz, 1H, CHCOOEt, major diastereomer), 
4.87 (d, J = 1.8 Hz, 1H, CHCOOEt, minor diastereomer), 4.23 – 4.13 (m, 
2H, CO2CH2CH3, both diastereomers), 3.97 (qd, J = 7.2, 1.8 Hz, 1H, CHCH3, 
major diastereomer), 3.90 (qd, J = 7.2, 1.1 Hz, 1H, CHCH3, minor 
diastereomer), 1.55 (dd, J = 7.2, 1.2 Hz, 3H, CHCH3, minor diastereomer), 1.28 (t, J = 7.2 Hz, 
3H, CO2CH2CH3, major diastereomer), 1.27 (t, J = 7.2 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 0.98 (d, J = 7.9 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 174.51 (s, COOEt), 164.82 (s, 
C=CHCOOEt), 135.0 (CAr), 129.71 (CAr), 128.8 (CAr), 126.4 (CAr) 124.0 (qCF, 1JCF = 283.0 Hz, 
CF3), 91.2 (d, CHCOOEt), 89.1 (qCF, 2JCF = 32.5 Hz, CCF3), 60.08 (t, CO2CH2CH3), 42.3 (d, 
CHCH3), 14.57 (q, CO2CH2CH3), 14.0 (q, CHCH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 174.50 (s, COOEt), 164.78 (d, CHCOOEt), 
130.2 (CAr), 129.69 (CAr), 128.7 (CAr), 125.6 (CAr) 123.6 (qCF, 1JCF = 283.9 Hz, CF3), 90.3 (d, 
CHCOOEt), 88.9 (qCF, 2JCF = 31.3 Hz, CCF3), 60.05 (t, CO2CH2CH3), 47.5 (d, CHCH3), 14.55 
(q, CO2CH2CH3) 12.2 (q, CHCH3). 
19F NMR (282 MHz, CDCl3) δ –74.8 (minor diastereomer), –79.6 (major diastereomer). 
IR (film) ν̃ = 3434 cm-1 (w), 2982 (m), 1962 (w), 1716 (s, CO2Et), 1454 (m), 1378 (m), 1258 
(m), 1183 (s), 1013 (s), 906 (m), 703 (m), 620 (w). 
MS (EI, 70 eV) m/z (%) 300.1 (4) [M+], 254.7 (12) [(M−OEt)+], 231.0 (12) [(M−Ph)+], 185.9 
(100) [C10H9F3+], 117.0 [C9H9+] (84), 115.0 (30), 77.1 (7) [Ph+], 69.2 (42) [CF3+]. 
MS (ESI, Orbitrap) m/z 339.1 (M+K+), 323.1 (M+Na+), 301.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H15F3NaO3+ (M+Na+): 323.08655; found: 323.08542 
Rac-benzyl 2-[(3R,4R)-3-methyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate (83ba) 
(Table 6, Entry 7) 
Allenoate 81b (110 mg, 584 µmol) and ketone 82a (82 µL, 102 mg, 584 µmol, 1.0 equiv.) were 
reacted in MeCN (2.3 mL) with TBD (8.1 mg, 58 µmol, 10 mol%) using standard procedure 
S4 (10 min, r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 20/1→7/1) 
OF3C
Ph
Me
H COOEt
major
diastereomer
(Z)-83aa
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gave product (E)-83ba (149 mg, 411 µmol, 70%, 19:81 d.r.) as a colorless oil and a minor 
product (Z)-83ba (20 mg, 55 µmol, 9%, 43:57 d.r.) as a colorless oil. 
(E)-83ba: 
Rf = 0.54 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.51 – 7.40 (m, 5H, CHAr, both diastereomers), 
7.40 – 7.31 (m, 5H, CHAr, both diastereomers), 5.52 (d, J = 1.9 Hz, 1H, 
CHCOOBn, major diastereomer), 5.49 (d, J = 2.1 Hz, 1H, CHCOOBn, minor 
diastereomer), 5.15 (2×d, J = 12.4 Hz, 2H, COOCH2Ph, major diastereomer), 
5.13 (2×d, J = 12.3 Hz, 2H, COOCH2Ph, minor diastereomer), 4.25 (qd, J = 
7.4, 1.9 Hz, 1H, CHCH3, major diastereomer), 4.16 (qd, J = 7.4, 1.8 Hz, 1H, CHCH3, minor 
diastereomer), 1.77 (dq, J = 7.5, 1.7 Hz, 3H, CHCH3, minor diastereomer), 1.16 (d, J = 7.4 Hz, 
3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 178.6 (s, COOBn), 166.3 (s, 
C=CHCOOBn), 136.2 (CAr), 129.6 (CAr), 128.7 (CAr), 128.34 (CAr), 126.1 (CAr) 124.2 (qCF, 1JCF 
= 283.1 Hz, CF3), 92.9 (d, CHCOOBn), 89.6 (qCF, 2JCF = 31.5 Hz, CCF3), 65.9 (t, COOCH2Ph), 
44.0 (d, CHCH3), 12.9 (q, CHCH3). Three CAr-signals were not included due to overlaps 
resulting from low resolution. 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 178.2 (s, COOBn), 166.2 (s, 
C=CHCOOBn), 136.7 (CAr), 134.9 (CAr), 130.6 (CAr), 128.6 (CAr), 128.29 (CAr), 125.4 (CAr) 
123.6 (qCF, 1JCF = 283.8 Hz, CF3), 88.7 (qCF, 2JCF = 30.9 Hz, CCF3), 65.8 (t, COOCH2Ph), 49.1 
(d, CHCH3), 11.4 (q, CHCH3). Two CAr-signals and the CHCOOBn signal were not included 
due to overlaps resulting from low resolution. 
19F NMR (376 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.6 (major diastereomer). 
IR  (film)  ν̃  =  3443  cm-1 (w),  2946  (m),  1714  (s, CO2Bn),  1455 (m), 1381 (m),  1258 (s),  
1179 (s), 1107 (s), 1010 (s), 916 (m), 729 (s), 604 (w). 
MS (EI, 70 eV) m/z (%) 362.1 [M+] (7), 255.1 (16) [(M−OBn)+], 185.9 (21) [C10H9F3+], 117.1 
[C9H9+] (27), 115.1 (6), 91.1 [Bn+] (100), 77.1 (5) [Ph+], 69.1 (17) [CF3+]. 
MS (ESI, Orbitrap) m/z 363.2 (M+H+), 385.1 (M+Na+). 
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HRMS (ESI, Orbitrap) calcd. for C20H17F3NaO3+ (M+Na+): 385.10220; found: 385.10263. 
(Z)-83ba: 
Rf = 0.5 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.29 (m, 10H, CHAr, both 
diastereomers), 5.21 (2×d, J = 12.5 Hz, 2H, COOCH2Ph, major 
diastereomer), 5.20 (s, 2H, COOCH2Ph, minor diastereomer), 4.97 (d, J = 
1.6 Hz, 1H, CHCOOBn, major diastereomer), 4.95 (d, J = 1.8 Hz, 1H, 
CHCOOBn, minor diastereomer),  4.01 (qd, J = 7.4, 1.6 Hz, 1H, CHCH3, 
major diastereomer), 3.94 (qd, J = 7.5, 1.5 Hz, 1H, CHCH3, minor diastereomer), 1.58 (dq, J = 
7.6, 1.5 Hz, 3H, CHCH3, minor diastereomer), 1.01 (d, J = 7.4 Hz, 3H, CHCH3, major 
diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 175.06 (s, COOBn), 164.45 (s, 
C=CHCOOBn), 136.51 (CAr), 134.8 (CAr), 130.1 (CAr), 128.8 (CAr), 128.61 (CAr), 128.2 (CAr), 
128.12 (CAr), 126.3 (CAr), 123.9 (qCF, 1JCF = 282.8 Hz, CF3), 90.8 (d, CHCOOBn), 89.15 (qCF, 
2JCF = 32.3 Hz, CCF3), 65.75 (t, COOCH2Ph), 42.3 (d, CHCH3), 14.0 (q, CHCH3).  
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 175.05 (s, COOBn), 164.43 (s, 
C=CHCOOBn), 136.53 (CAr), 129.67 (CAr), 128.7 (CAr), 128.59 (CAr), 128.10 (CAr), 128.08 
(CAr), 125.5 (CAr), 123.6 (qCF, 1JCF = 284.1 Hz, CF3), 90.0 (d, CHCOOBn), 89.03 (qCF, 2JCF = 
30.9 Hz, CCF3), 65.70 (t, COOCH2Ph), 47.5 (d, CHCH3), 12.1 (q, CHCH3). One CAr-signal was 
not included due to overlaps resulting from insufficient resolution. 
19F NMR (376 MHz, CDCl3) δ –74.8 (minor diastereomer), –79.7 (major diastereomer). 
IR (film) ν̃ = 3442 cm-1 (w), 2938 (m), 1718 (s, CO2Bn), 1453 (m), 1381 (m), 1259 (s), 1181 
(s), 1002 (s), 912 (w), 730 (m), 606 (w). 
MS  (EI,  70  eV) m/z  (%) 362.1  [M+]  (1),  255.1  (22)  [(M−OBn)+],  185.9  (19)  [C10H9F3+],  
117.1 [C9H9+] (27), 115.1 (7), 91.1 [Bn+] (100), 77.2 (6) [Ph+], 69.1 (20) [CF3+]. 
MS (ESI, Orbitrap) m/z 363.1 (M+H+), 385.1 (M+Na+), 401.1 (M+K+). 
HRMS (ESI, Orbitrap) calcd. for C20H18F3O3+ (M+H+): 363.12026; found: 363.12073. 
 
OF3C
Ph
Me
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diastereomer
(Z)-83ba
COOBn
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rac-methyl 2-[(3R,4S)-3-methyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate (83ca) 
(Table 6, Entry 8) 
Allenoate 81c (83 mg, 740 µmol) and ketone 82a (104 µL, 129 mg, 740 µmol, 1.0 equiv.) were 
reacted in MeCN (3 mL) with TBD (15.5 mg, 111 µmol, 15 mol%) using standard procedure 
S4 (20 h, r.t., TLC showed incomplete conversion of 81c). Flash column chromatography (Si, 
2.0×22 cm, pentane/EtOAc = 30/1→10/1) gave product (E)-83ca (108 mg, 377 µmol, 51%, 
27:73 d.r.) as a colorless oil. The yield of the minor isomer (Z)-83ca (7%, 57:73 d.r.) was 
determined from the 1H-NMR spectrum of the crude reaction mixture based on isolated product 
(E)-83ca. 
(E)-83ca: 
Rf = 0.54 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.39 (m, 5H, CHAr,  
both diastereomers), 5.44 (d, J = 1.9 Hz, 1H, CHCOOMe, major 
diastereomer), 5.40 (d, J = 2.2 Hz, 1H, CHCOOMe, minor diastereomer), 
4.23 (qd, J = 7.4, 1.9 Hz, 1H, CHCH3, major diastereomer), 4.13 (qd, J = 7.5, 
2.1 Hz, 1H, CHCH3, minor diastereomer), 3.68 (s, 3H, COOCH3, major 
diastereomer), 3.66 (s, 3H, COOCH3, minor diastereomer), 1.77 (dq, J = 7.6, 1.7 Hz, 3H, 
CHCH3, minor diastereomer), 1.17 (d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 178.3 (s, COOMe), 166.9 (s, 
C=CHCOOMe), 130.6 (CAr), 128.7 (CAr), 126.1 (CAr) 124.2 (qCF, 1JCF = 283.1 Hz, CF3), 92.79 
(d, CHCOOMe), 89.5 (qCF, 2JCF = 31.8 Hz, CCF3), 51.2 (q, COOCH3), 43.9 (d, CHCH3), 13.0 
(q, CHCH3). One CAr-signal was not included due to overlaps resulting from low resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 177.8 (s, COOMe), 166.8 (s, 
C=CHCOOMe), 135.0 (CAr), 129.6 (CAr), 128.64 (CAr), 125.4 (CAr) 123.6 (qCF, 1JCF = 283.6 
Hz, CF3), 92.80 (d, CHCOOMe), 88.7 (qCF, 2JCF = 31.1 Hz, CCF3), 51.1 (q, COOCH3), 49.1 (d, 
CHCH3), 11.4 (q, CHCH3). 
19F NMR (376 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.7 (major diastereomer). 
IR (film) ν̃ = 3439 cm-1 (w), 2953 (m), 1720 (s, CO2Me), 1444 (s), 1356 (s), 1287 (s), 1180 
(s), 1117 (s), 1011 (s), 923 (m), 719 (m), 665 (w). 
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MS (EI, 70 eV) m/z (%) 286.1 (3) [M+], 255.1 (11) [(M−OMe)+], 217.1 (16) [(M−CF3)+], 186.1 
(91) [C10H9F3+], 117.1 (100) [C9H9+], 115.1 (25), 77.1 (8) [Ph+], 69.1 (29) [CF3+]. 
MS (ESI, Orbitrap) m/z 287.1 (M+H+), 309.1 (M+Na+), 325.0 (M+K+). 
HRMS (ESI, Orbitrap) calcd. for C14H14F3O3+ (M+H+): 287.08896; found: 287.08942 
(Z)-83ca: 
This isomer was not isolated in pure form. Therefore, the signals were assigned 
from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 4.93 (d, J = 1.6 
Hz, 1H, CHCOOMe, minor diastereomer), 4.91 (d, J = 2.0 Hz, 1H, 
CHCOOMe, major diastereomer), 1.58 (dq, J = 7.2, 1.2 Hz, 3H, CHCH3, major 
diastereomer), 1.00 (d, J = 7.2 Hz, 3H, CHCH3, minor diastereomer). 
rac-isopropyl 2-[(3R,4S)-3-methyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate 
(83da) (Table 6, Entry 9) 
Allenoate 81d (103 mg, 735 µmol) and ketone 82a (103 µL, 128 mg, 735 µmol, 1.0 equiv.) 
were reacted in MeCN (3 mL) with TBD (10.3 mg, 73 µmol, 10 mol%) using standard 
procedure S4 (50 min, r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 
50/1→20/1) gave product (E)-83da (132 mg, 420 µmol, 57%, 30:70 d.r.) as a colorless oil. The 
yield of the minor isomer (Z)-83da (7%, 62:38 d.r.) was determined from the 1H-NMR 
spectrum of the crude reaction mixture based on isolated product (E)-83da. 
(E)-83da: 
Rf = 0.71 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.36 (m, 5H, CHAr, both diastereomers), 5.40 (d, J = 1.9 
Hz,  1H,  CHCOOi-Pr,  major  diastereomer),  5.37  (d,  J  =  2.2  Hz, 1H,  CHCOOi-Pr,  minor 
diastereomer), 5.06 – 4.97 (m, 1H, CHMe2, both diastereomers), 4.21 (qd, J = 
7.4, 1.9 Hz, 1H, CHCH3, major diastereomer), 4.13 (q, J = 7.2 Hz, 1H, 
CHCH3, minor diastereomer), 1.78 (dq, J = 7.5, 1.8 Hz, 3H, CHCH3, minor 
diastereomer), 1.26 – 1.21 (m, 6H, m, 1H, CHMe2 both diastereomers), 1.17 
(d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
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13C NMR (major diastereomer, 151 MHz, CDCl3) δ 177.7 (s, COOi-Pr), 166.0 (s, C=CHCOOi-
Pr), 130.7 (CAr), 128.66 (CAr), 126.1 (CAr) 124.2 (qCF, 1JCF = 283.1 Hz, CF3), 93.70 (d, 
CHCOOi-Pr), 89.38 (qCF, 2JCF = 30.9 Hz, CCF3), 67.27 (d, CO2CHMe2), 43.9 (d, CHCH3), 
22.09 [q, CO2CH(CH3)2], 13.0 (q, CHCH3). One CAr-signal was not included due to overlaps 
resulting from low resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 177.2 (s, COOi-Pr), 165.9 (s, C=CHCOOi-
Pr), 135.2 (CAr), 129.5 (CAr), 128.61 (CAr), 125.2 (CAr) 123.6 (qCF, 1JCF = 283.7 Hz, CF3), 93.73 
(d, CHCOOi-Pr), 88.51 (qCF, 2JCF = 30.9 Hz, CCF3), 67.23 (d, CO2CHMe2), 49.1 (d, CHCH3), 
22.07 [q, CO2CH(CH3)2], 11.5 (q, CHCH3). 
19F NMR (282 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.6 (major diastereomer). 
IR (film) ν̃ = 3437 cm-1 (w), 2983 (m), 1715 (s, CO2i-Pr), 1454 (m), 1374 (s), 1267 (m), 1179 
(s), 1107 (s), 1010 (s), 912 (m), 719 (m), 664 (w). 
MS (EI, 70 eV) m/z (%) 315.2 (5), 255.1 (8) [(M−Oi-Pr)+], 185.9 (100) [C10H9F3+], 117.1 
[C9H9+] (77), 115.1 (15), 77.1 (6) [Ph+], 69.1 (39) [CF3+]. 
MS (ESI, Orbitrap) m/z 315.1 (M+H+), 337.1 (M+Na+), 353.1 (M+K+). 
HRMS (ESI, Orbitrap) calcd. for C16H18F3O3+ (M+H+): 315.12026; found: 315.12088 
(Z)-83da: 
This isomer was not isolated in pure form. Therefore, the signals were assigned from the crude 
reaction mixture. 1H NMR (400 MHz, CDCl3) δ 4.90 (d, J = 1.6 Hz, 1H, 
CHCOOi-Pr, minor diastereomer), 4.88 (d, J = 1.6 Hz, 1H, CHCOOi-Pr, 
major diastereomer), 1.56 (dq, J = 7.6, 1.6 Hz, 3H, CHCH3, major 
diastereomer), 1.00 (d, J = 7.6 Hz, 3H, CHCH3, minor diastereomer). 
rac-tert-butyl 2-[(3R,4S)-3-methyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate 
(83ea) (Table 6, Entry 10) 
Allenoate 81e (107 mg, 694 µmol) and ketone 82a (97 µL, 121 mg, 694 µmol, 1.0 equiv.) were 
reacted in MeCN (2.8 mL) with TBD (14.5 mg, 104 µmol, 15 mol%) using standard procedure 
S4 (50 min., r.t., TLC showed incomplete conversion of 1e). Flash column chromatography (Si, 
2.0×22 cm, pentane/EtOAc = 20/1→15/1) gave product (E)-83ea (115 mg, 359 µmol, 50%, 
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43:57 d.r.) as a colorless oil. The yield of the minor isomer (Z)-83ea (6%, 79:21 d.r.) was 
determined from the 1H-NMR spectrum of the crude reaction mixture based on isolated product 
(E)-83ea. 
(E)-83ea: 
Rf = 0.57 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.48 – 7.38 (m, 5H, CHAr, both diastereomers), 
5.34 (d, J = 1.9 Hz, 1H, CHCOOt-Bu, minor diastereomer), 5.31 (d, J = 2.2 
Hz, 1H, CHCOOt-Bu, major diastereomer), 4.18 (qd, J = 7.4, 1.9 Hz, 1H, 
CHCH3, minor diastereomer), 4.11 (q, J = 7.3, 1.9 Hz, 1H, CHCH3, major 
diastereomer), 1.77 (dq, J = 7.6, 1.7 Hz, 3H, CHCH3, major diastereomer), 
1.47 [s, 9H, COOC(CH3)3, minor diastereomer], 1.45 [s, 9H, COOC(CH3)3, major 
diastereomer], 1.16 (d, J = 7.4 Hz, 3H, CHCH3, minor diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 176.9 (s, COOt-Bu), 165.8 (s, 
C=CHCOOt-Bu), 135.3 (CAr), 129.47 (CAr), 128.6 (CAr), 125.5 (CAr) 123.7 (qCF, 1JCF = 283.4 
Hz, CF3), 94.9 (d, CHCOOt-Bu), 88.4 (qCF, 2JCF = 30.7 Hz, CCF3), 80.2 [s, COOC(CH3)3], 49.0 
(d, CHCH3), 28.38 [q, COOC(CH3)3], 11.5 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 176.4 (s, COOt-Bu), 165.9 (s, 
C=CHCOOt-Bu), 130.9 (CAr), 129.49 (CAr), 128.7 (CAr), 126.1 (CAr) 124.3 (qCF, 1JCF = 283.2 
Hz, CF3), 89.3 (qCF, 2JCF = 31.7 Hz, CCF3), 80.3 [s, COOC(CH3)3], 43.8 (d, CHCH3), 28.40 [q, 
COOC(CH3)3], 13.1 (q, CHCH3). One signal was not included due to overlaps resulting from 
low resolution. 
19F NMR (282 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.6 (major diastereomer). 
IR  (film)  ν̃  =  3440  cm-1  (w),  2978  (m),  1713  (s,  CO2Et), 1454 (m), 1363  (s), 1250 (m),  
1179 (s), 1111 (s), 1009 (s), 912 (w), 707 (m), 664 (w). 
MS (EI, 70 eV) m/z (%) 272.7 [(M−t-Bu)+] (19), 255.0 (6) [(M−Ot-Bu)+], 185.9 (100) 
[C10H9F3+], 117.1 [C9H9+] (57), 115.0 (16), 77.1 (6) [Ph+], 69.1 (40) [CF3+]. 
MS (ESI, Orbitrap) m/z 351.1 (M+Na+), 329.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H19F3NaO3+ (M+Na+): 351.11785; found: 351.11829. 
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(Z)-83ea: 
This isomer was not isolated in pure form. Therefore, the signals were assigned from the crude 
reaction mixture. 1H NMR (400 MHz, CDCl3) δ 4.84 (d, J = 1.6 Hz, 1H, 
CHCOOt-Bu, minor diastereomer), 4.83 (d, J = 1.6 Hz, 1H, CHCOOt-Bu, 
major diastereomer), 1.56 (dq, J = 7.6, 1.6 Hz, 3H, CHCH3, major 
diastereomer), 1.00 (d, J = 7.2 Hz, 3H, CHCH3, minor diastereomer). 
rac-ethyl 2-[(3R,4R)-3-isopropyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate (83fa) 
(Table 6, Entry 11) 
Allenoate 81f (97 mg, 612 µmol) and ketone 82a (88 µL, 109 mg, 629 µmol, 1.0 equiv.) were 
reacted in MeCN (2.5 mL) with TBD (17.5 mg, 126 µmol, 20 mol%) using standard procedure 
S4 (1 h 20 min, r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 
50/1→15/1) gave product (E)-83fa (55 mg, 167 µmol, 27%, 3:97 d.r.) as a colorless oil and a 
major product (Z)-83fa (94 mg, 287 µmol, 46%, 58:42 d.r.) as a colorless oil. 
(E)-83fa: 
Rf = 0.60 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.57 – 7.48 (m, 2H, CHAr), 7.48 – 7.40 (m, 3H, 
CHAr), 5.55 (d, J = 1.9 Hz, 1H, CHCOOEt), 4.19 – 4.09 (m, 3H, CO2CH2CH3 
and CHi-Pr), 2.25 (heptd, J = 7.1, 4.0 Hz, 1H, CHMe2), 1.27 (t, J = 7.1 Hz, 
3H, CO2CH2CH3), 0.84 [d, J = 7.1 Hz, 3H, CHCH3(CH3)], 0.79 [d, J = 7.0 
Hz, 3H, CHCH3(CH3)]. 
13C NMR (101 MHz, CDCl3) δ 175.1 (s, COOEt), 166.5 (s, C=CHCOOEt), 130.1 (CAr), 129.1 
(CAr), 128.5 (CAr), 126.6 (CAr) 124.5 (qCF, 1JCF = 284.4 Hz, CF3), 94.8 (d, CHCOOEt), 89.3 
(qCF, 2JCF = 31.3 Hz, CCF3), 60.0 (t, CO2CH2CH3), 55.3 (d, CHi-Pr), 27.0 (d, CHMe2), 20.1 [q, 
CHCH3(CH3)], 18.9 [q, CHCH3(CH3)], 14.5 (q, CO2CH2CH3). 
19F NMR (376 MHz, CDCl3) δ –79.1. 
IR (film) ν̃ = 3457 cm-1 (m), 2973 (s), 1899 (w), 1716 (s, CO2Et), 1680 (s), 1459 (s), 1379 (s), 
1260 (s), 1176 (s), 1110 (s), 825 (m), 719 (s). 
O
COOEt
F3C
Ph
H
major
diastereomer
(E)-83fa
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MS (EI, 70 eV) m/z (%) 328.1 (12) [M+], 383.0 (8) [(M−OEt)+], 214.1 (32) [C12H13F3+], 199.0 
[C11H10F3+] (100), 145.0 [C11H13+] (35), 115.0 (18), 77.1 (9) [Ph+], 69.1 (31) [CF3+]. 
MS (ESI, Orbitrap) m/z 329.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H20F3O3+ (M+H+): 329.13591; found: 329.13510. 
 (Z)-83fa: 
Rf = 0.40 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.60 – 7.54 (m, 2H, CHAr, major diastereomer), 7.53 – 7.49 (m, 
2H, CHAr, minor diastereomer), 7.47 – 7.39 (m, 3H, CHAr, both 
diastereomers), 5.03 (d, J = 1.8 Hz, 1H, CHCOOEt, minor diastereomer), 
5.02 (d, J = 1.6 Hz, 1H, CHCOOEt, major diastereomer), 4.25 – 4.13 (m, 
2H, CO2CH2CH3 both diastereomers), 3.65 (dd, J = 7.9, 1.6 Hz, 1H, CHi-
Pr, major diasteromer), 3.50 (dd, J = 11.1, 1.7 Hz, 1H, CHi-Pr, minor 
diastereomer), 2.58 – 2.49 (m, 1H, CHMe2, minor diastereomer), 1.76 – 1.67 (m, 1H, CHMe2, 
major diastereomer), 1.30 (t, J = 7.3 Hz, 3H, CO2CH2CH3, major diasteromer), 1.28 (t, J = 7.0 
Hz, 3H, CO2CH2CH3, minor diasteromer), 1.23 [d, J = 6.5 Hz, 3H, CHCH3(CH3), minor 
diasteromer], 1.10 [d, J = 6.6 Hz, 3H, CHCH3(CH3), minor diastereomer], 0.79 [d, J = 6.7 Hz, 
3H, CHCH3(CH3), major diasteromer], 0.74 (d, J = 6.7 Hz, 3H, CHCH3(CH3), major 
diastereomer]. 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 172.0 (s, COOEt), 164.6 (s, 
C=CHCOOEt), 130.6 (CAr), 129.7 (CAr), 128.6 (CAr), 126.6 (CAr) 124.2 (qCF, 1JCF = 283.3 Hz, 
CF3), 92.8 (d, CHCOOEt), 88.8 (qCF, 2JCF = 31.9 Hz, CCF3), 60.0 (t, CO2CH2CH3), 54.6 (d, 
CHi-Pr), 26.5 (d, CHMe2), 21.35 [q, CHCH3(CH3)], 18.6 [q, CHCH3(CH3)], 14.47 (q, 
CO2CH2CH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 172.7 (s, COOEt), 164.7 (d, CHCOOEt), 
134.9 (CAr), 129.5 (CAr), 126.0 (CAr) 123.8 (qCF, 1JCF = 283.9 Hz, CF3), 92.0 (d, CHCOOEt), 
89.2 (qCF, 2JCF = 31.4 Hz, CCF3), 60.07 (t, CO2CH2CH3), 59.9 (d, CHi-Pr), 26.9 (d, CHMe2), 
22.35 [q, CHCH3(CH3)], 21.32 [q, CHCH3(CH3)], 14.45 (q, CO2CH2CH3). One CAr-signal was 
not included due to overlaps resulting from low resolution. 
19F NMR (564 MHz, CDCl3) δ –74.2 (minor diastereomer), –78.3 (major diastereomer). 
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IR (film) ν̃ = 3437 cm-1 (w), 2976 (s), 1712 (s, CO2Et), 1461 (s), 1374 (s), 1262 (s), 1180 (s), 
1004 (s), 806 (m), 713 (s). 
MS (EI, 70 eV) m/z (%) 328.1 (6) [M+], 383.1 (13) [(M−OEt)+], 214.1 (34) [C12H13F3+], 199.0 
[C11H10F3+] (94), 145.0 [C11H13+] (45), 115.0 (100), 77.1 (6) [Ph+], 69.1 (32) [CF3+]. 
MS (ESI, Orbitrap) m/z 367.1 (M+K+), 351.1 (M+Na+), 329.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C17H20F3O3+ (M+H+): 329.13591; found: 329.13556 
rac-benzyl 2-[(3R,4R)-3-isopropyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate 
(83ga) (Table 6, Entry 12) 
Allenoate 81g (106 mg, 490 µmol) and ketone 82a (85 mg, 490 µmol, 1.0 equiv.) were reacted 
in MeCN (2.0 mL) with TBD (13.7 mg, 98 µmol, 20 mol%) using standard procedure S4 (1 h, 
r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 50/1→15/1) gave product 
(E)-83ga (43 mg, 111 µmol, 23%, 3:97 d.r.) as a colorless oil and a major product (Z)-83ga (92 
mg, 236 µmol, 48%, 68:32 d.r.) as a colorless oil. 
(E)-83ga: 
Rf = 0.58 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H, CHAr), 7.47 – 7.43 (m, 
3H, CHAr), 7.39 – 7.31 (m, 5H, CHAr), 5.63 (d, J = 1.9 Hz, 1H, CHCOOBn), 
5.15 (s, 2H, COOCH2Ph), 4.13 (dd, J = 4.0, 1.9 Hz, 1H, CHi-Pr), 2.25 (heptd, 
J = 7.1, 4.0 Hz, 1H, CHMe2), 0.81 [d, J = 7.1 Hz, 3H, CHCH3(CH3)], 0.78 
[d, J = 7.1 Hz, 3H, CHCH3(CH3)]. 
13C NMR (151 MHz, CDCl3) δ 175.7 (s, COOBn), 166.3 (s, C=CHCOOBn), 136.2 (CAr), 130.8 
(CAr), 129.6 (CAr), 128.7 (CAr), 128.5 (CAr), 128.3 (CAr), 126.6 (CAr), 124.5 (qCF, 1JCF = 284.3 
Hz, CF3), 94.5 (d, CHCOOBn), 65.9 (t, CO2CH2Ph), 55.4 (d, CHi-Pr), 27.0 (d, CHMe2), 20.5 
[q, CHCH3(CH3)], 18.8 [q, CHCH3(CH3)]. One CAr-signal was not included due to overlaps 
resulting from insufficient resolution. 
19F NMR (564 MHz, CDCl3) δ –79.0. 
IR (film) ν̃ = 3439 cm-1 (w), 2966 (m), 1890 (w), 1717 (s, CO2Et), 1678 (s), 1455 (m), 1382 
(m), 1263 (s), 1176 (s), 1109 (s), 826 (m), 723 (s). 
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MS (EI, 70 eV) m/z (%) 390.1 (16) [M+], 283.1 (6) [(M−OBn)+], 214.1 (13) [C12H13F3+], 199.1 
[C11H10F3+] (49), 145.1 [C11H13+] (15), 91.1 (100) [Bn+], 69.1 (23) [CF3+]. 
MS (ESI, Orbitrap) m/z 429.1 (M+K+), 413.1 (M+Na+), 391.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C22H22F3O3+ (M+H+): 391.15156; found: 391.15115. 
(Z)-83ga: 
Rf = 0.35 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) 7.61 – 7.56 (m, 2H, CHAr, major diastereomer), 7.55 – 7.51 (m, 
2H, CHAr, minor diastereomer), 7.48 – 7.29 (m, 8H, CHAr, both diastereomers), 5.27 – 5.18 (m, 
2H, COOCH2Ph, both diastereomers), 5.10 (d, J = 1.8 Hz, 1H, CHCOOBn, 
minor diastereomer), 5.09 (d, J = 1.6 Hz, 1H, CHCOOBn, major 
diastereomer), 3.68 (dd, J = 7.9, 1.6 Hz, 1H, CHi-Pr, major diastereomer), 
3.53 (dd, J = 11.2, 1.7 Hz, 1H, CHi-Pr, minor diastereomer), 2.56 (hept, J = 
5.3 Hz, 1H, CHMe2, minor diastereomer), 1.73 (virt dp, J = 7.9, 6.6 Hz, 1H, CHMe2, major 
diastereomer), 1.24 [d, J = 6.5 Hz, 3H, CHCH3(CH3), minor diasteromer], 1.10 [d, J = 6.6 Hz, 
3H, CHCH3(CH3), minor diasteromer], 0.81 [d, J = 6.6 Hz, 3H, CHCH3(CH3), major 
diasteromer], 0.75 [d, J = 6.7 Hz, 1H, 3H, CHCH3(CH3), major diasteromer]. 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 172.6 (s, COOBn), 164.3 (s, 
C=CHCOOBn), 136.48 (CAr), 129.7 (CAr), 128.7 (CAr), 128.60 (CAr), 128.2 (CAr), 128.11 (CAr), 
126.6 (CAr), 124.2 (qCF, 1JCF = 283.3 Hz, CF3), 92.6 (d, CHCOOBn), 88.9 (qCF, 2JCF = 31.8 Hz, 
CCF3), 65.75 (t, COOCH2Ph), 54.7 (d, CHi-Pr), 26.5 (d, CHMe2), 21.35 [q, CHCH3(CH3)], 
18.6 [q, CHCH3(CH3)]. One CAr-signal was not included due to overlaps resulting from 
insufficient resolution. 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 173.3 (s, COOBn), 164.4 (s, 
C=CHCOOBn), 136.52 (CAr), 134.8 (CAr), 130.5 (CAr), 129.5 (CAr), 128.57 (CAr), 128.07 (CAr), 
126.0 (CAr), 123.7 (qCF, 1JCF = 284.0 Hz, CF3), 91.8 (d, CHCOOBn), 89.3 (qCF, 2JCF = 31.8 Hz, 
CCF3), 65.67 (t, COOCH2Ph), 60.5 (d, CHi-Pr), 26.9 (d, CHMe2), 22.3 [q, CHCH3(CH3)], 21.31 
[q, CHCH3(CH3)]. One CAr-signal was not included due to overlaps resulting from insufficient 
resolution. 
19F NMR (564 MHz, CDCl3) δ –74.2 (minor diastereomer), –78.3 (major diastereomer). 
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IR (film) ν̃ = 3396 cm-1 (w), 2968 (s), 1716 (s, CO2Et), 1455 (s), 1380 (m), 1263 (s), 1176 (s), 
1006 (s), 815 (m), 701 (s). 
MS (EI, 70 eV) m/z (%) 390.1 (13) [M+], 284.1 (35), 241.1 (45), 214.1 (16) [C12H13F3+], 199.1 
[C11H10F3+] (64), 145.1 [C11H13+] (23), 91.1 (100) [Bn+], 69.1 (28) [CF3+]. 
MS (ESI, Orbitrap) m/z 429.1 (M+K+), 413.1 (M+Na+), 391.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C22H22F3O3+ (M+H+): 391.15156; found: 391.15054 
rac-ethyl 2-[(3R,4R)-3-butyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]acetate (83ia) 
(Scheme 62) 
Alkynoate 81i (103 mg, 612 µmol) and ketone 82a (86 µL, 107 mg, 612 µmol, 1.0 equiv.) were 
reacted in MeCN (2.4 mL) with TBD (8.5 mg, 61 µmol, 10 mol%) using standard procedure 
S4 (10 min, r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 50/1→20/1) 
gave product (E)-83ia (137 mg, 400 µmol, 65%, 14:86 d.r.) as a colorless oil and a minor 
product (Z)-83ia (35 mg, 102 µmol, 17%, 65:35 d.r.) as a colorless oil. 
(E)-83ia: 
Rf = 0.50 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.52 – 7.48 (m, 2H, CHAr, both 
diastereomers), 7.48 – 7.40 (m, 3H, CHAr, both diastereomers), 5.46 (d, J = 
2.0 Hz, 1H, CHCOOEt, major diastereomer), 5.39 (d, J = 2.2 Hz, 1H, 
CHCOOEt, minor diastereomer), 4.19 – 4.08 (m, 3H, COOCH2CH3 and 
CHC4H9, both diastereomers), 4.00 (dt, J = 11.5, 2.6 Hz, 1H, CHC4H9, minor 
diastereomer), 2.55 – 2.48 (m, 1H, Halkyl, minor diastereomer), 2.13 – 2.05 
(m, 1H, Halkyl, minor diastereomer), 1.93 – 1.84 (m, 1H, Halkyl, major diastereomer), 1.71 – 1.63 
(m, 1H, Halkyl, minor diastereomer), 1.56 – 1.49 (m, 1H, Halkyl, major diastereomer), 1.49 – 1.38 
(m, 1H, Halkyl, major diastereomer), 1.26 (t, J = 7.2 Hz, 3H, COOCH2CH3, major diastereomer), 
1.24 (t, J = 7.1 Hz, 3H, COOCH2CH3, minor diastereomer), 1.12 – 1.04 (m, 2H, Halkyl, major 
diastereomer), 1.04 – 0.97 (m, 2H, Halkyl, major diastereomer), 0.99 (t, J = 7.3 Hz, 3H, 
CH2CH2CH2CH3, minor diastereomer), 0.65 (t, J = 6.9 Hz, 3H, CH2CH2CH2CH3, major 
diastereomer). Signals of two alkyl protons of the minor diastereomer were not included due to 
overlaps resulting from low resolution. 
O
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13C NMR (major diastereomer, 151 MHz, CDCl3) δ 176.9 (s, COOEt), 166.5 (s, 
C=CHCOOEt), 130.7 (CAr), 129.7 (CAr), 128.6 (CAr), 126.3 (CAr), 124.40 (qCF, 1JCF = 283.3 Hz, 
CF3), 93.6 (d, CHCOOEt), 89.9 (qCF, 2JCF = 31.7 Hz, CCF3), 60.0 (t, COOCH2CH3), 49.6 (d, 
CHC4H9), 28.5 (Calkyl), 25.5 (Calkyl), 22.3 (Calkyl), 14.43 (q, CO2CH2CH3), 13.6 (Calkyl). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 176.8 (s, COOEt), 166.4 (s, 
C=CHCOOEt), 135.0 (CAr), 129.4 (CAr), 125.9 (CAr), 123.73 (d qCF, 1JCF = 283.6 Hz, CF3), 93.4 
(d, CHCOOEt), 89.6 (qCF, 2JCF = 31.7 Hz, CCF3), 59.9 (t, COOCH2CH3), 55.1 (d, CHC4H9), 
30.4 (Calkyl), 25.3 (Calkyl), 22.8 (Calkyl), 14.41 (q, CO2CH2CH3), 14.0 (Calkyl). One CAr-signal was 
not included due to overlaps resulting from low resolution. 
19F NMR (282 MHz, CDCl3) δ –74.7 (minor diastereomer), –78.7 (major diastereomer). 
IR (film) ν̃ = 3434 cm-1 (w), 2958 (s), 1715 (s, CO2Et), 1457 (m), 1375 (m), 1252 (s), 1177 
(s), 1002 (s), 912 (w), 726 (m), 606 (w). 
MS (EI, 70 eV) m/z (%) 297.1 (3) [(M−OEt)+], 227.8 (12) [C13H15F3+], 171.9 (100), 114.9 (12), 
77.1 (5) [Ph+], 69.0 (30) [CF3+]. 
MS (ESI, Orbitrap) m/z 343.1 (M+H+), 365.1 (M+Na+), 381.1 (M+K+). 
HRMS (ESI, Orbitrap) calcd. for C18H22F3O3+ (M+H+): 343.15156; found: 343.15149. 
(Z)-83ia: 
Rf = 0.23 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.53 – 7.39 (m, 5H, CHAr, both 
diastereomers), 4.96 (d, J = 1.6 Hz, 1H, CHCOOEt, minor diastereomer), 
4.94 (d, J = 1.8 Hz, 1H, CHCOOEt, major diastereomer), 4.28 – 4.11 (m, 
2H, COOCH2CH3, both diastereomers), 3.85 – 3.80 (m, 1H, CHC4H9, 
minor diastereomer), 3.79 – 3.75 (m, 1H, CHC4H9, major diastereomer), 
2.09 – 1.92 (m, 2H, Halkyl, major diastereomer), 1.53 – 1.36 (m, 3H, Halkyl, 
both diastereomers), 1.31 (t, J = 7.2 Hz, 3H, COOCH2CH3, minor diastereomer), 1.29 (t, J = 
7.2 Hz, 3H, COOCH2CH3, major diastereomer), 1.25 – 1.12 (m, 2H, Halkyl, minor diastereomer), 
0.96 (t, J = 7.1 Hz, 3H, CH2CH2CH2CH3, major diastereomer), 0.79 (t, J = 7.2 Hz, 3H, 
CH2CH2CH2CH3, minor diastereomer). One Halkyl-signal of the minor diastereomer and one 
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Halkyl-signal of the major diastereomer were not included due to overlaps resulting from low 
resolution. 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 174.1 (s, COOEt), 164.71 (s, 
C=CHCOOEt), 129.5 (CAr), 128.6 (CAr), 126.2 (CAr), 125.7 (CAr), 123.69 (qCF, 1JCF = 284.1 Hz, 
CF3), 90.7 (d, CHCOOEt), 89.0 (qCF, 2JCF = 31.4 Hz, CCF3), 59.9 (t, COOCH2CH3), 53.0 (d, 
CHC4H9), 30.3 (Calkyl), 27.3 (Calkyl), 22.7 (Calkyl), 14.48 (q, CO2CH2CH3), 13.9 (Calkyl). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 173.7 (s, COOEt), 164.73 (s, 
C=CHCOOEt), 135.0 (CAr), 130.4 (CAr), 129.6 (CAr), 128.7 (CAr), 91.8 (d, CHCOOEt), 60.0 (t, 
COOCH2CH3), 47.4 (d, CHC4H9), 28.7 (Calkyl), 28.4 (Calkyl), 22.4 (Calkyl), 14.50 (q, 
CO2CH2CH3), 13.8 (Calkyl). Two signals (CCF3 and CF3) were not included due to low signal 
to noise ratio. 
19F NMR (282 MHz, CDCl3) δ –74.8 (major diastereomer), –79.0 (minor diastereomer). 
IR (film) ν̃ = 3435 cm-1 (w), 2961 (m), 1716 (s, CO2Et), 1456 (m), 1373 (w), 1260 (m), 1179 
(s), 1040 (m), 998 (s), 714 (m), 661 (w). 
MS (EI, 70 eV) m/z (%) 342.2 (1) [M+], 297.1 (7) [(M−OEt)+], 228.2 (20) [C13H15F3+], 172.1 
(100), 115.1 (42), 77.2 (4) [Ph+], 69.2 (25) [CF3+]. 
MS (ESI, Orbitrap) m/z 343.1 (M+H+), 365.1 (M+Na+), 381.1 (M+K+). 
HRMS (ESI, Orbitrap) calcd. for C18H22F3O3+ (M+H+): 343.15156; found: 343.15091. 
4.3.5  Spectroscopic Data Related to Table 7 
rac-ethyl 2-[(3R,4R)-4-(4-methoxyphenyl)-3-methyl-4-(trifluoromethyl)oxetanyliden] 
acetate (83ab) (Table 7, Entry 1) 
Allenoate 81a (113 mg, 553 µmol) and ketone 82b (70 mg, 553 µmol, 1.0 equiv.) were reacted 
in MeCN (2.2 mL) with TBD (7.7 mg, 55 µmol, 10 mol%) using standard procedure S4 (10 min, 
r.t.). The main product (E)-83ab (138 mg, 418 µmol, 76%, 17:83 d.r.) was obtained as a 
colorless oil after purification of the crude reaction mixture by flash column chromatography 
(Si, 2.0×20 cm, pentane/EtOAc = 20/1). The yield of the minor isomer (Z)-83ab (9%, 34:66 
d.r.) was determined from the 1H NMR spectrum of the crude reaction mixture based on isolated 
product (E)-83ab. 
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(E)-83ab: 
Rf = 0.45 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.6 Hz, 2H, CHAr, both 
diastereomers), 6.97 (d, J = 9.1 Hz, 2H, CHAr, major diastereomer), 6.94 (d, J 
= 8.9 Hz, 2H, CHAr, minor diastereomer), 5.40 (d, J = 1.9 Hz, 1H, CHCOOEt, 
major diastereomer), 5.37 (d, J = 2.2 Hz, 1H, CHCOOEt, minor 
diastereomer), 4.17 (qd, J = 7.4, 1.9 Hz, 1H, CHMe, major diastereomer), 4.17 
– 4.06 (m, 2H, CO2CH2CH3 both diastereomers and 1H, CHMe minor 
diastereomer), 3.82 (s, 3H, OCH3, major diastereomer), 3.81 (s, 3H, OCH3, 
minor diastereomer), 1.74 (dq, J = 7.6, 1.7 Hz, 3H, CHCH3, minor diastereomer), 1.26 (t, J = 
7.1 Hz, 3H, CO2CH2CH3, major diastereomer), 1.25 (t, J = 7.1 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 1.16 (d, J = 7.3 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 178.2 (s, COOEt), 166.5 (s, 
C=CHCOOEt), 160.46 (s, CArOMe), 132.8 (CAr), 127.5 (CAr), 124.3 (qCF, 1JCF = 283.1 Hz, CF3), 
114.1 (CAr), 93.1 (d, CHCOOEt), 89.4 (qCF, 2JCF = 31.8 Hz, CCF3), 59.94 (t, CO2CH2CH3), 
55.36 (q, OCH3), 43.9 (d, CHCH3), 14.39 (q, CO2CH2CH3), 12.9 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 177.8 (s, COOEt), 166.4 (s, 
C=CHCOOEt), 160.47 (s, CArOMe), 126.9 (CAr), 123.7 (qCF, 1JCF = 283.5 Hz, CF3), 122.5 (CAr), 
114.0 (CAr), 59.91 (t, CO2CH2CH3), 55.42 (q, OCH3), 49.0 (d, CHCH3), 14.40 (q, 
CO2CH2CH3), 11.4 (q, CHCH3). Two signals of the minor diastereomer CHCOOEt and CCF3 
were not included due to overlaps resulting from low signal to noise ratio and low resolution. 
19F NMR (376 MHz, CDCl3) δ –75.2 (minor diastereomer), –80.0 (major diastereomer). 
IR (film) ν̃ = 3435 cm-1 (w), 2980 (m), 2055 (w), 1898 (w), 1716 (s, CO2Et), 1613 (m), 1458 
(m), 1380 (m), 1254 (s), 1178 (s), 1110 (s), 918 (m), 720 (w), 590 (w). 
MS (EI, 70 eV) m/z (%) 330.1 (8) [M+], 285.1 (3) [(M−OEt)+], 257.1 (16) [(M−COOEt)+], 216.1 
(100) [C11H11F3O+], 147.1 (37), 115.0 (10), 69.1 (16) [CF3+]. 
MS (ESI, Orbitrap) m/z 311.1 (M+H+) HRMS (ESI, Orbitrap) calcd. for C16H18F3O4+ (M+H+): 
331.11517; found: 331.11475. 
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(Z)-83ab: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 
4.90 (d, J = 1.5 Hz, 1H, CHCOOEt, major diastereomer), 4.89 (d, J = 1.8 
Hz, 1H, CHCOOEt, minor diastereomer), 3.90 (s, 3H, OCH3, major 
diastereomer), 1.55 (dq, J = 7.5, 1.5 Hz, 3H, CHCH3, minor diastereomer), 
1.00 (d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
rac-ethyl 2-[(3S,4R)-4-(2-methoxyphenyl)-3-methyl-4-(trifluoromethyl)oxetanyliden] 
acetate (83ac) (Table 7, Entry 2) 
Allenoate 81a (61 mg, 483 µmol) and ketone 82c (101 mg, 494 µmol, 1.0 equiv.) were reacted 
in MeCN (1.9 mL) with TBD (10.1 mg, 72 µmol, 15 mol%) using standard procedure S4 (1 h, 
r.t.). The main product (E)-83ac (64 mg, 195 µmol, 40%, 81:19 d.r.) was obtained as a colorless 
oil after purification of the crude reaction mixture by flash column chromatography (Si, 2.0×20 
cm, pentane/EtOAc = 20/1). The yield of the minor isomer (Z)-83ac (10%, 89:11 d.r.) was 
determined from the 1H NMR spectrum of the crude reaction mixture based on isolated product 
(E)-83ac. 
(E)-83ac: 
Rf = 0.41 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) 7.46 (dd, J = 7.7, 1.7 Hz, 1H, CHAr, minor 
diastereomer), 7.44 – 7.37 (m, 2H, CHAr, major diastereomer and 1H, CHAr, 
minor diastereomer), 7.06 (t, J = 7.6 Hz, 1H, CHAr, minor diastereomer), 7.03 
(t, J = 7.5 Hz, 1H, CHAr, major diastereomer), 6.953 (d, J = 8.2 Hz, 1H, CHAr, 
minor diastereomer), 6.946 (d, J = 8.3 Hz, 1H, CHAr, major diastereomer), 
5.33 (d, J = 2.2 Hz, 1H, CHCOOEt, major diastereomer), 4.22 – 4.09 (m, 2H, 
CO2CH2CH3 and 1H, CHMe, both diastereomers), 3.86 (s, 3H, OCH3, major diastereomer), 
3.81 (s, 3H, OCH3, minor diastereomer), 1.74 (dd, J = 7.5, 1.7 Hz, 3H, CHCH3, major 
diastereomer), 1.35 (d, J = 7.3 Hz, 3H, CHCH3, minor diastereomer), 1.28 (t, J = 7.2 Hz, 3H, 
CO2CH2CH3, minor diastereomer), 1.25 (t, J = 7.1 Hz, 3H, CO2CH2CH3, major diastereomer). 
One CHCOOEt (minor diastereomer) was not included due to overlaps resulting from 
insufficient resolution. 
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13C NMR (major diastereomer, 151 MHz, CDCl3) δ 179.1 (s, COOEt), 166.67 (s, 
C=CHCOOEt), 156.5 (s, CArOMe), 131.1 (CAr), 128.2 (CAr), 123.8 (qCF, 1JCF = 284.6 Hz, CF3), 
122.8 (CAr), 120.6 (CAr), 111.3 (CAr), 92.4 (d, CHCOOEt), 88.5 (qCF, 2JCF = 31.8 Hz, CCF3), 
59.8 (t, CO2CH2CH3), 55.6 (q, OCH3), 47.9 (d, CHCH3), 14.47 (q, CO2CH2CH3), 11.0 (q, 
CHCH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 179.6 (s, COOEt), 166.69 (s, 
C=CHCOOEt), 156.2 (s, CArOMe), 131.2 (CAr), 128.6 (CAr), 124.4 (qCF, 1JCF = 285.1 Hz, CF3), 
121.0 (CAr), 119.5 (CAr), 111.4 (CAr), 92.1 (d, CHCOOEt), 90.7 (qCF, 2JCF = 32.3 Hz, CCF3), 
59.9 (t, CO2CH2CH3), 55.3 (q, OCH3), 44.4 (d, CHCH3), 14.44 (q, CO2CH2CH3), 12.0 (q, 
CHCH3). 
19F NMR (282 MHz, CDCl3) δ –75.4 (minor diastereomer), –79.0 (major diastereomer). 
IR (film) ν̃ = 3434 cm-1 (w), 2980 (s), 1914 (w), 1716 (s, CO2Et), 1677 (s), 1464 (s), 1376 (s), 
1259 (s), 1179 (s), 1113 (s), 918 (m), 714 (s), 655 (m). 
MS (EI, 70 eV) m/z (%) 330.1 (12) [M+], 285.0 (7) [(M−OEt)+], 216.1 (79) [C11H11F3O+], 196.0 
(100), 115.0 (17), 69.1 (18) [CF3+]. 
MS (ESI, Orbitrap) m/z 369.1 (M+K+), 353.1 (M+Na+), 331.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C16H18F3O4+ (M+H+): 331.11517; found: 331.11484. 
(Z)-83ac: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, DMSO-d6) 
δ 5.08 (d, J = 1.4 Hz, 1H, CHCOOEt, minor diastereomer), 5.04 (d, J = 1.8 
Hz, 1H, CHCOOEt, major diastereomer), 1.49 (dq, J = 7.5, 1.5 Hz, 3H, 
CHCH3, major diastereomer). 
rac-ethyl 2-[(3R,4S)-3-methyl-4-(2-thienyl)-4-(trifluoromethyl)oxetanyliden]acetate 
(83ad) (Table 7, Entry 3) 
Allenoate 81a (65 mg, 515 µmol) and ketone 82d (92 mg, 515 µmol, 1.0 equiv.) were reacted 
in MeCN (2.1 mL) with TBD (7.2 mg, 51 µmol, 10 mol%) using standard procedure S4 (1 h, 
r.t.). The main product (E)-83ad (113 mg, 368 µmol, 71%, 11:89 d.r.) was obtained after 
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purification of the crude reaction mixture by flash column chromatography (Si, 2.0×20 cm, 
pentane/EtOAc = 20/1) as a colorless oil which solidified upon standing at –20 °C. The yield 
of the minor isomer (Z)-83ad (7%, 35:65 d.r.) was determined from the 1H NMR spectrum of 
the crude reaction mixture based on isolated product (E)-83ad. 
(E)-83ad: 
Rf = 0.53 (P/EtOAc = 14/1, [UV, KMnO4]). 
m.p. 52-55 °C (CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.45 (dd, J = 4.9, 1.4 Hz, 1H, CHAr, major 
diastereomer), 7.43 (dd, J = 5.1, 1.2 Hz, 1H, CHAr, minor diastereomer), 7.20 
(d, J = 3.7 Hz, 1H, CHAr, minor diastereomer), 7.15 – 7.10 (m, 2H, CHAr, 
major diastereomer), 7.06 (dd, J = 5.1, 3.7 Hz, 1H, CHAr, minor 
diastereomer), 5.44 (d, J = 1.9 Hz, 1H, CHCOOEt, major diastereomer), 5.41 
(d, J = 2.2 Hz, 1H, CHCOOEt, minor diastereomer), 4.20 (qd, J = 7.4, 1.9 
Hz, 1H, CHMe, major diastereomer), 4.19 – 4.08 (m, 2H, CO2CH2CH3 both diastereomers and 
1H, CHMe minor diastereomer), 1.70 (dq, J = 7.5, 1.8 Hz, 3H, CHCH3, minor diastereomer), 
1.265 (t, J = 7.1 Hz, 3H, CO2CH2CH3, major diastereomer), 1.257 (t, J = 7.1 Hz, 3H, 
CO2CH2CH3, minor diastereomer), 1.21 (d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 177.3 (s, COOEt), 166.29 (s, 
C=CHCOOEt), 132.8 (CAr), 127.8 (CAr), 127.49 (CAr), 126.8 (qCF, 3JCF = 1.4 Hz, CAr), 123.7 
(qCF, 1JCF = 282.7 Hz, CF3), 94.0 (d, CHCOOEt), 88.8 (qCF, 2JCF = 33.7 Hz, CCF3), 60.1 (t, 
CO2CH2CH3), 44.8 (d, CHCH3), 14.39 (q, CO2CH2CH3), 12.4 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 177.0 (s, COOEt), 166.28 (s, 
C=CHCOOEt), 136.6 (CAr), 127.9 (CAr), 127.53 (CAr), 127.4 (CAr), 123.3 (qCF, 1JCF = 283.7 Hz, 
CF3), 93.8 (d, CHCOOEt), 60.0 (t, CO2CH2CH3), 50.7 (d, CHCH3), 14.41 (q, CO2CH2CH3), 
11.0 (q, CHCH3). Two signals of the minor diastereomer CHCOOEt and CCF3 were not 
included due to overlaps resulting from low signal to noise ratio and low resolution. 
19F NMR (282 MHz, CDCl3) δ –74.8 (minor diastereomer), –80.7 (major diastereomer). 
IR (film) ν̃ = 3385 cm-1 (w), 3104 (w), 2984 (s), 1718 (s, CO2Et), 1681 (s), 1447 (m), 1376 
(s), 1236 (s), 1177 (s), 1109 (s), 714 (s), 607 (w) 
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MS (EI, 70 eV) m/z (%) 306.1 (14) [M+], 261.0 (5) [(M−OEt)+], 192.0 (100) [C8H7F3S+], 123.0 
(52) [C7H7S+], 115.1 (34), 69.1 (9) [CF3+]. 
MS (ESI, Orbitrap) m/z 329.0 (M+Na+), 307.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C13H13F3NaO3S+ (M+Na+): 329.04297; found: 329.04251. 
(Z)-83ad: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 
4.90 (d, J = 1.6 Hz, 1H, CHCOOEt, major diastereomer), 4.89 (d, J = 1.8 
Hz, 1H, CHCOOEt, minor diastereomer), 1.46 (d, J = 7.5 Hz, 3H, CHCH3, 
minor diastereomer), 0.99 (d, J = 7.5 Hz, 3H, CHCH3, major diastereomer). 
rac-ethyl 2-[(3R,4R)-4-(4-isopropylphenyl)-3-methyl-4-(trifluoromethyl)oxetanyliden] 
acetate (83ae) (Table 7, Entry 4) 
Allenoate 81a (47 mg, 372 µmol) and ketone 82e (83 mg, 384 µmol, 1.0 equiv.) were reacted 
in MeCN (2.2 mL) with TBD (5.2 mg, 37 µmol, 10 mol%) using standard procedure S4 (10 
min, r.t.). The main product (E)-83ae (94 mg, 274 µmol, 74%, 21:79 d.r.) was obtained as a 
colorless oil after purification of the crude reaction mixture by flash column chromatography 
(Si, 2.0×20 cm, pentane/EtOAc = 20/1). The yield of the minor isomer (Z)-83ae (14%, 45:55 
d.r.) was determined from the 1H NMR spectrum of the crude reaction mixture based on isolated 
product (E)-83ae. 
(E)-83ae: 
Rf = 0.68 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR  (600 MHz,  CDCl3)  δ  7.34 – 7.27  (m, 4H, CHAr, both diastereomers),  5.41  (d, J = 
1.9 Hz, 1H, CHCOOEt, major diastereomer), 5.37 (d, J = 2.2 Hz, 1H, 
CHCOOEt, minor diastereomer), 4.20 (dq, J = 7.4, 1.9 Hz, 1H, CHMe, major 
diastereomer), 4.18 – 4.10 (m, 2H, CO2CH2CH3 both diastereomers and 1H, 
CHMe minor diastereomer), 2.94 (hept, J = 6.9 Hz, 1H, CHMe2, major 
diastereomer), 2.93 (hept, J = 6.8 Hz, 1H, CHMe2, minor diastereomer), 1.76 
(dq, J = 7.7, 1.8 Hz, 3H, CHCH3, minor diastereomer), 1.30 – 1.23 [m, 3H, 
O
COOEt
F3C
Me
H
major
diastereomer
(E)-83ae
MeMe
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CO2CH2CH3 and 6H, CH(CH3)2 both diastereomers], 1.17 (d, J = 7.5 Hz, 3H, CHCH3, major 
diastereomer). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 178.3 (s, COOEt), 166.6 (s, 
C=CHCOOEt), 150.3 (s, CAri-Pr), 132.4 (CAr), 126.75 (CAr), 126.08 (CAr), 124.3 (qCF, 1JCF = 
283.1 Hz, CF3), 93.11 (d, CHCOOEt), 89.6 (qCF, 2JCF = 31.6 Hz, CCF3), 60.0 (t, CO2CH2CH3), 
43.9 (d, CHCH3), 34.0 (d, CHMe2), 23.94 [q, CH(CH3)2], 14.43 (q, CO2CH2CH3), 13.0 (q, 
CHCH3). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 177.8 (s, COOEt), 166.4 (s, 
C=CHCOOEt), 150.4 (s, CAri-Pr), 127.9 (CAr), 126.71 (CAr), 125.5 (CAr), 123.7 (qCF, 1JCF = 
283.6 Hz, CF3), 93.07 (d, CHCOOEt), 88.7 (qCF, 2JCF = 31.0 Hz, CCF3), 59.9 (t, CO2CH2CH3), 
49.1 (d, CHCH3), 34.1 (d, CHMe2), 23.91 [q, CH(CH3)2], 14.44 (q, CO2CH2CH3), 11.4 (q, 
CHCH3).  
19F NMR (282 MHz, CDCl3) δ –75.0 (minor diastereomer), –79.8 (major diastereomer). 
IR (film) ν̃ = 3430 cm-1 (w), 2966 (s), 1915 (w), 1718 (s, CO2Et), 1679 (s), 1461 (m), 1375 (s), 
1264 (s), 1176 (s), 1109 (s), 920 (m), 715 (m). 
MS (EI, 70 eV) m/z (%) 342.1 (1) [M+], 297.1 (4) [(M−OEt)+], 228.1 (48) [C13H15F3+], 213.1 
(100), 115.0 (9), 69.1 (13) [CF3+]. 
MS (ESI, Orbitrap) m/z 365.1 (M+Na+), 343.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C18H21F3NaO3+ (M+Na+): 365.13350; found: 365.13391. 
(Z)-83ae: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (600 MHz, CDCl3) δ 
4.89 (d, J = 1.5 Hz, 1H, CHCOOEt, major diastereomer), 4.87 (d, J = 1.7 
Hz, 1H, CHCOOEt, minor diastereomer), 1.56 (dq, J = 7.6, 1.4 Hz, 3H, 
CHCH3, minor diastereomer), 1.00 (d, J = 7.4 Hz, 3H, CHCH3, major 
diastereomer). 
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rac-ethyl 2-[(3R,4R)-4-(4-chlorophenyl)-3-methyl-4-(trifluoromethyl)oxetanyliden]ace-
tate (83af) (Table 7, Entry 5) 
Allenoate 81a (73 mg, 579 µmol) and ketone 82f (121 mg, 579 µmol, 1.0 equiv.) were reacted 
in MeCN (2.3 mL) with TBD (8.1 mg, 58 µmol, 10 mol%) using standard procedure S4 (25 min, 
r.t., TLC showed incomplete conversion of 81a). The main product (E)-83af (104 mg, 312 
µmol, 54%, 25:75 d.r.) was obtained as a colorless oil after purification of the crude reaction 
mixture by flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 25/1). The yield of 
the minor isomer (Z)-83af (6%, 48:52 d.r.) was determined from the 1H NMR spectrum of the 
crude reaction mixture based on isolated product (E)-83af. 
(E)-83af: 
Rf = 0.63 (P/EtOAc = 14/1, [UV, KMnO4]). 
H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.9 Hz, 2H, CHAr, major diastereomer), 7.41 (d, J = 
8.8,  Hz, 2H, CHAr, minor diastereomer), 7.28 (d, J = 8.2 Hz, 2H, CHAr both diastereomers), 
5.42 (d, J = 1.9 Hz, 1H, CHCOOEt, major diastereomer), 5.39 (d, J = 2.2 Hz, 
1H, CHCOOEt, minor diastereomer), 4.20 (qd, J = 7.4, 1.9 Hz, 1H, CHMe, 
major diastereomer), 4.18 – 4.06 (m, 2H, CO2CH2CH3 both diastereomers 
and 1H, CHMe minor diastereomer), 1.75 (dq, J = 7.5, 1.7 Hz, 3H, CHCH3, 
minor diastereomer), 1.26 (t, J = 7.2 Hz, 3H, CO2CH2CH3, major 
diastereomer), 1.25 (t, J = 7.1 Hz, 3H, CO2CH2CH3, minor diastereomer), 
1.16 (d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 177.5 (s, COOEt), 166.4 (s, 
C=CHCOOEt), 135.94 (CAr), 129.1 (CAr), 127.62 (CAr), 126.96 (CAr), 124.0 (qCF, 1JCF = 283.2 
Hz, CF3), 93.59 (d, CHCOOEt), 89.1 (qCF, 2JCF = 32.4 Hz, CCF3), 60.09 (t, CO2CH2CH3), 43.9 
(d, CHCH3), 14.43 (q, CO2CH2CH3), 13.04 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 177.0 (s, COOEt), 166.3 (s, 
C=CHCOOEt), 135.86 (CAr), 129.3 (CAr), 129.0 (CAr), 93.60 (d, CHCOOEt), 60.06 (t, 
CO2CH2CH3), 49.1 (d, CHCH3), 14.45 (q, CO2CH2CH3), 11.41 (q, CHCH3). Only the most 
characteristic 13C-signals were given. 
19F NMR (282 MHz, CDCl3) δ –75.0 (minor diastereomer), –79.7 (major diastereomer). 
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IR (film)  ν̃ = 2985 cm-1 (s), 2108 (w), 1910 (w), 1719 (s, CO2Et), 1681 (s), 1493 (s), 1376 (s),  
1263 (s), 1179 (s), 1103 (s), 919 (m), 742 (m), 611 (w). 
MS (EI, 70 eV) m/z (%) 334.1 (2) [M+], 289.1 (5) [(M−OEt)+], 223.1 (4) [(M−Ar)+], 220.1 (100) 
[C10H8ClF3+], 185.1 (37), 165.1 (21), 111.1 (4) [Ar+], 69.2 (30) [CF3+]. 
MS (ESI, Orbitrap) m/z 357.0 (M+Na+), 335.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H15ClF3O3+ (M+H+): 335.06563; found: 335.06546. 
(Z)-83af: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 
4.92 (d, J = 1.6 Hz, 1H, CHCOOEt, minor diastereomer), 4.91 (d, J = 1.8 
Hz, 1H, CHCOOEt, major diastereomer), 1.55 (dq, J = 7.5, 1.5 Hz, 3H, 
CHCH3, minor diastereomer), 1.00 (d, J = 7.3 Hz, 3H, CHCH3, major 
diastereomer). 
rac-ethyl 2-{(3R,4R)-3-methyl-4-(trifluoromethyl)-4-[4-(trifluoromethyl)phenyl]oxetane-
yliden}acetate (83ag) (Table 7, Entry 6) 
Allenoate 81a (62 mg, 491 µmol) and ketone 82g (125 mg, 516 µmol, 1.0 equiv.) were reacted 
in MeCN (2 mL) with TBD (13.7 mg, 98 µmo8l, 20 mol%) using standard procedure S4 (1 h 
40 min, r.t., TLC showed incomplete conversion of 81a). The main product (E)-83ag (66 mg, 
179 µmol, 36%, 22:78 d.r.) was obtained as a colorless oil after purification of the crude 
reaction mixture by flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 
30/1→20/1) three times. The yield of the minor isomer (Z)-83ag (4%, 48:52 d.r.) was 
determined from the 1H-NMR spectrum of the crude reaction mixture based on isolated product 
(E)-83ag. 
(E)-83ag: 
Rf = 0.41 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.3 Hz, 2H, CHAr, both diastereomers), 7.54 (d, J = 
8.1 Hz, 2H, CHAr, both diastereomers), 5.43 (d, J = 1.9 Hz, 1H, CHCOOEt, major 
diastereomer), 5.40 (d, J = 2.2 Hz, 1H, CHCOOEt, minor diastereomer), 4.24 (qd, J = 7.4, 1.9 
    
 
 
 
133 
 
Hz, 1H, CHMe, major diastereomer), 4.20 – 4.04 (m, 2H, CO2CH2CH3 both 
diastereomers and 1H, CHMe minor diastereomer), 1.77 (dq, J = 7.5, 1.6 Hz, 
3H, CHCH3, minor diastereomer), 1.26 (t, J = 7.1 Hz, 3H, CO2CH2CH3, major 
diastereomer), 1.22 (t, J = 7.0 Hz, 3H, CO2CH2CH3, minor diastereomer), 1.16 
(d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 177.1 (s, COOEt), 166.3 
(s, C=CHCOOEt), 134.7 (CAr), 131.94 (qCF, 2JCF = 32.8 Hz, CArCF3), 126.8 (CAr), 125.79 (qCF, 
3JCF = 3.6 Hz, CHAr), 123.9 (qCF, 1JCF = 283.6 Hz, CF3), 123.8 (qCF, 1JCF = 272.3 Hz, CF3), 
93.81 (d, CHCOOEt), 89.04 (qCF, 2JCF = 32.4 Hz, CCF3), 60.16 (t, CO2CH2CH3), 44.1 (d, 
CHCH3), 14.4 (q, CO2CH2CH3), 13.1 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 176.6 (s, COOEt), 166.2 (s, 
C=CHCOOEt), 126.1 (CAr), 93.84 (d, CHCOOEt), 60.13 (t, CO2CH2CH3), 48.2 (d, CHCH3), 
11.4 (q, CHCH3). Only the most characteristic 13C-signals were given. 
19F NMR (376 MHz, CDCl3) δ –63.0 (CArCF3, both diastereomers), –74.7 [C(Ar)CF3 minor 
diastereomer], –79.5 [C(Ar)CF3 major diastereomer]. 
IR (film) ν̃ = 3444 cm-1 (m), 2984 (s), 1933 (w), 1718 (s, CO2Et), 1459 (s), 1380 (s), 1328 (s), 
1177 (s), 1119 (s), 921 (m), 721 (m), 608 (m). 
MS (EI, 70 eV) m/z (%) 368.1 (5) [M+], 323.0 (13) [(M−OEt)+], 254.0 (100) [C11H8F6+], 185.0 
[C10H8F3+] (79), 145.0 [Ar+] (8), 115.0 (22), 69.1 (34) [CF3+]. 
MS (ESI, Orbitrap) m/z 391.1 (M+Na+), 369.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C16H15F6O3+ (M+H+): 369.09199; found: 369.09167. 
(Z)-83ag: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 
4.93 (d, J = 1.6 Hz, 1H, CHCOOEt, minor diastereomer), 4.91 (d, J = 1.8 
Hz, 1H, CHCOOEt, major diastereomer), 1.56 (dq, J = 7.5, 1.5 Hz, 3H, 
CHCH3, major diastereomer). 
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rac-ethyl 2-[(3R,4R)-4-(4-bromophenyl)-3-methyl-4-(trifluoromethyl)oxetanyliden]aceta-
te (83ah) (Table 7, Entry 7) 
Allenoate 81a (27 mg, 214 µmol) and ketone 82h (54 mg, 214 µmol, 1.0 equiv.) were reacted 
in MeCN (0.8 mL) with TBD (3 mg, 21 µmol, 10 mol%) using standard procedure S4 (20 min, 
r.t., TLC showed incomplete conversion of 81a). The main product (E)-83ah (49 mg, 129 µmol, 
60%, 19:81 d.r.) was obtained as a colorless oil after purification of the crude reaction mixture 
by flash column chromatography (Si, 2.0×20 cm, pentane/EtOAc = 24/1). The yield of the 
minor isomer (Z)-83ah (7%, 43:57 d.r.) was determined from the 1H NMR spectrum of the 
crude reaction mixture based on isolated product (E)-83ah. 
(E)-83ah: 
Rf = 0.58 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 8.8 Hz, 2H, CHAr, major diastereomer), 7.57 (d, J = 
8.7,  Hz, 2H, CHAr, minor diastereomer), 7.28 (d, J = 8.3 Hz, 2H, CHAr, both diastereomers), 
5.42 (d, J = 1.9 Hz, 1H, CHCOOEt, major diastereomer), 5.39 (d, J = 2.2 
Hz, 1H, CHCOOEt, minor diastereomer), 4.20 (qd, J = 7.4, 1.9 Hz, 1H, 
CHMe, major diastereomer), 4.18 – 4.06 (m, 2H, CO2CH2CH3 both 
diastereomers and 1H, CHMe minor diastereomer), 1.75 (dq, J = 7.5, 1.7 Hz, 
3H, CHCH3, minor diastereomer), 1.25 (t, J = 7.1 Hz, 3H, CO2CH2CH3, 
major diastereomer), 1.22 (t, J = 7.0 Hz, 3H, CO2CH2CH3, minor 
diastereomer), 1.16 (d, J = 7.4 Hz, 3H, CHCH3, major diastereomer). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 177.5 (s, COOEt), 166.35 (s, 
C=CHCOOEt), 132.04 (CAr), 129.79 (CAr), 127.86 (CAr), 124.17 (CAr), 123.9 (qCF, 1JCF = 283.1 
Hz, CF3), 93.60 (d, CHCOOEt), 89.1 (qCF, 2JCF = 31.9 Hz, CCF3), 60.10 (t, CO2CH2CH3), 43.8 
(d, CHCH3), 14.43 (q, CO2CH2CH3), 13.0 (q, CHCH3). 
13C NMR (minor diastereomer, 101 MHz, CDCl3) δ 176.9 (s, COOEt), 166.29 (s, 
C=CHCOOEt), 134.1 (CAr), 131.96 (CAr), 127.2 (CAr), 124.03 (CAr), 93.61 (d, CHCOOEt), 
60.06 (t, CO2CH2CH3), 49.1 (d, CHCH3), 14.44 (q, CO2CH2CH3), 11.4 (q, CHCH3). Two 
signals (CCF3 and CF3) were not included due to low signal to noise ratio. 
IR (film) ν̃ = 3433 cm-1 (w), 2984 (m), 2105 (w), 1911 (w), 1718 (s, CO2Et), 1681 (s), 1461 
(m), 1379 (m), 1252 (m), 1180 (s), 1109 (s), 918 (m), 737 (m), 562 (w). 
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MS (EI, 70 eV) m/z (%) 378.1 (2) [M+], 333.0 (6) [(M−OEt)+], 305.0 (7) [(M−COOEt)+], 264.0 
(100) [C10H8BrF3+], 185.1 (31), 165.1 (40), 115.1 (40), 69.2 (39) [CF3+]. 
MS (ESI, Orbitrap) m/z 417.2 (M+K+), 400.1 (M+Na+), 379.0 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C15H15BrF3O3+ (M+H+): 379.01512; found: 379.01425. 
(Z)-83ah: 
This isomer was not isolated in pure form. Therefore, the signals were 
assigned from the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 
4.93 (d, J = 1.5 Hz, 1H, CHCOOEt, minor diastereomer), 4.91 (d, J = 1.8 
Hz, 1H, CHCOOEt, major diastereomer), 1.56 (dq, J = 7.5, 1.5 Hz, 3H, 
CHCH3, minor diastereomer). 
4.3.6  Spectroscopic Data Related to Scheme 66 
rac-ethyl 2-[(3R,4R)-3-butyl-4-phenyl-4-(trifluoromethyl)oxetanyliden]propanoate (3ia) 
(Scheme 66, Left) 
Allenoate 79a (82 mg, 585 µmol) and ketone 82a (82 µL, 102 mg, 585 µmol, 1.0 equiv.) were 
reacted in MeCN (2.3 mL) with TBD (24.4 mg, 176 µmol, 30 mol%) using standard procedure 
S4 (21 h, r.t.). Flash column chromatography (Si, 2.0×22 cm, pentane/EtOAc = 50/1→20/1) 
gave product (E)-83ha (132 mg, 421 µmol, 72%, 15:85 d.r.) as a colorless oil. 
(E)-83ha: 
Rf = 0.51 (P/EtOAc = 14/1, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.37 (m, 5H, CHAr, both diastereomers), 4.21 – 4.21 (m, 
2H, COOCH2CH3, both diastereomers), 4.15 (qd, J = 7.3, 1.3 Hz, 1H, CHCH3, major 
diastereomer), 4.07 (qd, J = 7.5, 1.7 Hz, 1H, CHCH3, minor diastereomer), 1.81 (d, J = 1.3 Hz, 
3H, C=C(CH3)COOEt, major diastereomer), 1.81 (d, J = 1.3 Hz, 3H, 
C=C(CH3)COOEt, minor diastereomer), 1.72 (dq, J = 7.5, 1.7 Hz, 3H, CHCH3, 
minor diastereomer), 1.28 (t, J = 7.1 Hz, 3H, COOCH2CH3, major 
diastereomer), 1.26 (t, J = 7.1 Hz, 3H, COOCH2CH3, minor diastereomer), 
1.11 (d, J = 7.3 Hz, 3H, CHCH3, major diastereomer). 
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13C NMR (major diastereomer, 151 MHz, CDCl3) δ 171.5 (s, COOEt), 167.53 (s, 
C=C(CH3)COOEt), 135.7 (CAr), 129.4 (CAr), 128.58 (CAr), 126.2 (CAr) 124.4 (qCF, 1JCF = 283.3 
Hz, CF3), 100.8 (s, C(CH3)COOEt), 87.8 (qCF, 2JCF = 31.5 Hz, CCF3), 60.13 (t, COOCH2CH3), 
43.8 (d, CHCH3), 14.40 (q, COOCH2CH3), 13.4 (q, CHCH3), 8.8 (q, C(CH3)COOEt). 
13C NMR (minor diastereomer, 151 MHz, CDCl3) δ 171.0 (s, COOEt), 167.46 (s, 
C=C(CH3)COOEt), 131.2 (CAr), 128.54 (CAr), 125.5 (CAr) 123.8 (qCF, 1JCF = 283.5 Hz, CF3), 
100.9 (s, C(CH3)COOEt), 86.9 (qCF, 2JCF = 30.7 Hz, CCF3), 60.09 (t, COOCH2CH3), 49.0 (d, 
CHCH3), 14.43 (q, COOCH2CH3), 11.8 (q, CHCH3), 8.9 (q, C(CH3)COOEt). One CAr-signal 
was not included due to overlaps resulting from low resolution. 
19F NMR (564 MHz, CDCl3) δ –74.9 (minor diastereomer), –79.7 (major diastereomer). 
IR (film) ν̃ = 3390 cm-1 (w), 2984 (m), 1711 (s, CO2Et), 1453 (m), 1374 (m), 1302 (s), 1180 
(s), 1100 (s), 1006 (s), 914 (m), 726 (m), 645 (w). 
MS (EI, 70 eV) m/z (%) 314.1 (13) [M+], 269.1 (7) [(M−OEt)+], 241.1 (41) [(M−COOEt)+], 
186.1 (95) [C10H9F3+], 117.1 [C9H9+] (100), 115.1 (24), 77.1 (9) [Ph+], 69.2 (2) [CF3+]. 
MS (ESI, Orbitrap) m/z 315.1 (M+H+), 337.1 (M+Na+). 
HRMS (ESI, Orbitrap) calcd. for C16H18F3O3+ (M+H+): 315.12026; found: 315.11961. 
ethyl 2-[5-phenyl-5-(trifluoromethyl)dihydro-2(3H)-furanyliden]propanoate (171)  
(Scheme 66, Right) 
Allenoate 79a (67 mg, 478 µmol) and ketone 81a (67 µL, 83 mg, 478 µmol, 1.0 equiv.) were 
dissolved in MeCN (2.0 mL) at room temperature in a Schlenk-flask under Ar. 
Triphenylphosphine (25.1 mg, 96 µmol, 20 mol%) was added all at once, and the reaction 
mixture was stirred at r.t. for 24 h (complete conversion of 79a according to TLC). The reaction 
mixture was concentrated in vacuo. Flash column chromatography (Si, 2.0×22 cm, 
pentane/EtOAc = 20/1→15/1) gave product (E)-171 (51 mg, 163 µmol, 34%) as a colorless oil. 
The double bond configuration of the product was determined by 2D NOESY. 
(E)-171: 
Rf = 0.33 (P/EtOAc = 14/1, [UV, KMnO4]). 
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1H NMR (400 MHz, CDCl3) δ 7.53 – 7.49 (m, 2H, CHAr), 7.43 – 7.39 (m, 3H, CHAr), 4.17 (q, 
J = 7.1 Hz, 2H, COOCH2CH3), 3.32 – 3.25 (m, 1H, CHH), 3.11 – 3.03 (m, 1H, CHH), 2.84 
(ddd, J = 13.2, 9.7, 6.1 Hz, 1H, CHH), 2.48 (dddd, J = 13.2, 9.7, 6.7, 1.1 Hz, 
1H, CHH), 2.00 (t, J = 1.7 Hz, 3H, =C(CH3)COOEt), 1.28 (t, J = 7.2 Hz, 3H, 
COOCH2CH3). 
13C NMR (151 MHz, CDCl3) δ 168.8 (s, COOEt), 167.5 (s, C=C(Me)COOEt), 136.0 (CAr), 
129.3 (CAr), 128.6 (CAr), 126.5 (CAr), 124.7 (qCF, 1JCF = 284.4 Hz, CF3), 100.6 (s, 
C(Me)COOEt), 88.1 (qCF, 2JCF = 30.1 Hz, CCF3), 60.0 (t, CO2CH2CH3), 32.3 (t, CH2), 30.6 (t, 
CH2), 14.5 (q, COOCH2CH3), 11.6 (q, C(CH3)COOEt).  
19F NMR (564 MHz, CDCl3) δ –79.0. 
IR (film) ν̃ = 3439 cm-1 (w), 2966 (m), 1890 (w), 1717 (s, CO2Et), 1678 (s), 1455 (m), 1382 
(m), 1263 (s), 1176 (s), 1109 (s), 826 (m), 723 (s). 
MS (EI, 70 eV) m/z (%) 390.1 (16) [M+], 283.1 (6) [(M−OBn)+], 214.1 (13) [C12H13F3+], 199.1 
[C11H10F3+] (49), 145.1 [C11H13+] (15), 91.1 (100) [Bn+], 69.1 (23) [CF3+]. 
MS (ESI, Orbitrap) m/z 429.1 (M+K+), 413.1 (M+Na+), 391.1 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C22H22F3O3+ (M+H+): 391.15156; found: 391.15115. 
4.3.7  Details of the Reaction Leading to cis-83aa with PPh3 as Catalyst (Scheme 68, Right) 
Allenoate 81a (80 mg, 634 µmol) and ketone 82a (89 µL, 110 mg, 634 µmol, 1.0 equiv.) were 
dissolved in MeCN (2.5 mL) at room temperature in a Schlenk-flask under Ar. 
Triphenylphosphine (33.5 mg, 127 µmol, 20 mol%) was added all at once, and the reaction 
mixture was stirred at r.t. for 1.5 h (complete conversion of 81a according to TLC). The reaction 
mixture was concentrated in vacuo. Flash column chromatography (Si, 2.0×22 cm, 
pentane/EtOAc = 35/1→20/1→15/1→5/1) gave product (E)-83aa (109 mg, 362 µmol, 57%, 
cis:trans = 75:25) as a colorless oil. The yield of the minor isomer (Z)-83aa (13%, cis:trans 
71:29) was determined from the 1H NMR spectrum of the crude reaction mixture based on 
isolated product (E)-83aa. 
In addition to (E)-83aa a more polar fraction was isolated which consisted of a mixture of 
several compounds and contained traces of tetrahydrofuran byproduct (E)-83aa’ among other 
things (see Schemes 123 and 124 below). This suggestion was based on the comparison of 
(E)-171
O
EtO2C
Me
Ph
CF3
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characteristic 1H NMR signals with those of (E)-171 and reported compounds with similar 
structure.[80] 
(E)-83aa’: 
This isomer was not isolated in pure form. Only characteristic signals are listed. 1H NMR (600 
MHz, CDCl3) δ 5.57 (t, J = 1.9 Hz, 1H, CHCOOEt), 3.34 – 3.27 (m, 1H, 
CHH), 3.14 – 3.06 (m, 1H, CHH), 2.83 (ddd, J = 13.3, 9.7, 6.1 Hz, 1H, 
CHH), 2.47 (dddd, J = 13.3, 9.6, 6.6, 1.1 Hz, 1H, CHH).  
 
Scheme 123: Example 1H NMR spectrum: characteristic signals were assigned to (E)-83aa’. 
Due to the fact that the isomers of 84aa and 83aa’ have α-protons with characteristic chemical 
shifts in 1H NMR, their relative amounts could be determined from the crude 1H NMR spectrum 
based on isolated (E)-83aa (see Schemes 124 and 125). 
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Scheme 124: All isomers of the products 83aa and 83aa’ present in the crude mixture after the reaction between 
81a and 82a with PPh3 catalyst. 
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Scheme 125: Example 1H NMR spectrum of the crude reaction mixture containing isomers of 83aa and 83aa’. 
Characteristic signals of α-protons are shown. 
4.4  Experimental Procedures and Analytical Data for Section 2.3 
4.4.1  Standard Experimental Procedures  
Standard experimental procedure (S5) for reactions in MeCN (electron-poor aldehydes) 
Allenoates 81a/81f or alkynoate 81i and the respective aldehyde 1 (4.0 equiv.) are dissolved in 
MeCN and cooled to –25 °C with a dry ice cooling bath. TBD (15 mol%) is added all at once, 
and the reaction is stirred between –25 °C and –20 °C bath temperature (typically 0.5-3.0 h). 
The reaction is quenched by the addition of solid NH4Cl (excess), warmed to r.t., filtered and 
the NH4Cl washed with CH2Cl2. After evaporation of the solvents, the residue is purified by 
flash column chromatography to give the product.  
Standard experimental procedure (S6) for reactions in DMF (electron-rich aldehydes) 
Allenoates 81a/81f or alkynoate 81i and the respective aldehyde 1 (4.0 equiv.) are dissolved in 
DMF and cooled to –25 °C with a dry ice cooling bath. TBD (25 mol%) is added all at once, 
and the reaction is stirred between –25 °C and –20 °C bath temperature or at –20 °C in a freezer 
until TLC (following mini-workup using NH4Cl/LiCl (aq.) and EtOAc) shows no more 
formation of the product (typically 4-24 h). The reaction is quenched by the addition of NH4Cl 
(sat.) and warmed to r.t.. The mixture is extracted with EtOAc and the combined organic phases 
are washed with NH4Cl (sat.), LiCl (5% aq) and NaCl (sat.), dried over Na2SO4, filtered and 
the solvent evaporated. The residue is purified by flash column chromatography to give the 
product. 
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4.4.2  Spectroscopic Data related to Scheme 77  
rac-ethyl 2,4-bis((4-chlorophenyl)(hydroxy)methyl)hepta-2,3-dienoate (197) 
Alkynoate 81i (258 mg, 1.53 mmol) and aldehyde 1b (863 mg, 6.14 
mmol, 4.0 equiv.) were reacted in MeCN (31 mL) with TBD (64.0 
mg, 460 µmol, 30 mol%) using standard procedure S5 (Reaction 
time: 50 min). Flash column chromatography (Si, 2.0×25 cm, 
pentane/EtOAc = 9/1→85/15→8/2→7/3) gave the bis-MBH product 197 (186 mg, 417 µmol, 
28%, 2:1 d.r.) as a yellowish oil. Compound 84ib (37%) was isolated as a less polar fraction. 
For the detailed analytical data of 84ib, see Table 12. 
Rf = 0.15 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.34 – 7.24 (m, 8H, CHAr, major diastereoisomer and 6H, CHAr, 
minor diastereoisomer), 7.15 (d, J = 8.6 Hz, 2H, CHAr, minor diastereoisomer), 5.61 (s, 1H, 
CHOH, both diastereoisomers), 5.18 (s, 1H, CHOH, minor diastereoisomers), 5.03 (s, 1H, 
CHOH, major diastereoisomers), 4.27 – 4.13 (m, 2H, COOCH2CH3, both diastereoisomers), 
4.10 (s br, 1H, OH, minor diastereoisomer), 3.77 (s br, 1H, OH, major diastereoisomer), 3.55 
(s, br, 1H, OH, minor diastereoisomer), 3.23 (s, br, 1H, OH, major diastereoisomer), 1.92 – 1.83 
(m, alkyl-CH, both diastereoisomers), 1.292 (t, J = 7.1 Hz, 3H, CO2CH2CH3, major 
diastereoisomer), 1.287 (t, J = 7.1 Hz, 3H, CO2CH2CH3, minor diastereoisomer), 1.23 – 1.11 
(m, alkyl-CH, both diastereoisomers), 0.77 (t, J = 6.8 Hz, 3H, CH2CH2CH2CH3, minor 
diastereoisomer), 0.76 (t, J = 6.7 Hz, 3H, CH2CH2CH2CH3, major diastereoisomer). 
13C NMR (major diastereoisomer 151 MHz, CDCl3) δ 206.3 (s, C=C=C), 166.7 (s, COOEt), 
140.4 (s, CAr), 139.2 (s, CAr), 134.1 (s, CAr), 133.38 (s, CAr), 128.6 (d, CHAr), 128.52 (d, CHAr), 
128.32 (d, CHAr), 127.7 (d, CHAr), 116.3 (s, =C-n-Bu), 108.9 (s, CCO2Et), 73.8 (d, COH), 70.8 
(d, COH), 61.4 (t, CO2CH2CH3), 29.4 (t, CH2CH2CH2CH3), 28.6 (t, CH2CH2CH2CH3), 22.12 
(t, CH2CH2CH2CH3), 14.21 (q, CO2CH2CH3), 13.73 (t, CH2CH2CH2CH3). 
13C NMR (minor diastereoisomer, 151 MHz, CDCl3) δ 206.6 (s, C=C=C), 166.8 (s, COOEt), 
140.3 (s, CAr),  139.0 (s, CAr), 133.7 (s, CAr), 133.42 (s, CAr), 128.51 (d, CHAr), 128.31 (d, CHAr), 
128.0 (d, CHAr), 127.8 (d, CHAr), 115.5 (s, =C-n-Bu), 107.6 (s, CCO2Et), 73.7 (d, C(OH)), 70.9 
(d, C(OH)), 61.5 (t, CO2CH2CH3), 29.6 (t, CH2CH2CH2CH3), 27.4 (t, CH2CH2CH2CH3), 22.12 
(t, CH2CH2CH2CH3), 14.19 (q, CO2CH2CH3), 13.75 (t, CH2CH2CH2CH3). 
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IR (ATR): ν̃ = 3748 cm-1 (w), 3365 (s), 2959 (m), 2933 (m), 2870 (m), 2662 (w), 2322 (w), 
2070 (w), 1961 (m), 1906 (w), 1790 (w), 1706 (s), 1675 (s), 1593 (m), 1486 (s), 1404 (m), 1372 
(m), 1271 (s), 1190 (m), 1138 (w), 1087 (s), 1034 (s), 937 (w), 903 (m), 832 (s), 786 (s), 731 
(s), 688 (m), 661 (w). 
MS (ESI, Orbitrap) m/z: 471.11 [(M+Na+)], 431.12 [(M–OH-)+], 291.11 [(M–ArCHO–OH-)+]. 
HRMS (ESI, Orbitrap): calcd. for C24H26Cl2NaO4+ (M+Na+): 471.11004; found: 471.11060. 
4.4.3  Spectroscopic Data related to Table 9 
rac-methyl (2S,3S)-3-hydroxy-2-[(2R,4R)-5-methyl-2,4-bis(4-nitrophenyl)-4H-1,3-dioxin-
6-yl]-3-(4-nitrophenyl)propanoate (84cc) (Table 9, entry 1). 
Allenoate 81c (105 mg, 936 µmol) and aldehyde 1c (565 mg, 3.74 mmol, 4.0 equiv.) were 
reacted in MeCN (19 mL) with TBD (39 mg, 280 µmol, 30 mol%) using standard procedure 
S5 (Reaction time: 15 min). Flash column chromatography (Si, 
2.0×22 cm, pentane/EtOAc = 7/3→6/4→6/4→1/1→4/6) gave 
product 84cc (253 mg, 447 µmol, 48%) as a yellow oil. 
Rf = 0.24 (P/EtOAc = 8/2, [UV, KMnO4]). 
1H-NMR (400 MHz, CDCl3): 8.25 (d, J = 8.7 Hz, 2H, H-Ar), 8.19 
(d, J = 8.7 Hz, 2H, H-Ar), 8.00 (d, J = 8.6 Hz, 2H, H-Ar), 7.67 (d, J = 8.5 Hz, 2H, H-Ar), 7.64 
(d, J = 8.8 Hz, 2H, H-Ar), 7.00 (d, J = 8.7 Hz, 2H, H-Ar), 5.93 [s, 1H, CH(OR)2], 5.49 (d, J = 
9.6 Hz, 1H, CHOH), 5.42 (s, 1H, ArCHOR), 3.90 (s br, 1H, OH), 3.88 (s, 3H, COOCH3), 3.81 
(d, J = 9.6 Hz, 1H, CHCO2Me), 1.19 (s, 3H, R-CH3). 
13C-NMR (100 MHz, CDCl3): 171.5 (s, COOMe), 148.5 (s, =CqOR), 148.0 (CAr), 147.78 (CAr), 
147.76 (CAr), 145.0 (CAr), 144.0 (CAr), 142.6 (CAr), 128.8 (CAr), 128.2 (CAr), 127.3 (CAr), 123.7 
(CAr), 123.50 (CAr), 123.47 (CAr), 112.0 (s, =CqCH3), 96.7 (d, CH(OR)2),  79.7 (d, ArCHOR), 
71.9 (d, CHOH), 54.0 (d, CHCO2Me), 52.9 (q, OCH3), 12.9 (q, R-CH3). 
IR (ATR): ν̃ = 3871 cm-1 (w), 3520 (w), 3081 (w), 2954 (w), 2856 (w), 2647 (w), 2322 (w), 
2155 (w), 2082 (w), 1950 (w), 1731 (s), 1687 (m), 1604 (m), 1518 (s), 1435 (w), 1391 (w), 
1345 (s), 1252 (m), 1202 (w), 1163 (m) , 1101 (m), 1009 (m), 925 (w), 851 (s), 746 (m), 691 
(s). 
MS (ESI, Orbitrap) m/z: 1169.22 [(2M+K+)], 604.09 [(M+K+)], 453.07 [(M–ArCHO+K+]. 
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HRMS (ESI, Orbitrap): calcd. for C27H23KN3O11+ (M+K+): 604.09642; found: 604.09216. 
rac-isopropyl (2S,3S)-3-hydroxy-2-[(2R,4R)-5-methyl-2,4-bis(4-nitrophenyl)-4H-1,3-
dioxin-6-yl]-3-(4-nitrophenyl)propanoate (84dc) (Table 9, entry 3). 
Allenoate 81d (101 mg, 720 µmol) and aldehyde 1c (435 mg, 2.88 mmol, 4.0 equiv.) were 
reacted in MeCN (14.5 mL) with TBD (30 mg, 216 µmol, 30 mol%) using standard procedure 
S5 (Reaction time: 30 min). Flash column chromatography (Si, 
2.0×22 cm, pentane/EtOAc = 7/3→6/4) gave product 84dc (215 mg, 
362 µmol, 50%) as a white foam. 
Rf = 0.35 (P/EtOAc = 7/3, [UV, KMnO4]). 
1H-NMR (400 MHz, CDCl3): 8.27 (d, 3J = 8.8 Hz, 2H, HAr), 8.20 (d, 
3J = 8.9 Hz, 2H, HAr), 8.03 (d, 3J = 8.6 Hz, 2H, HAr), 7.64 (d, 3J = 8.9 Hz, 2H, HAr), 7.63 (d, 3J 
= 8.7 Hz, 2H, HAr), 7.02 (d, 3J = 8.6 Hz, 2H, HAr), 5.84 [s, 1H, CH(OR)2], 5.44 (dd, J = 9.5, 2.9 
Hz, 1H, CHOH), 5.41 (s, 1H, ArCHOR), 5.21 [hept, 3J = 6.3 Hz, 1H, CHCH3(CH3)], 3.87 (d, 
J = 2.9 Hz, 1H, OH), 3.72 (d, J = 9.5 Hz, 1H, CHCO2i-Pr), 1.34 [d, J = 6.3 Hz, 3H, 
CHCH3(CH3)], 1.28 [d, 3J = 6.2 Hz, 3H, CHCH3(CH3)], 1.17 (s, 3H, R-CH3). 
13C-NMR (100 MHz, CDCl3): 170.7 (s, COOi-Pr), 148.6 (s, =CqOR), 148.1 (CAr), 147.8 (CAr), 
147.6 (CAr), 144.9 (CAr), 144.4 (CAr), 142.4 (CAr), 128.8 (d, CHAr), 128.1 (d, CHAr), 127.2 (d, 
CHAr), 123.7 (d, CHAr), 123.6 (d, CHAr), 123.4 (d, CHAr), 111.8 (s, =CqCH3), 96.8 [d, CH(OR)2], 
79.7 (d, ArCHOR), 72.0 (d, CHOH), 69.8 (d, CHMe2), 54.4 (d, CHCO2Me), 21.9 [q, 
CHCH3(CH3)], 21.8 [q, CHCH3(CH3)], 12.9 (q, R-CH3). 
IR (ATR): ν̃ = 3520 cm-1 (w), 3082 (w), 2984 (w), 2862 (w), 2644 (w) ,2456 (w), 2291 (w), 
2179 (w), 2110 (w), 1993 (w), 1927 (w), 1803 (w), 1722 (s), 1605 (m), 1520 (s), 1454 (w), 
1391 (w), 1345 (s), 1254 (m), 1170 (s), 1101 (s), 1008 (s), 909 (w), 850 (s), 749 (s), 699 (s). 
MS (EI, 70 eV) m/z (%) 291.3 (2) [(M–2ArCHO)+], 190.3 (28), 151.2 (98), 115.2 (80), 105.3 
(28), 77.4 (100), 51.6 (94). 
MS (ESI, Deca) m/z: 1208.53 [(2M+Na+)], 616.07 [(M+Na+)], 443.07 [(M–ArCHO+Na)+], 
292.00 [(M–2ArCHO)+]. 
HRMS (ESI, Orbitrap): calcd. for C29H27N3NaO11+ (M+Na+): 616.15378; found: 616.15234. 
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tert butyl (2S,3S)-3-hydroxy-2-[(2R,4R)-5-methyl-2,4-bis(4-nitrophenyl)-4H-1,3-dioxin-6-
yl]-3-(4-nitrophenyl)propanoate (84ec) (Table 9, entry 5). 
Allenoate 81e (109 mg, 707 µmol) and aldehyde 1c (427 mg, 2.83 mmol, 4.0 equiv.) were 
reacted in MeCN (14 mL) with TBD (30 mg, 212 µmol, 30 mol%) using standard procedure 
S5 (Reaction time: 28 h). Flash column chromatography (Si, 2.0×25 
cm, pentane/EtOAc = 7/3→1/1) gave product 84ec (162 mg, 267 
µmol, 38%) as a yellowish foam. 
Rf = 0.33 (P/EtOAc = 7/3, [UV, KMnO4]). 
1H-NMR (600 MHz, CDCl3): 8.27 (d, 3J = 8.9 Hz, 2H, HAr), 8.19 (d, 
3J = 8.7 Hz, 2H, HAr), 8.03 (d, 3J = 8.7 Hz, 2H, HAr), 7.66 (d, J = 8.6 Hz, 2H, HAr), 7.62 (d, J = 
8.6 Hz, 2H, HAr), 7.03 (d, J = 8.6 Hz, 2H, HAr), 5.84 [s, 1H, CH(OR)2], 5.42 (d, 3J = 1.9 Hz, 
1H, CHOH), 5.41 (s, 1H, ArCHOR), 3.93 (d, 3J = 2.8 Hz, 1H, OH), 3.68 (d, 3J = 9.6 Hz, 1H, 
CHCO2t-Bu), 1.53 [s, 9H, COOC(CH3)3], 1.17 (s, 3H, R-CH3). 
13C-NMR (160 MHz, CDCl3): 170.43 (s, COOt-Bu), 148.70 (s, =CqOR), 148.22 (CAr), 147.87 
(CAr), 147.85 (CAr), 145.11 (CAr), 144.92 (CAr), 142.63 (CAr), 128.87 (d, CHAr), 128.20 (d, 
CHAr), 127.26 (d, CHAr), 123.84 (d, CHAr), 123.64 (d, CHAr), 123.51 (d, CHAr), 111.62 (s, 
=CqCH3), 96.94 [d, CH(OR)2], 83.18 [s, COOC(CH3)3], 79.85 (d, ArCHOR), 72.04 (d, CHOH), 
55.14 (CHCOOt-Bu), 28.25 [q, COOC(CH3)3], 12.90 (q, R-CH3). 
IR (ATR): ν̃ = 3599 cm-1 (w), 3449 (w), 2932 (m), 2324 (w), 2186 (w), 2082 (w), 1994 (w), 
1937 (w),  1695 (s), 1550 (m), 1472 (m), 1424 (m), 1361 (s), 1286 (s), 1248 (m), 1145 (s), 1036 
(m), 970 (s), 851 (s), 740 (s), 676 (s). 
MS (EI, 70 eV) m/z (%) 305.3 (11) [(M–2ArCHO)+], 250.3 (100), 190.3 (52), 150.2 (84), 115.3 
(34), 139.2 (100), 57.5 (93). 
MS (ESI, Orbitrap) m/z: 630.17 [(M+Na+)]. 
HRMS (ESI, Orbitrap): calcd. for C30H29N3NaO11+ (M+Na+): 630.16943; found: 630.168
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4.4.4  Spectroscopic Data related to Scheme 80 
rac-ethyl (2S,3S)-3-hydroxy-2-[(2R,4R)-5-methyl-2,4-di(2-naphthyl)-4H-1,3-dioxin-6-yl]-
3-(2-naphthyl)propanoate (84ah) 
Allenoate 81a (73 mg, 579 µmol) and aldehyde 1h (369 mg, 2.36 mmol, 4.0 equiv.) were 
reacted in DMF (11.5 mL) with TBD (20.1 mg, 145 µmol, 25 
mol%) using standard procedure S6 (Reaction time: 2h 15 
min). Flash column chromatography (Si, 2.0×25 cm, 
pentane/EtOAc = 85/15→80/20) gave product 84ah (169 mg, 
283 µmol, 49%) as a white foam. 
Rf = 0.26 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 8.02 (s, 1H, CHAr), 7.96 (d, J = 8.1 Hz, 1H, CHAr), 7.93 (d, J = 
8.1 Hz, 1H, CHAr), 7.90 (s, 1H, CHAr), 7.90 – 7.85 (m, 4H, CHAr), 7.68 – 7.55 (m, 5H, CHAr), 
7.51 (dt, J = 6.2, 3.4 Hz, 2H, CHAr), 7.46 (d, J = 7.8 Hz, 1H, CHAr), 7.39 (s, 1H, CHAr), 7.38 – 
7.33 (m, 2H, CHAr), 6.71 (d, J = 8.5 Hz, 1H, CHAr), 6.11 (dd, J = 8.5, 1.7 Hz, 1H, CHAr), 5.94 
[s, 1H, ArCH(OR)2], 5.61 (dd, J = 9.8, 2.3 Hz, 1H, CHOH), 5.38 (s, 1H, ArCHOR), 4.36 (2×dq, 
J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.99 (d, J = 9.7 Hz, 1H, CHCO2Et), 3.71 (s, 1H, OH), 1.38 
(t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.21 (s, 3H, =CCH3). 
13C NMR (151 MHz, CDCl3) δ 172.3 (s, COOEt), 144.7 (s, C=CMe), 137.9 (s, CAr), 135.8 (s, 
CAr), 134.5 (s, CAr), 133.8 (s, CAr), 133.5 (s, CAr), 133.4 (s, CAr), 133.2 (s, CAr), 132.9 (s, CAr), 
132.7 (s, CAr), 128.40 (d, CHAr), 128.4 (d, CHAr), 128.4 (d, CHAr), 128.2 (d, CHAr), 128.0 (d, 
CHAr), 127.92 (d, CHAr), 127.86 (d, CHAr), 127.7 (d, CHAr), 127.5 (d, CHAr), 126.9 (d, CHAr), 
126.4 (d, CHAr), 126.3 (d, CHAr), 126.2 (d, CHAr), 126.1 (d, CHAr), 125.91 (d, CHAr), 125.87 
(d, CHAr), 125.7 (d, CHAr), 124.9 (d, CHAr), 124.8 (d, CHAr), 123.9 (d, CHAr), 111.3 (s, =CMe), 
98.3 [d, ArCH(OR)2], 81.1 (d, ArCHOR), 73.3 (d, CHOH), 61.5 (t, CO2CH2CH3), 54.3 (d, 
CHCO2Et), 14.4 (q, CO2CH2CH3), 13.2 (q, =CCH3). One CHAr-signal was not included due to 
overlaps resulting from low resolution. 
IR (ATR) ν̃ = 3800 cm-1 (w), 3648 (w), 3491 (w, OH), 3055 (w), 2652 (w), 2102 (w), 1726 (s, 
CO2Et), 1687 (s), 1601 (m), 1509 (m), 1467 (m), 1368 (m), 1320 (s), 1252 (s), 1171 (s), 1026 
(s), 955 (s), 895 (s), 818 (s), 745 (s), 694 (w), 660 (w). 
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MS (ESI, Orbitrap) m/z 633.2 (M+K+), 617.2 (M+Na+), 477.1 (M–ArCHO+K+), 461.2 (M–
ArCHO+Na+), 283.1 (M–2ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C40H34NaO5+ (M+Na+):  617.22985; found: 617.23248. 
4.4.5  Spectroscopic Data related to Table 12  
rac-ethyl (2S,3S)-2-[(2R,4R)-2,4-bis(4-chlorophenyl)-5-isopropyl-4H-1,3-dioxin-6-yl]-3-
(4-chlorophenyl)-3-hydroxypropanoate (84fb) (Table 12, entry 1, left row) 
Allenoate 81f (103 mg, 668 µmol) and aldehyde 1b (375 mg, 
2.67 mmol, 4.0 equiv.) were reacted in MeCN (13.5 mL) with 
TBD (28.0 mg, 200 µmol, 30 mol%) using standard procedure 
S5 (6.0 h). Flash column chromatography (Si, 2.0×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84fb (167 mg, 
291 µmol, 44%) as a white foam. 
Rf = 0.51 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.44 (d, J = 8.5 Hz, 2H, CHAr), 7.40 – 7.34 (m, 6H, CHAr), 7.18 
(d, J = 8.4 Hz, 2H, CHAr), 6.65 (d, J = 8.5 Hz, 2H, CHAr), 5.61 [s, 1H, ArCH(OR)2], 5.36 (dd, 
J = 9.8, 2.2 Hz, 1H, CHOH), 5.35 (s, 1H, ArCHOR), 4.28 (2×dq,  J = 9.8, 2.2 Hz, 2H, 
CO2CH2CH3), 3.77 (d, J = 9.5 Hz, 1H, CHCO2Et), 3.65 (d, J = 5.8 Hz, 1H, OH), 2.52 (hept, J 
= 7.0 Hz, 1H, CHMe2), 1.31 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 0.91 (d, J = 7.2 Hz, 3H, 
CH(CH3)CH3), 0.27 (d, J = 7.2 Hz, 3H, CH(CH3)CH3). 
13H NMR (151 MHz, CDCl3) δ 171.9 (s, COOEt), 144.9 (s, C=Ci-Pr), 139.1 (s, CAr), 138.1 (s, 
CAr), 135.4 (s, CAr), 135.1 (s, CAr), 134.3 (s, CAr), 134.0 (s, CAr), 134.0 (d, CHAr), 129.1 (d, 
CHAr), 128.6 (d, CHAr), 128.5 (d, CHAr), 128.4 (d, CHAr), 127.7 (d, CHAr), 121.4 (s, Ci-Pr), 92.4 
[d, ArCH(OR)2], 77.8 (d, ArCHOR), 72.3 (d, CHOH), 61.6 (t, CO2CH2CH3), 54.5 (d, 
CHCO2Et), 27.7 (d, CHMe2), 21.9 [q, CH(CH3)CH3], 21.0 [q, CH(CH3)CH3], 14.3 (q, 
CO2CH2CH3). 
IR (Film) ν̃ = 3467 cm-1 (s, OH), 2921 (s), 2671 (w), 2251 (m), 2079 (w), 1957 (w), 1904 (m), 
1736 (s, CO2Et), 1661 (s), 1596 (s), 1489 (s), 1383 (s), 1324 (w), 1249 (w), 1155 (m), 1022 (s), 
830 (s), 773 (w), 730 (s), 647 (w), 604 (w), 574 (w), 461 (w). 
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MS (EI, 70 eV) m/z (%) 434.3 (3) [(M–ArCHO)+], 295.3 (100) [(M–2 ArCHO)+], 276.3 (39), 
207.2 (65), 179.2 (62), 139.2 (76), 111.2 (20) [(4-Cl-C6H4)+]. 
MS (ESI, Orbitrap) m/z 597.1 (M+Na+), 457.1 (M–ArCHO+Na+), 295.1 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C30H29Cl3NaO5+ (M+Na+): 597.09728; found: 597.09552. 
rac-ethyl (2S,3S)-2-[(2R,4R)-5-butyl-2,4-bis(4-chlorophenyl)-4H-1,3-dioxin-6-yl]-3-(4-
chlorophenyl)-3-hydroxypropanoate (84ib) (Table 12, entry 1, right row) 
Alkynoate 81i (98 mg, 582 µmol) and aldehyde 1b (327 mg, 
2.33 mmol, 4.0 equiv.) were reacted in MeCN (12 mL) with 
TBD (24.5 mg, 170 µmol, 30 mol%) using standard procedure 
S5 (1.0 h). Flash column chromatography (Si, 2×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84ib (174 mg, 
295 µmol, 51%) as a white foam. 
Rf = 0.44 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.34 (m, 8H, CHAr), 7.20 (d, J = 8.3 Hz, 2H, CHAr), 6.57 
(d, J = 8.3 Hz, 2H, CHAr) 5.71 [s, 1H, ArCH(OR)2], 5.31 (dd, J = 9.7, 2.5 Hz, 1H, CHOH), 5.29 
(s, 1H, ArCHOR), 4.28 (2×dq,  J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.77 (d, J = 9.6 Hz, 1H, 
CHCO2Et), 3.66 (d, J = 2.8 Hz, 1H, OH), 1.31 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 1.28 – 1.12 
(m, 6H, CH2CH2CH2CH3), 0.84 (t, J = 6.6 Hz, 3H, CH2CH2CH2CH3). 
13C NMR (151 MHz, CDCl3) δ 172.0 (s, COOEt), 144.7 (s, C=Cn-Bu), 139.0 (s, CAr), 136.9 (s, 
CAr), 135.3 (s, CAr), 135.1 (s, CAr), 134.3 (s, CAr), 134.0 (s, CAr), 129.6 (d, CHAr), 128.8 (d, 
CHAr), 128.62 (d, CHAr), 128.59 (d, CHAr), 128.58 (d, CHAr), 127.6 (d, CHAr), 116.2 (s, Cn-
Bu), 97.4 [d, ArCH(OR)2], 79.0 (d, ArCHOR), 72.5 (d, CHOH), 61.6 (t, CO2CH2CH3), 53.8 (d, 
CHCO2Et), 30.5 (t, CH2CH2CH2CH3), 27.2 (t, CH2CH2CH2CH3), 22.4 (t, CH2CH2CH2CH3), 
14.3 (q, CO2CH2CH3), 13.9 (q, CH2CH2CH2CH3). 
IR (Film) ν̃ = 3496 cm-1 (s, OH), 3061 (m), 2957 (s), 2866 (s), 2282 (w), 2097 (w), 1904 (m), 
1733 (s, CO2Et), 1677 (s), 1597 (s), 1490 (s), 1384 (s), 1327 (m), 1254 (w), 1159 (s), 1017 (s), 
872 (m), 826 (s), 732 (s), 571 (m), 509 (w), 463 (w). 
MS (EI, 70 eV) m/z (%) 448.3 (6) [(M–ArCHO)+], 308.3 (18) [(M–2 ArCHO)+], 235.4 (24), 
194.3 (27), 151.2 (28), 139.2 (100), 111.2 (20) [(4-Cl-C6H4)+]. 
O O
CO2Et
OH
84ib
Cl
Cl
Cl
Me
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MS (ESI, Orbitrap) m/z 611.1 (M+Na+), 471.1 (M–ArCHO+Na+), 309.1 (M–2ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C31H31Cl3NaO5+ (M+Na+): 611.11293; found: 611.11310. 
rac-methyl 4-(2R,4R)-6-((1S)-2-ethoxy-1-(S)-hydroxy[4-(methoxycarbonyl)phenyl] 
methyl-2-oxoethyl)-5-isopropyl-4-[4-(methoxycarbonyl)phenyl]-4H-1,3-dioxin-2-
ylbenzenecarboxylate (84fi) (Table 12, entry 2, left row) 
Allenoate 81f (103 mg, 668 µmol) and aldehyde 1i (382 mg, 2.85 mmol, 4.0 equiv.) were 
reacted in MeCN (13.5 mL) with TBD (23.4 mg, 167 µmol, 25 mol%) using standard procedure  
S5 (1.5 h). Flash column chromatography (Si, 2.0×25 cm, 
pentane/EtOAc = 85/15→60/40) gave product 84fi (218.4 
mg, 338 µmol, 51%) as a white foam. 
Rf = 0.34 (P/EtOAc = 70/30, [UV, KMnO4]) 
1H NMR (400 MHz, CDCl3) δ 8.12 (d, J = 8.4 Hz, 2H, 
CHAr), 8.07 (d, J = 8.5 Hz, 2H, CHAr), 7.77 (d, J = 8.4 Hz, 2H, CHAr), 7.61 (d, J = 8.2 Hz, 2H, 
CHAr), 7.54 (d, J = 8.1 Hz, 2H, CHAr), 6.82 (d, J = 8.3 Hz, 2H, CHAr), 5.70 [s, 1H, ArCH(OR)2], 
5.47 (dd, J = 9.5, 2.3 Hz, 1H, CHOH), 5.43 (s, 1H, ArCHOR), 4.30 (2×dq, J = 10.8, 7.1 Hz, 
2H, CO2CH2CH3), 4.04 (s, 3H, COOCH3), 3,93 (s, 3H, COOCH3), 3.89 (s, 3H, COOCH3), 3.82 
(d, J = 9.5 Hz, 1H, CHCO2Et), 3.75 (s br, 1H, OH), 2.51 (hept, J = 7.1 Hz, 1H, CHMe2), 1.33 
(t, J = 7.1 Hz, 3H, CO2CH2CH3), 0.88 [d, J = 7.1 Hz, 3H, CH(CH3)CH3], 0.19 [d, J = 7.2 Hz, 
3H, CH(CH3)CH3]. 
13C NMR (101 MHz, CDCl3) δ 171.7 (s, COOEt), 166.8 (s, COOMe), 166.6 (s, COOMe), 166.5 
(s, COOMe), 145.5 (s, C=Ci-Pr), 144.7 (s, CAr), 144.5 (s, CAr), 141.2 (s, CAr), 130.9 (s, CAr), 
130.2 (s, CAr), 130.1 (s, CAr), 129.7 (d, CHAr), 129.3 (d, CHAr), 128.7 (d, CHAr), 127.6 (d, CHAr), 
126.3 (d, CHAr), 121.6 (s, Ci-Pr), 97.5 [d, ArCH(OR)2], 78.0 (d, ArCHOR), 72.4 (d, CHOH), 
61.6 (t, CO2CH2CH3), 54.6 (d, CHCO2Et), 52.2 (q, CO2CH3), 52.2 (q, CO2CH3), 52.0 (q, 
CO2CH3), 27.7 (d, CHMe2), 21.8 [q, CH(CH3)CH3], 21.0 [q, CH(CH3)CH3], 14.3 (q, 
CO2CH2CH3). One CHAr-signal was not included due to overlaps resulting from low resolution. 
IR (ATR) ν̃ = 3490 cm-1 (w, OH), 2959 (m), 1942 (w), 1717 (s, CO2Et), 1511 (w), 1435 (m), 
1275 (s), 1181 (m), 1105 (s), 1018 (s), 858 (s), 814 (m), 767 (s), 708 (s). 
MS (ESI, Orbitrap) m/z 685.2 (M+K+), 669.2 (M+Na+), 647.2 (M+H+), 521.2 (M–ArCHO+K+),  
    
 
 
 
148 
 
505.2 (M–ArCHO+Na+), 319.2 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C36H39O11+ (M+H+): 647.24869; found: 647.24957. 
rac-methyl 4-(2R,4R)-5-butyl-6-((1S)-2-ethoxy-1-(S)-hydroxy[4-(methoxycarbonyl)phe-
nyl]-methyl-2-oxoethyl)-4-[4-(methoxycarbonyl)phenyl]-4H-1,3-dioxin-2-ylben-zene-
carboxylate (84ii) (Table 12, entry 2, right row) 
Alkynoate 81i (112 mg, 660 µmol) and aldehyde 1i (438 mg, 2.65 mmol, 4.0 equiv.) were 
reacted in MeCN (13.5 mL) with TBD (23.2 mg, 167 
µmol, 25 mol%) using standard procedure S5 
(1 h 10 min). Flash column chromatography (Si, 2×22 cm, 
pentane/EtOAc = 85/15→80/20→75/25→ 70/30) gave 
product 84ii (225 mg, 340 µmol, 52%) as a white foam. 
Rf = 0.50 (P/EtOAc = 70/30, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ  8.07 (d, J = 8.2 Hz, 4H, CHAr), 7.78 (d, J = 8.3 Hz, 2H, CHAr), 
7.54 (d, J = 8.4 Hz, 4H, CHAr), 6.73 (d, J = 8.2 Hz, 2H, CHAr), 5.80 [s, 1H, ArCH(OR)2], 5.42 
(dd, J = 9.6, 2.3 Hz, 1H, CHOH), 5.38 (s, 1H, ArCHOR), 4.38 – 4.23 (m, 2H, CO2CH2CH3), 
4.02 (s, 3H, CO2CH3), 3.93 (s, 3H, CO2CH3), 3.89 (s, 3H, CO2CH3), 3.81 (d, J = 9.7 Hz, 1H, 
CHCO2Et), 3.76 (s br, 1H, OH), 1.79 – 1.68 (m, 1H), 1.32 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 
1.28 – 1.05 (m, 5H), 0.82 (t, J = 6.9 Hz, 3H, CH2CH2CH2CH3). 
13C NMR (151 MHz, CDCl3) δ 171.9 (s, COOEt), 166.8 (s, COOMe), 166.6 (s, COOMe), 166.5 
(s, COOMe), 145.4 (s, C=Cn-Bu), 144.6 (s, CAr), 143.4 (s, CAr), 141.2 (s, CAr), 131.0 (s, CAr), 
130.2 (s, CAr), 130.1 (s, CAr), 129.8 (d, CHAr), 129.7 (d, CHAr), 129.5 (d, CHAr), 128.2 (d, CHAr), 
127.3 (d, CHAr), 126.3 (d, CHAr), 116.5 (s, Cn-Bu), 97.5 [d, ArCH(OR)2], 79.2 (d, ArCHOR), 
72.7 (d, CHOH), 61.6 (t, CO2CH2CH3), 53.9 (d, CHCO2Et) 52.23 (q, CO2CH3), 52.22 (q, 
CO2CH3), 52.1 (q, CO2CH3), 30.4 (t, CH2CH2CH2CH3), 27.1 (t, CH2CH2CH2CH3), 22.4 (t, 
CH2CH2CH2CH3), 14.3 (q, CO2CH2CH3), 13.9 (q, CH2CH2CH2CH3). 
IR (ATR) ν̃ = 3495 cm-1 (w, OH), 2954 (m), 1927 (w), 1718 (s, CO2Et), 1613 (w), 1511 (w), 
1435 (m), 1274 (s), 1169 (s), 1105 (s), 1018 (s), 858 (s), 816 (w), 765 (s), 706 (s), 660 (w). 
MS (ESI, Orbitrap) m/z 699.2 (M+K+), 683.2 (M+Na+), 661.3 (M+H+), 535.2 (M–ArCHO+K+), 
519.2 (M–ArCHO+Na+), 333.2 (M–2ArCHO+H+). 
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HRMS (ESI, Orbitrap) calcd. for C37H41O11+ (M+H+): 661.26434; found: 661.26501. 
rac-ethyl (2S,3S)-2-[(2R,4R)-2,4-bis(3-formylphenyl)-5-isopropyl-4H-1,3-dioxin-6-yl]-3-
(3-formylphenyl)-3-hydroxypropanoate (84fj) (Table 12, entry 3, left row). 
 Allenoate 81f (98 mg, 635 µmol) and aldehyde 1j (341 mg, 2.54 mmol, 4.0 equiv.) were reacted 
in MeCN (13 mL) with TBD (22.2 mg, 159 µmol, 25 mol%) using standard procedure S5 
(1.0 h). Flash column chromatography (Si, 2.0×24 cm, pentane/EtOAc = 70/30→65/35) gave 
product 84fj (141 mg, 253 µmol, 40%) as a white foam. 
Rf = 0.41 (P/EtOAc = 60/40, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 10.07 (s, 1H, CHO), 10.06 (s, 
1H, CHO), 9.91 (s, 1H, CHO), 8.10 (s, 1H, CHAr), 7.99 (s, 
1H, CHAr), 7.96 (d, J = 7.6 Hz, 1H, CHAr), 7.92 (d, J = 7.7 Hz, 1H, CHAr), 7.84 (d, J = 7.7 Hz, 
1H, CHAr), 7.76 (d, J = 7.8 Hz, 1H, CHAr), 7.73 (d, J = 7.8 Hz, 1H, CHAr), 7.62 (virt. pent, J = 
7.6 Hz, 2H, CHAr), 7.55 (s, 1H, CHAr), 7.24 (t, J = 7.6 Hz, 1H, CHAr), 6.79 (d, J = 7.7 Hz, 1H, 
CHAr), 5.77 [s, 1H, ArCH(OR)2], 5.52 (s, 1H, ArCHOR), 5.51 (d, J = 9.6 Hz, 1H, CHOH), 4.32 
(2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.90 (s br, 1H, OH), 3.88 (d, J = 9.5 Hz, 1H, 
CHCO2Et), 2.55 (hept, J = 7.1 Hz, 1H, CHMe2), 1.35 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 0.89 
[d, J = 7.1 Hz, 3H, CH(CH3)CH3], 0.19 [d, J = 7.2 Hz, 3H, CH(CH3)CH3]. 
13C NMR  (101 MHz, CDCl3)  δ  191.93  (s,  CHO),  191.90 (s, CHO), 191.7  (s,  CHO), 171.7  
(s, COOEt), 144.8 (s, C=Ci-Pr), 141.9 (s, CAr), 140.7 (s, CAr), 137.8 (s, CAr), 136.58 (s, 
CArCHO), 136.4 (s, CArCHO), 134.5 (d, CHAr), 133.6 (d, CHAr), 132.3 (d, CHAr), 130.7 (d, 
CHAr), 130.7 (d, CHAr), 129.5 (d, CHAr), 129.3 (d, CHAr), 129.24 (d, CHAr), 129.16 (d, CHAr), 
129.0 (d, CHAr), 128.7 (d, CHAr), 127.6 (d, CHAr), 121.6 (s, Ci-Pr), 97.6 [d, ArCH(OR)2], 78.2 
(d, ArCHOR), 72.2 (d, CHOH), 61.8 (t, CO2CH2CH3), 54.6 (d, CHCO2Et), 27.6 (d, CHMe2), 
21.8 [q, CH(CH3)CH3], 20.9 [q, CH(CH3)CH3], 14.3 (q, CO2CH2CH3). One CAr-signal was not 
included due to overlaps resulting from low resolution. 
IR (ATR) ν̃ = 3477 cm-1 (m, OH), 2971 (m), 2735 (w), 1951 (w), 1693 (s, CO2Et), 1599 (s), 
1457 (m), 1381 (m), 1242 (s), 1150 (s), 1024 (s), 908 (m), 695 (s). 
MS (ESI, Orbitrap) m/z 579.2 (M+Na+), 557.2 (M+H+), 445.2 (M–ArCHO+Na+), 289.1 (M–
2 ArCHO+H+). 
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HRMS (ESI, Orbitrap) calcd. for C33H32NaO8+ (M+Na+): 579.19894; found: 579.20020. 
rac-ethyl (2S,3S)-2-[(2R,4R)-5-butyl-2,4-bis(3-formylphenyl)-4H-1,3-dioxin-6-yl]-3-(3-
formylphenyl)-3-hydroxypropanoate (84ij) (Table 12, entry 3, right row). 
 Alkynoate 81i (120 mg, 713 µmol) and aldehyde 1j (382 mg, 2.85 mmol, 4.0 equiv.) were 
reacted in MeCN (14.5 mL) with TBD (24.9 mg, 178 µmol, 
25 mol%) using standard procedure S5 (1.0 h). Flash column 
chromatography (Si, 2.0×25 cm, pentane/EtOAc = 70/30) 
gave product 84ij (175 mg, 307 µmol, 43%) as a white foam. 
Rf = 0.53 (P/EtOAc = 60/40, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 10.07 (s, 1H, CHO), 10.02 (s, 1H, CHO), 9.92 (s, 1H, CHO), 
8.04 (t, J = 1.7 Hz, 1H, CHAr), 7.99 (t, J = 1.7 Hz, 1H, CHAr), 7.92 (dt, J = 6.6, 1.5 Hz, 1H, 
CHAr), 7.90 (dt, J = 6.9, 1.5 Hz, 1H, CHAr), 7.79 – 7.77 (m, 1H, CHAr), 7.77 – 7.75 (m, 1H, 
CHAr) 7.74 (dt, J = 7.9, 1.4 Hz, 1H, CHAr), 7.61 (d, J = 7.8 Hz, 1H, CHAr), 7.57 (d, J = 7.8 Hz, 
1H, CHAr), 7.51 (t, J = 1.7 Hz, 1H, CHAr), 7.27 (t, J = 7.6 Hz, 1H, CHAr), 6.72 (d, J = 7.7 Hz, 
1H, CHAr), 5.86 [s, 1H, ArCH(OR)2], 5.47 (d, J = 9.5 Hz, 1H, CHOH), 5.46 (s, 1H, ArCHOR), 
4.32 (2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.91 (s br, 1H, OH), 3.84 (d, J = 9.6 Hz, 1H, 
CHCO2Et), 1.85 – 1.73 (m, 1H), 1.34 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.30 – 1.00 (m, 5H), 
0.80 (t, J = 6.9 Hz, 3H, CH2CH2CH2CH3). 
13C NMR (101 MHz, CDCl3) δ 191.95 (s, CHO), 191.91 (s, CHO), 191.7 (s, CHO), 171.7 (s, 
COOEt), 144.6 (s, C=Cn-Bu), 141.8 (s, CAr), 139.6 (s, CAr), 137.7 (s, CAr), 136.6 (s, CArCHO), 
136.5 (s, CArCHO), 136.4 (s, CArCHO), 133.6 (d, CHAr), 133.4 (d, CHAr), 132.3 (d, CHAr), 130.6 
(d, CHAr), 130.5 (d, CHAr), 129.4 (d, CHAr), 129.3 (d, CHAr), 129.2 (d, CHAr), 129.1 (d, CHAr), 
129.0 (d, CHAr), 128.4 (d, CHAr), 127.6 (d, CHAr), 116.6 (s, Cn-Bu), 97.5 [d, ArCH(OR)2], 79.3 
(d, ArCHOR), 72.3 (d, CHOH), 61.7 (t, CO2CH2CH3), 54.0 (d, CHCO2Et), 30.4 (t, 
CH2CH2CH2CH3), 27.1 (t, CH2CH2CH2CH3), 22.4 (t, CH2CH2CH2CH3), 14.3 (q, 
CO2CH2CH3), 13.8 (q, CH2CH2CH2CH3).  
IR (ATR) ν̃ = 3474 cm-1 (w, OH), 3064 (w), 2953 (m), 2862 (m), 2733 (w), 2167 (w), 2045 
(w), 1912 (w), 1693 (s, CO2Et), 1598 (m), 1454 (m), 1381 (m), 1300 (m), 1242 (s), 1152 (s), 
1077 (m), 1030 (s), 906 (m), 796 (s), 694 (s). 
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MS (ESI, LCQ) m/z 1162.4 (2M+Na+), 894.3 (3M+2K+), 593.1 (M+Na+), 459.1 (M–
ArCHO+Na+), 303.1 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C34H34NaO8+ (M+Na+): 593.21459; found: 593.21619. 
rac-ethyl (2S,3S)-3-hydroxy-2-(2R,4R)-5-isopropyl-2,4-bis[4-(trifluoromethyl)phenyl]-
4H-1,3-dioxin-6-yl-3-[4-(trifluoromethyl)phenyl]propanoate (84fk) (Table 12, entry 4, left 
row) 
Allenoate 81f (103 mg, 668 µmol) and aldehyde 1k (471 mg, 2.70 mmol, 4.0 equiv.) were 
reacted in MeCN (13.5 mL) with TBD (23.4 mg, 167 µmol, 25 mol%) using standard procedure 
S5 (2.5 h). Flash column chromatography (Si, 2.0×25 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84fk (149.4 
mg, 221 µmol, 33%) as a white foam. 
Rf = 0.50 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 2H, CHAr), 
7.66 (d, J = 5.0 Hz, 4H, CHAr), 7.59 (virt. d, J = 8.1 Hz, 2H, CHAr), 7.41 (d, J = 7.9 Hz, 2H, 
CHAr), 6.89 (d, J = 7.9 Hz, 2H, CHAr), 5.73 [s, 1H, ArCH(OR)2], 5.48 (dd, J = 8.1, 2.4 Hz, 1H, 
CHOH), 5.47 (s, 1H, ArCHOR), 4.32 (2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.84 (d, J = 
9.5 Hz, 1H, CHCO2Et), 3.71 (s, 1H, OH), 2.52 (hept, J = 7.2 Hz, 1H, CHMe2), 1.34 (t, J = 7.1 
Hz, 3H, CO2CH2CH3), 0.89 [d, J = 7.1 Hz, 3H, CH(CH3)CH3], 0.22 [d, J = 7.2 Hz, 3H, 
CH(CH3)CH3]. 
13C NMR (151 MHz, CDCl3) δ 171.7 (s, COOEt), 144.8 (s, C=Ci-Pr), 144.5 (s, CAr), 143.3 (s, 
CAr), 140.2 (s, CAr), 131.5 (qCF, 2JCF = 32.7 Hz, CArCF3), 131.0 (qCF, 2JCF = 32.5 Hz, CArCF3), 
130.6 (qCF, 2JCF = 32.5 Hz, CArCF3), 128.9 (d, CHAr), 128.0 (d, CHAr), 126.7 (d, CHAr), 125.5 
(d, qCF, 3JCF = 3.8 Hz, CHAr), 125.3 (d, qCF, 3JCF = 3.7 Hz, CHAr), 125.1 (d, qCF, 3JCF = 3.8 Hz, 
CHAr), 124.1 (qCF, 1JCF = 272.4 Hz, CF3), 123.9 (qCF, 1JCF = 272.4 Hz, CF3), 123.8 (qCF, 1JCF = 
272.4 Hz, CF3), 104.7 (s, Ci-Pr), 97.3 [d, ArCH(OR)2], 78.0 (d, ArCHOR), 72.3 (d, CHOH), 
61.8 (t, CO2CH2CH3) 54.6 (d, CHCO2Et), 27.7 (d, CHMe2), 21.9 [q, CH(CH3)CH3], 20.9 [q, 
CH(CH3)CH3], 14.3 (q, CO2CH2CH3). 
IR (ATR) ν̃ = 3471 cm-1 (w, OH), 2975 (w), 2879 (w), 2644 (w), 2302 (w), 2080 (w), 1979 
(w), 1924 (w), 1728 (m, CO2Et), 1661 (w), 1621 (w), 1417 (m), 1320 (s), 1249 (m), 1165 (m), 
1117 (s), 1064 (s), 1015 (s), 839 (s), 760 (w), 711 (w), 679 (w). 
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MS (ESI, Orbitrap) m/z 715.2 (M+K+), 699.2 (M+Na+), 541.1 (M–ArCHO+K+), 525.1 (M–
ArCHO+Na+), 329.1 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C33H29F9NaO5+ (M+Na+): 699.17635; found: 699.17834. 
rac-ethyl (2S,3S)-2-(2R,4R)-5-butyl-2,4-bis[4-(trifluoromethyl)phenyl]-4H-1,3-dioxin-6-
yl-3-hydroxy-3-[4-(trifluoromethyl)phenyl]propanoate (84ik) (Table 12, entry 4, right 
row) 
Alkynoate 81i (98 mg, 582 µmol) and aldehyde 1k (409 mg, 2.35 mmol, 4.0 equiv.) were 
reacted in MeCN (12 mL) with TBD (20.5 mg, 147 µmol, 25 mol%) using standard procedure 
S5 (1.0 h). Flash column chromatography (Si, 2×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84ik (203 mg, 
295 µmol, 51%) as a white foam. 
Rf = 0.31 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 8.1 Hz, 2H, CHAr), 
7.65 (d, J = 7.4 Hz, 2H, CHAr), 7.59 (virt. d, J = 8.5 Hz, 4H, CHAr), 7.43 (d, J = 8.0 Hz, 2H, 
CHAr), 6.82 (d, J = 8.0 Hz, 2H, CHAr), 5.83 [s, 1H, ArCH(OR)2], 5.45-5.40 (m, 1H, CHOH), 
5.42 (s, 1H, ArCHOR), 4.31 (2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.81 (d, J = 9.7 Hz, 
1H, CHCO2Et), 3.72 (s br, 1H, OH), 1.84 - 1.71 (m, 1H) 1.33 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 
1.28 – 1.09 (s, 5H), 1.83 (t, J = 6.9 Hz, 3H, CH2CH2CH2CH3). 
13C NMR (101 MHz, CDCl3) δ 171.7 (s, COOEt), 144.5 (s, C=Cn-Bu), 144.4 (s, CAr), 142.2 (s, 
CAr), 140.2 (s, CAr), 131.2 (qCF, 2JCF = 33.1 Hz, CArCF3), 130.9 (qCF, 2JCF = 32.6 Hz, CArCF3), 
130.5 (qCF, 2JCF = 32.3 Hz, CArCF3r), 128.3 (d, CHAr), 127.7 (d, CHAr), 126.6 (d, CHAr), 125.5 
(d, qCF, 3J = 3.9 Hz, CHAr), 125.4 (d, qCF, 3J = 4.0 Hz, CHAr), 124.0 (qCF, 1JCF = 272.0 Hz, CF3), 
123.9 (qCF, 1JCF = 272.0 Hz, CF3), 123.8 (qCF, 1JCF = 272.0 Hz, CF3), 116.6 (s, Cn-Bu), 97.2 [d, 
ArCH(OR)2], 79.1 (d, ArCHOR), 72.4 (d, CHOH), 61.8 (t, CO2CH2CH3), 53.8 (d, CHCO2Et), 
30.5 (t, CH2CH2CH2CH3), 27.1 (t, CH2CH2CH2CH3), 22.4 (t, CH2CH2CH2CH3), 14.3 (q, 
CO2CH2CH3), 13.9 (q, CH2CH2CH2CH3). One CHAr-signal was not included due to overlaps 
resulting from low resolution. 
IR (ATR) ν̃ = 3492 cm-1 (w, OH), 2961 (w), 2868 (w), 1990 (w), 1728 (m, CO2Et), 1677 (m), 
1627 (w), 1522 (w), 1466 (w), 1419 (m), 1321 (s), 1255 (m), 1162 (s), 1118 (s), 1065 (s), 
1016 (s), 838 (s), 759 (w). 
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MS (ESI, Orbitrap) m/z 713.2 (M+Na+), 539.2 (M–ArCHO+Na+), 343.2 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C34H31F9NaO5+ (M+Na+): 713.19200; found: 713.19672. 
rac-ethyl (2S,3S)-2-[(2R,4R)-2,4-bis(3-fluorophenyl)-5-isopropyl-4H-1,3-dioxin-6-yl]-3-
(3-fluorophenyl)-3-hydroxypropanoate (84fl) (Table 12, entry 5, left row) 
Allenoate 81f (98 mg, 635 µmol) and aldehyde 1l (315 mg, 2.54 mmol, 4.0 equiv.) were reacted 
in MeCN (13 mL) with TBD (26.5 mg, 190 µmol, 30 mol%) using standard procedure S5 (1 h 
40 min.). Flash column chromatography (Si, 2.0×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84fl (132 mg, 251 
µmol, 40%) as a yellowish syrup. 
Rf = 0.37 (P/EtOAc = 85/15, [UV, KMnO4]) 
1H NMR (600 MHz, CDCl3) δ 7.40 (virt. q, J = 7.3 Hz, 1H, CHAr), 
7.35 (virt. q, J = 7.5 Hz, 1H, CHAr), 7.31 (d, J = 7.6 Hz, 1H, CHAr), 7.25 (d, J = 7.7 Hz, 2H, 
CHAr), 7.19 (d, J = 9.1 Hz, 1H, CHAr), 7.14 (virt. q, J = 7.3 Hz, 1H, CHAr), 7.10 – 7.04 (m, 2H, 
CHAr), 6.92 (t, J = 8.0 Hz, 1H, CHAr), 6.72 (d, J = 7.5 Hz, 1H, CHAr), 6.57 (d, J = 9.3 Hz, 1H, 
CHAr), 5.64 [s, 1H, ArCH(OR)2], 5.40 (d, J = 9.0 Hz, 1H, CHOH), 5.39 (s, 1H, ArCHOR), 4.28 
(2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.78 (d, J = 12.0 Hz, 1H, CHCO2Et), 3.77 (s, 1H, 
OH), 2.51 (hept, J = 6.7 Hz, 1H, CHMe2), 1.31 (t, J = 7.0 Hz, 3H, CO2CH2CH3), 0.89 [d, J = 
7.0 Hz, 3H, CH(CH3)CH3], 0.23 [d, J = 7.1 Hz, 3H, CH(CH3)CH3]. 
13C NMR (151 MHz, CDCl3) δ 171.9 (s, COOEt), 162.8 (dCF, 1JCF = 246.1 Hz, CF), 162.7 (dCF, 
1JCF = 246.2 Hz, CF), 162.6 (dCF, 1JCF = 246.2 Hz, CF), 144.7 (s, C=Ci-Pr), 143.1 (dCF, 3JCF = 
6.8 Hz, CAr), 142.1 (dCF, 3JCF = 6.8 Hz, CAr), 139.2 (dCF, 3JCF = 7.4 Hz, CAr), 130.05 (d, dCF, 
3JCF = 8.1 Hz, CHAr), 129.96 (d, dCF, 3JCF = 8.2 Hz, CHAr), 129.6, (d, dCF, 3JCF = 8.1 Hz, CHAr), 
124.5 (d, dCF, 4JCF = 3.0 Hz, CHAr), 123.1 (d, dCF, 4JCF = 3.0 Hz, CHAr), 122.0 (d, dCF, 4JCF = 
3.1 Hz, CHAr), 121.7 (s, Ci-Pr), 116.2 (d, dCF, 2JCF = 21.0 Hz, CHAr), 115.6 (d, dCF, 2JCF = 21.2 
Hz, CHAr), 115.5 (d, dCF, 2JCF = 21.5 Hz, CHAr), 115.3 (d, dCF, 2JCF = 21.4 Hz, CHAr), 114.2 (d, 
dCF, 2JCF = 21.8 Hz, CHAr), 113.5 (d, dCF, 2JCF = 22.6 Hz, CHAr), 97.4 [d, ArCH(OR)2], 78.1 (d, 
ArCHOR), 72.1 (d, CHOH), 61.6 (t, CO2CH2CH3), 54.6 (d, CHCO2Et), 27.7 (d, CHMe2), 21.6 
[q, CH(CH3)CH3], 20.9 [q, CH(CH3)CH3], 14.3 (t, CO2CH2CH3). 
IR (ATR) ν̃ = 3478 cm-1 (m, OH), 2972 (m), 1942 (w), 1726 (s, CO2Et), 1662 (m), 1594 (s), 
1451 (s), 1388 (m), 1250 (s), 1148 (s), 1027 (s), 874 (s), 785 (s), 732 (s), 695 (s). 
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MS (ESI, Orbitrap) m/z 549.2 (M+Na+), 279.1 (M–2 ArCHO+H+). 
MS (EI, 70 eV) m/z (%) 402.3 (42) [(M–ArCHO)+], 359.2 (55), 279.2 (68) [(M–2ArCHO) +], 
191.2 (82), 163.2 (100) 124.2 (53) [ArCHO+], 95.2 (36) [Ar+]. 
HRMS (ESI, Orbitrap): calcd. for C30H29F3NaO5+ (M+Na+):  549.18593; found: 549.18707. 
rac-ethyl (2S,3S)-2-[(2R,4R)-5-butyl-2,4-bis(3-fluorophenyl)-4H-1,3-dioxin-6-yl]-3-(3-
fluorophenyl)-3-hydroxypropanoate (84il) (Table 12, entry 5, right row) 
Alkynoate 81i (110 mg, 654 µmol) and aldehyde 1l (325 mg, 2.62 
mmol, 4.0 equiv.) were reacted in MeCN (13.5 mL) with TBD 
(27.5 mg, 200 µmol, 30 mol%) using standard procedure S5 (40 
min.). Flash column chromatography (Si, 2×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84il (180 mg, 333 
µmol, 51%) as a yellowish syrup. 
Rf = 0.37 (P/EtOAc = 85/15, [UV, KMnO4]). 
1H NMR (300 MHz, CDCl3) δ 7.37 (t, J = 7.8 Hz, 1H, CHAr), 7.35 (t, J = 7.7 Hz, 1H, CHAr), 
7.28 – 7.12 (m, 5H, CHAr), 7.11 – 7.02 (m, 2H, CHAr), 6.93 (td, J = 8.4, 2.2 Hz, 1H, CHAr), 6.64 
(d, J = 7.6 Hz, 1H, CHAr), 6.48 (ddd, J = 9.4, 2.6, 1.6 Hz, 1H, CHAr), 5.74 [s, 1H, ArCH(OR)2], 
5.35 (dd, J = 9.7, 2.3 Hz, 1H, CHOH), 5.34 (s, 1H, ArCHOR), 4.29 (2×dq, J = 10.8, 7.1 Hz, 
2H, CO2CH2CH3), 3.75 (d, J = 9.7 Hz, 1H, CHCO2Et), 3.73 (d, J = 2.8 Hz, 1H, OH), 1.84 – 
1.70 (m, 1H), 1.32 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.27 – 1.01 (m, 5H), 0.81 (t, J = 7.0 Hz, 
3H, CH2CH2CH2CH3). 
13C NMR (151 MHz, CDCl3) δ 172.0 (s, COOEt), 162.8 (dCF, 1JCF = 246.3 Hz, CF), 162.7 (dCF, 
1JCF = 246.2 Hz, CF), 162.7 (dCF, 1JCF = 246.0 Hz, CF), 144.5 (s, C=Cn-Bu), 142.9 (dCF, 3JCF = 
7.0 Hz, CAr), 141.0 (dCF, 3JCF = 6.8 Hz, CAr), 139.1 (dCF, 3JCF = 7.5 Hz, CAr), 130.1 (d, dCF, 3JCF 
= 7.9 Hz, CHAr), 130.0 (d, dCF, 3JCF = 8.2 Hz, CHAr), 129.7 (d, dCF, 3JCF = 8.0 Hz, CHAr), 124.0 
(d, dCF, 4JCF = 2.8 Hz, CHAr), 123.0 (d, dCF, 4JCF = 2.5 Hz, CHAr), 122.0 (d, dCF, 4JCF = 3.0 Hz, 
CHAr), 116.6 (s, Cn-Bu), 116.2 (d, dCF, 2JCF = 21.1 Hz, CHAr), 115.6 (d, dCF, 2JCF = 21.4 Hz, 
CHAr), 115.3 (d, dCF, 2JCF = 21.4 Hz, CHAr), 114.9 (d, dCF, 2JCF = 21.9 Hz, CHAr), 114.0 (d, dCF, 
2JCF = 22.0 Hz, CHAr), 113.5 (d, dCF, 2JCF = 22.6 Hz, CHAr), 97.3 [d, ArCH(OR)2], 79.2 (d, 
ArCHOR), 72.3 (d, CHOH), 61.6 (t, CO2CH2CH3), 54.0 (d, CHCO2Et), 30.5 (t, 
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CH2CH2CH2CH3), 27.1 (t, CH2CH2CH2CH3), 22.4 (t, CH2CH2CH2CH3), 14.3 (q, 
CO2CH2CH3), 13.9 (q, CH2CH2CH2CH3). 
IR (Film) ν̃ = 3482 cm-1 (s, OH), 3068 (m), 2951 (s), 1942 (w), 1728 (s, CO2Et), 1598 (s), 1457 
(s), 1390 (s), 1256 (s), 1163 (s), 1034 (s), 951 (m), 877 (s), 788 (s), 525 (m), 464 (w). 
MS (ESI, Orbitrap) m/z 979.4 (2 M–ArCHO+Na+), 855.3 [2 (M–2ArCHO)+Na+], 563.2 
(M+Na+), 439.2 (M–ArCHO+Na+), 293.2 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C31H31F3NaO5+ (M+Na+): 563.20158; found: 563.19940. 
rac-ethyl (2S,3S)-2-[(2R,4R)-2,4-bis(3-bromophenyl)-5-isopropyl-4H-1,3-dioxin-6-yl]-3-
(3-bromophenyl)-3-hydroxypropanoate (84fm) (Table 12, entry 6, left row) 
Allenoate 81f (94 mg, 609 µmol) and aldehyde 1m (450 mg, 2.44 mmol, 4.0 equiv.) were 
reacted in MeCN (12 mL) with TBD (25.5 mg, 183 µmol, 30 mol%) using standard procedure 
S5 (8 h). Flash column chromatography (Si, 2.0×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84fm (192 mg, 
270 µmol, 44%) as a yellowish syrup. 
Rf = 0.53 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (400 MHz, CDCl3) δ 7.69 (t, J = 1.8 Hz, 1H, CHAr), 7.60 (t, J = 1.8 Hz, 1H, CHAr), 
7.55  (ddd, J = 8.0, 2.1, 1.1 Hz, 1H, CHAr), 7.51 (ddd, J = 8.0, 2.0, 1.1 Hz, 1H, CHAr), 7.44 (d, 
J = 7.7 Hz, 1H, CHAr), 7.40 (d, J = 7.7 Hz, 1H, CHAr), 7.38 (ddd, J = 8.0, 2.0, 1.1 Hz, 1H, 
CHAr), 7.33 (t, J = 7.8 Hz, 1H, CHAr), 7.26 (t, J = 7.8 Hz, 1H, CHAr), 7.14 (t, J = 1.8 Hz, 1H, 
CHAr), 7.07 (t, J = 7.8 Hz, 1H, CHAr), 6.66 (dt, J = 7.7, 1.3 Hz, 1H, CHAr), 5.60 [s, 1H, 
ArCH(OR)2], 5.34 (s, 1H, ArCHOR), 5.34 (d, J = 9.4 Hz, 1H, CHOH), 4.28 (2×dq, J = 10.8, 
7.1 Hz, 2H, CO2CH2CH3), 3.78 (d, J = 9.5 Hz, 1H, CHCO2Et), 3.71 (s, 1H, OH), 2.52 (hept, J 
= 7.2 Hz, 1H, CHMe2), 1.32 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 0.90 [d, J = 7.1 Hz, 3H, 
CH(CH3)CH3], 0.27 [d, J = 7.2 Hz, 3H, CH(CH3)CH3]. 
13C NMR (101 MHz, CDCl3) δ 171.7 (s, COOEt), 144.6 (s, C=Ci-Pr), 142.8 (s, CAr), 141.7 (s, 
CAr), 138.8 (s, CAr), 132.4 (d, CHAr), 131.7 (d, CHAr), 131.6 (d, CHAr), 131.4 (d, CHAr), 130.5 
(d, CHAr), 130.04 (d, CHAr), 130.00 (d, CHAr), 129.9 (d, CHAr), 129.6 (d, CHAr), 127.4 (d, 
CHAr), 126.1 (d, CHAr), 125.1 (d, CHAr), 122.5 (s, CArBr), 122.0 (s, CArBr), 121.39 (s, Ci-Pr), 
121.35 (s, CArBr), 97.3 [d, ArCH(OR)2], 78.1 (d, ArCHOR), 72.1 (d, CHOH),  61.6 (t, 
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CO2CH2CH3), 54.7 (d, CHCO2Et), 27.7 (d, CHMe2), 21.8 [q, CH(CH3)CH3], 20.9 [q, 
CH(CH3)CH3], 14.3 (q, CO2CH2CH3). 
IR (ATR) ν̃ = 3477 cm-1 (m, OH), 2969 (m), 2654 (w), 2308 (w), 2161 (w), 2060 (w), 1960 
(w), 1888 (w), 1724 (s, CO2Et), 1662 (m), 1572 (m), 1467 (m), 1383 (m), 1246 (s), 1194 (s), 
1021 (s), 878 (s), 783 (s), 685 (s). 
MS (EI, 70 eV) m/z (%) 524.3 (1) [(M–ArCHO)+], 341.3 (2) [(M–2 ArCHO)+], 251.2 (21), 
223.3 (27), 185.1 (100), 155.1 (40) [(3-Br-C6H4)+], 144.3 (94), 129.3 (86), 77.3 (59). 
MS (ESI, Orbitrap) m/z 730.9 (M+Na+), 547.0 (M–ArCHO+Na+), 339.1 (M–2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C30H29Br3NaO5+ (M+Na+): 730.94368; found: 730.94427. 
rac-ethyl (2S,3S)-2-[(2R,4R)-2,4-bis(3-bromophenyl)-5-butyl-4H-1,3-dioxin-6-yl]-3-(3-
bromophenyl)-3-hydroxypropanoate (84im) (Table 12, entry 6, right row) 
Alkynoate 81i (116 mg, 689 µmol) and aldehyde 1m (510 mg, 2.76 mmol, 4.0 equiv.) were 
reacted in MeCN (14 mL) with TBD (28.5 mg, 207 µmol, 30 mol%) using standard procedure 
S5 (1 h 15 min.). Flash column chromatography (Si, 2×22 cm, 
pentane/EtOAc = 90/10→85/15) gave product 84im (223 mg, 
308 µmol, 44%) as a white foam. 
Rf = 0.66 (P/EtOAc = 80/20, [UV, KMnO4]). 
1H NMR (600 MHz, CDCl3) δ 7.64 (t, J = 1.8 Hz, 1H, CHAr), 
7.61 (t, J = 1.8 Hz, 1H, CHAr), 7.51  (dddd, J = 7.8, 4.7, 2.0, 1.0 Hz, 1H, CHAr), 7.40 (d, J = 8.3 
Hz, 1H, CHAr), 7.40 (d, J = 7.7 Hz, 1H, CHAr), 7.40 – 7.37 (m, 2H, CHAr), 7.28 (t, J = 7.8 Hz, 
1H, CHAr), 7.26 (t, J = 7.8 Hz, 1H, CHAr), 7.11 (t, J = 1.8 Hz, 1H, CHAr), 7.08 (t, J = 7.8 Hz, 
1H, CHAr), 6.60 (dt, J = 7.7, 1.3 Hz, 1H, CHAr), 5.70 [s, 1H, ArCH(OR)2], 5.29 (d, J = 9.7 Hz, 
1H, CHOH), 5.29 (s, 1H, ArCHOR), 4.28 (2×dq, J = 10.8, 7.1 Hz, 2H, CO2CH2CH3), 3.73 (d, 
J = 9.7 Hz, 1H, CHCO2Et), 3.72 (s br, 1H, OH), 1.76 (ddd, J = 15.0, 9.3, 6.2 Hz, 1H), 1.31 (t, 
J = 7.1 Hz, 3H, CO2CH2CH3), 1.26 (ddd, J = 14.5, 9.8, 5.0 Hz, 1H), 1.23 – 1.12 (m, 3H), 1.07 
– 0.99 (m, 1H), 0.82 (t, J = 7.1 Hz, 3H, CH2CH2CH2CH3). 
13C NMR (151 MHz, CDCl3) δ 171.8 (s, COOEt), 144.4 (s, C=Cn-Bu), 142.6 (s, CAr), 140.7 (s, 
CAr), 138.8 (s, CAr), 132.4 (d, CHAr), 131.7 (d, CHAr), 131.4 (d, CHAr), 131.2 (d, CHAr), 130.2 
(d, CHAr), 130.1 (d, CHAr), 130.03 (d, CHAr), 130.01 (d, CHAr), 129.5 (d, CHAr), 126.7 (d, 
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CHAr), 125.9 (d, CHAr), 125.0 (d, CHAr), 122.45 (s, CArBr), 122.44 (s, CArBr) 122.3 (s, CArBr), 
116.4 (s, C-n-Bu), 97.3 [d, ArCH(OR)2], 79.3 (d, ArCHOR), 72.2 (d, CHOH), 61.6 (t, 
CO2CH2CH3), 54.0 (d, CHCO2Et), 30.4 (t, CH2CH2CH2CH3), 27.1 (t, CH2CH2CH2CH3), 22.4 
(t, CH2CH2CH2CH3), 14.3 (q, CO2CH2CH3), 13.9 (q, CH2CH2CH2CH3). 
IR (Film) ν̃ = 3456 cm-1 (s), 2928 (s), 2862 (s), 2359 (m), 1949 (m), 1728 (s, CO2Et), 1675 (m), 
1576 (m), 1466 (m), 1385 (s), 1164 (s), 1072 (s), 885 (w), 781 (s), 690 (s). 
MS (ESI, Orbitrap) m/z 1468.9 (2M+Na+), 1114.9 [2(M–ArCHO)+K+], 353.1 (M–
2 ArCHO+H+). 
HRMS (ESI, Orbitrap) calcd. for C62H62Br6NaO10+ (2M+Na+): 1468.92740; found: 
1468.92505. 
4.5  Experimental Procedures and Analytical Data for Section 3.1 
(2S)-1-[tert-butyl(diphenyl)silyl]oxy-3,3-dimethyl-2-butanamine (234).[140] 
Aminoalcohol 228 (3.05 g, 26 mmol) and imidazole (5.31 g, 78 mmol, 3.0 equiv.) were 
dissolved in MeCN (109 mL, HPLC-grade). After addition of TBDPSCl (13.5 mL, 14.3 g, 52 
mmol, 2.0 equiv.), the resulting solution was stirred at r.t. under Ar for 2 
h. The solvent was removed under reduced pressure and the crude product 
(gummy mass) was purified by flash column chromatography (Si, 5.0×20 
cm, CH2Cl2/MeOH = 97/3→95/5). The final product 234 (4.08 g, 11.5 
mmol, 44%) was obtained as a colorless oil. The corresponding 
hydrochloride salt was isolated as a slightly more polar fraction (ca. 1.86 g). This HCl salt was 
dissolved in CH2Cl2 (150 mL) and washed with saturated aq. NaHCO3 (3×150 mL) solution. 
Combined aqueous phases were washed with CH2Cl2 (50 mL). Combined organic phases were 
dried over MgSO4, the solvent was removed under reduced pressure to give additional portion 
of the product 234 (3.29 g, 9.2 mmol, 36%). The total yield of 234 was 80% (7.37 g, 20.7 
mmol). 
Rf = 0.5 (CH2Cl2/MeOH = 9/1, [UV, ninhydrin]). 
1H NMR (400 MHz, CDCl3) δ 7.70 – 7.66 (m, 4H, CHAr), 7.44 – 7.35 (m, 6H, CHAr), 3.79 (dd, 
J = 9.6, 3.2 Hz, 1H, CHHO), 3.45 (virt t, J = 9.6 Hz, 1H, CHHO), 2.63 (dd, J = 8.8, 2.8 Hz, 1H, 
CHNH2), 1.53 (br s, 2H, NH2), 1.06 [s, 9H, SiC(CH3)3], 0.82 [s, 9H, C(CH3)3]. 
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13C NMR (151 MHz, CDCl3) δ 135.74 (d, CArH), 135.72 (d, CArH), 133.8 (s, CAr), 133.7 (s, 
CAr), 129.83 (d, CArH), 129.80 (d, CArH), 127.85 (d, CArH), 127.83 (d, CArH), 66.0 (t, CH2O), 
61.8 (d, CHNH2), 33.0 [s, CHC(CH3)3], 27.0 [q, SiC(CH3)3], 26.7 [q, CHC(CH3)3], 19.4 [s, 
SiC(CH3)3].   
[α]D21°C = 18.4 (CH3Cl, c = 1). 
IR (ATR) ν̃ = 3069 cm-1 (w), 2952 (s), 2861 (s), 2329 (w), 2111 (w), 1588 (w), 1470 (s), 1427 
(m), 1391 (m), 1361 (m), 1189 (w), 1106 (s), 1171 (s), 999 (m), 938 (w), 820 (s), 735 (s), 700 
(s). 
MS (EI, 70 eV) m/z (%) 356.4 (30) [M+], 298.3 (100) [(M-t-Bu)+], 198.2 (77), 178.2 (12), 135.1 
(15), 86.2 (52), 57.3 (23). 
MS (ESI, Orbitrap) m/z 733.4 [2M+Na+], 711.5 [2M+H+], 378.2 [M+Na+], 356.2 [M+H+], 
278.2 [(M-Ph)+] 
HRMS (ESI, Orbitrap) calcd. for C22H34NOSi+ [M+H+]: 356.24042; found: 356.24023. 
This is a known compound. Spectroscopic data agree with those reported in the literature.[140] 
(6S,10S)-6,10-Di(tert-butyl)-2,2,14,14-tetramethyl-3,3,13,13-tetraphenyl-4,12-dioxa-7,9-
diaza-3,13-disilapentadecan-8-iminium 2,2,2-trifluoroacetate (235) 
To a flask containing protected aminoalcohol 234 (2.01 g, 5.65 mmol, 2.0 equiv.) and 
guanylating reagent 224[136] (456 mg, 2.83 mmol) 1 mL of CH2Cl2 was added and the resulting 
mixture was concentrated using a rotary evaporator under 
reduced pressure at r.t.. Upon removal of CH2Cl2, a suspension 
containing finely distributed guanylating reagent 224 was 
obtained. After the addition of TFA (217 µL, 323 mg, 2.83 
mmol), the resulting suspension was mixed in a Kugelrohr oven 
at 105 °C for 4 h. Upon heating the heterogeneous mixture became a very viscous brownish 
solution. The resulting crude product was purified by column chromatography (Si, 30×5 cm, 
CH2Cl2/MeOH/AcOH = 100/1/0.5→98/2/0.5) to give the symmetrically substituted 
guanidinium salt 235 (1.2 g) as an off-white foam. Isolated product contained approx. 10 to 20 
mol% of unknown impurities which were visible in the 1H NMR spectrum. Taking this into 
account, the estimated amount of the pure product was approx. 980 mg (1.13 mmol, 40%). 
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Rf = 0.31 (CH2Cl2/MeOH/AcOH = 100/8/0.5, [UV, bromocresol green]). 
1H NMR (600 MHz, CDCl3) δ 9.18 (br s, 2H, NH), 7.61 (d, J = 6.6 Hz, 4H, CHAr), 7.58 (d, J = 
6.6 Hz, 4H, CHAr), 7.46 – 7.34 (m, 12H, CHAr), 6.51 (br s, 2H, NH), 3.91 (dd, J = 10.2, , 0.6 
Hz, 2H, CHHO), 3.67 (virt t, J = 10.2 Hz, 2H, CHHO), 3.18 (virt t, J = 8.4 Hz, 2H, CHNH), 
1.03 [s, 18H, SiC(CH3)3], 0.98 [s, 18H, C(CH3)3]. 
13C NMR (151 MHz, CDCl3) δ 159.7 (s, C=N), 135.6 (d, CArH), 135.5 (d, CArH), 132.2 (s, CAr), 
131.9 (s, CAr), 130.54 (d, CArH), 130.49 (d, CArH), 128.4 (d, CArH), 128.3 (d, CArH), 66.8 (d, 
CHNH), 60.6 (t, CH2O), 34.0 [s, CHC(CH3)3], 27.2 [q, SiC(CH3)3], 27.1 [q, CHC(CH3)3], 19.2 
[s, SiC(CH3)3].   
19F NMR (564 MHz, CDCl3) δ –75.7 (s, CF3). 
[α]D21°C = –80.2 (CHCl3, c = 1). 
IR (ATR) ν̃ = 3317 cm-1 (w), 2956 (m), 2170 (w), 1897 (w), 1640 (s), 1471 (m), 1427 (m), 1367 
(w), 1309 (w), 1245 (w), 1197 (m), 1107 (s), 1000 (m), 938 (w), 819 (s), 738 (s), 700 (s). 
MS (EI, 70 eV) m/z (%) 736.9 (2) [(M-CF3COO-)+], 678.7 [(M-CF3COO--t-Bu)+] (45), 466.5 
(100), 340.3 (12), 224.1 (27), 135.1 (33).   
MS (ESI, Orbitrap) m/z 736.5 [(M-CF3COO-)+]. 
HRMS (ESI, Orbitrap) calcd. for C45H66N3O2Si2+ [(M-CF3COO-)+]: 736.46881; found: 
736.46930. 
Bis[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]aminomethaniminium fluoride (236) 
To a flask containing a solution of protected guanidine 235 (844 mg; due to impurities, 
estimated amount of the starting material ca. 950 µmol) in 19 mL MeCN (HPLC-grade), 
fluoride on polymer (1.2 g, 3.58 mmol, 4 equiv.; 3.0 mmol/g loading on 
Amberlyst® A-26 resin; obtained from Sigma-Aldrich, cat. No. 387789) 
was added and the resulting mixture was stirred under Ar atmosphere at 
r.t.. During this time, a white precipitate was formed. After 25 h, MeOH 
was added to the resulting suspension until the formed precipitate completely dissolved. 
Fluoride on polymer beads were filtered off, washed with additional 10 mL MeOH and the 
solvents were removed under reduced pressure. When the resulting crude product (oily mass) 
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was washed with an Et2O/pentane = 1/5 mixture (3×5 mL), the product 236 was obtained as a 
white solid (261 mg, 934 µmol, 98%: estimated value due to impurities in the starting material).  
Rf = 0.0 (CH2Cl2/MeOH = 9/1, [bromocresol green]). 
1H NMR (400 MHz, CD3OD) δ 3.91 (dd, J = 10.8, 2.8 Hz, 2H, CHHO), 3.51 (dd, J = 9.2, 10.8 
Hz, 2H, CHHO), 3.35 (dd, J = 8.8, 2.8 Hz, 2H, CHNH), 1.01 [s, 18H, C(CH3)3]. 
13C NMR (151 MHz, CD3OD) δ 160.4 (s, C=N), 65.1 (d, CHNH), 63.3 (t, CH2O), 35.0 [s, 
CHC(CH3)3], 27.2 [q, CHC(CH3)3]. 
19F NMR (376 MHz, CD3OD) δ –150.6 (s, F-). 
[α]D21°C = –97.3 (MeOH, c = 1). 
m.p. 161-164 °C. 
IR (ATR) ν̃ = 3386 cm-1 (s), 3230 (s), 2956 (s), 2869 (s), 2325 (w), 2103 (w), 1689 (s), 1630 
(s), 1523 (m), 1470 (s), 1362 (m), 1303 (m), 1251 (m), 1090 (m), 1056 (s), 1015 (m), 930 (m), 
857 (m), 738 (m), 673 (m). 
MS (EI, 70 eV) m/z (%) 260.4 (100) [(M-F-)+], 228.3 (34), 202.3 (25) [(M-F--t-Bu)+], 57.3 (12) 
[t-Bu+]. 
MS (ESI, Orbitrap) m/z 260.2 [(M-F-)+]. 
HRMS (ESI, Orbitrap) calcd. for C13H30N3O2+ [(M-F-)+]: 260.23325; found: 260.23312. 
Bis[(1S)-1-(chloromethyl)-2,2-dimethylpropyl]aminomethaniminium chloride (237) 
To a flask containing a suspension of guanidinium salt 236 (110 mg, 394 µmol) in 12 mL MeCN 
(HPLC-grade), thionyl chloride (343 µL, 563 mg, 4.7 mmol, 12 eq.) was added. Upon addition 
of SOCl2, all solids immediately dissolved and the resulting mixture was 
stirred under an Ar atmosphere at 65-70 °C for 24 h. It is highly 
recommended to monitor the reaction progress by TLC using KMnO4 
staining reagent (a very characteristic and intensive staining of the product), 
since starting material and product are not UV active and using bromocresol green gave a very 
weak staining. After addition of MeOH (15 mL) the resulting mixture was stirred for 1 h at r.t.. 
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The solvents were removed under reduced pressure to give the crude product as a yellow solid. 
The crude product was used without further purification. 
A small amount of the crude product (ca. 120 mg) was purified by column chromatography (Si, 
2.0×20 cm, CH2Cl2/MeOH = 98/2→95/5) to give the analytically pure sample for 
characterization (66 mg, 198 µmol) as a yellowish solid. 
Rf = 0.33 (CH2Cl2/MeOH = 9/1, [KMnO4, bromocresol green]) 
1H NMR (600 MHz, CD3OD) δ 3.95 (dd, J = 12.0, 3.0 Hz, 2H, CHHO), 3.79 – 3.69 (br m, 2H, 
CHHO), 3.64 – 3.55 (br m, 2H, CHNH), 1.03 [s, 18H, C(CH3)3]. 
13C NMR (151 MHz, CD3OD) δ 159.6 (s, C=N), 63.9 (d, CHNH), 46.3 (t, CH2O), 36.9 [s, 
CHC(CH3)3], 26.7 [q, CHC(CH3)3]. 
[α]D21°C = 0.5 (MeOH, c = 1). 
m.p.: decomposes above 220 °C 
IR (ATR) ν̃ = 3156 cm-1 (s), 2963 (s), 2411 (m), 2326 (m), 1661 (s), 1620 (s), 1473 (s), 1439 
(m), 1368 (m), 1270 (m), 1213 (m), 1095 (m), 1053 (m), 1016 (m), 915 (m), 852 (w), 791 (w), 
734 (s). 
MS (EI, 70 eV) m/z (%) 297.4 (2) [(M-Cl-)+], 236.1 (100), 200.6 (50). 
MS (ESI, Orbitrap) m/z 296.2 [(M-Cl-)+]. 
HRMS (ESI, Orbitrap) calcd. for C13H28Cl2N3+ [(M-Cl-)+]: 296.16548; found: 296.16486. 
(2S,5S)-2,5-Di(tert-butyl)-1H,2H,3H,5H,6H,7H-imidazo[1,2-a]imidazol-4-ium chloride 
(239) 
To a flask containing a suspension of crude guanidinium salt 237 (769 µmol considering 
quantitative yield of the previous reaction) in 13 mL MeCN (HPLC-grade), DBU (460 µL, 469 
mg, 3.1 mmol, 4 eq.) was added. After addition of DBU, all solids slowly 
dissolved and the resulting brown solution was stirred under an Ar 
atmosphere at r.t. for 28 h. The reaction mixture was acidified with HCl 
solution (1M in MeOH) and the solvents were removed under reduced 
pressure. Resulting crude product (brown sticky mass) was purified by 
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column chromatography (Si, 23×3 cm, EtOAc/MeOH = 20/1→7/1→7/3) to give the final 
product as a yellowish solid (97 mg, 373 µmol, 48%).  
Rf = 0.41 (EtOAc/MeOH = 8/2, [bromocresol green]) 
1H NMR (600 MHz, CD3OD) δ 4.13 (dd, J = 9.6, 3.6 Hz, 1H, CHNH), 3.96 (virt t, J = 9.6 Hz, 
1H, CHHN), 3.79 (virt t, J = 9.6 Hz, 1H, CHHN), 3.64 (virt t, J = 9.6 Hz, 1H, CHHN), 3.62 
(dd, J = 9.6, 3.6 Hz, 1H, CHNH), 3.56 (virt t, J = 9.6, Hz, 1H, CHHN), 0.99 [s, 9H, C(CH3)3], 
0.96 [s, 9H, C(CH3)3]. 
13C NMR (101 MHz, CD3OD) δ 167.4 (s, C=N), 73.0 (d, CHNH), 69.8 (d, CHNH), 51.8 (t, 
CH2O), 49.8 (t, CH2O), 35.3 [s, CHC(CH3)3], 34.0 [s, CHC(CH3)3], 26.4 [q, CHC(CH3)3], 25.5 
[q, CHC(CH3)3]. 
1H NMR (400 MHz, CDCl3) δ 9.14 (br s, 1H, NH), 8.85 (br s, 1H, NH), 4.06 (dd, J = 10.0, 3.6 
Hz, 1H, CHNH), 3.93 (virt t, J = 10.0 Hz, 1H, CHHN), 3.72 (virt t, J = 10.0 Hz, 1H, CHHN), 
3.44 (virt t, J = 9.6 Hz, 1H, CHHN), 3.43 (dd, J = 9.6, 3.6 Hz, 1H, CHNH), 3.38 (virt t, J = 9.6, 
Hz, 1H, CHHN), 0.92 [s, 9H, C(CH3)3], 0.91 [s, 9H, C(CH3)3]. 
13C NMR (101 MHz, CDCl3) δ 166.2 (s, C=N), 71.7 (d, CHNH), 69.1 (d, CHNH), 50.9 (t, 
CH2O), 49.0 (t, CH2O), 34.5 [s, CHC(CH3)3], 33.3 [s, CHC(CH3)3], 26.2 [q, CHC(CH3)3], 25.3 
[q, CHC(CH3)3]. 
[α]D21°C = –18.5 (MeOH, c = 0.1). 
m.p.: decomposes above 200 °C. 
IR (ATR) ν̃ = 2957 cm-1 (s), 1699 (s), 1559 (s), 1471 (s), 1399 (m), 1366 (m), 1272 (s), 1136 
(m), 1067 (m), 1024 (m), 934 (w), 843 (m), 714 (m). 
MS (EI, 70 eV) m/z (%) 224.3 (4) [(M-Cl-)+], 166.2 (100) [(M-HCl-t-Bu)+], 96.1 (39), 57.2 
(28). 
MS (ESI, Orbitrap) m/z 224.2 [(M-Cl-)+]. 
HRMS (ESI, Orbitrap) calcd. for C13H26N3+ [(M-Cl-)+]: 224.21212; found: 224.21201. 
A mono-cyclized guanidinium salt 240 (89 mg, 301 µmol, 39%) was isolated as a minor 
reaction product (yellow oil). Due to the fact that the structure could not be unambiguously 
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determined by using NMR methods, two possible structures can be assigned to the compound 
240. In view of the proposed reaction mechanism (Scheme 104), the formation of the alternative 
monocyclized product 240‘ seems to be unlikely. 
1H NMR (400 MHz, CD3OD) δ 3.97 (d, J = 11.6 Hz, 1H, CHHO), 3.88 – 3.81 (br m, 1H), 3.77 
– 3.67 (br m, 1H), 3.62 – 3.44 (br m, 1H), 1.01 [s, 9H, C(CH3)3], 0.95 [s, 9H, C(CH3)3]. 
13C NMR (101 MHz, CD3OD) δ 161.2 (s, C=N), 66.2 (d, CHNH), 65.8 
(d, CHNH), 46.0 (t, CH2O), 45.4 (t, CH2O), 36.6 [s, CHC(CH3)3], 35.2 
[s, CHC(CH3)3], 26.7 [q, CHC(CH3)3], 25.4 [q, CHC(CH3)3]. 
[α]D21°C = –24.3 (CHCl3, c = 0.5). 
m.p.: decomposes above 200 °C 
IR (ATR) ν̃ = 3427 cm-1 (w), 3105 (m), 2960 (s), 2209 (w), 1696 (s), 
1560 (s), 1471 (m), 1365 (m), 1273 (s), 1212 (s), 1140 (m), 1022 (m), 
923 (s), 846 (m), 725 (s), 680 (w). 
MS (EI, 70 eV) m/z (%) 260.3 (9) [(M-Cl-)+], 202.2 (48), 166.2 (7), 57.3 (100). 
MS (ESI, Orbitrap) m/z 260.2 [(M-Cl-)+]. 
HRMS (ESI, Orbitrap) calcd. for C13H27ClN3+ [(M-Cl-)+]: 260.18880; found: 260.18878. 
4.6  Experimental Procedures and Analytical Data for Section 3.2 
(3S)-3-(Acetylamino)-4-hydroxy-4,4-diphenylbutyl acetate (247)[140][143] 
Acetic anhydride (15.3 g, 14.2 mL, 149.9 mmol, 4.3 equiv.) was slowly added to a suspension 
containing the diol 246[143] (8.88 g, 34.5 mmol) and pyridine (69.7 g, 71 mL, 881.4 mmol, 25.5 
equiv.) and the resulting solution was stirred at r.t. for 23 h. The reaction 
mixture was poured into a separatory funnel containing aqueous HCl (560 
mL, 2 M), and the resulting emulsion was extracted with CH2Cl2 (3×450 
mL). Combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The resulting crude product was re-suspended in hexane (132 mL) and 
heated to reflux. EtOAc (ca. 70 mL) was added in small portions until the solid material 
dissolved. After the solution was slowly cooled to r.t., it was stored at +7 °C for 8 d and at –20 
°C for 2 d. The formed precipitate was collected by filtration and washed with 20 mL hexane. 
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After drying under reduced pressure the final product (9.84 g, 28.8 mmol, 83%) was obtained 
as a white solid. 
1H NMR (400 MHz, CDCl3) δ 7.47 – 7.44 (m, 4H, CHAr), 7.32 – 7.14 (m, 6H, CHAr), 6.00 (br 
d, J = 8.0 Hz, 1H, NHAc), 5.00 – 4.94 (m, 1H, CHNHAc), 4.09 (virt t, J = 6.4 Hz, 2H, CH2OAc), 
2.02 (s, 3H, OCOCH3), 1.85 – 1.79 (m, 2 H, CH2CHNH), 1.76 (s, 3H, NHCOCH3). 
13C NMR (101 MHz, CDCl3) δ 171.3 (s, COCH3), 170.9 (s, COCH3), 145.3 (s, CAr), 144.8 (s, 
CAr), 128.7 (d, CArH), 128.5 (d, CArH), 127.3 (d, CArH), 127.2 (d, CArH), 125.7 (d, CArH), 125.6 
(d, CArH), 81.0 (s, COH), 61.9 (t, CH2OAc), 53.5 (d, CHN), 29.5 (t, CH2CH2OAc), 23.3 (q, 
NHCOCH3), 21.2 (q, OCOCH3). 
This is a known compound. Spectroscopic data agree with those reported in the literature.[143] 
(3S)-3-(Acetylamino)-4,4-diphenylbutyl acetate (248)[140][143] 
To a solution containing (3S)-3-(acetylamino)-4-hydroxy-4,4-diphenylbutyl acetate (247) (9.84 
g, 28.8 mmol) in glacial acetic acid (99 mL) palladium on charcoal (10%, 1.33 g) and 
ammonium formate (9.18 g, 146 mmol, 5.0 equiv.) were added. The resulting mixture was 
stirred at 110 °C for 32 h. It is highly recommended to monitor the reaction 
progress by NMR spectroscopy, since complete conversion of the starting 
material could not be sufficiently detected using TLC. The reaction 
mixture was cooled to r.t. and filtered through a plug of Celite which was 
additionally washed with a portion of CH2Cl2 (150 mL). The solution was washed with 
saturated aqueous Na2CO3 (3×600 mL), brine (1×100 mL) and dried over MgSO4. After 
evaporation of the solvents under reduced pressure the product 248 (8.0 g, 24.6 mmol, 85%) 
was obtained as a yellow solid and used for subsequent reactions without additional 
purification. 
Rf = 0.40 (Pentante/EtOAc = 1/1, [UV, mostain]) 
1H NMR (600 MHz, CDCl3) δ 7.26 – 7.22 (m, 8H, CHAr), 7.19 – 7.12 (m, 2H, CHAr), 5.26 (br 
d, J = 9.0 Hz, 1H, NHAc), 4.89 (virt qd, J = 9.0, 3.0 Hz, 1H, CHNHAc), 4.11 – 4.02 (m, 2H, 
CH2OAc), 3.95 (d, J = 10.2 Hz, 1H, CHPh2), 1.99 (s, 3H, OCOCH3) 1.92 – 1.86 (m, 1 H, 
CHHCHNH), 1.74 (s, 3H, NHCOCH3), 1.63 – 1.56 (m, 1 H, CHHCHNH). 
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13C NMR (151 MHz, CDCl3) δ 171.2 (s, COCH3), 170.0 (s, COCH3), 142.0 (s, CAr), 141.8 (s, 
CAr), 129.0 (d, CArH), 128.8 (d, CArH), 128.32 (d, CArH), 128.28 (d, CArH), 127.1 (d, CArH), 
126.9 (d, CArH), 61.7 (t, CH2OAc), 56.9 (d, CHPh2), 49.2 (CHNHAc), 32.9 (t, CH2CH2OAc), 
23.4 (q, NHCOCH3), 21.2 (q, OCOCH3). 
This is a known compound. Spectroscopic data agree with those reported in the literature.[143] 
(3S)-3-amino-4,4-diphenyl-1-butanol (242)[140][143] 
A suspension of (3S)-3-(acetylamino)-4,4-diphenylbutyl acetate (248) (2.65 g, 8.14 mmol) in 
aqueous HCl (33 mL, 1.4 M) was stirred at 100 °C for 7 h. The resulting solution was then 
cooled to r.t. and basified with solid NaOH until pH 14 was reached. Upon 
addition of NaOH, an oily precipitate was formed. The resulting emulsion was 
extracted with CH2Cl2 (3×200 mL) and the combined organic layers were dried 
over MgSO4. The solvent was removed under reduced pressure and the product 242 (1.81 g, 
7.5 mmol, 92%) was obtained as brownish oil which solidified upon standing at r.t.. 
Rf = 0.28 (CH2Cl2/MeOH = 9/1, [UV, ninhydrin]) 
1H NMR (600 MHz, CDCl3) δ 7.36 – 7.30 (m, 4H, CHAr), 7.28 – 7.25 (m, 4H, CHAr), 7.22 – 
7.15 (m, 2H, CHAr), 3.82 – 3.69 (m, 4 H, CHPh2, CHNH2, CH2O), 2.55 (s br, 3 H, OH, NH2), 
1.71 – 1.67 (m, 1 H, CHHCHNH2), 1.49 – 1.43 (m, 1 H, CHHCHNH2). 
13C NMR (101 MHz, CDCl3) δ 142.7 (s, CAr), 142.0 (s, CAr), 129.3 (d, CArH), 129.0 (d, CArH), 
128.4 (d, CArH), 128.1 (d, CArH), 127.2 (d, CArH), 126.9 (d, CArH), 62.7 (t, CH2OH), 60.9 (d, 
CHPh2), 56.0 (CHNH2), 35.4 (t, CH2CH2OH). 
[α]D21°C = 15.5 (CH2Cl2, c = 1) 
This is a known compound. Spectroscopic data agree with those reported in the literature.[143] 
(2S)-4-[tert-butyl(diphenyl)silyl]oxy-1,1-diphenyl-2-butanamine (245)[140] 
Aminoalcohol 242 (4.42 g, 16.4 mmol) and imidazole (3.74 g, 54.9 mmol, 3.3 equiv.) were 
dissolved in MeCN (93 mL, HPLC-garde). After addition of TBDPSCl (9.6 mL, 10.1 g, 37 
mmol, 2.2 equiv.), the resulting solution was stirred at r.t. under Ar for 
2.5 h. The solvent was removed under reduced pressure and the crude 
product (gummy mass) was purified by flash column chromatography 
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(Si, 7.0×24 cm, CH2Cl2/MeOH = 99/1→98/2→97/3→95/5). The product 245 (7.41 g, 15.4 
mmol, 94%) was obtained as brownish viscous oil. 
Rf = 0.42 (CH2Cl2/MeOH = 9/1, [UV, ninhydrin]). 
1H NMR (600 MHz, CDCl3) δ 7.68 (dd, J = 8.4, 1.2 Hz, 2H, CHAr), 7.64 (dd, J = 8.4, 1.2 Hz, 
2H, CHAr), 7.45 – 7.41 (m, 2H, CHAr), 7.40 – 7.35 (m, 6H, CHAr), 7.33 – 7.24 (m, 6H, CHAr), 
7.21 – 7.16 (m, 2H, CHAr), 3.89 – 3.83 (m, 2 H, CHHO and CHNH2), 3.78 – 3.75 (m, 1H, 
CHHO), 3.72 (d, J = 10.2 Hz, 1H, CHPh2), 1.83 – 31.78 (m, 1H, CHHCHNH2), 1.55 (br s, 2H, 
NH2), 1.44 – 1.37 (m, 1H, CHHCHNH2), 1.08 [s, 9H, C(CH3)3]. 
13C NMR (151 MHz, CDCl3) δ 143.3 (s, CAr), 143.1 (s, CAr), 135.78 (d, CArH), 135.76 (d, 
CArH), 133.9 (s, CAr), 133.8 (s, CAr), 129.84 (d, CArH), 129.80 (d, CArH), 128.9 (d, CArH), 128.8 
(d, CArH), 128.5 (d, CArH), 128.4 (d, CArH), 127.9 (d, CArH), 127.8 (d, CArH), 126.7 (d, CArH), 
126.5 (d, CArH), 62.3 (t, CH2O), 60.3 (d, CHPh2), 52.1 (d, CHNH2), 37.8 (t, CH2CH2O), 27.1 
[q, C(CH3)3], 19.4 [s, C(CH3)3]. 
IR (ATR) ν̃ = 3386 cm-1 (w), 3065 (w), 2931 (m), 1593 (w), 1491 (w), 1427 (w), 1256 (w), 
1104 (s), 936 (w), 722 (s), 740 (s). 
MS (EI, 70 eV) m/z (%) 480.6 (11) [M+], 422.4 (76) [(M-t-Bu)+], 312.4 (82) [(M-CHPh2)+], 
234.3 (100), 198.2 (54), 167.2 (43) [CHPh2+], 135.2 (40). 
MS (ESI, Orbitrap) m/z 502.2 (M+Na+), 480.3 (M+H+). 
HRMS (ESI, Orbitrap) calcd. for C32H38NOSi+ (M+H+): 480.27171; found: 480.27063. 
[α]D21°C = 3.9 (CHCl3, c = 1). 
This is a known compound. Spectroscopic data agree with those reported in the literature.[140] 
(7S,11S)-7,11-dibenzhydryl-2,2,16,16-tetramethyl-3,3,15,15-tetraphenyl-4,14-dioxa-8,10-
diaza-3,15-disilaheptadecan-9-iminium 2,2,2-trifluoroacetate (249) 
To a flask containing TBDPS-protected aminoalcohol 245 (1.8 g, 3.75 mmol, 2.0 equiv.) and 
guanylating reagent 224 (303 mg, 1.88 mmol) 1 mL of CH2Cl2 was added and the resulting 
mixture was concentrated on a rotary evaporator under reduced pressure at r.t.. Upon removal 
of CH2Cl2, a suspension containing finely distributed guanylating reagent 224 was obtained. 
After the addition of TFA (144 µL, 214 mg, 1.88 mmol), the resulting suspension was mixed 
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in a Kugelrohr oven at 105 °C for 4 h. Upon heating, the 
heterogeneous mixture became a very viscous brownish 
solution. The resulting crude product was purified by column 
chromatography (Si, 30×5 cm, CH2Cl2/MeOH/AcOH = 
100/2/0.5→97/3/0.5) to give the symmetrically substituted 
guanidinium salt 249 (758 mg, 690 µmol, 38%) as a brownish 
oil. 
Rf = 0.56 (CH2Cl2/MeOH/AcOH = 100/8/0.5, [UV, bromocresol green]). 
1H NMR (600 MHz, CDCl3) δ 9.39 (br s, 2H, NH), 7.62 (d, J = 6.6 Hz, 4H, CHAr), 7.47 (t, J = 
7.2 Hz, 8H, CHAr), 7.41 – 7.38 (m, 2H, CHAr), 7.36 (d, J = 7.8 Hz, 4H, CHAr), 7.33 – 7.28 (m, 
10H, CHAr), 7.27 – 7.25 (m, 8H, CHAr), 7.19 (t, J = 7.2 Hz, 4H, CHAr), 7.04 (t, J = 7.2 Hz, 2H, 
CHAr), 6.25 (br s, 2H, NH), 4.47 (virt q, J = 10.8 Hz, 2H, CHNH), 4.05 (d, J = 11.4 Hz, 2H, 
CHPh2), 3.52 (dd, J = 4.2, 10.8 Hz, 2H, CHHO), 3.34 (virt t, J = 11.4 Hz, 2H, CHHO), 1.67 – 
1.62 (m, 2H, CHHCH2O), 1.18 – 1.12 (m, 2H, CHHCH2O), 1.03 [s, 9H, C(CH3)3]. 
13C NMR (151 MHz, CDCl3) δ 158.1 (s, C=N), 142.2 (s, CAr), 141.6 (s, CAr), 135.5 (d, CArH), 
135.4 (d, CArH), 133.0 (s, CAr), 132.1 (s, CAr), 130.47 (d, CArH), 130.46 (d, CArH), 129.1 (d, 
CArH), 128.8 (d, CArH), 128.2 (d, CArH), 128.1 (d, CArH), 127.9 (d, CArH), 127.1 (d, CArH), 
126.9 (d, CArH), 60.3 (t, CH2O), 56.8 (d, CHPh2), 53.7 (d, CHN), 35.1 (t, CH2CH2O), 27.3 [q, 
C(CH3)3], 19.4 [s, C(CH3)3]. 
19F NMR (282 MHz, CDCl3) δ –75.6 (s, CF3). 
[α]D21°C = 2.5 (CHCl3, c = 1). 
IR (ATR) ν̃ = 3335 cm-1 (w), 3187 (w), 3065 (w), 2935 (w), 2860 (w), 1805 (w), 1685 (s), 1428 
(m), 1379 (w), 1305 (w), 1250 (w), 1194 (s), 1107 (s), 936 (m), 823 (m), 747 (s), 698 (s). 
MS (EI, 70 eV) m/z (%) 984.1 (1) [(M-CF3COO-)+], 816.9 (29) [(M-CF3COO--CHPh2)+], 465.4 
(35), 422.4 (80), 405.3 (100), 312.3 (71), 234.3 (49), 224.2 (37), 199.2 (43), 167.2 (37) 
[CHPh2+]. 
MS (ESI, Orbitrap) m/z 984.5 [(M-CF3COO-)+]. 
HRMS (ESI, Orbitrap) calcd. for C65H74N3O2Si2+ [(M-CF3COO-)+]: 984.53141; found: 
984.52673. 
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Bis[(1S)-1-benzhydryl-3-hydroxypropyl]aminomethaniminium fluoride and 
trifluoroacetate (244) 
To a flask containing a solution of protected guanidinium salt 249 
(1.33 g, 1.21 mmol) in 80 mL MeCN (HPLC-grade), fluoride on 
polymer (2.0 g, 6.0 mmol, 5.0 equiv.; 3.0 mmol/g loading on 
Amberlyst® A-26 resin; obtained from Sigma-Aldrich, cat. No. 
387789) was added and the resulting mixture was stirred under Ar 
at r.t.. During this time, a white precipitate was formed. After 43 h, 
MeOH was added to the resulting suspension until the formed precipitate completely dissolved. 
Fluoride on polymer beads were filtered off, washed with additional 10 mL MeOH and the 
solvents were removed under reduced pressure. When the resulting crude product (oily mass) 
was washed with an Et2O/pentane = 1/1 mixture (20 mL), a precipitate was formed. It was 
washed with pentane (10 mL), dried under reduced pressure and the product 244 (640 mg) was 
obtained as an off-white solid.  
According to 19F-NMR, the final product was obtained as a mixture of guanidinium fluoride 
and trifluoroacetate salts. Considering the fact that the major anion is fluoride (Mw = 527.67), 
the final yield was estimated to be ca. 1.2 mmol, 99%.  
Rf = 0.0 (CH2Cl2/MeOH = 9/1, [UV, bromocresol green]). 
1H NMR (600 MHz, CD3OD) 7.43 – 7.38 (m, 8H, CHAr), 7.30 (t, J = 7.8 Hz, 4H, CHAr), 7.25 
(t, J = 7.8 Hz, 4H, CHAr), 7.20 – 7.15 (m, 4H, CHAr), 6.86 (br d, J = 8.4 Hz, 2H, NH), 4.51 – 
4.37 (br m, 2H, CHNH), 3.90 (br d, J = 9.6 Hz, 2H, CHPh2), 3.21 – 3.10 (br m, 2H, CHHOH), 
3.08 – 2.97 (br m, 2H, CHHOH), 1.91 – 1.81 (br m, 2H, CHHCH2OH), 1.75 – 1.62 (br m, 2H, 
CHHCH2OH). 
13C NMR (151 MHz, CD3OD) δ 157.0 (s, C=N), 143.1 (s, CAr), 142.5 (s, CAr), 130.47 (d, CArH), 
130.1 (d, CArH), 129.6 (d, CArH), 129.2 (d, CArH), 128.2 (d, CArH), 128.1 (d, CArH), 59.6 (d, 
CHN), 54.6 (d, CHPh2), 41.8 (t, CH2OH), 37.9 (t, CH2CH2OH). One CArH-signal was not 
included due to overlaps resulting from low resolution. 
19F NMR (282 MHz, CD3OD) δ –76.9 (s, CF3, minor signal), –150.5 (s, F-, major signal). 
[α]D24°C = –4.7 (MeOH, c = 1). 
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m.p. 115-118 °C 
IR (ATR) ν̃ = 3309 cm-1 (w), 3176 (w), 3060 (w), 3029 (w), 2929 (w), 1780 (w), 1646 (s), 1551 
(w), 1493 (m), 1330 (w), 1251 (w), 1184 (w), 1106 (m), 1044 (m), 912 (w), 822 (m), 747 (s), 
698 (s). 
MS (EI, 70 eV) m/z (%) 508.1 (1) [(M-F-)+], 340.5 (6) [(M-CF3COO--CHPh2)+], 167.2 (100) 
[CHPh2+], 152.2 (32), 99.2 (8). 
MS (ESI, Orbitrap) m/z 508.3 [(M-F-)+]. 
HRMS (ESI, Orbitrap) calcd. for C33H38N3O2+ [(M-F-)+]: 508.29585; found: 508.29373. 
Bis[(1S)-1-benzhydryl-3-chloropropyl]aminomethaniminium chloride (250) 
To a flask containing a suspension of guanidinium salt 244 (914 mg, 1.7 mmol) in 106 mL 
MeCN (HPLC-grade), thionyl chloride (1.3 mL, 2.1 g, 17.6 mmol, 12 equiv.) was added. Upon 
addition of SOCl2, all solids immediately dissolved and the resulting mixture was stirred under 
Ar at r.t. for 24 h. After addition of MeOH (20 mL) the resulting 
mixture was stirred for 1 h at r.t.. The solvents were removed 
under reduced pressure to give the crude product 250 (1.41 g) 
as a yellowish solid. The crude product was used without 
further purification.  
A small amount of the crude product (ca. 100 mg) was purified by column chromatography (Si, 
2.0×20 cm, CH2Cl2/MeOH = 99/1→97/3) to give an analytically pure sample for 
characterization (50 mg, 86 µmol) as an off-white solid. 
Rf = 0.71 (CH2Cl2/MeOH = 9/1, [bromocresol green]). 
1H NMR (300 MHz, CD3OD) 7.41 – 7.18 (m, 20H, CHAr), 4.45 (virt t, J = 9.6 Hz, 2H, CHNH), 
3.87 (br d, J = 10.8 Hz, 2H, CHPh2), 3.24 – 3.12 (br m, 2H, CHHCl), 3.09 – 2.94 (br m, 2H, 
CHHCl), 1.95 – 1.80 (br m, 2H, CHHCH2Cl), 1.74 – 1.57 (br m, 2H, CHHCH2Cl). 
13C NMR (151 MHz, CD3OD) δ 157.0 (s, C=N), 143.2 (s, CAr), 142.5 (s, CAr), 130.2 (d, CArH), 
129.7 (d, CArH), 129.6 (d, CArH), 129.2 (d, CArH), 128.3 (d, CArH), 128.2 (d, CArH), 59.7 (d, 
CHN), 54.5 (d, CHPh2), 41.8 (t, CH2OH), 37.9 (t, CH2CH2OH). 
[α]D21°C = 61.6 (MeOH, c = 1). 
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m.p. 133-136 °C 
IR (ATR) ν̃ = 3633 cm-1 (w), 3031 (m), 2317 (m), 2087 (w), 1961 (w), 1716 (w), 1582 (s), 1493 
(m), 1449 (m), 1361 (m), 1251 (w), 1169 (w), 1083 (m), 1039 (m), 918 (w), 814 (w), 749 (s), 
699 (s). 
MS (EI, 70 eV) m/z (%) 471.6 (4), 304.4 (100), 137.3 (7). 
MS (ESI, Orbitrap) m/z 544.2 [(M-Cl-)+]. 
HRMS (ESI, Orbitrap) calcd. for C33H36Cl2N3+ [(M-Cl-)+]: 544.22808; found: 544.22595. 
(2S,8S)-2,8-dibenzhydryl-1H,2H,3H,4H,6H,7H,8H,9H-pyrimido[1,2-a]pyrimidin-5-ium 
chloride (223•HCl) 
To a flask containing a suspension of crude guanidinium salt 250 (1.6 mmol assuming 
quantitative yield of the previous reaction) in dry MeCN (30 mL), DBU (955 µL, 974 mg, 6.4 
mmol, 4.0 equiv.) was added. The resulting brown suspension was stirred under Ar at r.t. for 4 
h. After addition of one more portion of DBU (470 µL, 479 mg, 3.2 
mmol, 2.0 equiv.), the mixture was stirred at r.t. for another 16 h. 
The reaction mixture was acidified with HCl (1M in MeOH) and 
the solvents were removed under reduced pressure. The resulting 
crude product (brown sticky mass) was purified by column chromatography (Si, 26×3.5 cm, 
CH2Cl2/MeOH = 97/3→92/8). Due to the very similar polarities of the formed regioisomers 
223•HCl and 251, one more chromatographic purification was necessary (Si, 20×2.0 cm, 
toluene/CH2Cl2/MeOH = 1/98/1→1/97/2→1/96/3→1/95/4→CH2Cl2/MeOH = 96/4). The 
desired regioisomer 223•HCl (69 mg, 301 µmol, 4.6%) was obtained as yellowish foam.  
Rf = 0.46 (CH2Cl2/MeOH = 9/1, [bromocresol green]). 
1H NMR (600 MHz, CD3OD) 7.41 (d, J = 7.2 Hz, 4H, CHAr), 7.32 – 7.27 (m, 12H, CHAr), 7.22 
– 7.17 (m, 4H, CHAr), 4.33 (ddd, J = 9.0, 10.8, 3.6 Hz, 2H, CHNH), 3.87 (br d, J = 10.8 Hz, 
2H, CHPh2), 3.42 – 3.35 (m, 4H, CH2N), 1.83 – 1.79 (m, 2H, CHHCH2N), 1.74 – 1.67 (m, 2H, 
CHHCH2N). 
13C NMR (151 MHz, CD3OD) δ 152.3 (s, C=N), 142.6 (s, CAr), 141.8 (s, CAr), 130.3 (d, CArH), 
130.1 (d, CArH), 129.4 (d, CArH), 129.1 (d, CArH), 128.6 (d, CArH), 128.3 (d, CArH), 58.4 (d, 
CHN), 52.7 (d, CHPh2), 46.9 (t, CH2N), 26.7 (t, CH2CH2N). 
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[α]D21°C = –23.0 (MeOH, c = 1). 
IR (ATR) ν̃ = 3645 cm-1 (w), 3263 (w), 3138 (w), 2938 (w), 2873 (w), 2081 (w), 1620 (s), 1526 
(w), 1493 (m), 1448 (m), 1360 (m), 1314 (s), 1106 (m), 1029 (w), 919 (s), 898 (s).  
MS (EI, 70 eV) m/z (%) 472.6 (1) [(M-Cl-)+], 304.4 (100), 137.2 (7). 
MS (ESI, Orbitrap) m/z 472.3 [(M-Cl-)+]. 
HRMS (ESI, Orbitrap) calcd. for C33H34N3+ [(M-Cl-)+]: 472.27472; found: 472.27390. 
(2S,6S)-2,6-dibenzhydryl-1H,2H,3H,4H,6H,7H,8H,9H-pyrimido[1,2-a]pyrimidin-5-ium 
chloride (251) 
The undesired regioisomer 251 (250 mg, 492 µmol, 31%) was the 
main reaction product and obtained as a slightly less polar fraction. 
Furthermore, a mixture containing both regioisomers isomers 
(223•HCl/251 = 1/3) was obtained in total yield of 24%. The total 
yield of the desired guanidinium salt 223•HCl is therefore ca. 11%. 
Rf = 0.46 (CH2Cl2/MeOH = 9/1, [bromocresol green]). 
1H NMR (400 MHz, CD3OD) 7.59 (d, J = 7.2 Hz, 2H, CHAr), 7.52 (d, J = 7.2 Hz, 2H, CHAr), 
7.49 – 7.35 (m, 9H, CHAr), 7.29 – 7.22 (m, 4H, CHAr), 7.18 – 7.14 (m, 1H, CHAr), 7.06 (d, J = 
7.2 Hz, 2H, CHAr), 4.50 (d, J = 11.6 Hz, 1H, NCHCHPh2), 4.30 – 4.25 (m, 1H), 4.22 (d, J = 
11.6 Hz, 1H, NCHCHPh2), 3.52 (d, J = 11.2 Hz, 1H, NHCHCHPh2), 3.44 – 3.36 (m, 1H), 3.27 
– 3.16 (m, 2H), 2.54 – 2.47 (m, 1H), 2.03 – 1.93 (m, 1H), 1.87 (dd, J = 14.0, 5.6 Hz, 1H), 1.61 
– 1.53 (m, 1H), 1.18 – 1.11 (m, 1H). 
13C NMR (101 MHz, CD3OD) δ 151.8 (s, C=N), 143.5 (s, CAr), 142.4 (s, CAr), 142.3 (s, CAr), 
142.2 (s, CAr), 130.5 (d, CArH), 130.3 (d, CArH), 130.2 (d, CArH), 130.0 (d, CArH), 129.4 (d, 
CArH), 129.2 (d, CArH), 128.9 (d, CArH), 128.5 (d, CArH), 128.4 (d, CArH), 128.3 (d, CArH), 62.0 
(d, CHN), 57.1 (d, CHN), 55.4 (d, CHPh2), 52.5 (d, CHPh2), 47.5 (t, CH2N), 36.1 (t, CH2N), 
25.3 (t, CH2CH2N), 24.0 (t, CH2CH2N). 
[α]D21°C = 111.2 (MeOH, c = 1). 
IR (ATR) ν̃ = 3636 cm-1 (w), 3278 (w), 3028 (w), 2945 (w), 2884 (w), 2059 (w), 1630 (s), 1527 
(w), 1493 (m), 1449 (m), 1363 (m), 1316 (s), 1205 (w), 1101 (m), 1027 (m), 749 (s), 699 (s).  
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MS (EI, 70 eV) m/z (%) 472.6 (5) [(M-Cl-)+], 304.4 (100), 137.1 (19). 
MS (ESI, Orbitrap) m/z 472.3 [(M-CF3COO-)+]. 
HRMS (ESI, Orbitrap) calcd. for C33H34N3+ [(M-CF3COO-)+]: 472.27472; found: 472.27481. 
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6. List of Abbreviations 
DABCO 1,4-Diazabicyclo[2.2.2]octane 
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene 
DFT Density functional theory 
DMAP 4-Dimethylaminopyridine 
DMF N,N-Dimethylformamide 
DMSO Dimethyl sulfoxide 
d.r. Diastereomeric ratio 
ee Enantiomeric excess 
e.r. Enantiomeric ratio 
MBH Morita–Baylis–Hillman (reaction) 
MTBD 7-Methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene 
LA Lewis acid 
LUMO Lowest Unoccupied Molecular Orbital 
NOE Nuclear Overhauser Effect 
NOESY Nuclear Overhauser enhancement spectroscopy 
PG Protecting group 
RDS Rate determining step 
TBAF Tetra-n-butylammonium fluoride 
TBD 1,5,7-Triazabicyclo[4.4.0]dec-5-ene 
TBDPS tert-butyldiphenylsilyl 
TBO 1,4,6-Triazabicyclo[3.3.0]oct-4-ene 
tert Tertiary 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin-layer chromatography 
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